<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><title>KeiserLab Journal Blitz</title><link>keiserlab.org</link><description>Read your journals, peeps.</description><language>en-us</language><channel><item><engagement>453</engagement><crawled>1548270343644</crawled><fingerprint>f517a3e3</fingerprint><published>1548269442000</published><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/476/eaat9321?rss=1</link><content><content>&lt;p&gt;Retinoblastoma is a pediatric solid tumor of the retina activated upon homozygous inactivation of the tumor suppressor &lt;i&gt;RB1&lt;/i&gt;. VCN-01 is an oncolytic adenovirus designed to replicate selectively in tumor cells with high abundance of free E2F-1, a consequence of a dysfunctional RB1 pathway. Thus, we reasoned that VCN-01 could provide targeted therapeutic activity against even chemoresistant retinoblastoma. In vitro, VCN-01 effectively killed patient-derived retinoblastoma models. In mice, intravitreous administration of VCN-01 in retinoblastoma xenografts induced tumor necrosis, improved ocular survival compared with standard-of-care chemotherapy, and prevented micrometastatic dissemination into the brain. In juvenile immunocompetent rabbits, VCN-01 did not replicate in retinas, induced minor local side effects, and only leaked slightly and for a short time into the blood. Initial phase 1 data in patients showed the feasibility of the administration of intravitreous VCN-01 and resulted in antitumor activity in retinoblastoma vitreous seeds and evidence of viral replication markers in tumor cells. The treatment caused local vitreous inflammation but no systemic complications. Thus, oncolytic adenoviruses targeting RB1 might provide a tumor-selective and chemotherapy-independent treatment option for retinoblastoma.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/476/eaat9321?rss=1</originId><description>&lt;p&gt;Retinoblastoma is a pediatric solid tumor of the retina activated upon homozygous inactivation of the tumor suppressor &lt;i&gt;RB1&lt;/i&gt;. VCN-01 is an oncolytic adenovirus designed to replicate selectively in tumor cells with high abundance of free E2F-1, a consequence of a dysfunctional RB1 pathway. Thus, we reasoned that VCN-01 could provide targeted therapeutic activity against even chemoresistant retinoblastoma. In vitro, VCN-01 effectively killed patient-derived retinoblastoma models. In mice, intravitreous administration of VCN-01 in retinoblastoma xenografts induced tumor necrosis, improved ocular survival compared with standard-of-care chemotherapy, and prevented micrometastatic dissemination into the brain. In juvenile immunocompetent rabbits, VCN-01 did not replicate in retinas, induced minor local side effects, and only leaked slightly and for a short time into the blood. Initial phase 1 data in patients showed the feasibility of the administration of intravitreous VCN-01 and resulted in antitumor activity in retinoblastoma vitreous seeds and evidence of viral replication markers in tumor cells. The treatment caused local vitreous inflammation but no systemic complications. Thus, oncolytic adenoviruses targeting RB1 might provide a tumor-selective and chemotherapy-independent treatment option for retinoblastoma.&lt;/p&gt;</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/476/eaat9321?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1687c1a95dc:2f64338:ad2b6584</id><title>[Research Articles] Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01</title><canonicalUrl>http://stm.sciencemag.org/content/11/476/eaat9321.full</canonicalUrl></item><item><entities><item><label>United Kingdom</label><id>nlp/f/entity/en/w/United Kingdom</id><mentions><item><text>UK</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>James Wilsdon</label><id>nlp/f/entity/en/-/james wilsdon</id><mentions><item><text>James Wilsdon</text></item><item><text>Wilsdon</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Mark Walport</label><id>nlp/f/entity/en/w/Mark Walport</id><mentions><item><text>Mark Walport</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>﻿Julie Gould</label><id>nlp/f/entity/en/-/﻿julie gould</id><mentions><item><text>﻿Julie Gould</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>ERC</label><id>nlp/f/entity/en/-/erc</id><mentions><item><text>ERC</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548433337330</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00300-z/d41586-019-00300-z_16419898.jpg</url></visual><author><name>Julie Gould</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00300-z</link><content><content>&lt;p&gt;&lt;b&gt;Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00300-z&quot;&gt;doi:10.1038/d41586-019-00300-z&lt;/a&gt;&lt;/p&gt;An expert guide for early career researchers to UK Research and Innovation, the UK&apos;s new central funding agency.</content><direction>ltr</direction></content><commonTopics><item><label>science policy</label><id>nlp/f/topic/2019</id><probability>0.99</probability></item><item><label>strategy</label><id>nlp/f/topic/2192</id><probability>0.951</probability></item><item><label>phd</label><id>nlp/f/topic/1737</id><probability>0.92</probability></item><item><label>conservation</label><id>nlp/f/topic/532</id><probability>0.869</probability></item><item><label>management</label><id>nlp/f/topic/1398</id><probability>0.864</probability></item><item><label>university</label><id>nlp/f/topic/2378</id><probability>0.843</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00300-z</originId><description>&lt;p&gt;&lt;b&gt;Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00300-z&quot;&gt;doi:10.1038/d41586-019-00300-z&lt;/a&gt;&lt;/p&gt;An expert guide for early career researchers to UK Research and Innovation, the UK&apos;s new central funding agency.</description><engagementRate>0.09</engagementRate><published>1548403200000</published><engagement>1</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00300-z</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16885d1abf2:3da0943:ad2b6584</id><title>Working Scientist podcast: How to navigate the UK&apos;s new research funding landscape</title><fingerprint>6f9830ae</fingerprint></item><item><entities><item><label>Chang&apos;e 4</label><id>nlp/f/entity/en/w/Chang&apos;e 4</id><mentions><item><text>Chang&apos;e - 4</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Arabidopsis thaliana</label><id>nlp/f/entity/en/w/Arabidopsis thaliana</id><mentions><item><text>Arabidopsis</text></item><item><text>thale - cress</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Xie Genxin</label><id>nlp/f/entity/en/-/xie genxin</id><mentions><item><text>Xie Genxin</text></item><item><text>Xie</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Zuma</label><id>nlp/f/entity/en/w/Zuma (satellite)</id><mentions><item><text>Zuma</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Xinhua News Agency</label><id>nlp/f/entity/en/w/Xinhua News Agency</id><mentions><item><text>Xinhua</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547575482944</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00159-0/d41586-019-00159-0_16398932.jpg</url></visual><author><name>Davide Castelvecchi</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00159-0</link><content><content>&lt;p&gt;&lt;b&gt;Plant sprouts on the Moon for first time ever&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Plant sprouts on the Moon for first time ever, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00159-0&quot;&gt;doi:10.1038/d41586-019-00159-0&lt;/a&gt;&lt;/p&gt;China’s Chang’e-4 lander has sent back pictures of a cotton seed sprouting in a miniature biosphere experiment on the craft.</content><direction>ltr</direction></content><commonTopics><item><label>plants</label><id>nlp/f/topic/1770</id><probability>0.96</probability></item><item><label>space</label><id>nlp/f/topic/2140</id><probability>0.952</probability></item><item><label>gardening</label><id>nlp/f/topic/944</id><probability>0.784</probability></item><item><label>astrophysics</label><id>nlp/f/topic/173</id><probability>0.704</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00159-0</originId><description>&lt;p&gt;&lt;b&gt;Plant sprouts on the Moon for first time ever&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Plant sprouts on the Moon for first time ever, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00159-0&quot;&gt;doi:10.1038/d41586-019-00159-0&lt;/a&gt;&lt;/p&gt;China’s Chang’e-4 lander has sent back pictures of a cotton seed sprouting in a miniature biosphere experiment on the craft.</description><published>1547539200000</published><engagement>32</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00159-0</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16852afda40:35b1e28:c2ce2e2e</id><title>Plant sprouts on the Moon for first time ever</title><fingerprint>c6be837e</fingerprint></item><item><entities><item><label>His73</label><id>nlp/f/entity/en/-/his73</id><mentions><item><text>His73</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Adenosine triphosphate</label><id>nlp/f/entity/en/w/Adenosine triphosphate</id><mentions><item><text>ATP</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Automatic Data Processing</label><id>nlp/f/entity/en/w/Automatic Data Processing</id><mentions><item><text>ADP</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Wilkinson et al</label><id>nlp/f/entity/en/-/wilkinson et al</id><mentions><item><text>Wilkinson et al</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>SETD3</label><id>nlp/f/entity/en/w/SETD3 (gene)</id><mentions><item><text>SETD3</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547057114190</crawled><visual><height>450</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>800</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07882-0/d41586-018-07882-0_16375250.jpg</url></visual><author><name>Pekka Lappalainen</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07882-0</link><content><content>&lt;p&gt;&lt;b&gt;Protein modification fine-tunes the cell’s force producers&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Protein modification fine-tunes the cell’s force producers, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07882-0&quot;&gt;doi:10.1038/d41586-018-07882-0&lt;/a&gt;&lt;/p&gt;Identification of the enzyme that catalyses a site-specific modification of the protein actin reveals how this change modulates the function of the cell’s force-producing machinery.</content><direction>ltr</direction></content><commonTopics><item><label>cell</label><id>nlp/f/topic/403</id><probability>0.996</probability></item><item><label>biochemistry</label><id>nlp/f/topic/257</id><probability>0.995</probability></item><item><label>proteomics</label><id>nlp/f/topic/1840</id><probability>0.931</probability></item><item><label>biology</label><id>nlp/f/topic/263</id><probability>0.914</probability></item><item><label>microscopy</label><id>nlp/f/topic/1457</id><probability>0.799</probability></item><item><label>fitness</label><id>nlp/f/topic/874</id><probability>0.798</probability></item><item><label>stem cells</label><id>nlp/f/topic/2185</id><probability>0.772</probability></item><item><label>bodybuilding</label><id>nlp/f/topic/294</id><probability>0.753</probability></item><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.712</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-018-07882-0</originId><description>&lt;p&gt;&lt;b&gt;Protein modification fine-tunes the cell’s force producers&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Protein modification fine-tunes the cell’s force producers, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07882-0&quot;&gt;doi:10.1038/d41586-018-07882-0&lt;/a&gt;&lt;/p&gt;Identification of the enzyme that catalyses a site-specific modification of the protein actin reveals how this change modulates the function of the cell’s force-producing machinery.</description><published>1547020800000</published><engagement>11</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07882-0</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b07a:8675cc2c</id><title>Protein modification fine-tunes the cell’s force producers</title><fingerprint>3c77a57</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37904-w</href></item></canonical><engagement>7</engagement><crawled>1548412119508</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Annemieke Milks</name></author><visual><height>546</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37904-w/MediaObjects/41598_2018_37904_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37904-w</link><content><content>&lt;p&gt;&lt;b&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution&lt;/b&gt;&lt;/p&gt;&lt;p&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37904-w&quot;&gt;doi:10.1038/s41598-018-37904-w&lt;/a&gt;&lt;/p&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/2Q5DjUKhJDs&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37904-w</originId><description>&lt;p&gt;&lt;b&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution&lt;/b&gt;&lt;/p&gt;&lt;p&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37904-w&quot;&gt;doi:10.1038/s41598-018-37904-w&lt;/a&gt;&lt;/p&gt;External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/2Q5DjUKhJDs&quot; height=&quot;1&quot;&gt;</description><engagementRate>1.4</engagementRate><published>1548403200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/2Q5DjUKhJDs/s41598-018-37904-w</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168848de9d4:3bb247f:ad2b6584</id><title>External ballistics of Pleistocene hand-thrown spears: experimental performance data and implications for human evolution</title><fingerprint>27af89c0</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Rosati, P.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>567c3bb</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/349?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/349?rss=1</originId><published>1548355045000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/349?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a8b:c2ce2e2e</id><title>Riccardo Giacconi (1931-2018)</title><canonicalUrl>http://science.sciencemag.org/content/363/6425/349.full</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41573-018-0007-y</href></item></canonical><entities><item><label>O</label><id>nlp/f/entity/en/-/o</id><mentions><item><text>O</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>PD - 1</label><id>nlp/f/entity/en/-/pd - 1</id><mentions><item><text>PD - 1</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>J. Clin</label><id>nlp/f/entity/en/-/j. clin</id><mentions><item><text>J. Clin</text></item><item><text>Clin</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Nat</label><id>nlp/f/entity/en/-/nat</id><mentions><item><text>Nat</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>J. Oncol</label><id>nlp/f/entity/en/-/j. oncol</id><mentions><item><text>J. Oncol</text></item><item><text>Oncol</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546619502307</crawled><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><author><name>Jérôme Galon</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>560</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41573-018-0007-y/MediaObjects/41573_2018_7_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41573-018-0007-y</link><content><content>&lt;p&gt;&lt;b&gt;Approaches to treat immune hot, altered and cold tumours with combination immunotherapies&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Approaches to treat immune hot, altered and cold tumours with combination immunotherapies, Published online: 04 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41573-018-0007-y&quot;&gt;doi:10.1038/s41573-018-0007-y&lt;/a&gt;&lt;/p&gt;Immunoscore classifies cancers according to their immune infiltration. In this Review, Galon and Bruni provide a panel of therapeutic strategies to use, combine and develop to treat hot, altered and cold tumours.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/SjvdXY5aVks&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.988</probability></item><item><label>cancer</label><id>nlp/f/topic/377</id><probability>0.949</probability></item><item><label>classics</label><id>nlp/f/topic/477</id><probability>0.932</probability></item><item><label>brain</label><id>nlp/f/topic/314</id><probability>0.927</probability></item><item><label>hematology</label><id>nlp/f/topic/1058</id><probability>0.882</probability></item><item><label>emergency medicine</label><id>nlp/f/topic/764</id><probability>0.844</probability></item><item><label>rationality</label><id>nlp/f/topic/1895</id><probability>0.818</probability></item><item><label>mp3</label><id>nlp/f/topic/1508</id><probability>0.783</probability></item><item><label>ecology</label><id>nlp/f/topic/725</id><probability>0.719</probability></item><item><label>fat</label><id>nlp/f/topic/842</id><probability>0.718</probability></item></commonTopics><originId>https://www.nature.com/articles/s41573-018-0007-y</originId><description>&lt;p&gt;&lt;b&gt;Approaches to treat immune hot, altered and cold tumours with combination immunotherapies&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Approaches to treat immune hot, altered and cold tumours with combination immunotherapies, Published online: 04 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41573-018-0007-y&quot;&gt;doi:10.1038/s41573-018-0007-y&lt;/a&gt;&lt;/p&gt;Immunoscore classifies cancers according to their immune infiltration. In this Review, Galon and Bruni provide a panel of therapeutic strategies to use, combine and develop to treat hot, altered and cold tumours.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/SjvdXY5aVks&quot; height=&quot;1&quot;&gt;</description><published>1546588800000</published><engagement>3</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/SjvdXY5aVks/s41573-018-0007-y</href></item></alternate><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_16819b4bee3:4c6cb5:ad2b6584</id><title>Approaches to treat immune hot, altered and cold tumours with combination immunotherapies</title><fingerprint>aea3987f</fingerprint></item><item><engagement>0</engagement><crawled>1546559437919</crawled><fingerprint>19aafae6</fingerprint><author><name>Amodio, M.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/237065v4?rss=1</link><content><content>Biomedical researchers are generating high-throughput, high-dimensional single-cell data at a staggering rate. As costs of data generation decrease, experimental design is moving towards measurement of many different single-cell samples in the same dataset. These samples can correspond to different patients, conditions, or treatments. While scalability of methods to datasets of these sizes is a challenge on its own, dealing with large-scale experimental design presents a whole new set of problems, including batch effects and sample comparison issues. Currently, there are no computational tools that can both handle large amounts of data in a scalable manner (many cells) and at the same time deal with many samples (many patients or conditions). Moreover, data analysis currently involves the use of different tools that each operate on their own data representation, not guaranteeing a synchronized analysis pipeline. For instance, data visualization methods can be disjoint and mismatched with the clustering method. For this purpose, we present SAUCIE, a deep neural network that leverages the high degree of parallelization and scalability offered by neural networks, as well as the deep representation of data that can be learned by them to perform many single-cell data analysis tasks, all on a unified representation. A well-known limitation of neural networks is their interpretability. Our key contribution here are newly formulated regularizations (penalties) that render features learned in hidden layers of the neural network interpretable. When large multi-patient datasets are fed into SAUCIE, the various hidden layers contain denoised and batch-corrected data, a low dimensional visualization, unsupervised clustering, as well as other information that can be used to explore the data. We show this capability by analyzing a newly generated 180-sample dataset consisting of T cells from dengue patients in India, measured with mass cytometry. We show that SAUCIE, for the first time, can batch correct and process this 11-million cell data to identify cluster-based signatures of acute dengue infection and create a patient manifold, stratifying immune response to dengue on the basis of single-cell measurements.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/237065v4?rss=1</originId><description>Biomedical researchers are generating high-throughput, high-dimensional single-cell data at a staggering rate. As costs of data generation decrease, experimental design is moving towards measurement of many different single-cell samples in the same dataset. These samples can correspond to different patients, conditions, or treatments. While scalability of methods to datasets of these sizes is a challenge on its own, dealing with large-scale experimental design presents a whole new set of problems, including batch effects and sample comparison issues. Currently, there are no computational tools that can both handle large amounts of data in a scalable manner (many cells) and at the same time deal with many samples (many patients or conditions). Moreover, data analysis currently involves the use of different tools that each operate on their own data representation, not guaranteeing a synchronized analysis pipeline. For instance, data visualization methods can be disjoint and mismatched with the clustering method. For this purpose, we present SAUCIE, a deep neural network that leverages the high degree of parallelization and scalability offered by neural networks, as well as the deep representation of data that can be learned by them to perform many single-cell data analysis tasks, all on a unified representation. A well-known limitation of neural networks is their interpretability. Our key contribution here are newly formulated regularizations (penalties) that render features learned in hidden layers of the neural network interpretable. When large multi-patient datasets are fed into SAUCIE, the various hidden layers contain denoised and batch-corrected data, a low dimensional visualization, unsupervised clustering, as well as other information that can be used to explore the data. We show this capability by analyzing a newly generated 180-sample dataset consisting of T cells from dengue patients in India, measured with mass cytometry. We show that SAUCIE, for the first time, can batch correct and process this 11-million cell data to identify cluster-based signatures of acute dengue infection and create a patient manifold, stratifying immune response to dengue on the basis of single-cell measurements.</description><published>1546502400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/237065v4?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16816203c5f:6d19:3a104d3b</id><title>Exploring Single-Cell Data with Deep Multitasking Neural Networks [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/03/237065</canonicalUrl></item><item><engagement>0</engagement><crawled>1547134694182</crawled><fingerprint>50f0220c</fingerprint><author><name>C. Silva, A. S.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/428805v2?rss=1</link><content><content>The use of post-processing tools to maximize the information gained from a proteomics search engine is widely accepted and used by the community, with the most notable example being Percolator - a semi-supervised machine learning model which learns a new scoring function for a given dataset. The usage of such tools is however bound to the search engine&apos;s scoring scheme, which doesn&apos;t always make full use of the intensity information present in a spectrum. We aim to show how this tool can be applied in such a way that maximizes the use of spectrum intensity information by leveraging another machine learning-based tool, MS2PIP. MS2PIP predicts fragment ion peak intensities. We show how comparing these intensities to annotated experimental spectra by calculating direct similarity metrics provides enough information for a tool such as Percolator to accurately separate two classes of PSMs. This approach allows using more information out of the data (compared to simpler intensity based metrics, like peak counting or explained intensities summing) while maintaining control of statistics such as the false discovery rate.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/428805v2?rss=1</originId><description>The use of post-processing tools to maximize the information gained from a proteomics search engine is widely accepted and used by the community, with the most notable example being Percolator - a semi-supervised machine learning model which learns a new scoring function for a given dataset. The usage of such tools is however bound to the search engine&apos;s scoring scheme, which doesn&apos;t always make full use of the intensity information present in a spectrum. We aim to show how this tool can be applied in such a way that maximizes the use of spectrum intensity information by leveraging another machine learning-based tool, MS2PIP. MS2PIP predicts fragment ion peak intensities. We show how comparing these intensities to annotated experimental spectra by calculating direct similarity metrics provides enough information for a tool such as Percolator to accurately separate two classes of PSMs. This approach allows using more information out of the data (compared to simpler intensity based metrics, like peak counting or explained intensities summing) while maintaining control of statistics such as the false discovery rate.</description><published>1547107200000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/428805v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1683869f326:1417f25:8675cc2c</id><title>Accurate peptide fragmentation predictions allow data driven approaches to replace and improve upon proteomics search engine scoring functions [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/10/428805</canonicalUrl></item><item><engagement>0</engagement><crawled>1547593386695</crawled><fingerprint>28b02611</fingerprint><author><name>Taroni, J. N.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/395947v2?rss=1</link><content><content>Unsupervised machine learning methods provide a promising means to analyze and interpret large datasets. However, most gene expression datasets generated by individual researchers remain too small to fully benefit from these methods. In the case of rare diseases, there may be too few cases available, even when multiple studies are combined. We trained a Pathway Level Information ExtractoR (PLIER) model using on a large public data compendium comprised of multiple experiments, tissues, and biological conditions. We then transferred the model to small rare disease datasets in an approach we term MultiPLIER. Models constructed from large, diverse public data i) included features that aligned well to important biological factors; ii) were more comprehensive than those constructed from individual datasets or conditions; iii) transferred to rare disease datasets where the models describe biological processes related to disease severity more effectively than models trained on specifically those datasets.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/395947v2?rss=1</originId><description>Unsupervised machine learning methods provide a promising means to analyze and interpret large datasets. However, most gene expression datasets generated by individual researchers remain too small to fully benefit from these methods. In the case of rare diseases, there may be too few cases available, even when multiple studies are combined. We trained a Pathway Level Information ExtractoR (PLIER) model using on a large public data compendium comprised of multiple experiments, tissues, and biological conditions. We then transferred the model to small rare disease datasets in an approach we term MultiPLIER. Models constructed from large, diverse public data i) included features that aligned well to important biological factors; ii) were more comprehensive than those constructed from individual datasets or conditions; iii) transferred to rare disease datasets where the models describe biological processes related to disease severity more effectively than models trained on specifically those datasets.</description><published>1547539200000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/395947v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16853c10ac7:38531f3:8675cc2c</id><title>MultiPLIER: a transfer learning framework for transcriptomics reveals systemic features of rare disease [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/15/395947</canonicalUrl></item><item><updateCount>1</updateCount><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006719</href></item></canonical><engagement>0</engagement><crawled>1546887105720</crawled><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><published>1546898400000</published><link>10.1371/journal.pcbi.1006719</link><visual><height>182</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>320</width><url>https://journals.plos.org/ploscompbiol/article/figure/image?size=inline&amp;id=10.1371/journal.pcbi.1006719.g001</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><description>&lt;p&gt;by Sathyavani Malyala, Yizhu Zhang, Jasiel O. Strubbe, Jason N. Bazil&lt;/p&gt;
Early studies have shown that moderate levels of calcium overload can cause lower oxidative phosphorylation rates. However, the mechanistic interpretations of these findings were inadequate. And while the effect of excessive calcium overload on mitochondrial function is well appreciated, there has been little to no reports on the consequences of low to moderate calcium overload. To resolve this inadequacy, mitochondrial function from guinea pig hearts was quantified using several well-established methods including high-resolution respirometry and spectrofluorimetry and analyzed using mathematical modeling. We measured key mitochondrial variables such as respiration, mitochondrial membrane potential, buffer calcium, and substrate effects for a range of mitochondrial calcium loads from near zero to levels approaching mitochondrial permeability transition. In addition, we developed a computer model closely mimicking the experimental conditions and used this model to design experiments capable of eliminating many hypotheses generated from the data analysis. We subsequently performed those experiments and determined why mitochondrial ADP-stimulated respiration is significantly lowered during calcium overload. We found that when calcium phosphate levels, not matrix free calcium, reached sufficient levels, complex I activity is inhibited, and the rate of ATP synthesis is reduced. Our findings suggest that calcium phosphate granules form physical barriers that isolate complex I from NADH, disrupt complex I activity, or destabilize cristae and inhibit NADH-dependent respiration.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/WBuKxc7t56w&quot; height=&quot;1&quot;&gt;</description><updated>1546898400000</updated><content><content>&lt;p&gt;by Sathyavani Malyala, Yizhu Zhang, Jasiel O. Strubbe, Jason N. Bazil&lt;/p&gt;
Early studies have shown that moderate levels of calcium overload can cause lower oxidative phosphorylation rates. However, the mechanistic interpretations of these findings were inadequate. And while the effect of excessive calcium overload on mitochondrial function is well appreciated, there has been little to no reports on the consequences of low to moderate calcium overload. To resolve this inadequacy, mitochondrial function from guinea pig hearts was quantified using several well-established methods including high-resolution respirometry and spectrofluorimetry and analyzed using mathematical modeling. We measured key mitochondrial variables such as respiration, mitochondrial membrane potential, buffer calcium, and substrate effects for a range of mitochondrial calcium loads from near zero to levels approaching mitochondrial permeability transition. In addition, we developed a computer model closely mimicking the experimental conditions and used this model to design experiments capable of eliminating many hypotheses generated from the data analysis. We subsequently performed those experiments and determined why mitochondrial ADP-stimulated respiration is significantly lowered during calcium overload. We found that when calcium phosphate levels, not matrix free calcium, reached sufficient levels, complex I activity is inhibited, and the rate of ATP synthesis is reduced. Our findings suggest that calcium phosphate granules form physical barriers that isolate complex I from NADH, disrupt complex I activity, or destabilize cristae and inhibit NADH-dependent respiration.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/WBuKxc7t56w&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>10.1371/journal.pcbi.1006719</originId><author><name>Sathyavani Malyala</name></author><recrawled>1546896425181</recrawled><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/WBuKxc7t56w/article</href></item></alternate><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_16829a80cb8:138510:ce262a36</id><title>Calcium phosphate precipitation inhibits mitochondrial energy metabolism</title><fingerprint>9ef90db8</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08369-w</href></item></canonical><engagement>0</engagement><crawled>1548411385568</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>John Rönn</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>499</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-08369-w/MediaObjects/41467_2019_8369_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-019-08369-w</link><content><content>&lt;p&gt;&lt;b&gt;Ultra-high on-chip optical gain in erbium-based hybrid slot waveguides&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ultra-high on-chip optical gain in erbium-based hybrid slot waveguides, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08369-w&quot;&gt;doi:10.1038/s41467-019-08369-w&lt;/a&gt;&lt;/p&gt;Realizing efficient on-chip amplification in silicon is challenging due to either non-compatible integration or small gain per unit length of the amplifier material. Here, the authors report ultra-high on-chip optical gain in erbium-based hybrid silicon nitride slot waveguides with a monolithic, CMOS-compatible and scalable atomic-layer deposition process.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/L9x-b4veboo&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-019-08369-w</originId><description>&lt;p&gt;&lt;b&gt;Ultra-high on-chip optical gain in erbium-based hybrid slot waveguides&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ultra-high on-chip optical gain in erbium-based hybrid slot waveguides, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08369-w&quot;&gt;doi:10.1038/s41467-019-08369-w&lt;/a&gt;&lt;/p&gt;Realizing efficient on-chip amplification in silicon is challenging due to either non-compatible integration or small gain per unit length of the amplifier material. Here, the authors report ultra-high on-chip optical gain in erbium-based hybrid silicon nitride slot waveguides with a monolithic, CMOS-compatible and scalable atomic-layer deposition process.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/L9x-b4veboo&quot; height=&quot;1&quot;&gt;</description><published>1548403200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/L9x-b4veboo/s41467-019-08369-w</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1688482b6e0:3b9c08b:3a104d3b</id><title>Ultra-high on-chip optical gain in erbium-based hybrid slot waveguides</title><fingerprint>8a3b14a4</fingerprint></item><item><entities><item><label>S.</label><id>nlp/f/entity/en/-/s.</id><mentions><item><text>S.</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>J. Catal</label><id>nlp/f/entity/en/-/j. catal</id><mentions><item><text>J. Catal</text></item><item><text>Catal</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>A.</label><id>nlp/f/entity/en/-/a.</id><mentions><item><text>A.</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Lu</label><id>nlp/f/entity/en/-/lu</id><mentions><item><text>Lu</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>T.</label><id>nlp/f/entity/en/-/t.</id><mentions><item><text>T.</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548872162027</crawled><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>665</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0869-5/MediaObjects/41586_2018_869_Fig1_HTML.png</url></visual><author><name>Lina Cao</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-018-0869-5</link><content><content>&lt;p&gt;&lt;b&gt;Atomically dispersed iron hydroxide anchored on Pt for preferential oxidation of CO in H&lt;sub&gt;2&lt;/sub&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Atomically dispersed iron hydroxide anchored on Pt for preferential oxidation of CO in H&amp;lt;sub&gt;2&amp;lt;/sub&gt;, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0869-5&quot;&gt;doi:10.1038/s41586-018-0869-5&lt;/a&gt;&lt;/p&gt;Atomically dispersed iron hydroxide deposited on silica-supported platinum nanoparticles enables complete and selective carbon monoxide removal through preferential oxidation in hydrogen in the temperature range from 198 to 380 kelvin.</content><direction>ltr</direction></content><commonTopics><item><label>brain</label><id>nlp/f/topic/314</id><probability>0.982</probability></item><item><label>cell</label><id>nlp/f/topic/403</id><probability>0.939</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-018-0869-5</originId><description>&lt;p&gt;&lt;b&gt;Atomically dispersed iron hydroxide anchored on Pt for preferential oxidation of CO in H&lt;sub&gt;2&lt;/sub&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Atomically dispersed iron hydroxide anchored on Pt for preferential oxidation of CO in H&amp;lt;sub&gt;2&amp;lt;/sub&gt;, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0869-5&quot;&gt;doi:10.1038/s41586-018-0869-5&lt;/a&gt;&lt;/p&gt;Atomically dispersed iron hydroxide deposited on silica-supported platinum nanoparticles enables complete and selective carbon monoxide removal through preferential oxidation in hydrogen in the temperature range from 198 to 380 kelvin.</description><published>1548835200000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0869-5</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac52:3a104d3b</id><title>Atomically dispersed iron hydroxide anchored on Pt for preferential oxidation of CO in H2</title><fingerprint>7fe8d8ea</fingerprint></item><item><engagement>0</engagement><crawled>1548685021531</crawled><visual><url>none</url></visual><author><name>Xiaoxiao Liu, Bilan Wang, Yanyan Li, Yuzhu Hu, Xiaoling Li, Ting Yu, Yan Ju, Tao Sun, Xiang Gao, Yuquan Wei</name></author><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acscentsci.8b00688</link><originId>http://dx.doi.org/10.1021/acscentsci.8b00688</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00688/20190128/images/medium/oc-2018-00688f_0013.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00688&lt;/div&gt;</description><published>1548651600000</published><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00688</href></item></alternate><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_16894d2115b:229adb6:56b782f7</id><title>[ASAP] Powerful Anticolon Tumor Effect of Targeted Gene Immunotherapy Using Folate-Modified Nanoparticle Delivery of CCL19 To Activate the Immune System</title><fingerprint>ccef03c3</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00688/20190128/images/medium/oc-2018-00688f_0013.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00688&lt;/div&gt;</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1546558991040</crawled><fingerprint>5443fda0</fingerprint><author><name>McMillan, J.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/511477v1?rss=1</link><content><content>The transcription initiation landscape of eukaryotic genes is complex and highly dynamic. In eukaryotes, genes can generate multiple transcript variants that differ in 5&apos; boundaries due to usages of alternative transcription start sites (TSSs), and the abundance of transcript isoforms are highly variable. Due to a large number and complexity of the TSSs, it is not feasible to depict details of transcript initiation landscape of all genes using text-format genome annotation files. Therefore, it is necessary to provide data visualization of TSSs to represent quantitative TSS maps and the core promoters. In addition, the selection and activity of TSSs are influenced by various factors, such as transcription factors, chromatin remodeling, and histone modifications. Thus, integration and visualization of functional genomic data related to these features could provide a better understanding of the gene promoter architecture and regulatory mechanism of transcription initiation. Yeast species play important roles for the research and human society, yet no database provides visualization and integration of functional genomic data in yeast. Here, we generated quantitative TSS maps for twelve important yeast species, inferred their core promoters, and built a public database, YeasTSS (www.yeastss.org). YeasTSS was designed as a central portal for visualization and integration of the TSS maps, core promoters and functional genomic data related to transcription initiation in yeast. YeasTSS is expected to benefit the research community and public education for improving genome annotation, studies of promoter structure, regulated control of transcription initiation and inferring gene regulatory network.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/511477v1?rss=1</originId><description>The transcription initiation landscape of eukaryotic genes is complex and highly dynamic. In eukaryotes, genes can generate multiple transcript variants that differ in 5&apos; boundaries due to usages of alternative transcription start sites (TSSs), and the abundance of transcript isoforms are highly variable. Due to a large number and complexity of the TSSs, it is not feasible to depict details of transcript initiation landscape of all genes using text-format genome annotation files. Therefore, it is necessary to provide data visualization of TSSs to represent quantitative TSS maps and the core promoters. In addition, the selection and activity of TSSs are influenced by various factors, such as transcription factors, chromatin remodeling, and histone modifications. Thus, integration and visualization of functional genomic data related to these features could provide a better understanding of the gene promoter architecture and regulatory mechanism of transcription initiation. Yeast species play important roles for the research and human society, yet no database provides visualization and integration of functional genomic data in yeast. Here, we generated quantitative TSS maps for twelve important yeast species, inferred their core promoters, and built a public database, YeasTSS (www.yeastss.org). YeasTSS was designed as a central portal for visualization and integration of the TSS maps, core promoters and functional genomic data related to transcription initiation in yeast. YeasTSS is expected to benefit the research community and public education for improving genome annotation, studies of promoter structure, regulated control of transcription initiation and inferring gene regulatory network.</description><published>1546502400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/511477v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16816196ac0:6b2845e:3a104d3b</id><title>YeasTSS: An Integrative Web Database of Yeast Transcription Start Sites [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/03/511477</canonicalUrl></item><item><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Zahn, L. M.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-k?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-k?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.11.full</canonicalUrl><published>1548355045000</published><keywords><item>Genetics</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-k?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a76:c2ce2e2e</id><title>Human recombination and mutation mapped</title><fingerprint>c03f8e84</fingerprint></item><item><entities><item><label>China</label><id>nlp/f/entity/en/w/China</id><mentions><item><text>China</text></item><item><text>Chinese</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Zhejiang University</label><id>nlp/f/entity/en/w/Zhejiang University</id><mentions><item><text>Zhejiang University</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Wuhan University</label><id>nlp/f/entity/en/w/Wuhan University</id><mentions><item><text>Wuhan University</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>daily Nature Briefing</label><id>nlp/f/entity/en/-/daily nature briefing</id><mentions><item><text>daily Nature Briefing</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547644798374</crawled><visual><url>none</url></visual><author><name>Jiangjiang Zhang</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00152-7</link><content><content>&lt;p&gt;&lt;b&gt;Chinese universities lure postdocs back home&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Chinese universities lure postdocs back home, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00152-7&quot;&gt;doi:10.1038/d41586-019-00152-7&lt;/a&gt;&lt;/p&gt;Chinese universities lure postdocs back home</content><direction>ltr</direction></content><commonTopics><item><label>china</label><id>nlp/f/topic/448</id><probability>0.998</probability></item><item><label>retirement</label><id>nlp/f/topic/1938</id><probability>0.953</probability></item><item><label>higher ed</label><id>nlp/f/topic/1063</id><probability>0.939</probability></item><item><label>culture</label><id>nlp/f/topic/597</id><probability>0.906</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00152-7</originId><description>&lt;p&gt;&lt;b&gt;Chinese universities lure postdocs back home&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Chinese universities lure postdocs back home, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00152-7&quot;&gt;doi:10.1038/d41586-019-00152-7&lt;/a&gt;&lt;/p&gt;Chinese universities lure postdocs back home</description><published>1547625600000</published><engagement>1</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00152-7</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16856d185a6:3bfe65d:3a104d3b</id><title>Chinese universities lure postdocs back home</title><fingerprint>b2835261</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/d41573-019-00012-z</href></item></canonical><entities><item><label>Adalimumab</label><id>nlp/f/entity/en/w/Adalimumab</id><mentions><item><text>Humira</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>AbbVie Inc.</label><id>nlp/f/entity/en/w/AbbVie Inc.</id><mentions><item><text>AbbVie</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Hoffmann-La Roche</label><id>nlp/f/entity/en/w/Hoffmann-La Roche</id><mentions><item><text>Roche</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Lenalidomide</label><id>nlp/f/entity/en/w/Lenalidomide</id><mentions><item><text>Revlimid</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Xa</label><id>nlp/f/entity/en/-/xa</id><mentions><item><text>Xa</text></item></mentions><salienceLevel>about</salienceLevel></item></entities><crawled>1547466001621</crawled><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><author><name>Lisa Urquhart</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/d41573-019-00012-z</link><content><content>&lt;p&gt;&lt;b&gt;Top product forecasts for 2019&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Top product forecasts for 2019, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00012-z&quot;&gt;doi:10.1038/d41573-019-00012-z&lt;/a&gt;&lt;/p&gt;Top product forecasts for 2019&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/Pbz30bC21Yc&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>sales</label><id>nlp/f/topic/1989</id><probability>0.978</probability></item><item><label>thrifting</label><id>nlp/f/topic/2294</id><probability>0.918</probability></item><item><label>anarchism</label><id>nlp/f/topic/91</id><probability>0.839</probability></item><item><label>drugs</label><id>nlp/f/topic/698</id><probability>0.738</probability></item></commonTopics><originId>https://www.nature.com/articles/d41573-019-00012-z</originId><description>&lt;p&gt;&lt;b&gt;Top product forecasts for 2019&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Top product forecasts for 2019, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00012-z&quot;&gt;doi:10.1038/d41573-019-00012-z&lt;/a&gt;&lt;/p&gt;Top product forecasts for 2019&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/Pbz30bC21Yc&quot; height=&quot;1&quot;&gt;</description><published>1547452800000</published><engagement>1</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/Pbz30bC21Yc/d41573-019-00012-z</href></item></alternate><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_1684c294cd5:2bb69da:c2ce2e2e</id><title>Top product forecasts for 2019</title><fingerprint>b92c3ca8</fingerprint></item><item><crawled>1548686883235</crawled><engagementRate>0.04</engagementRate><engagement>1</engagement><unread>True</unread><link>http://blogs.sciencemag.org/pipeline/?p=14132</link><commonTopics><item><label>acs</label><id>nlp/f/topic/26</id><probability>0.867</probability></item><item><label>lightroom</label><id>nlp/f/topic/1342</id><probability>0.84</probability></item></commonTopics><alternate><item><type>text/html</type><href>https://blogs.sciencemag.org/pipeline/archives/2019/01/28/blue-light-gives-way-to-red</href></item></alternate><title>Blue Light Gives Way to Red</title><updateCount>3</updateCount><entities><item><label>Blue Light</label><id>nlp/f/entity/en/-/blue light</id><mentions><item><text>Blue Light</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Ru</label><id>nlp/f/entity/en/-/ru</id><mentions><item><text>Ru</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>NIR</label><id>nlp/f/entity/en/-/nir</id><mentions><item><text>NIR</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Eosin</label><id>nlp/f/entity/en/w/Eosin</id><mentions><item><text>Eosin</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>bpy</label><id>nlp/f/entity/en/-/bpy</id><mentions><item><text>bpy</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><origin><htmlUrl>https://blogs.sciencemag.org/pipeline</htmlUrl><streamId>feed/http://blogs.sciencemag.org/pipeline/feed</streamId><title>Sciencemag</title></origin><published>1548686584000</published><fingerprint>4488009b</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><content><content>&lt;p&gt;Photochemistry’s rise over the last ten years or so has been one of the big stories in organic chemistry, but there are still some difficulties with using it. The use of photoredox catalysts has brought blue light into a lot of fume hoods, which is certainly more selective and easier to use than than old ultraviolet sources – I will not miss mercury lamps, I can tell you. But the physical problem remains of getting enough photons poured into the reaction. It’s been demonstrated that with any of these sources that you only tend to get photoreactions in the outer few millimeters of the solution. Thus the flow photochemistry rigs that people have used, which are attempts to turn the entire reaction into a 2mm-deep layer around the light source – otherwise, you have to stir vigorously and just keep beaming away until things are finally done.&lt;/p&gt;
&lt;p&gt;But physics to the rescue: there are other possibilities. &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0835-2&quot;&gt;Here’s a paper&lt;/a&gt; on one, triplet upconversion. Near-infrared light has far better ability to penetrate solutions (and tissue, for that matter). But taking advantage of that isn’t always easy. One of the reasons it’s penetrating is that it’s not be absorbed by anything along the way, and even when it is, light of those wavelengths isn’t packing enough energy to do a lot of work. It’s definitely not going to break or form any bonds by itself – absorption at those frequencies all goes into things like rotational or vibrational energy, so you’re just going to warm things up. And it’s not enough to send any of your favorite photoredox catalysts into an electronically excited state, either.&lt;/p&gt;
&lt;p&gt;Triplet upconversion, though, is a way of pooling this energy and making something out of it. A sensitizer species is chosen that can usefully absorb the NIR light to provide a singlet excited state, and this decays to a triplet form. That interacts with another species (the “annihilator”), turning it into an excited triplet, and then &lt;a href=&quot;https://en.wikipedia.org/wiki/Triplet-triplet_annihilation&quot;&gt;two of those react&lt;/a&gt; with each other. One falls back to the ground state, and the other ends up boosted to yet a higher energy state, and then emits a photon with some oomph to it – you’ve upconverted near-IR light into the visible or even UV range by doing a two-for-one exchange. This is a big topic &lt;a href=&quot;https://www.nature.com/articles/s41566-018-0188-2&quot;&gt;in many fields&lt;/a&gt;, not least solar energy production.&lt;/p&gt;
&lt;p&gt;You have to pick your species carefully – the sensitizer, the annihilator, and eventual photoredox catalyst that absorbs that last photon – but what’s organic chemistry for if we can’t tune the properties of our molecules by changing their structures? This latest paper has gotten things to line up with a palladium octabutoxyphthalocyanine complex that absorbs down at 730nM, furanyldiketopyrrolopyrrole as the annhilator, and eosin as the eventual catalyst. Eosin is known to (for example) catalyze dehalogenation under blue-light conditions, and in this system it’ll do so under near-IR illumination. But you get comparable yields with the triplet-upconversion system while using a light source that’s only one-thousandth the power (!)&lt;/p&gt;
&lt;p&gt;That’s because, physically, this would seem to be equivalent to setting off photochemical illumination sources, molecule-by-molecule, throughout most of the solution. Absorption tests showed that the NIR light was penetrating typical reaction solutions hundreds of times better than blue LED light, so that’s quite an improvement over trying to beat in the photons from the outside. Switching to a different (tetraphenyltetranaphthoporphyrin) palladium complex and a tetra-t-butylperylene annihilator (which emits up into the blue range), they were able to use the popular Ru(bpy)&lt;sub&gt;3&lt;/sub&gt; catalyst. Interestingly, in one of the systems tried (a cyclobutane-forming reaction), the catalyzed system gave a 48% yield, while leaving out the Ru catalyst still gave a 38% one, so it appears that the excited singlet perylene species is enough by itself to get the reaction to go in some cases.&lt;/p&gt;
&lt;p&gt;This idea would seem to have real applications for photochemical scaleup. The higher penetration is a great feature, as is the lower power consumption, and the excess heat of whole setup would be a lot easier to deal with (it’s a major problem as you go to larger rigs). Getting your photons this way might be the photochemistry of the future, if enough good absorber/annihilator pairs can be identified.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://blogs.sciencemag.org/pipeline/?p=14132</originId><description>Photochemistry’s rise over the last ten years or so has been one of the big stories in organic chemistry, but there are still some difficulties with using it. The use of photoredox catalysts has brought blue light into a lot of fume hoods, which is certainly more selective and easier to use than than old</description><author><name>Derek Lowe</name></author><keywords><item>Chemical News</item></keywords><id>2k24/TFePIh3MUUJr/vqRk++EkKG/RZ2TtOvsKiJXX4=_16894ee79a3:4e40ddf:c2ce2e2e</id><recrawled>1548859785603</recrawled><summary><content>Photochemistry’s rise over the last ten years or so has been one of the big stories in organic chemistry, but there are still some difficulties with using it. The use of photoredox catalysts has brought blue light into a lot of fume hoods, which is certainly more selective and easier to use than than old</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1547489397494</crawled><visual><url>none</url></visual><author><name>Shengming Cheng, Bin Shen, Wei Yuan, Xiaobo Zhou, Qingyun Liu, Mengya Kong, Yibing Shi, Pengyuan Yang, Wei Feng, Fuyou Li</name></author><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acscentsci.8b00763</link><originId>http://dx.doi.org/10.1021/acscentsci.8b00763</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00763/20190114/images/medium/oc-2018-00763c_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00763&lt;/div&gt;</description><published>1547442000000</published><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00763</href></item></alternate><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_1684d8e4af6:1069c05:b77f238b</id><title>[ASAP] Time-Gated Ratiometric Detection with the Same Working Wavelength To Minimize the Interferences from Photon Attenuation for Accurate in Vivo Detection</title><fingerprint>a8178a77</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00763/20190114/images/medium/oc-2018-00763c_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00763&lt;/div&gt;</content><direction>ltr</direction></summary></item><item><entities><item><label>Luo et al</label><id>nlp/f/entity/en/-/luo et al</id><mentions><item><text>Luo et al</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Will Luo</label><id>nlp/f/entity/en/-/will luo</id><mentions><item><text>Luo</text></item><item><text>Will Luo</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>National Academy of Sciences</label><id>nlp/f/entity/en/w/National Academy of Sciences</id><mentions><item><text>National Academy of Sciences</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Chlamydomonas reinhardtii 4</label><id>nlp/f/entity/en/-/chlamydomonas reinhardtii 4</id><mentions><item><text>Chlamydomonas reinhardtii 4</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>vivo</label><id>nlp/f/entity/en/-/vivo</id><mentions><item><text>vivo</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547481048457</crawled><visual><height>450</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>800</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00093-1/d41586-019-00093-1_16395194.jpg</url></visual><author><name>Thomas G. McWilliams</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00093-1</link><content><content>&lt;p&gt;&lt;b&gt;Mitochondrial DNA can be inherited from fathers, not just mothers&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mitochondrial DNA can be inherited from fathers, not just mothers, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00093-1&quot;&gt;doi:10.1038/d41586-019-00093-1&lt;/a&gt;&lt;/p&gt;A tenet of elementary biology is that mitochondria — the cell’s powerhouses — and their DNA are inherited exclusively from mothers. A provocative study suggests that fathers also occasionally contribute.</content><direction>ltr</direction></content><commonTopics><item><label>genetics</label><id>nlp/f/topic/955</id><probability>0.986</probability></item><item><label>dna</label><id>nlp/f/topic/679</id><probability>0.975</probability></item><item><label>cell</label><id>nlp/f/topic/403</id><probability>0.799</probability></item><item><label>bioinformatics</label><id>nlp/f/topic/262</id><probability>0.791</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00093-1</originId><description>&lt;p&gt;&lt;b&gt;Mitochondrial DNA can be inherited from fathers, not just mothers&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mitochondrial DNA can be inherited from fathers, not just mothers, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00093-1&quot;&gt;doi:10.1038/d41586-019-00093-1&lt;/a&gt;&lt;/p&gt;A tenet of elementary biology is that mitochondria — the cell’s powerhouses — and their DNA are inherited exclusively from mothers. A provocative study suggests that fathers also occasionally contribute.</description><published>1547452800000</published><engagement>8</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00093-1</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1684d0ee589:2d14b2c:c2ce2e2e</id><title>Mitochondrial DNA can be inherited from fathers, not just mothers</title><fingerprint>6774b71</fingerprint></item><item><updateCount>1</updateCount><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006568</href></item></canonical><crawled>1547752840893</crawled><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><published>1547762400000</published><link>10.1371/journal.pcbi.1006568</link><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><description>&lt;p&gt;by Ada W. C. Yan, Sophie G. Zaloumis, Julie A. Simpson, James M. McCaw&lt;/p&gt;
Laboratory models are often used to understand the interaction of related pathogens via host immunity. For example, recent experiments where ferrets were exposed to two influenza strains within a short period of time have shown how the effects of cross-immunity vary with the time between exposures and the specific strains used. On the other hand, studies of the workings of different arms of the immune response, and their relative importance, typically use experiments involving a single infection. However, inferring the relative importance of different immune components from this type of data is challenging. Using simulations and mathematical modelling, here we investigate whether the sequential infection experiment design can be used not only to determine immune components contributing to cross-protection, but also to gain insight into the immune response during a single infection. We show that virological data from sequential infection experiments can be used to accurately extract the timing and extent of cross-protection. Moreover, the broad immune components responsible for such cross-protection can be determined. Such data can also be used to infer the timing and strength of some immune components in controlling a primary infection, even in the absence of serological data. By contrast, single infection data cannot be used to reliably recover this information. Hence, sequential infection data enhances our understanding of the mechanisms underlying the control and resolution of infection, and generates new insight into how previous exposure influences the time course of a subsequent infection.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/w7DAFCOVv-I&quot; height=&quot;1&quot;&gt;</description><updated>1547762400000</updated><content><content>&lt;p&gt;by Ada W. C. Yan, Sophie G. Zaloumis, Julie A. Simpson, James M. McCaw&lt;/p&gt;
Laboratory models are often used to understand the interaction of related pathogens via host immunity. For example, recent experiments where ferrets were exposed to two influenza strains within a short period of time have shown how the effects of cross-immunity vary with the time between exposures and the specific strains used. On the other hand, studies of the workings of different arms of the immune response, and their relative importance, typically use experiments involving a single infection. However, inferring the relative importance of different immune components from this type of data is challenging. Using simulations and mathematical modelling, here we investigate whether the sequential infection experiment design can be used not only to determine immune components contributing to cross-protection, but also to gain insight into the immune response during a single infection. We show that virological data from sequential infection experiments can be used to accurately extract the timing and extent of cross-protection. Moreover, the broad immune components responsible for such cross-protection can be determined. Such data can also be used to infer the timing and strength of some immune components in controlling a primary infection, even in the absence of serological data. By contrast, single infection data cannot be used to reliably recover this information. Hence, sequential infection data enhances our understanding of the mechanisms underlying the control and resolution of infection, and generates new insight into how previous exposure influences the time course of a subsequent infection.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/w7DAFCOVv-I&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>10.1371/journal.pcbi.1006568</originId><author><name>Ada W. C. Yan</name></author><recrawled>1547760425467</recrawled><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/w7DAFCOVv-I/article</href></item></alternate><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_1685d421ebd:fe255:1451c985</id><title>Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection</title><fingerprint>eb1c46de</fingerprint></item><item><engagement>0</engagement><crawled>1547060852440</crawled><visual><url>none</url></visual><author><name>Lavine, K.</name></author><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/474/eaaw0532?rss=1</link><content><content>&lt;p&gt;Exome sequencing reveals the genetic complexity of chronic kidney disease.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/474/eaaw0532?rss=1</originId><description>&lt;p&gt;Exome sequencing reveals the genetic complexity of chronic kidney disease.&lt;/p&gt;</description><canonicalUrl>http://stm.sciencemag.org/content/11/474/eaaw0532.full</canonicalUrl><published>1547059839000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/474/eaaw0532?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_168340336d8:d6f313:3a104d3b</id><title>[Editors&apos; Choice] Defining chronic kidney disease at the genetic level</title><fingerprint>e24de218</fingerprint></item><item><entities><item><label>O</label><id>nlp/f/entity/en/-/o</id><mentions><item><text>O</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>E. et al</label><id>nlp/f/entity/en/-/e. et al</id><mentions><item><text>E. et al</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>vivo</label><id>nlp/f/entity/en/-/vivo</id><mentions><item><text>vivo</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Nat</label><id>nlp/f/entity/en/-/nat</id><mentions><item><text>Nat</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Messenger RNA</label><id>nlp/f/entity/en/w/Messenger RNA</id><mentions><item><text>mRNA</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548872162027</crawled><visual><height>622</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0888-x/MediaObjects/41586_2019_888_Fig1_HTML.png</url></visual><author><name>Avni Baser</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-019-0888-x</link><content><content>&lt;p&gt;&lt;b&gt;Onset of differentiation is post-transcriptionally controlled in adult neural stem cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Onset of differentiation is post-transcriptionally controlled in adult neural stem cells, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0888-x&quot;&gt;doi:10.1038/s41586-019-0888-x&lt;/a&gt;&lt;/p&gt;Sequencing of total and ribosome-associated mRNAs enables identification of specific mRNAs that are differentially translationally regulated along the neuronal stem cell lineage, independently of their availability.</content><direction>ltr</direction></content><commonTopics><item><label>cell</label><id>nlp/f/topic/403</id><probability>1.0</probability></item><item><label>stem cells</label><id>nlp/f/topic/2185</id><probability>1.0</probability></item><item><label>brain</label><id>nlp/f/topic/314</id><probability>1.0</probability></item><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.982</probability></item><item><label>neuroscience</label><id>nlp/f/topic/1565</id><probability>0.979</probability></item><item><label>bioinformatics</label><id>nlp/f/topic/262</id><probability>0.87</probability></item><item><label>neurology</label><id>nlp/f/topic/1563</id><probability>0.832</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-019-0888-x</originId><description>&lt;p&gt;&lt;b&gt;Onset of differentiation is post-transcriptionally controlled in adult neural stem cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Onset of differentiation is post-transcriptionally controlled in adult neural stem cells, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0888-x&quot;&gt;doi:10.1038/s41586-019-0888-x&lt;/a&gt;&lt;/p&gt;Sequencing of total and ribosome-associated mRNAs enables identification of specific mRNAs that are differentially translationally regulated along the neuronal stem cell lineage, independently of their availability.</description><published>1548835200000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0888-x</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac57:3a104d3b</id><title>Onset of differentiation is post-transcriptionally controlled in adult neural stem cells</title><fingerprint>7554db77</fingerprint></item><item><entities><item><label>d</label><id>nlp/f/entity/en/-/d</id><mentions><item><text>d</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Gpr31b</label><id>nlp/f/entity/en/-/gpr31b</id><mentions><item><text>Gpr31b</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>NS</label><id>nlp/f/entity/en/-/ns</id><mentions><item><text>NS</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>CMRA</label><id>nlp/f/entity/en/-/cmra</id><mentions><item><text>CMRA</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Typhimurium</label><id>nlp/f/entity/en/-/typhimurium</id><mentions><item><text>Typhimurium</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548266506557</crawled><visual><height>664</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0884-1/MediaObjects/41586_2019_884_Fig1_HTML.png</url></visual><author><name>Naoki Morita</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-019-0884-1</link><content><content>&lt;p&gt;&lt;b&gt;GPR31-dependent dendrite protrusion of intestinal CX3CR1&lt;sup&gt;+&lt;/sup&gt; cells by bacterial metabolites&lt;/b&gt;&lt;/p&gt;&lt;p&gt;GPR31-dependent dendrite protrusion of intestinal CX3CR1&amp;lt;sup&gt;+&amp;lt;/sup&gt; cells by bacterial metabolites, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0884-1&quot;&gt;doi:10.1038/s41586-019-0884-1&lt;/a&gt;&lt;/p&gt;In the mouse intestine, pyruvate and lactate produced from bacterial metabolites enhance immune responses through inducing dendrite protrusion, mediated by GPR31, of small intestinal mononuclear cells that express CX3CR1.</content><direction>ltr</direction></content><commonTopics><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.955</probability></item><item><label>microscopy</label><id>nlp/f/topic/1457</id><probability>0.918</probability></item><item><label>classics</label><id>nlp/f/topic/477</id><probability>0.835</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-019-0884-1</originId><description>&lt;p&gt;&lt;b&gt;GPR31-dependent dendrite protrusion of intestinal CX3CR1&lt;sup&gt;+&lt;/sup&gt; cells by bacterial metabolites&lt;/b&gt;&lt;/p&gt;&lt;p&gt;GPR31-dependent dendrite protrusion of intestinal CX3CR1&amp;lt;sup&gt;+&amp;lt;/sup&gt; cells by bacterial metabolites, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0884-1&quot;&gt;doi:10.1038/s41586-019-0884-1&lt;/a&gt;&lt;/p&gt;In the mouse intestine, pyruvate and lactate produced from bacterial metabolites enhance immune responses through inducing dendrite protrusion, mediated by GPR31, of small intestinal mononuclear cells that express CX3CR1.</description><published>1548230400000</published><engagement>3</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0884-1</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687be0093d:2e2c1b7:c2ce2e2e</id><title>GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolites</title><fingerprint>47215894</fingerprint></item><item><updateCount>1</updateCount><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006711</href></item></canonical><engagement>0</engagement><crawled>1548183000873</crawled><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><published>1548194400000</published><link>10.1371/journal.pcbi.1006711</link><visual><height>153</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>320</width><url>https://journals.plos.org/ploscompbiol/article/figure/image?size=inline&amp;id=10.1371/journal.pcbi.1006711.g001</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><description>&lt;p&gt;by Debmalya Chakrabarty, Mounya Elhilali&lt;/p&gt;
Our current understanding of how the brain segregates auditory scenes into meaningful objects is in line with a Gestaltism framework. These Gestalt principles suggest a theory of how different attributes of the soundscape are extracted then bound together into separate groups that reflect different objects or streams present in the scene. These cues are thought to reflect the underlying statistical structure of natural sounds in a similar way that statistics of natural images are closely linked to the principles that guide figure-ground segregation and object segmentation in vision. In the present study, we leverage inference in stochastic neural networks to learn emergent grouping cues directly from natural soundscapes including speech, music and sounds in nature. The model learns a hierarchy of local and global spectro-temporal attributes reminiscent of simultaneous and sequential Gestalt cues that underlie the organization of auditory scenes. These mappings operate at multiple time scales to analyze an incoming complex scene and are then fused using a Hebbian network that binds together coherent features into perceptually-segregated auditory objects. The proposed architecture successfully emulates a wide range of well established auditory scene segregation phenomena and quantifies the complimentary role of segregation and binding cues in driving auditory scene segregation.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/vyBkEuhJkjY&quot; height=&quot;1&quot;&gt;</description><updated>1548194400000</updated><content><content>&lt;p&gt;by Debmalya Chakrabarty, Mounya Elhilali&lt;/p&gt;
Our current understanding of how the brain segregates auditory scenes into meaningful objects is in line with a Gestaltism framework. These Gestalt principles suggest a theory of how different attributes of the soundscape are extracted then bound together into separate groups that reflect different objects or streams present in the scene. These cues are thought to reflect the underlying statistical structure of natural sounds in a similar way that statistics of natural images are closely linked to the principles that guide figure-ground segregation and object segmentation in vision. In the present study, we leverage inference in stochastic neural networks to learn emergent grouping cues directly from natural soundscapes including speech, music and sounds in nature. The model learns a hierarchy of local and global spectro-temporal attributes reminiscent of simultaneous and sequential Gestalt cues that underlie the organization of auditory scenes. These mappings operate at multiple time scales to analyze an incoming complex scene and are then fused using a Hebbian network that binds together coherent features into perceptually-segregated auditory objects. The proposed architecture successfully emulates a wide range of well established auditory scene segregation phenomena and quantifies the complimentary role of segregation and binding cues in driving auditory scene segregation.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/vyBkEuhJkjY&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>10.1371/journal.pcbi.1006711</originId><author><name>Debmalya Chakrabarty</name></author><recrawled>1548192423393</recrawled><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/vyBkEuhJkjY/article</href></item></alternate><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_16876e5d729:325dae5:b77f238b</id><title>A Gestalt inference model for auditory scene segregation</title><fingerprint>ec72f462</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37539-x</href></item></canonical><engagement>0</engagement><crawled>1548758002641</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Seena Fazel</name></author><visual><height>556</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37539-x/MediaObjects/41598_2018_37539_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37539-x</link><content><content>&lt;p&gt;&lt;b&gt;Prediction of violent reoffending in prisoners and individuals on probation: a Dutch validation study (OxRec)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Prediction of violent reoffending in prisoners and individuals on probation: a Dutch validation study (OxRec), Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37539-x&quot;&gt;doi:10.1038/s41598-018-37539-x&lt;/a&gt;&lt;/p&gt;Prediction of violent reoffending in prisoners and individuals on probation: a Dutch validation study (OxRec)&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/HLzuydHZxiE&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37539-x</originId><description>&lt;p&gt;&lt;b&gt;Prediction of violent reoffending in prisoners and individuals on probation: a Dutch validation study (OxRec)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Prediction of violent reoffending in prisoners and individuals on probation: a Dutch validation study (OxRec), Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37539-x&quot;&gt;doi:10.1038/s41598-018-37539-x&lt;/a&gt;&lt;/p&gt;Prediction of violent reoffending in prisoners and individuals on probation: a Dutch validation study (OxRec)&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/HLzuydHZxiE&quot; height=&quot;1&quot;&gt;</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/HLzuydHZxiE/s41598-018-37539-x</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168992babd1:22a03d:ad2b6584</id><title>Prediction of violent reoffending in prisoners and individuals on probation: a Dutch validation study (OxRec)</title><fingerprint>852ab1fb</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00458</href></item></canonical><engagement>0</engagement><crawled>1547245045821</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><author><name>Zheng Zhao, Lei Xie, Philip E. Bourne</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jcim.8b00458</link><originId>http://dx.doi.org/10.1021/acs.jcim.8b00458</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00458/20190111/images/medium/ci-2018-00458p_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00458&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=Wn3PcUHnY8A:bI5V2y9bs-A:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/Wn3PcUHnY8A&quot; height=&quot;1&quot;&gt;</description><published>1547182800000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/Wn3PcUHnY8A/acs.jcim.8b00458</href></item></alternate><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_1683efdc83d:20678c:875042c9</id><title>[ASAP] Structural Insights into Characterizing Binding Sites in Epidermal Growth Factor Receptor Kinase Mutants</title><fingerprint>201efd12</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00458/20190111/images/medium/ci-2018-00458p_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00458&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=Wn3PcUHnY8A:bI5V2y9bs-A:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/Wn3PcUHnY8A&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><entities><item><label>Nature 562</label><id>nlp/f/entity/en/-/nature 562</id><mentions><item><text>Nature 562</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>UK Biobank</label><id>nlp/f/entity/en/w/UK Biobank</id><mentions><item><text>UK Biobank</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Python</label><id>nlp/f/entity/en/w/Python (programming language)</id><mentions><item><text>Python</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Eye and Vision consortium</label><id>nlp/f/entity/en/-/eye and vision consortium</id><mentions><item><text>Eye and Vision consortium</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>daily Nature Briefing</label><id>nlp/f/entity/en/-/daily nature briefing</id><mentions><item><text>daily Nature Briefing</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548248901536</crawled><visual><url>none</url></visual><author><name>Philipp Berens</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00231-9</link><content><content>&lt;p&gt;&lt;b&gt;Proprietary data formats block health research&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Proprietary data formats block health research, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00231-9&quot;&gt;doi:10.1038/d41586-019-00231-9&lt;/a&gt;&lt;/p&gt;Proprietary data formats block health research</content><direction>ltr</direction></content><commonTopics><item><label>big data</label><id>nlp/f/topic/253</id><probability>0.96</probability></item><item><label>data science</label><id>nlp/f/topic/618</id><probability>0.934</probability></item><item><label>analytics</label><id>nlp/f/topic/90</id><probability>0.927</probability></item><item><label>data protection</label><id>nlp/f/topic/617</id><probability>0.92</probability></item><item><label>epidemiology</label><id>nlp/f/topic/783</id><probability>0.88</probability></item><item><label>healthcare it</label><id>nlp/f/topic/1049</id><probability>0.851</probability></item><item><label>business</label><id>nlp/f/topic/349</id><probability>0.765</probability></item><item><label>proteomics</label><id>nlp/f/topic/1840</id><probability>0.744</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00231-9</originId><description>&lt;p&gt;&lt;b&gt;Proprietary data formats block health research&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Proprietary data formats block health research, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00231-9&quot;&gt;doi:10.1038/d41586-019-00231-9&lt;/a&gt;&lt;/p&gt;Proprietary data formats block health research</description><published>1548230400000</published><engagement>7</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00231-9</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687ad367a0:2d3ea73:3a104d3b</id><title>Proprietary data formats block health research</title><fingerprint>bdbe114f</fingerprint></item><item><engagement>0</engagement><crawled>1548734518133</crawled><fingerprint>9f345fa1</fingerprint><author><name>Ayati, M.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/251009v2?rss=1</link><content><content>We present CoPhosK to predict kinase-substrate associations for phosphopeptide substrates detected by mass spectrometry (MS). The tool utilizes a Naive Bayes framework with priors of known kinase-substrate associations (KSAs) to generate its predictions. Through the mining of MS data for the collective dynamic signatures of the kinases substrates revealed by correlation analysis of phosphopeptide intensity data, the tool infers KSAs in the data for the considerable body of substrates lacking such annotations. We benchmarked the tool against existing approaches for predicting KSAs that rely on static information (e.g. sequences, structures and interactions) using publically available MS data, including breast, colon, and ovarian cancer models. The benchmarking reveals that co-phosphorylation analysis can significantly improve prediction performance when static information is available (about 35% of sites) while providing reliable predictions for the remainder, thus tripling the KSAs available from the experimental MS data providing a to comprehensive and reliable characterization of the landscape of kinase-substrate interactions well beyond current limitations.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/251009v2?rss=1</originId><description>We present CoPhosK to predict kinase-substrate associations for phosphopeptide substrates detected by mass spectrometry (MS). The tool utilizes a Naive Bayes framework with priors of known kinase-substrate associations (KSAs) to generate its predictions. Through the mining of MS data for the collective dynamic signatures of the kinases substrates revealed by correlation analysis of phosphopeptide intensity data, the tool infers KSAs in the data for the considerable body of substrates lacking such annotations. We benchmarked the tool against existing approaches for predicting KSAs that rely on static information (e.g. sequences, structures and interactions) using publically available MS data, including breast, colon, and ovarian cancer models. The benchmarking reveals that co-phosphorylation analysis can significantly improve prediction performance when static information is available (about 35% of sites) while providing reliable predictions for the remainder, thus tripling the KSAs available from the experimental MS data providing a to comprehensive and reliable characterization of the landscape of kinase-substrate interactions well beyond current limitations.</description><published>1548662400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/251009v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16897c55375:16157:3a104d3b</id><title>CoPhosK: A Method for Comprehensive Kinase Substrate Annotation Using Co-phosphorylation Analysis [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/251009v2</canonicalUrl></item><item><entities><item><label>Commonwealth Climate Resilience Network</label><id>nlp/f/entity/en/-/commonwealth climate resilience network</id><mentions><item><text>Commonwealth Climate Resilience Network</text></item><item><text>commonwealth</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Association of Commonwealth Universities</label><id>nlp/f/entity/en/w/Association of Commonwealth Universities</id><mentions><item><text>Association of Commonwealth Universities</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>University of the West Indies</label><id>nlp/f/entity/en/w/University of the West Indies</id><mentions><item><text>University of the West Indies</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Fiji National University</label><id>nlp/f/entity/en/w/Fiji National University</id><mentions><item><text>Fiji National University</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>University of the South Pacific</label><id>nlp/f/entity/en/w/University of the South Pacific</id><mentions><item><text>University of the South Pacific</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546434278506</crawled><visual><url>none</url></visual><author><name>Joanna Newman</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07873-1</link><content><content>&lt;p&gt;&lt;b&gt;Islands’ institutes band together against climate change&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Islands’ institutes band together against climate change, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07873-1&quot;&gt;doi:10.1038/d41586-018-07873-1&lt;/a&gt;&lt;/p&gt;Islands’ institutes band together against climate change</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/d41586-018-07873-1</originId><description>&lt;p&gt;&lt;b&gt;Islands’ institutes band together against climate change&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Islands’ institutes band together against climate change, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07873-1&quot;&gt;doi:10.1038/d41586-018-07873-1&lt;/a&gt;&lt;/p&gt;Islands’ institutes band together against climate change</description><published>1546416000000</published><engagement>3</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07873-1</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680eaa746a:60d06e8:3a104d3b</id><title>Islands’ institutes band together against climate change</title><fingerprint>b5dc3104</fingerprint></item><item><entities><item><label>HIF - 1α</label><id>nlp/f/entity/en/-/hif - 1α</id><mentions><item><text>HIF - 1α</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>αKG / Fum</label><id>nlp/f/entity/en/-/αkg / fum</id><mentions><item><text>αKG</text></item><item><text>αKG / Fum</text></item><item><text>Fum</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>o</label><id>nlp/f/entity/en/-/o</id><mentions><item><text>o</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Glu</label><id>nlp/f/entity/en/-/glu</id><mentions><item><text>Glu</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Suc</label><id>nlp/f/entity/en/-/suc</id><mentions><item><text>Suc</text></item></mentions><salienceLevel>about</salienceLevel></item></entities><crawled>1547662375584</crawled><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><author><name>Steve Stegen</name></author><engagement>24</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-019-0874-3</link><content><content>&lt;p&gt;&lt;b&gt;HIF-1α metabolically controls collagen synthesis and modification in chondrocytes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;HIF-1α metabolically controls collagen synthesis and modification in chondrocytes, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0874-3&quot;&gt;doi:10.1038/s41586-019-0874-3&lt;/a&gt;&lt;/p&gt;Increased glutamine metabolism caused by unregulated HIF-1α signalling in mouse chondrocytes results in increased post-translational modification of collagen and skeletal dysplasia, demonstrating that strict regulation of HIF-1α signalling in chondrocytes is essential for normal bone growth.</content><direction>ltr</direction></content><commonTopics><item><label>classics</label><id>nlp/f/topic/477</id><probability>0.957</probability></item><item><label>data science</label><id>nlp/f/topic/618</id><probability>0.892</probability></item><item><label>algorithms</label><id>nlp/f/topic/76</id><probability>0.883</probability></item><item><label>ctf</label><id>nlp/f/topic/592</id><probability>0.852</probability></item><item><label>nlp</label><id>nlp/f/topic/1585</id><probability>0.706</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-019-0874-3</originId><description>&lt;p&gt;&lt;b&gt;HIF-1α metabolically controls collagen synthesis and modification in chondrocytes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;HIF-1α metabolically controls collagen synthesis and modification in chondrocytes, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0874-3&quot;&gt;doi:10.1038/s41586-019-0874-3&lt;/a&gt;&lt;/p&gt;Increased glutamine metabolism caused by unregulated HIF-1α signalling in mouse chondrocytes results in increased post-translational modification of collagen and skeletal dysplasia, demonstrating that strict regulation of HIF-1α signalling in chondrocytes is essential for normal bone growth.</description><published>1547625600000</published><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0874-3</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05ec:3a104d3b</id><title>HIF-1α metabolically controls collagen synthesis and modification in chondrocytes</title><fingerprint>e20961c6</fingerprint></item><item><entities><item><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id><mentions><item><text>CSS</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id><mentions><item><text>Explorer</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id><mentions><item><text>WEBSITEnature_com</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id><mentions><item><text>JavaScript</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548177141579</crawled><visual><height>658</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>676</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41587-018-0005-y/MediaObjects/41587_2018_5_Fig1_HTML.png</url></visual><author><name>Sergey Koren</name></author><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><link>https://www.nature.com/articles/s41587-018-0005-y</link><content><content>&lt;p&gt;&lt;b&gt;Reply to ‘Errors in long-read assemblies can critically affect protein prediction’&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Reply to ‘Errors in long-read assemblies can critically affect protein prediction’, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41587-018-0005-y&quot;&gt;doi:10.1038/s41587-018-0005-y&lt;/a&gt;&lt;/p&gt;Reply to ‘Errors in long-read assemblies can critically affect protein prediction’</content><direction>ltr</direction></content><commonTopics><item><label>web design</label><id>nlp/f/topic/2461</id><probability>0.933</probability></item><item><label>css</label><id>nlp/f/topic/590</id><probability>0.933</probability></item></commonTopics><originId>https://www.nature.com/articles/s41587-018-0005-y</originId><description>&lt;p&gt;&lt;b&gt;Reply to ‘Errors in long-read assemblies can critically affect protein prediction’&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Reply to ‘Errors in long-read assemblies can critically affect protein prediction’, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41587-018-0005-y&quot;&gt;doi:10.1038/s41587-018-0005-y&lt;/a&gt;&lt;/p&gt;Reply to ‘Errors in long-read assemblies can critically affect protein prediction’</description><published>1548144000000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41587-018-0005-y</href></item></alternate><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_168768c6f4b:2627b91:c2ce2e2e</id><title>Reply to ‘Errors in long-read assemblies can critically affect protein prediction’</title><fingerprint>320d5d6e</fingerprint></item><item><entities><item><label>Nick Sireau</label><id>nlp/f/entity/en/-/nick sireau</id><mentions><item><text>Nick Sireau</text></item><item><text>Nick</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Geoff Marsh</label><id>nlp/f/entity/en/-/geoff marsh</id><mentions><item><text>Geoff Marsh</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Ranga</label><id>nlp/f/entity/en/-/ranga</id><mentions><item><text>Ranga</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>National Health Service</label><id>nlp/f/entity/en/w/National Health Service (England)</id><mentions><item><text>NHS</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>AKU centre</label><id>nlp/f/entity/en/-/aku centre</id><mentions><item><text>AKU centre</text></item><item><text>AKU</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547473336197</crawled><visual><height>450</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>800</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00136-7/d41586-019-00136-7_16395366.jpg</url></visual><published>1547452800000</published><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00136-7</link><content><content>&lt;p&gt;&lt;b&gt;Podcast Extra: The quest for a rare disease treatment&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Podcast Extra: The quest for a rare disease treatment, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00136-7&quot;&gt;doi:10.1038/d41586-019-00136-7&lt;/a&gt;&lt;/p&gt;One father’s search to help his sons.</content><direction>ltr</direction></content><commonTopics><item><label>ehealth</label><id>nlp/f/topic/745</id><probability>0.969</probability></item><item><label>digital health</label><id>nlp/f/topic/657</id><probability>0.965</probability></item><item><label>medical devices</label><id>nlp/f/topic/1430</id><probability>0.859</probability></item><item><label>rheumatology</label><id>nlp/f/topic/1947</id><probability>0.852</probability></item><item><label>epidemiology</label><id>nlp/f/topic/783</id><probability>0.77</probability></item><item><label>medicine</label><id>nlp/f/topic/1433</id><probability>0.766</probability></item><item><label>healthcare it</label><id>nlp/f/topic/1049</id><probability>0.727</probability></item><item><label>home theater</label><id>nlp/f/topic/1078</id><probability>0.717</probability></item><item><label>drug discovery</label><id>nlp/f/topic/697</id><probability>0.711</probability></item><item><label>drugs</label><id>nlp/f/topic/698</id><probability>0.702</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00136-7</originId><description>&lt;p&gt;&lt;b&gt;Podcast Extra: The quest for a rare disease treatment&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Podcast Extra: The quest for a rare disease treatment, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00136-7&quot;&gt;doi:10.1038/d41586-019-00136-7&lt;/a&gt;&lt;/p&gt;One father’s search to help his sons.</description><author><name>NA</name></author><engagement>13</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00136-7</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1684c993785:2ca8fa7:3a104d3b</id><title>Podcast Extra: The quest for a rare disease treatment</title><fingerprint>f34aae95</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37586-4</href></item></canonical><engagement>0</engagement><crawled>1548238772764</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Yang Liu</name></author><visual><height>561</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37586-4/MediaObjects/41598_2018_37586_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37586-4</link><content><content>&lt;p&gt;&lt;b&gt;Field-free Magnetization Switching by Utilizing the Spin Hall Effect and Interlayer Exchange Coupling of Iridium&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Field-free Magnetization Switching by Utilizing the Spin Hall Effect and Interlayer Exchange Coupling of Iridium, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37586-4&quot;&gt;doi:10.1038/s41598-018-37586-4&lt;/a&gt;&lt;/p&gt;Field-free Magnetization Switching by Utilizing the Spin Hall Effect and Interlayer Exchange Coupling of Iridium&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/2EAP0JHHQQQ&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37586-4</originId><description>&lt;p&gt;&lt;b&gt;Field-free Magnetization Switching by Utilizing the Spin Hall Effect and Interlayer Exchange Coupling of Iridium&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Field-free Magnetization Switching by Utilizing the Spin Hall Effect and Interlayer Exchange Coupling of Iridium, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37586-4&quot;&gt;doi:10.1038/s41598-018-37586-4&lt;/a&gt;&lt;/p&gt;Field-free Magnetization Switching by Utilizing the Spin Hall Effect and Interlayer Exchange Coupling of Iridium&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/2EAP0JHHQQQ&quot; height=&quot;1&quot;&gt;</description><published>1548230400000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/2EAP0JHHQQQ/s41598-018-37586-4</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1687a38da1c:2c4c17f:3a104d3b</id><title>Field-free Magnetization Switching by Utilizing the Spin Hall Effect and Interlayer Exchange Coupling of Iridium</title><fingerprint>af28e140</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01473</href></item></canonical><engagement>0</engagement><crawled>1547817471562</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><author><name>Kevin M. Peese, Christopher W. Allard, Timothy Connolly, Barry L. Johnson, Chen Li, Manoj Patel, Margaret E. Sorensen, Michael A. Walker, Nicholas A. Meanwell, Brian McAuliffe, Beatrice Minassian, Mark Krystal, Dawn D. Parker, Hal A. Lewis, Kevin Kish, Ping Zhang, Robert T. Nolte, Jean Simmermacher, Susan Jenkins, Christopher Cianci, B. Narasimhulu Naidu</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01473</link><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01473</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01473/20190117/images/medium/jm-2018-01473e_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01473&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=saYfXohRd48:GT0855puOOY:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/saYfXohRd48&quot; height=&quot;1&quot;&gt;</description><published>1547787600000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/saYfXohRd48/acs.jmedchem.8b01473</href></item></alternate><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_168611c4e4a:13b2a8:1451c985</id><title>[ASAP] 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors</title><fingerprint>3e762af0</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01473/20190117/images/medium/jm-2018-01473e_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01473&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=saYfXohRd48:GT0855puOOY:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/saYfXohRd48&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><crawled>1547486096938</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1547424000000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Instructed-Assembly_as_Context-Dependent_Nanoscale_Signals_for_Death_and_Morphogenesis_of_Cells/7581590</link><originId>https://chemrxiv.org/articles/Instructed-Assembly_as_Context-Dependent_Nanoscale_Signals_for_Death_and_Morphogenesis_of_Cells/7581590</originId><description>Context-dependent signaling, as a ubiquitous phenomenon in nature, is a dynamic molecular process at nano- and microscales, but how to mimic its essence using non-covalent synthesis in cellular environment has yet to be developed. Here we show a dynamic continuum of non-covalent filaments formed by instructed-assembly (iA) of a supramolecular phosphoglycopeptide (sPGP) as context-dependent signals for controlling death and morphogenesis of cells. Specifically, while enzymes (i.e., ectophosphatases) on cancer cells catalyze the formation of the filaments of the sPGP to result in cell death, damping the enzyme activity induces 3D cell spheroids. Similarly, relying on the ratio of stromal and cancer cells in a co-culture to modulate the expression of the ectophosphatase, the iA process enables cell spheroids. The spheroids act as a mimic of tumor microenvironment for drug screening. As the first demonstration of iA as multifunctional processes according to local enzyme activity for controlling cell behavior, this work illustrates context-dependent biological functions of non-covalent synthesis in cellular environment.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Instructed-Assembly_as_Context-Dependent_Nanoscale_Signals_for_Death_and_Morphogenesis_of_Cells/7581590</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1684d5bee2a:2df15cb:3a104d3b</id><title>Instructed-Assembly as Context-Dependent Nanoscale Signals for Death and Morphogenesis of Cells</title><fingerprint>4abee4a9</fingerprint><summary><content>Context-dependent signaling, as a ubiquitous phenomenon in nature, is a dynamic molecular process at nano- and microscales, but how to mimic its essence using non-covalent synthesis in cellular environment has yet to be developed. Here we show a dynamic continuum of non-covalent filaments formed by instructed-assembly (iA) of a supramolecular phosphoglycopeptide (sPGP) as context-dependent signals for controlling death and morphogenesis of cells. Specifically, while enzymes (i.e., ectophosphatases) on cancer cells catalyze the formation of the filaments of the sPGP to result in cell death, damping the enzyme activity induces 3D cell spheroids. Similarly, relying on the ratio of stromal and cancer cells in a co-culture to modulate the expression of the ectophosphatase, the iA process enables cell spheroids. The spheroids act as a mimic of tumor microenvironment for drug screening. As the first demonstration of iA as multifunctional processes according to local enzyme activity for controlling cell behavior, this work illustrates context-dependent biological functions of non-covalent synthesis in cellular environment.</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1548270343644</crawled><visual><url>none</url></visual><published>1548269442000</published><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw6162?rss=1</link><originId>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw6162?rss=1</originId><fingerprint>5b11ce42</fingerprint><author><name>NA</name></author><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/476/eaaw6162?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1687c1a95dc:2f64339:ad2b6584</id><title>[Errata] Erratum for the Research Article: &quot;Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence&quot; by J. M. Balko, L. J. Schwarz, N. Luo, M. V. Estrada, J. M. Giltnane, D. Davila-Gonzalez, K. Wang, V. Sanchez, P. T. Dean, S. E. Combs, D. Hicks, J. A. Pinto, M. D. Landis, F. D. Doimi, R. Yelensky, V. A. Miller, P. J. Stephens, D. L. Rimm, H. Gomez, J. C. Chang, M. E. Sanders, R. S. Cook, C. L. Arteaga</title><canonicalUrl>http://stm.sciencemag.org/content/11/476/eaaw6162.full</canonicalUrl></item><item><entities><item><label>Primo Levi</label><id>nlp/f/entity/en/w/Primo Levi</id><mentions><item><text>Primo Levi</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Levi Strauss &amp; Co.</label><id>nlp/f/entity/en/w/Levi Strauss &amp; Co.</id><mentions><item><text>Levi</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Periodic table</label><id>nlp/f/entity/en/w/Periodic table</id><mentions><item><text>Periodic Table</text></item><item><text>The Periodic Table</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Bridgeman</label><id>nlp/f/entity/en/-/bridgeman</id><mentions><item><text>Bridgeman</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Jews</label><id>nlp/f/entity/en/w/Jews</id><mentions><item><text>Jewish</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548670585944</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00288-6/d41586-019-00288-6_16420130.jpg</url></visual><author><name>Tim Radford</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00288-6</link><content><content>&lt;p&gt;&lt;b&gt;In his element: looking back on Primo Levi’s &lt;i&gt;The Periodic Table&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;In his element: looking back on Primo Levi’s &amp;lt;i&gt;The Periodic Table&amp;lt;/i&gt;, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00288-6&quot;&gt;doi:10.1038/d41586-019-00288-6&lt;/a&gt;&lt;/p&gt;Tim Radford celebrates an extraordinary short-story collection.</content><direction>ltr</direction></content><commonTopics><item><label>books</label><id>nlp/f/topic/303</id><probability>0.916</probability></item><item><label>germany</label><id>nlp/f/topic/964</id><probability>0.78</probability></item><item><label>jewish</label><id>nlp/f/topic/1235</id><probability>0.758</probability></item><item><label>peak oil</label><id>nlp/f/topic/1712</id><probability>0.752</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00288-6</originId><description>&lt;p&gt;&lt;b&gt;In his element: looking back on Primo Levi’s &lt;i&gt;The Periodic Table&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;In his element: looking back on Primo Levi’s &amp;lt;i&gt;The Periodic Table&amp;lt;/i&gt;, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00288-6&quot;&gt;doi:10.1038/d41586-019-00288-6&lt;/a&gt;&lt;/p&gt;Tim Radford celebrates an extraordinary short-story collection.</description><engagementRate>0.44</engagementRate><published>1548662400000</published><engagement>4</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00288-6</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16893f5cc58:4de9b91:ad2b6584</id><title>In his element: looking back on Primo Levi’s The Periodic Table</title><fingerprint>500d25a8</fingerprint></item><item><engagement>1</engagement><crawled>1546452174256</crawled><visual><height>324</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>250</width><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14014484/thumb.png</url></visual><published>1546387200000</published><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Metallopolymerization_as_a_Strategy_to_Translate_Ligand-Modulated_Chemoselectivity_to_Porous_Catalysts/7538747</link><originId>https://chemrxiv.org/articles/Metallopolymerization_as_a_Strategy_to_Translate_Ligand-Modulated_Chemoselectivity_to_Porous_Catalysts/7538747</originId><description>Porous catalysts have garnered substantial interest as potential platforms for
group-transfer catalysis due to the ability to site-isolate catalysts and to non-covalently co-
localize substrates in proximity to reactive intermediates. In contrast to soluble molecular
catalysts, the limited synthetic toolbox available to prepare porous catalysts presents a
formidable challenge to controlling the primary coordination sphere of lattice-confined
catalysts and thus modulating the electronic structures of reactive catalyst intermediates.
Here, we utilize Sonogashira cross-coupling chemistry to prepare a family of porous
metallopolymers, in which the primary coordination sphere of Ru2 sites is systematically
varied. The newly synthesized materials are characterized by IR, elemental analysis, gas
sorption, powder X-ray diffraction, thermogravimetric analysis, X-ray absorption
spectroscopy, and diffuse-reflectance UV-vis-NIR spectroscopy. The resulting porous
materials are catalysts for nitrene-transfer chemistry and the chemoselectivty for allylic
amination of olefin aziridination can be tuned by modulating the primary coordination
sphere of the catalyst sites. The demonstration of metallopolymerization as a rational
synthetic strategy allows to translate ligand-modulated chemoselectivity to porous
catalysts, which represents a new opportunity to tailor the functionality of heterogeneous
analogues of molecular complexes.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Metallopolymerization_as_a_Strategy_to_Translate_Ligand-Modulated_Chemoselectivity_to_Porous_Catalysts/7538747</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1680fbb85b0:615f868:c2ce2e2e</id><title>Metallopolymerization as a Strategy to Translate Ligand-Modulated Chemoselectivity to Porous Catalysts</title><fingerprint>448cdeea</fingerprint><summary><content>Porous catalysts have garnered substantial interest as potential platforms for
group-transfer catalysis due to the ability to site-isolate catalysts and to non-covalently co-
localize substrates in proximity to reactive intermediates. In contrast to soluble molecular
catalysts, the limited synthetic toolbox available to prepare porous catalysts presents a
formidable challenge to controlling the primary coordination sphere of lattice-confined
catalysts and thus modulating the electronic structures of reactive catalyst intermediates.
Here, we utilize Sonogashira cross-coupling chemistry to prepare a family of porous
metallopolymers, in which the primary coordination sphere of Ru2 sites is systematically
varied. The newly synthesized materials are characterized by IR, elemental analysis, gas
sorption, powder X-ray diffraction, thermogravimetric analysis, X-ray absorption
spectroscopy, and diffuse-reflectance UV-vis-NIR spectroscopy. The resulting porous
materials are catalysts for nitrene-transfer chemistry and the chemoselectivty for allylic
amination of olefin aziridination can be tuned by modulating the primary coordination
sphere of the catalyst sites. The demonstration of metallopolymerization as a rational
synthetic strategy allows to translate ligand-modulated chemoselectivity to porous
catalysts, which represents a new opportunity to tailor the functionality of heterogeneous
analogues of molecular complexes.</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acschembio.8b01043</href></item></canonical><engagement>0</engagement><crawled>1548796870348</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acbcct</streamId><title>ACS Chemical Biology: Latest Articles (ACS Publications)</title></origin><author><name>Reham Al-Dhelaan, Paul S. Russo, Sean E. Padden, Anthony Amaya, Debbie W. Dong, Young-Ok You</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acschembio.8b01043</link><originId>http://dx.doi.org/10.1021/acschembio.8b01043</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b01043/20190129/images/medium/cb-2018-01043x_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b01043&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=NjXq3W9-3kM:qshe0xvk17o:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/NjXq3W9-3kM&quot; height=&quot;1&quot;&gt;</description><published>1548738000000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/acbcct/~3/NjXq3W9-3kM/acschembio.8b01043</href></item></alternate><id>ofNPcmQ46PpGzt1nO49W9STAvkUsM7jssLxNXMp09ME=_1689b7cbecc:228142:875042c9</id><title>[ASAP] Condensation-Incompetent Ketosynthase Inhibits trans-Acyltransferase Activity</title><fingerprint>c5e14d5a</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b01043/20190129/images/medium/cb-2018-01043x_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b01043&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=NjXq3W9-3kM:qshe0xvk17o:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/NjXq3W9-3kM&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><engagement>181</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Wade, L.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/333?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/333?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6425/333.full</canonicalUrl><published>1548355045000</published><keywords><item>Evolution, Genetics</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/333?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a93:c2ce2e2e</id><title>Light skin may be legacy of Native American ancestors</title><fingerprint>20e553c4</fingerprint></item><item><engagement>0</engagement><crawled>1548741740132</crawled><fingerprint>cfb666b9</fingerprint><author><name>Xie, X.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/503458v2?rss=1</link><content><content>Identification of functional non-coding variants (polymorphisms) and their mechanistic interpretation is a major challenge of modern genomics, especially for precision medicine. Transcription factor (TF) binding profiles and epigenomic landscapes in reference samples can help us functionally annotate the genome, but do not provide ready answers regarding the effects of non-coding variants. A promising computational approach is to build models that predict TF-DNA binding from sequence, and use such models to score a variant&apos;s impact on TF binding strength. Here, we asked if this mechanistic approach to variant interpretation can be combined with information on genotype-phenotype associations to discover important transcription factors regulating phenotypic variation among individuals. We developed a statistical approach that integrates phenotype, genotype, gene expression, TF ChIP-seq and Hi-C chromatin interaction data to answer this question. Using drug sensitivity measured in lymphoblastoid cell lines as the phenotype of interest, we tested if the non-coding variants statistically linked to the phenotype are enriched for strong predicted impact on DNA-binding strength of a TF, and used this test to identify TFs regulating individual differences in the phenotype. Our method relies on a new method for predicting variant impact on TF-DNA binding, that uses a combination of biophysical modelling and machine learning. We report statistical and literature-based support for many of the TFs discovered here as regulators of drug response variation. We show that the use of mechanistically driven variant impact predictors can identify TF-drug associations that would otherwise be missed. We examined in depth the evidence underlying one reported association - that of the transcription factor ELF1 with the drug doxorubicin - and identified several genes that may mediate this regulatory relationship.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/503458v2?rss=1</originId><description>Identification of functional non-coding variants (polymorphisms) and their mechanistic interpretation is a major challenge of modern genomics, especially for precision medicine. Transcription factor (TF) binding profiles and epigenomic landscapes in reference samples can help us functionally annotate the genome, but do not provide ready answers regarding the effects of non-coding variants. A promising computational approach is to build models that predict TF-DNA binding from sequence, and use such models to score a variant&apos;s impact on TF binding strength. Here, we asked if this mechanistic approach to variant interpretation can be combined with information on genotype-phenotype associations to discover important transcription factors regulating phenotypic variation among individuals. We developed a statistical approach that integrates phenotype, genotype, gene expression, TF ChIP-seq and Hi-C chromatin interaction data to answer this question. Using drug sensitivity measured in lymphoblastoid cell lines as the phenotype of interest, we tested if the non-coding variants statistically linked to the phenotype are enriched for strong predicted impact on DNA-binding strength of a TF, and used this test to identify TFs regulating individual differences in the phenotype. Our method relies on a new method for predicting variant impact on TF-DNA binding, that uses a combination of biophysical modelling and machine learning. We report statistical and literature-based support for many of the TFs discovered here as regulators of drug response variation. We show that the use of mechanistically driven variant impact predictors can identify TF-drug associations that would otherwise be missed. We examined in depth the evidence underlying one reported association - that of the transcription factor ELF1 with the drug doxorubicin - and identified several genes that may mediate this regulatory relationship.</description><published>1548662400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/503458v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16898338664:a571c:3a104d3b</id><title>Mechanistic interpretation of non-coding variants helps discover transcriptional regulators of drug response [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/503458v2</canonicalUrl></item><item><crawled>1548081011051</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1548028800000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Rising_Importance_of_Organosulfur_Species_for_Aerosol_Properties_and_Future_Air_Quality/7597397</link><originId>https://chemrxiv.org/articles/Rising_Importance_of_Organosulfur_Species_for_Aerosol_Properties_and_Future_Air_Quality/7597397</originId><description>Acid-driven multiphase chemistry of isoprene epoxydiols (IEPOX), a key isoprene oxidation product, with inorganic sulfate aerosol yields substantial amounts of secondary organic aerosol (SOA) through the formation of organosulfur. The extent and implications of inorganic-to-organic sulfate conversion, however, are unknown. Herein, we reveal that extensive consumption of inorganic sulfate occurs, which increases with the IEPOX-to-inorganic sulfate ratio (IEPOX:Sulfinorg), as determined by laboratory and field measurements. We further demonstrate that organosulfur greatly modifies critical aerosol properties, such as acidity, morphology, viscosity, and phase state. These new mechanistic insights reveal that changes in SO2 emissions, especially in isoprene-dominated environments, will significantly alter biogenic SOA physicochemical properties. Consequently, IEPOX:Sulfinorg will play a central role in understanding historical climate and determining future impacts of biogenic SOA on global climate and air quality.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Rising_Importance_of_Organosulfur_Species_for_Aerosol_Properties_and_Future_Air_Quality/7597397</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16870d1996b:1e6dcdf:3a104d3b</id><title>Rising Importance of Organosulfur Species for Aerosol Properties and Future Air Quality</title><fingerprint>35f4894a</fingerprint><summary><content>Acid-driven multiphase chemistry of isoprene epoxydiols (IEPOX), a key isoprene oxidation product, with inorganic sulfate aerosol yields substantial amounts of secondary organic aerosol (SOA) through the formation of organosulfur. The extent and implications of inorganic-to-organic sulfate conversion, however, are unknown. Herein, we reveal that extensive consumption of inorganic sulfate occurs, which increases with the IEPOX-to-inorganic sulfate ratio (IEPOX:Sulfinorg), as determined by laboratory and field measurements. We further demonstrate that organosulfur greatly modifies critical aerosol properties, such as acidity, morphology, viscosity, and phase state. These new mechanistic insights reveal that changes in SO2 emissions, especially in isoprene-dominated environments, will significantly alter biogenic SOA physicochemical properties. Consequently, IEPOX:Sulfinorg will play a central role in understanding historical climate and determining future impacts of biogenic SOA on global climate and air quality.</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1546130261095</crawled><fingerprint>b8ad1f42</fingerprint><author><name>Tran, A. N.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>False</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/355032v2?rss=1</link><content><content>Background: The Human Protein Atlas (HPA) aims to map human proteins via multiple technologies including imaging, proteomics and transcriptomics. Access of the HPA data is mainly via web-based interface allowing views of individual proteins, which may not be optimal for data analysis of a gene set, or automatic retrieval of original images. Results: HPAanalyze is an R package for retrieving and performing exploratory analysis of data from HPA. HPAanalyze provides functionality for importing data tables and xml files from HPA, exporting and visualizing data, as well as downloading all staining images of interest. The package is free, open source, and available via Bioconductor and Github. Conclusions: HPAanalyze integrates into the R workflow via the tidyverse philosophy and data structures, and it can be used in combination with Bioconductor packages for easy analysis of HPA data.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/355032v2?rss=1</originId><description>Background: The Human Protein Atlas (HPA) aims to map human proteins via multiple technologies including imaging, proteomics and transcriptomics. Access of the HPA data is mainly via web-based interface allowing views of individual proteins, which may not be optimal for data analysis of a gene set, or automatic retrieval of original images. Results: HPAanalyze is an R package for retrieving and performing exploratory analysis of data from HPA. HPAanalyze provides functionality for importing data tables and xml files from HPA, exporting and visualizing data, as well as downloading all staining images of interest. The package is free, open source, and available via Bioconductor and Github. Conclusions: HPAanalyze integrates into the R workflow via the tidyverse philosophy and data structures, and it can be used in combination with Bioconductor packages for easy analysis of HPA data.</description><published>1546070400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/355032v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_167fc8b8467:4db5f25:3a104d3b</id><title>HPAanalyze: An R Package that Facilitates the Retrieval and Analysis of The Human Protein Atlas Data [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2018/12/29/355032</canonicalUrl></item><item><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Stajic, J.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-b?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-b?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.2.full</canonicalUrl><published>1548355045000</published><keywords><item>Physics</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-b?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a7f:c2ce2e2e</id><title>Simulating transport with cold atoms</title><fingerprint>26466ee6</fingerprint></item><item><engagement>0</engagement><crawled>1546370737859</crawled><fingerprint>e8c0eff3</fingerprint><author><name>Wang, S.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/168922v3?rss=1</link><content><content>The use of single-cell transcriptomics has become a major approach to delineate cell subpopulations and the transitions between them. While various computational tools using different mathematical methods have been developed to infer clusters, marker genes, and cell lineage, none yet integrate these within a mathematical framework to perform multiple tasks coherently. Such coherence is critical for the inference of cell-cell communication, a major remaining challenge. Here we present similarity matrix-based optimization for single-cell data analysis (SoptSC), in which unsupervised clustering, pseudotemporal ordering, lineage inference, and marker gene identification are inferred via a structured cell-to-cell similarity matrix. SoptSC then predicts cell-cell communication networks, enabling reconstruction of complex cell lineages that include feedback or feedforward interactions. Application of SoptSC to early embryonic development, epidermal regeneration, and hematopoiesis demonstrates robust identification of subpopulations, lineage relationships, and pseudotime, and prediction of pathway-specific cell communication patterns regulating processes of development and differentiation.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/168922v3?rss=1</originId><description>The use of single-cell transcriptomics has become a major approach to delineate cell subpopulations and the transitions between them. While various computational tools using different mathematical methods have been developed to infer clusters, marker genes, and cell lineage, none yet integrate these within a mathematical framework to perform multiple tasks coherently. Such coherence is critical for the inference of cell-cell communication, a major remaining challenge. Here we present similarity matrix-based optimization for single-cell data analysis (SoptSC), in which unsupervised clustering, pseudotemporal ordering, lineage inference, and marker gene identification are inferred via a structured cell-to-cell similarity matrix. SoptSC then predicts cell-cell communication networks, enabling reconstruction of complex cell lineages that include feedback or feedforward interactions. Application of SoptSC to early embryonic development, epidermal regeneration, and hematopoiesis demonstrates robust identification of subpopulations, lineage relationships, and pseudotime, and prediction of pathway-specific cell communication patterns regulating processes of development and differentiation.</description><published>1546329600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/168922v3?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1680ae0e6c3:5b99b8e:c2ce2e2e</id><title>Cell Lineage and Communication Network Inference via Optimization for Single-Cell Transcriptomics [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/01/168922</canonicalUrl></item><item><engagement>0</engagement><crawled>1546587888885</crawled><fingerprint>9dd453ee</fingerprint><author><name>Starosolski, Z. A.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/506154v2?rss=1</link><content><content>Pediatric tibial fractures are commonly diagnosed by radiographs and constitute one of the common tasks performed by pediatric radiologists. Here, we assess the performance of a convolutional neural network for the detection of acute tibial fractures trained with a limited number of cases in skeletally immature patients. This retrospective study was performed on radiology reports manually classified as normal or tibial fracture. Classified images of orthopaedic implants, casting, and images including other pathology were excluded. The remaining cases constituted 516 studies containing 2118 radiographs. These radiographs were truncated to include a limited investigated field of view which included the distal third of the leg, inclusive of the distal physis. After exclusions, the culled dataset was randomly divided into a training set containing 784 radiographs, a validation set containing 98 radiographs, and a test set 98 radiographs. We used a modified transfer learning approach based on the Xception architecture with additional fully convoluted reasoning and drop-out layers. Of 49 distal Tibial fractures, two were misdiagnosed as normal. Of 49 normal exams, none were misdiagnosed. This led to model accuracy of 97.9%, sensitivity 95.9%, and specificity 100%, comparable to or better than human radiologists. In no instances were normal physes or normal developmental epiphyseal fragmentation of the tibial tuberosity or medial malleolus misclassified as a fracture. We report an efficient method to use a pre-trained network and adapt it to a medical classification task using only a small number of radiographs dedicated to precise anatomical location.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/506154v2?rss=1</originId><description>Pediatric tibial fractures are commonly diagnosed by radiographs and constitute one of the common tasks performed by pediatric radiologists. Here, we assess the performance of a convolutional neural network for the detection of acute tibial fractures trained with a limited number of cases in skeletally immature patients. This retrospective study was performed on radiology reports manually classified as normal or tibial fracture. Classified images of orthopaedic implants, casting, and images including other pathology were excluded. The remaining cases constituted 516 studies containing 2118 radiographs. These radiographs were truncated to include a limited investigated field of view which included the distal third of the leg, inclusive of the distal physis. After exclusions, the culled dataset was randomly divided into a training set containing 784 radiographs, a validation set containing 98 radiographs, and a test set 98 radiographs. We used a modified transfer learning approach based on the Xception architecture with additional fully convoluted reasoning and drop-out layers. Of 49 distal Tibial fractures, two were misdiagnosed as normal. Of 49 normal exams, none were misdiagnosed. This led to model accuracy of 97.9%, sensitivity 95.9%, and specificity 100%, comparable to or better than human radiologists. In no instances were normal physes or normal developmental epiphyseal fragmentation of the tibial tuberosity or medial malleolus misclassified as a fracture. We report an efficient method to use a pre-trained network and adapt it to a medical classification task using only a small number of radiographs dedicated to precise anatomical location.</description><published>1546502400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/506154v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16817d25cf5:21d5c5:c2ce2e2e</id><title>CNN-based radiographic acute tibial fracture detection in the setting of open growth plates [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/03/506154</canonicalUrl></item><item><entities><item><label>Mickle et al</label><id>nlp/f/entity/en/-/mickle et al</id><mentions><item><text>Mickle</text></item><item><text>Mickle et al</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Optogenetics</label><id>nlp/f/entity/en/w/Optogenetics</id><mentions><item><text>optogenetics</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>daily Nature Briefing</label><id>nlp/f/entity/en/-/daily nature briefing</id><mentions><item><text>daily Nature Briefing</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546452338856</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07811-1/d41586-018-07811-1_16353094.jpg</url></visual><author><name>Ellen T. Roche</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07811-1</link><content><content>&lt;p&gt;&lt;b&gt;Implanted device enables responsive bladder control&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Implanted device enables responsive bladder control, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07811-1&quot;&gt;doi:10.1038/d41586-018-07811-1&lt;/a&gt;&lt;/p&gt;Implants that electrically stimulate nerves continuously to treat disease can cause off-target effects and pain. An implant that uses light to modulate the activity of genetically modified nerve cells might offer a solution.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/d41586-018-07811-1</originId><description>&lt;p&gt;&lt;b&gt;Implanted device enables responsive bladder control&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Implanted device enables responsive bladder control, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07811-1&quot;&gt;doi:10.1038/d41586-018-07811-1&lt;/a&gt;&lt;/p&gt;Implants that electrically stimulate nerves continuously to treat disease can cause off-target effects and pain. An implant that uses light to modulate the activity of genetically modified nerve cells might offer a solution.</description><published>1546416000000</published><engagement>2</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07811-1</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680fbe08a8:6162ccd:c2ce2e2e</id><title>Implanted device enables responsive bladder control</title><fingerprint>a4c71bca</fingerprint></item><item><entities><item><label>Feline calicivirus VP2</label><id>nlp/f/entity/en/-/feline calicivirus vp2</id><mentions><item><text>Calicivirus VP2</text></item><item><text>Feline calicivirus VP2</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>J. Virol</label><id>nlp/f/entity/en/-/j. virol</id><mentions><item><text>Virol</text></item><item><text>J. Virol</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>O</label><id>nlp/f/entity/en/-/o</id><mentions><item><text>O</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Chang</label><id>nlp/f/entity/en/-/chang</id><mentions><item><text>Chang</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>D.</label><id>nlp/f/entity/en/-/d.</id><mentions><item><text>D.</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547057114190</crawled><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>421</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0852-1/MediaObjects/41586_2018_852_Fig1_HTML.png</url></visual><author><name>Michaela J. Conley</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-018-0852-1</link><content><content>&lt;p&gt;&lt;b&gt;Calicivirus VP2 forms a portal-like assembly following receptor engagement&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Calicivirus VP2 forms a portal-like assembly following receptor engagement, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0852-1&quot;&gt;doi:10.1038/s41586-018-0852-1&lt;/a&gt;&lt;/p&gt;Cryo-electron microscopy structures of feline calicivirus and its cellular receptor show that twelve copies of the minor capsid protein VP2 form a portal-like assembly arranged about a pore in the capsid shell.</content><direction>ltr</direction></content><commonTopics><item><label>classics</label><id>nlp/f/topic/477</id><probability>0.982</probability></item><item><label>emergency medicine</label><id>nlp/f/topic/764</id><probability>0.88</probability></item><item><label>mp3</label><id>nlp/f/topic/1508</id><probability>0.867</probability></item><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.862</probability></item><item><label>brain</label><id>nlp/f/topic/314</id><probability>0.833</probability></item><item><label>rationality</label><id>nlp/f/topic/1895</id><probability>0.791</probability></item><item><label>graphics</label><id>nlp/f/topic/1000</id><probability>0.751</probability></item><item><label>data science</label><id>nlp/f/topic/618</id><probability>0.723</probability></item><item><label>bioinformatics</label><id>nlp/f/topic/262</id><probability>0.718</probability></item><item><label>fat</label><id>nlp/f/topic/842</id><probability>0.715</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-018-0852-1</originId><description>&lt;p&gt;&lt;b&gt;Calicivirus VP2 forms a portal-like assembly following receptor engagement&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Calicivirus VP2 forms a portal-like assembly following receptor engagement, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0852-1&quot;&gt;doi:10.1038/s41586-018-0852-1&lt;/a&gt;&lt;/p&gt;Cryo-electron microscopy structures of feline calicivirus and its cellular receptor show that twelve copies of the minor capsid protein VP2 form a portal-like assembly arranged about a pore in the capsid shell.</description><published>1547020800000</published><engagement>62</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0852-1</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b06e:8675cc2c</id><title>Calicivirus VP2 forms a portal-like assembly following receptor engagement</title><fingerprint>dc79d9d0</fingerprint></item><item><crawled>1547021759702</crawled><visual><height>500</height><processor>feedly-nikon-v3.1</processor><contentType>image/png; charset=UTF-8</contentType><width>382</width><url>https://onlinelibrary.wiley.com/cms/attachment/bfa237d4-e06e-4356-b4bd-dac563ed2278/jcc25464-toc-0001-m.png</url></visual><published>1546966835000</published><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25464?af=R</link><content><content>&lt;img alt=&quot;Journal of Computational Chemistry Cover Image, Volume 40, Issue 6&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/bfa237d4-e06e-4356-b4bd-dac563ed2278/jcc25464-toc-0001-m.png&quot;&gt;
&lt;p&gt;eSHAFTS is an integrated and graphical drug design software based on 3D molecular similarity. For the given query molecule, the tool is capable of finding the most suitable matching results through effective computation and analysis. The article by Honglin Li and colleagues on page 826 describes it as a graphical software geared to help both experts and non‐specialists design molecules for daily research demands. (DOI: &lt;a href=&quot;https://doi.org/10.1002/jcc.25769&quot; title=&quot;Link to external resource&quot; target=&quot;_blank&quot;&gt;10.1002/jcc.25769&lt;/a&gt;)
&lt;/p&gt;&lt;br&gt;</content><direction>ltr</direction></content><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25464?af=R</originId><description>eSHAFTS is an integrated and graphical drug design software based on 3D molecular similarity. For the given query molecule, the tool is capable of finding the most suitable matching results through effective computation and analysis. The article by Honglin Li and colleagues on page 826 describes it as a graphical software geared to help both experts and non‐specialists design molecules for daily research demands. (DOI: 10.1002/jcc.25769)</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25464?af=R</href></item></alternate><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_16831aeb4d6:9e1075:8675cc2c</id><title>Cover Image, Volume 40, Issue 6</title><fingerprint>ba2c736e</fingerprint><summary><content>eSHAFTS is an integrated and graphical drug design software based on 3D molecular similarity. For the given query molecule, the tool is capable of finding the most suitable matching results through effective computation and analysis. The article by Honglin Li and colleagues on page 826 describes it as a graphical software geared to help both experts and non‐specialists design molecules for daily research demands. (DOI: 10.1002/jcc.25769)</content><direction>ltr</direction></summary></item><item><entities><item><label>Hubble Space Telescope</label><id>nlp/f/entity/en/w/Hubble Space Telescope</id><mentions><item><text>Hubble Space Telescope</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Stockholm University</label><id>nlp/f/entity/en/w/Stockholm University</id><mentions><item><text>Stockholm University</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Jesper Sollerman</label><id>nlp/f/entity/en/-/jesper sollerman</id><mentions><item><text>Jesper Sollerman</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548435470057</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00279-7/d41586-019-00279-7_16411336.jpg</url></visual><published>1548403200000</published><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00279-7</link><content><content>&lt;p&gt;&lt;b&gt;How lagging swimmers can use physics to get ahead&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How lagging swimmers can use physics to get ahead, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00279-7&quot;&gt;doi:10.1038/d41586-019-00279-7&lt;/a&gt;&lt;/p&gt;Racers can take advantage of a competitor ahead of them to save energy.</content><direction>ltr</direction></content><commonTopics><item><label>astrophysics</label><id>nlp/f/topic/173</id><probability>0.982</probability></item><item><label>entertainment</label><id>nlp/f/topic/777</id><probability>0.912</probability></item><item><label>space</label><id>nlp/f/topic/2140</id><probability>0.89</probability></item><item><label>astrophotography</label><id>nlp/f/topic/172</id><probability>0.753</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00279-7</originId><description>&lt;p&gt;&lt;b&gt;How lagging swimmers can use physics to get ahead&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How lagging swimmers can use physics to get ahead, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00279-7&quot;&gt;doi:10.1038/d41586-019-00279-7&lt;/a&gt;&lt;/p&gt;Racers can take advantage of a competitor ahead of them to save energy.</description><engagementRate>0.18</engagementRate><author><name>NA</name></author><engagement>2</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00279-7</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16885f236e9:3cc6214:c2ce2e2e</id><title>How lagging swimmers can use physics to get ahead</title><fingerprint>e26a9a87</fingerprint></item><item><updateCount>1</updateCount><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006639</href></item></canonical><engagement>252</engagement><crawled>1547061906344</crawled><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><published>1547071200000</published><link>10.1371/journal.pcbi.1006639</link><visual><height>619</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>320</width><url>https://journals.plos.org/ploscompbiol/article/figure/image?size=inline&amp;id=10.1371/journal.pcbi.1006639.g001</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><description>&lt;p&gt;by Matías Fuentealba, Handan Melike Dönertaş, Rhianna Williams, Johnathan Labbadia, Janet M. Thornton, Linda Partridge&lt;/p&gt;
Advancing age is the dominant risk factor for most of the major killer diseases in developed countries. Hence, ameliorating the effects of ageing may prevent multiple diseases simultaneously. Drugs licensed for human use against specific diseases have proved to be effective in extending lifespan and healthspan in animal models, suggesting that there is scope for drug repurposing in humans. New bioinformatic methods to identify and prioritise potential anti-ageing compounds for humans are therefore of interest. In this study, we first used drug-protein interaction information, to rank 1,147 drugs by their likelihood of targeting ageing-related gene products in humans. Among 19 statistically significant drugs, 6 have already been shown to have pro-longevity properties in animal models (p &amp;lt; 0.001). Using the targets of each drug, we established their association with ageing at multiple levels of biological action including pathways, functions and protein interactions. Finally, combining all the data, we calculated a ranked list of drugs that identified tanespimycin, an inhibitor of HSP-90, as the top-ranked novel anti-ageing candidate. We experimentally validated the pro-longevity effect of tanespimycin through its HSP-90 target in &lt;i&gt;Caenorhabditis elegans&lt;/i&gt;.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/Yjtn-ZF7ak8&quot; height=&quot;1&quot;&gt;</description><updated>1547071200000</updated><content><content>&lt;p&gt;by Matías Fuentealba, Handan Melike Dönertaş, Rhianna Williams, Johnathan Labbadia, Janet M. Thornton, Linda Partridge&lt;/p&gt;
Advancing age is the dominant risk factor for most of the major killer diseases in developed countries. Hence, ameliorating the effects of ageing may prevent multiple diseases simultaneously. Drugs licensed for human use against specific diseases have proved to be effective in extending lifespan and healthspan in animal models, suggesting that there is scope for drug repurposing in humans. New bioinformatic methods to identify and prioritise potential anti-ageing compounds for humans are therefore of interest. In this study, we first used drug-protein interaction information, to rank 1,147 drugs by their likelihood of targeting ageing-related gene products in humans. Among 19 statistically significant drugs, 6 have already been shown to have pro-longevity properties in animal models (p &amp;lt; 0.001). Using the targets of each drug, we established their association with ageing at multiple levels of biological action including pathways, functions and protein interactions. Finally, combining all the data, we calculated a ranked list of drugs that identified tanespimycin, an inhibitor of HSP-90, as the top-ranked novel anti-ageing candidate. We experimentally validated the pro-longevity effect of tanespimycin through its HSP-90 target in &lt;i&gt;Caenorhabditis elegans&lt;/i&gt;.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/Yjtn-ZF7ak8&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>10.1371/journal.pcbi.1006639</originId><author><name>Matías Fuentealba</name></author><recrawled>1547069228337</recrawled><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/Yjtn-ZF7ak8/article</href></item></alternate><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_16834134ba8:d376a7:b77f238b</id><title>Using the drug-protein interactome to identify anti-ageing compounds for humans</title><fingerprint>884c16e</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37096-3</href></item></canonical><engagement>0</engagement><crawled>1547115498266</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Tomoyuki Maruyama</name></author><visual><height>548</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37096-3/MediaObjects/41598_2018_37096_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37096-3</link><content><content>&lt;p&gt;&lt;b&gt;Compton Scattering of γ-Ray Vortex with Laguerre Gaussian Wave Function&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Compton Scattering of γ-Ray Vortex with Laguerre Gaussian Wave Function, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37096-3&quot;&gt;doi:10.1038/s41598-018-37096-3&lt;/a&gt;&lt;/p&gt;Compton Scattering of γ-Ray Vortex with Laguerre Gaussian Wave Function&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/d8szb3WWba8&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37096-3</originId><description>&lt;p&gt;&lt;b&gt;Compton Scattering of γ-Ray Vortex with Laguerre Gaussian Wave Function&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Compton Scattering of γ-Ray Vortex with Laguerre Gaussian Wave Function, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37096-3&quot;&gt;doi:10.1038/s41598-018-37096-3&lt;/a&gt;&lt;/p&gt;Compton Scattering of γ-Ray Vortex with Laguerre Gaussian Wave Function&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/d8szb3WWba8&quot; height=&quot;1&quot;&gt;</description><published>1547107200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/d8szb3WWba8/s41598-018-37096-3</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16837450b1a:120d154:3a104d3b</id><title>Compton Scattering of γ-Ray Vortex with Laguerre Gaussian Wave Function</title><fingerprint>33e268d4</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36433-w</href></item></canonical><engagement>0</engagement><crawled>1548843710327</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Chang-Ming Bai</name></author><visual><height>653</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36433-w/MediaObjects/41598_2018_36433_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36433-w</link><content><content>&lt;p&gt;&lt;b&gt;RNA-seq of HaHV-1-infected abalones reveals a common transcriptional signature of &lt;i&gt;Malacoherpesviruses&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;RNA-seq of HaHV-1-infected abalones reveals a common transcriptional signature of &amp;lt;i&gt;Malacoherpesviruses&amp;lt;/i&gt;, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36433-w&quot;&gt;doi:10.1038/s41598-018-36433-w&lt;/a&gt;&lt;/p&gt;RNA-seq of HaHV-1-infected abalones reveals a common transcriptional signature of &lt;i&gt;Malacoherpesviruses&lt;/i&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/hX2FJu2jKlI&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36433-w</originId><description>&lt;p&gt;&lt;b&gt;RNA-seq of HaHV-1-infected abalones reveals a common transcriptional signature of &lt;i&gt;Malacoherpesviruses&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;RNA-seq of HaHV-1-infected abalones reveals a common transcriptional signature of &amp;lt;i&gt;Malacoherpesviruses&amp;lt;/i&gt;, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36433-w&quot;&gt;doi:10.1038/s41598-018-36433-w&lt;/a&gt;&lt;/p&gt;RNA-seq of HaHV-1-infected abalones reveals a common transcriptional signature of &lt;i&gt;Malacoherpesviruses&lt;/i&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/hX2FJu2jKlI&quot; height=&quot;1&quot;&gt;</description><published>1548835200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/hX2FJu2jKlI/s41598-018-36433-w</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1689e477777:9c5976:ad2b6584</id><title>RNA-seq of HaHV-1-infected abalones reveals a common transcriptional signature of Malacoherpesviruses</title><fingerprint>8ed3d94d</fingerprint></item><item><engagement>0</engagement><crawled>1546442555521</crawled><fingerprint>af8b72ef</fingerprint><author><name>Rowe, J.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/509455v1?rss=1</link><content><content>Motivation: High-throughput analysis in the current era of systems biology encompasses a range of analysis workflows for different applications, such as transcriptomics, epigenetics, variant discovery, de novo genome assembly, etc. Many research institutes house a genomics core facility that is responsible for generating high-throughput sequencing data and often includes a core bioinformatics team that carries out data analysis. Core teams must both keep track of data and maintain numerous software packages and databases, which must be scalable according to ever-changing research needs, and they must allocate computational resources to them. Typical data analysis pipelines involve multiple software packages and require the ability to install, execute, and maintain software stacks on a variety of hardware/operating system configurations, including high-performance computing (HPC) facilities, stand-alone servers, and Cloud services. At the same time, individual researchers need to analyze their data and share their analysis steps with collaborators. Having to rely on ad hoc scripts and rigid internally developed pipelines is inefficient, difficult to track and maintain, and ultimately, limits the ability to adapt and evolve as research methods progress. Results: Here, we present BioSAILs (Bioinformatics Standardized Analysis Information Layers), a scientific workflow management system (WMS) developed by the Core Bioinformatics team at NYU Abu Dhabi. BioSAILs comprises two central components, BioX command and HPCRunner command, supported by BioStacks software stacks. BioX structures executable workflows that may be either run directly on a desktop or lab server, or submitted by HPCRunner to HPC infrastructure or the Cloud. BioSAILs is supported by a range of pre-configured, customizable BioStacks software stacks for various applications (e.g. RNA-seq, de novo genome/transcriptome assembly, variant discovery, etc.) Software stacks are built using Conda and BioConda (6), have been pre-packaged into modules using EasyBuild, and can be deployed with or without BioSAILs. Within the BioSAILs WMS, users can also invoke commands that take advantage of containerized software in Docker (10) and Singularity (8). Finally, the BioSAILs web resource provides documentation, blog posts related to various BioSAILs analysis tasks, forums, knowledge base &amp;amp; FAQs, as well as an interactive web-based workflow editor/creator. BioSAILs is production-level software that has been in use as the main WMS at NYU Abu Dhabi for the past 2 years and is continuously developed and maintained by the core bioinformatics team. Availability: BioSAILs is open source software, available under the GNU license. Online documentation, support and guides can be found at biosails.abudhabi.nyu.edu. The public Github project is available at Github - BioSAILs. HPC-Runner and BioX-Workflow can be installed through Conda using the BioConda channel</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/509455v1?rss=1</originId><description>Motivation: High-throughput analysis in the current era of systems biology encompasses a range of analysis workflows for different applications, such as transcriptomics, epigenetics, variant discovery, de novo genome assembly, etc. Many research institutes house a genomics core facility that is responsible for generating high-throughput sequencing data and often includes a core bioinformatics team that carries out data analysis. Core teams must both keep track of data and maintain numerous software packages and databases, which must be scalable according to ever-changing research needs, and they must allocate computational resources to them. Typical data analysis pipelines involve multiple software packages and require the ability to install, execute, and maintain software stacks on a variety of hardware/operating system configurations, including high-performance computing (HPC) facilities, stand-alone servers, and Cloud services. At the same time, individual researchers need to analyze their data and share their analysis steps with collaborators. Having to rely on ad hoc scripts and rigid internally developed pipelines is inefficient, difficult to track and maintain, and ultimately, limits the ability to adapt and evolve as research methods progress. Results: Here, we present BioSAILs (Bioinformatics Standardized Analysis Information Layers), a scientific workflow management system (WMS) developed by the Core Bioinformatics team at NYU Abu Dhabi. BioSAILs comprises two central components, BioX command and HPCRunner command, supported by BioStacks software stacks. BioX structures executable workflows that may be either run directly on a desktop or lab server, or submitted by HPCRunner to HPC infrastructure or the Cloud. BioSAILs is supported by a range of pre-configured, customizable BioStacks software stacks for various applications (e.g. RNA-seq, de novo genome/transcriptome assembly, variant discovery, etc.) Software stacks are built using Conda and BioConda (6), have been pre-packaged into modules using EasyBuild, and can be deployed with or without BioSAILs. Within the BioSAILs WMS, users can also invoke commands that take advantage of containerized software in Docker (10) and Singularity (8). Finally, the BioSAILs web resource provides documentation, blog posts related to various BioSAILs analysis tasks, forums, knowledge base &amp;amp; FAQs, as well as an interactive web-based workflow editor/creator. BioSAILs is production-level software that has been in use as the main WMS at NYU Abu Dhabi for the past 2 years and is continuously developed and maintained by the core bioinformatics team. Availability: BioSAILs is open source software, available under the GNU license. Online documentation, support and guides can be found at biosails.abudhabi.nyu.edu. The public Github project is available at Github - BioSAILs. HPC-Runner and BioX-Workflow can be installed through Conda using the BioConda channel</description><published>1546416000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/509455v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1680f28c081:6088287:c2ce2e2e</id><title>BioSAILs: versatile workflow management for high-throughput data analysis [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/02/509455</canonicalUrl></item><item><engagement>0</engagement><crawled>1548593866776</crawled><fingerprint>a87882c8</fingerprint><author><name>Haseeb, M.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/531681v1?rss=1</link><content><content>The most commonly used strategy for peptide identification in shotgun LC-MS/MS proteomics involves searching of MS/MS data against an in-silico digested protein sequence database. Typically, the digested peptide sequences are indexed into the memory to allow faster search times. However, subjecting a database to post-translational modifications (PTMs) during digestion results in an exponential increase in the number of peptides and therefore memory consumption. This limits the usage of existing fragment-ion based open-search algorithms for databases with several PTMs. In this paper, we propose a novel fragment-ion indexing technique which is analogous to suffix array transformation and allows constant time querying of indexed ions. We extend our transformation method, called SLM-Transform, by constructing ion buckets that allow querying of indexed ions by mass by only storing information on distribution of ion-frequencies within buckets. The stored information is used with a regression technique to locate the position of ions in constant time. Moreover, the number of theoretical b- and y-ions generated and indexed for each theoretical spectrum are limited. Our results show that SLM-Transform allows indexing of up to 4x peptides than other leading fragment-ion based database search tools within the same memory constraints. We show that SLM-Transform based index allows indexing of over 83 million peptides within 26GB RAM as compared to 80GB required by MSFragger. Finally, we show the constant ion retrieval time for SLM-Transform based index allowing ultrafast peptide search speeds. Source code will be made available at: https://github.com/pcdslab/slmindex</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/531681v1?rss=1</originId><description>The most commonly used strategy for peptide identification in shotgun LC-MS/MS proteomics involves searching of MS/MS data against an in-silico digested protein sequence database. Typically, the digested peptide sequences are indexed into the memory to allow faster search times. However, subjecting a database to post-translational modifications (PTMs) during digestion results in an exponential increase in the number of peptides and therefore memory consumption. This limits the usage of existing fragment-ion based open-search algorithms for databases with several PTMs. In this paper, we propose a novel fragment-ion indexing technique which is analogous to suffix array transformation and allows constant time querying of indexed ions. We extend our transformation method, called SLM-Transform, by constructing ion buckets that allow querying of indexed ions by mass by only storing information on distribution of ion-frequencies within buckets. The stored information is used with a regression technique to locate the position of ions in constant time. Moreover, the number of theoretical b- and y-ions generated and indexed for each theoretical spectrum are limited. Our results show that SLM-Transform allows indexing of up to 4x peptides than other leading fragment-ion based database search tools within the same memory constraints. We show that SLM-Transform based index allows indexing of over 83 million peptides within 26GB RAM as compared to 80GB required by MSFragger. Finally, we show the constant ion retrieval time for SLM-Transform based index allowing ultrafast peptide search speeds. Source code will be made available at: https://github.com/pcdslab/slmindex</description><published>1548576000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/531681v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1688f632818:488c5dc:3a104d3b</id><title>SLM-Transform: A Method for Memory-Efficient Indexing of Spectra for Database Search in LC-MS/MS Proteomics [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/531681v1</canonicalUrl></item><item><engagement>0</engagement><crawled>1546529934154</crawled><visual><height>324</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>250</width><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14016530/thumb.png</url></visual><published>1546473600000</published><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Enhanced_Electrocatalytic_CO2_Reduction_at_Lower_Overpotentials_Using_Iron_III_Tetra_thienyl_porphyrin/7539839</link><originId>https://chemrxiv.org/articles/Enhanced_Electrocatalytic_CO2_Reduction_at_Lower_Overpotentials_Using_Iron_III_Tetra_thienyl_porphyrin/7539839</originId><description>Iron(III) tetra(5,10,15,20-thienyl)porphyrin chloride (FeTThP) is
introduced as a new CO2 reduction catalyst. The optical and
electrochemical properties, as well as the CO2 reduction
capabilities of FeTThP are directly compared to those of iron(III)
tetra(5,10,15,20-phenyl)porphyrin chloride (FeTPP). Relative to FeTPP, the
newly developed FeTThP achieves a higher TONCO, with comparable
faradaic efficiency, using a much lower overpotential.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Enhanced_Electrocatalytic_CO2_Reduction_at_Lower_Overpotentials_Using_Iron_III_Tetra_thienyl_porphyrin/7539839</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168145e0b4a:6871448:ad2b6584</id><title>Enhanced Electrocatalytic CO2 Reduction at Lower Overpotentials Using Iron (III) Tetra(thienyl)porphyrin</title><fingerprint>18e0904e</fingerprint><summary><content>Iron(III) tetra(5,10,15,20-thienyl)porphyrin chloride (FeTThP) is
introduced as a new CO2 reduction catalyst. The optical and
electrochemical properties, as well as the CO2 reduction
capabilities of FeTThP are directly compared to those of iron(III)
tetra(5,10,15,20-phenyl)porphyrin chloride (FeTPP). Relative to FeTPP, the
newly developed FeTThP achieves a higher TONCO, with comparable
faradaic efficiency, using a much lower overpotential.</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1548176431561</crawled><fingerprint>6e48ffe1</fingerprint><author><name>Brito Correia, F.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/527606v1?rss=1</link><content><content>Protein-protein interactions (PPI) can be conveniently represented as networks, allowing the use of graph theory in their study. Network topology studies may reveal patterns associated to specific organisms. Here we propose a new methodology to denoise PPI networks and predict missing links solely based on the network topology, the Organization Measurement (OM) method. The OM methodology was applied in the denoising of the PPI networks of two Saccharomyces cerevisiae datasets (Yeast and CS2007) and one Homo sapiens dataset (Human). To evaluate the denoising capabilities of OM methodology, two strategies were applied. The first compared its application in random networks and in the reference set networks, while the second perturbed the networks with the gradual random addition and removal of edges. The application of OM methodology to the Yeast and Human reference sets achieved an AUC of 0.95 and 0.87, in Yeast and Human networks, respectively. The random removal of 80% of the Yeast and Human reference sets interactions resulted in an AUC of 0.71 and 0.62, whereas the random addition of 80% interactions resulted in an AUC of 0.75 and 0.72, respectively. Applying the OM methodology to the CS2007 dataset yields an AUC of 0.99. We also perturbed the network of the CS2007 dataset by randomly inserting and removing edges in the same proportions previously described. The false positives identified and removed from the network varied from 97%, when inserting 20% more edges, to 89% when 80% more edges were inserted. The true positives identified and inserted in the network varied from 95% when removing 20% of the edges, to 40% after the random deletion 80% edges. The OM methodology is sensitive to the topological structure of the biological networks. The obtained results suggest that the present approach can efficiently be used to denoise PPI networks.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/527606v1?rss=1</originId><description>Protein-protein interactions (PPI) can be conveniently represented as networks, allowing the use of graph theory in their study. Network topology studies may reveal patterns associated to specific organisms. Here we propose a new methodology to denoise PPI networks and predict missing links solely based on the network topology, the Organization Measurement (OM) method. The OM methodology was applied in the denoising of the PPI networks of two Saccharomyces cerevisiae datasets (Yeast and CS2007) and one Homo sapiens dataset (Human). To evaluate the denoising capabilities of OM methodology, two strategies were applied. The first compared its application in random networks and in the reference set networks, while the second perturbed the networks with the gradual random addition and removal of edges. The application of OM methodology to the Yeast and Human reference sets achieved an AUC of 0.95 and 0.87, in Yeast and Human networks, respectively. The random removal of 80% of the Yeast and Human reference sets interactions resulted in an AUC of 0.71 and 0.62, whereas the random addition of 80% interactions resulted in an AUC of 0.75 and 0.72, respectively. Applying the OM methodology to the CS2007 dataset yields an AUC of 0.99. We also perturbed the network of the CS2007 dataset by randomly inserting and removing edges in the same proportions previously described. The false positives identified and removed from the network varied from 97%, when inserting 20% more edges, to 89% when 80% more edges were inserted. The true positives identified and inserted in the network varied from 95% when removing 20% of the edges, to 40% after the random deletion 80% edges. The OM methodology is sensitive to the topological structure of the biological networks. The obtained results suggest that the present approach can efficiently be used to denoise PPI networks.</description><published>1548144000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/527606v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168768199c9:2613483:c2ce2e2e</id><title>Handling noise in protein interaction networks [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/22/527606</canonicalUrl></item><item><engagement>1</engagement><crawled>1547665791807</crawled><visual><url>none</url></visual><author><name>Singh, A.</name></author><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/475/eaaw5313?rss=1</link><content><content>&lt;p&gt;Specialized T cells in induced bronchus-associated lymphoid tissue regulate alloimmune responses in the lung allograft.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/475/eaaw5313?rss=1</originId><description>&lt;p&gt;Specialized T cells in induced bronchus-associated lymphoid tissue regulate alloimmune responses in the lung allograft.&lt;/p&gt;</description><canonicalUrl>http://stm.sciencemag.org/content/11/475/eaaw5313.full</canonicalUrl><published>1547664692000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/475/eaaw5313?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1685811db3f:3e26698:3a104d3b</id><title>[Editors&apos; Choice] T cells, the last samurai against humoral rejection in lung transplants</title><fingerprint>d2f20c64</fingerprint></item><item><crawled>1548875250003</crawled><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><author><name>Hewitt, S. L., Bai, A., Bailey, D., Ichikawa, K., Zielinski, J., Karp, R., Apte, A., Arnold, K., Zacharek, S. J., Iliou, M. S., Bhatt, K., Garnaas, M., Musenge, F., Davis, A., Khatwani, N., Su, S. V., MacLean, G., Farlow, S. J., Burke, K., Frederick, J. P.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/477/eaat9143?rss=1</link><content><content>&lt;p&gt;Many solid cancers contain dysfunctional immune microenvironments. Immune system modulators that initiate responses to foreign pathogens could be promising candidates for reigniting productive responses toward tumors. Interleukin-1 (IL-1) and IL-12 cytokine family members cooperate at barrier tissues after microbial invasion, in human inflammatory diseases, and in antitumoral immunity. IL-36, in classic alarmin fashion, acts in damaged tissues, whereas IL-23 centrally coordinates immune responses to danger signals. In this study, direct intratumoral delivery of messenger RNAs (mRNAs) encoding these cytokines produced robust anticancer responses in a broad range of tumor microenvironments. The addition of mRNA encoding the T cell costimulator OX40L increased complete response rates in treated and untreated distal tumors compared to the cytokine mRNAs alone. Mice exhibiting complete responses were subsequently protected from tumor rechallenge. Treatments with these mRNA mixtures induced downstream cytokine and chemokine expression, and also activated multiple dendritic cell (DC) and T cell types. Consistent with this, efficacy was dependent on Batf3-dependent cross-presenting DCs and cytotoxic CD8&lt;sup&gt;+&lt;/sup&gt; T cells. IL-23/IL-36/OX40L triplet mRNA mixture triggered substantial immune cell recruitment into tumors, enabling effective tumor destruction irrespective of previous tumoral immune infiltrates. Last, combining triplet mRNA with checkpoint blockade led to efficacy in models otherwise resistant to systemic immune checkpoint inhibition. Human cell studies showed similar cytokine responses to the individual components of this mRNA mixture, suggesting translatability of immunomodulatory activity to human patients.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/477/eaat9143?rss=1</originId><description>&lt;p&gt;Many solid cancers contain dysfunctional immune microenvironments. Immune system modulators that initiate responses to foreign pathogens could be promising candidates for reigniting productive responses toward tumors. Interleukin-1 (IL-1) and IL-12 cytokine family members cooperate at barrier tissues after microbial invasion, in human inflammatory diseases, and in antitumoral immunity. IL-36, in classic alarmin fashion, acts in damaged tissues, whereas IL-23 centrally coordinates immune responses to danger signals. In this study, direct intratumoral delivery of messenger RNAs (mRNAs) encoding these cytokines produced robust anticancer responses in a broad range of tumor microenvironments. The addition of mRNA encoding the T cell costimulator OX40L increased complete response rates in treated and untreated distal tumors compared to the cytokine mRNAs alone. Mice exhibiting complete responses were subsequently protected from tumor rechallenge. Treatments with these mRNA mixtures induced downstream cytokine and chemokine expression, and also activated multiple dendritic cell (DC) and T cell types. Consistent with this, efficacy was dependent on Batf3-dependent cross-presenting DCs and cytotoxic CD8&lt;sup&gt;+&lt;/sup&gt; T cells. IL-23/IL-36/OX40L triplet mRNA mixture triggered substantial immune cell recruitment into tumors, enabling effective tumor destruction irrespective of previous tumoral immune infiltrates. Last, combining triplet mRNA with checkpoint blockade led to efficacy in models otherwise resistant to systemic immune checkpoint inhibition. Human cell studies showed similar cytokine responses to the individual components of this mRNA mixture, suggesting translatability of immunomodulatory activity to human patients.&lt;/p&gt;</description><published>1548874208000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/477/eaat9143?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_168a028b953:cc891a:3a104d3b</id><title>[Research Articles] Durable anticancer immunity from intratumoral administration of IL-23, IL-36{gamma}, and OX40L mRNAs</title><fingerprint>51d73b9c</fingerprint></item><item><engagement>0</engagement><crawled>1546975262889</crawled><fingerprint>2edb8f4e</fingerprint><author><name>Roth, L., Wakim, J., Wasserman, E., Shalev, M., Arman, E., Stein, M., Brumfeld, V., Sagum, C. A., Bedford, M. T., Tuckermann, J., Elson, A.</name></author><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stke.sciencemag.org/cgi/content/short/12/563/eaau0240?rss=1</link><content><content>&lt;p&gt;Bone resorption by osteoclasts is essential for bone homeostasis. The kinase Src promotes osteoclast activity and is activated in osteoclasts by the receptor-type tyrosine phosphatase PTPROt. In other contexts, however, PTPROt can inhibit Src activity. Through in vivo and in vitro experiments, we show that PTPROt is bifunctional and can dephosphorylate Src both at its inhibitory residue Tyr&lt;sup&gt;527&lt;/sup&gt; and its activating residue Tyr&lt;sup&gt;416&lt;/sup&gt;. Whereas wild-type and PTPROt knockout mice exhibited similar bone masses, mice in which a putative C-terminal phosphorylation site, Tyr&lt;sup&gt;399&lt;/sup&gt;, in endogenous PTPROt was replaced with phenylalanine had increased bone mass and reduced osteoclast activity. Osteoclasts from the knock-in mice also showed reduced Src activity. Experiments in cultured cells and in osteoclasts derived from both mouse strains demonstrated that the absence of phosphorylation at Tyr&lt;sup&gt;399&lt;/sup&gt; caused PTPROt to dephosphorylate Src at the activating site pTyr&lt;sup&gt;416&lt;/sup&gt;. In contrast, phosphorylation of PTPROt at Tyr&lt;sup&gt;399&lt;/sup&gt; enabled PTPROt to recruit Src through Grb2 and to dephosphorylate Src at the inhibitory site Tyr&lt;sup&gt;527&lt;/sup&gt;, thus stimulating Src activity. We conclude that reversible phosphorylation of PTPROt at Tyr&lt;sup&gt;399&lt;/sup&gt; is a molecular switch that selects between its opposing activities toward Src and maintains a coherent signaling output, and that blocking this phosphorylation event can induce physiological effects in vivo. Because most receptor-type tyrosine phosphatases contain potential phosphorylation sites at their C termini, we propose that preventing phosphorylation at these sites or its consequences may offer an alternative to inhibiting their catalytic activity to achieve therapeutic benefit.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stke.sciencemag.org/cgi/content/short/12/563/eaau0240?rss=1</originId><description>&lt;p&gt;Bone resorption by osteoclasts is essential for bone homeostasis. The kinase Src promotes osteoclast activity and is activated in osteoclasts by the receptor-type tyrosine phosphatase PTPROt. In other contexts, however, PTPROt can inhibit Src activity. Through in vivo and in vitro experiments, we show that PTPROt is bifunctional and can dephosphorylate Src both at its inhibitory residue Tyr&lt;sup&gt;527&lt;/sup&gt; and its activating residue Tyr&lt;sup&gt;416&lt;/sup&gt;. Whereas wild-type and PTPROt knockout mice exhibited similar bone masses, mice in which a putative C-terminal phosphorylation site, Tyr&lt;sup&gt;399&lt;/sup&gt;, in endogenous PTPROt was replaced with phenylalanine had increased bone mass and reduced osteoclast activity. Osteoclasts from the knock-in mice also showed reduced Src activity. Experiments in cultured cells and in osteoclasts derived from both mouse strains demonstrated that the absence of phosphorylation at Tyr&lt;sup&gt;399&lt;/sup&gt; caused PTPROt to dephosphorylate Src at the activating site pTyr&lt;sup&gt;416&lt;/sup&gt;. In contrast, phosphorylation of PTPROt at Tyr&lt;sup&gt;399&lt;/sup&gt; enabled PTPROt to recruit Src through Grb2 and to dephosphorylate Src at the inhibitory site Tyr&lt;sup&gt;527&lt;/sup&gt;, thus stimulating Src activity. We conclude that reversible phosphorylation of PTPROt at Tyr&lt;sup&gt;399&lt;/sup&gt; is a molecular switch that selects between its opposing activities toward Src and maintains a coherent signaling output, and that blocking this phosphorylation event can induce physiological effects in vivo. Because most receptor-type tyrosine phosphatases contain potential phosphorylation sites at their C termini, we propose that preventing phosphorylation at these sites or its consequences may offer an alternative to inhibiting their catalytic activity to achieve therapeutic benefit.&lt;/p&gt;</description><published>1546973708000</published><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/563/eaau0240?rss=1</href></item></alternate><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_1682ee938a9:5d2d1f:3a104d3b</id><title>Phosphorylation of the phosphatase PTPROt at Tyr399 is a molecular switch that controls osteoclast activity and bone mass in vivo</title><canonicalUrl>http://stke.sciencemag.org/content/12/563/eaau0240.full</canonicalUrl></item><item><engagement>0</engagement><crawled>1547081656096</crawled><fingerprint>2d6a63f2</fingerprint><author><name>Bai, Y.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/516658v1?rss=1</link><content><content>The paired repeated measures (PRM) design has been commonly used in comparison studies to demonstrate that two measures agree sufficiently up to a pre-specified threshold. Due to the nature of dependence in repeated measures, existing methods for analyzing these comparison studies are often ad hoc and less than satisfactory. We propose a new test together with sample size and power calculation for PRM designs, which exhibit very good finite sample performance. We demonstrate favorable performance of the proposed methods through numerical studies. We provide very efficient R programs for our methods in a publicly available R package. Our proposed methods and developed R package provide practical tools which bridge an existing gap in the field.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/516658v1?rss=1</originId><description>The paired repeated measures (PRM) design has been commonly used in comparison studies to demonstrate that two measures agree sufficiently up to a pre-specified threshold. Due to the nature of dependence in repeated measures, existing methods for analyzing these comparison studies are often ad hoc and less than satisfactory. We propose a new test together with sample size and power calculation for PRM designs, which exhibit very good finite sample performance. We demonstrate favorable performance of the proposed methods through numerical studies. We provide very efficient R programs for our methods in a publicly available R package. Our proposed methods and developed R package provide practical tools which bridge an existing gap in the field.</description><published>1547020800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/516658v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1683540a720:f0c99b:c2ce2e2e</id><title>Statistical test with sample size and power calculation for paired repeated measures designs of method comparison studies [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/09/516658</canonicalUrl></item><item><updateCount>1</updateCount><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006649</href></item></canonical><engagement>4</engagement><crawled>1547751007885</crawled><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><published>1547762400000</published><link>10.1371/journal.pcbi.1006649</link><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><description>&lt;p&gt;by Arne Elofsson, Berk Hess, Erik Lindahl, Alexey Onufriev, David van der Spoel, Anders Wallqvist&lt;/p&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/DQL75FGnudQ&quot; height=&quot;1&quot;&gt;</description><updated>1547762400000</updated><content><content>&lt;p&gt;by Arne Elofsson, Berk Hess, Erik Lindahl, Alexey Onufriev, David van der Spoel, Anders Wallqvist&lt;/p&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/DQL75FGnudQ&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>10.1371/journal.pcbi.1006649</originId><author><name>Arne Elofsson</name></author><recrawled>1547760425467</recrawled><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/DQL75FGnudQ/article</href></item></alternate><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_1685d26268d:fbdfe:1451c985</id><title>Ten simple rules on how to create open access and reproducible molecular simulations of biological systems</title><fingerprint>6ed7fafd</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36299-y</href></item></canonical><engagement>0</engagement><crawled>1548152137226</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Tristan Whitmarsh</name></author><visual><height>631</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36299-y/MediaObjects/41598_2018_36299_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36299-y</link><content><content>&lt;p&gt;&lt;b&gt;A cross-sectional study on the age-related cortical and trabecular bone changes at the femoral head in elderly female hip fracture patients&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A cross-sectional study on the age-related cortical and trabecular bone changes at the femoral head in elderly female hip fracture patients, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36299-y&quot;&gt;doi:10.1038/s41598-018-36299-y&lt;/a&gt;&lt;/p&gt;A cross-sectional study on the age-related cortical and trabecular bone changes at the femoral head in elderly female hip fracture patients&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Gm1X2IUcGFs&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36299-y</originId><description>&lt;p&gt;&lt;b&gt;A cross-sectional study on the age-related cortical and trabecular bone changes at the femoral head in elderly female hip fracture patients&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A cross-sectional study on the age-related cortical and trabecular bone changes at the femoral head in elderly female hip fracture patients, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36299-y&quot;&gt;doi:10.1038/s41598-018-36299-y&lt;/a&gt;&lt;/p&gt;A cross-sectional study on the age-related cortical and trabecular bone changes at the femoral head in elderly female hip fracture patients&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Gm1X2IUcGFs&quot; height=&quot;1&quot;&gt;</description><published>1548144000000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/Gm1X2IUcGFs/s41598-018-36299-y</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168750ee60a:23b88bc:c2ce2e2e</id><title>A cross-sectional study on the age-related cortical and trabecular bone changes at the femoral head in elderly female hip fracture patients</title><fingerprint>7ffcc458</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08152-3</href></item></canonical><crawled>1548325717848</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Xia Sheng</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08152-3</link><content><content>&lt;p&gt;&lt;b&gt;IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08152-3&quot;&gt;doi:10.1038/s41467-018-08152-3&lt;/a&gt;&lt;/p&gt;ER stress and UPR are implicated in various cancers. Here, the authors show that one of the canonical UPR pathways, IRE1α-XBP1 regulates c-MYC signaling to promote prostate tumorigenesis, and pharmacological inhibition of IRE1α with MKC8866 inhibits prostate cancer growth and synergizes with clinically used prostate cancer drugs.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/1GLdyjRkMlM&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08152-3</originId><description>&lt;p&gt;&lt;b&gt;IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08152-3&quot;&gt;doi:10.1038/s41467-018-08152-3&lt;/a&gt;&lt;/p&gt;ER stress and UPR are implicated in various cancers. Here, the authors show that one of the canonical UPR pathways, IRE1α-XBP1 regulates c-MYC signaling to promote prostate tumorigenesis, and pharmacological inhibition of IRE1α with MKC8866 inhibits prostate cancer growth and synergizes with clinically used prostate cancer drugs.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/1GLdyjRkMlM&quot; height=&quot;1&quot;&gt;</description><published>1548316800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/1GLdyjRkMlM/s41467-018-08152-3</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687f678758:3406952:3a104d3b</id><title>IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling</title><fingerprint>4412b0dd</fingerprint></item><item><engagement>0</engagement><crawled>1548703072665</crawled><visual><height>354</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>250</width><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14185100/thumb.png</url></visual><published>1548633600000</published><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/The_Periodic_Table_as_a_Cultural_Meme/7635905</link><originId>https://chemrxiv.org/articles/The_Periodic_Table_as_a_Cultural_Meme/7635905</originId><description>The Mendeleev periodic table is 150 years old this year. This article looks at how it has changed in its history and its wider recognition in human society.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/The_Periodic_Table_as_a_Cultural_Meme/7635905</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16895e58199:5102378:ad2b6584</id><title>The Periodic Table as a Cultural Meme</title><fingerprint>40aa6c72</fingerprint><summary><content>The Mendeleev periodic table is 150 years old this year. This article looks at how it has changed in its history and its wider recognition in human society.</content><direction>ltr</direction></summary></item><item><updateCount>1</updateCount><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006595</href></item></canonical><engagement>0</engagement><crawled>1547752840893</crawled><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><published>1547762400000</published><link>10.1371/journal.pcbi.1006595</link><visual><height>225</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>320</width><url>https://journals.plos.org/ploscompbiol/article/figure/image?size=inline&amp;id=10.1371/journal.pcbi.1006595.g001</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><description>&lt;p&gt;by Abdul-Saboor Sheikh, Nicol S. Harper, Jakob Drefs, Yosef Singer, Zhenwen Dai, Richard E. Turner, Jörg Lücke&lt;/p&gt;
We investigate how the neural processing in auditory cortex is shaped by the statistics of natural sounds. Hypothesising that auditory cortex (A1) represents the structural primitives out of which sounds are composed, we employ a statistical model to extract such components. The input to the model are cochleagrams which approximate the non-linear transformations a sound undergoes from the outer ear, through the cochlea to the auditory nerve. Cochleagram components do not superimpose linearly, but rather according to a rule which can be approximated using the max function. This is a consequence of the compression inherent in the cochleagram and the sparsity of natural sounds. Furthermore, cochleagrams do not have negative values. Cochleagrams are therefore not matched well by the assumptions of standard linear approaches such as sparse coding or ICA. We therefore consider a new encoding approach for natural sounds, which combines a model of early auditory processing with maximal causes analysis (MCA), a sparse coding model which captures both the non-linear combination rule and non-negativity of the data. An efficient truncated EM algorithm is used to fit the MCA model to cochleagram data. We characterize the generative fields (GFs) inferred by MCA with respect to &lt;i&gt;in vivo&lt;/i&gt; neural responses in A1 by applying reverse correlation to estimate spectro-temporal receptive fields (STRFs) implied by the learned GFs. Despite the GFs being non-negative, the STRF estimates are found to contain both positive and negative subfields, where the negative subfields can be attributed to explaining away effects as captured by the applied inference method. A direct comparison with ferret A1 shows many similar forms, and the spectral and temporal modulation tuning of both ferret and model STRFs show similar ranges over the population. In summary, our model represents an alternative to linear approaches for biological auditory encoding while it captures salient data properties and links inhibitory subfields to explaining away effects.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/9z31h2VhhpY&quot; height=&quot;1&quot;&gt;</description><updated>1547762400000</updated><content><content>&lt;p&gt;by Abdul-Saboor Sheikh, Nicol S. Harper, Jakob Drefs, Yosef Singer, Zhenwen Dai, Richard E. Turner, Jörg Lücke&lt;/p&gt;
We investigate how the neural processing in auditory cortex is shaped by the statistics of natural sounds. Hypothesising that auditory cortex (A1) represents the structural primitives out of which sounds are composed, we employ a statistical model to extract such components. The input to the model are cochleagrams which approximate the non-linear transformations a sound undergoes from the outer ear, through the cochlea to the auditory nerve. Cochleagram components do not superimpose linearly, but rather according to a rule which can be approximated using the max function. This is a consequence of the compression inherent in the cochleagram and the sparsity of natural sounds. Furthermore, cochleagrams do not have negative values. Cochleagrams are therefore not matched well by the assumptions of standard linear approaches such as sparse coding or ICA. We therefore consider a new encoding approach for natural sounds, which combines a model of early auditory processing with maximal causes analysis (MCA), a sparse coding model which captures both the non-linear combination rule and non-negativity of the data. An efficient truncated EM algorithm is used to fit the MCA model to cochleagram data. We characterize the generative fields (GFs) inferred by MCA with respect to &lt;i&gt;in vivo&lt;/i&gt; neural responses in A1 by applying reverse correlation to estimate spectro-temporal receptive fields (STRFs) implied by the learned GFs. Despite the GFs being non-negative, the STRF estimates are found to contain both positive and negative subfields, where the negative subfields can be attributed to explaining away effects as captured by the applied inference method. A direct comparison with ferret A1 shows many similar forms, and the spectral and temporal modulation tuning of both ferret and model STRFs show similar ranges over the population. In summary, our model represents an alternative to linear approaches for biological auditory encoding while it captures salient data properties and links inhibitory subfields to explaining away effects.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/9z31h2VhhpY&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>10.1371/journal.pcbi.1006595</originId><author><name>Abdul-Saboor Sheikh</name></author><recrawled>1547760425467</recrawled><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/9z31h2VhhpY/article</href></item></alternate><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_1685d421ebd:fe256:1451c985</id><title>STRFs in primary auditory cortex emerge from masking-based statistics of natural sounds</title><fingerprint>7c0f82e8</fingerprint></item><item><engagement>0</engagement><crawled>1547656278926</crawled><visual><url>none</url></visual><author><name>Korzhenkov, A.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/521286v1?rss=1</link><content><content>YAMB is a novel metagenome binning tool, which uses tetranucletotide composition and average contig coverage and performs t-SNE dimensionality reduction and sequential DBSCAN data clusterization. YAMB provided with metagenomics assembly and reads may be used for straightforward metagenome binning on a recent personal computer running Linux OS. Source code of YAMB is freely available on GitHub (https://github.com/laxeye/YAMB), implemented in R, Perl and Bash and supported on Linux.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/521286v1?rss=1</originId><description>YAMB is a novel metagenome binning tool, which uses tetranucletotide composition and average contig coverage and performs t-SNE dimensionality reduction and sequential DBSCAN data clusterization. YAMB provided with metagenomics assembly and reads may be used for straightforward metagenome binning on a recent personal computer running Linux OS. Source code of YAMB is freely available on GitHub (https://github.com/laxeye/YAMB), implemented in R, Perl and Bash and supported on Linux.</description><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/16/521286</canonicalUrl><published>1547625600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/521286v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1685780b38e:3cf37ad:c2ce2e2e</id><title>YAMB: metagenome binning using nonlinear dimensionality reduction and density-based clustering [NEW RESULTS]</title><fingerprint>2e96d5b9</fingerprint></item><item><entities><item><label>Biol</label><id>nlp/f/entity/en/-/biol</id><mentions><item><text>Biol</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Arabidopsis</label><id>nlp/f/entity/en/w/Arabidopsis</id><mentions><item><text>Arabidopsis</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Cell Physiol</label><id>nlp/f/entity/en/-/cell physiol</id><mentions><item><text>Cell Physiol</text></item><item><text>Physiol</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>D.</label><id>nlp/f/entity/en/-/d.</id><mentions><item><text>D.</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Curr</label><id>nlp/f/entity/en/-/curr</id><mentions><item><text>Curr</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547057114190</crawled><visual><height>651</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0837-0/MediaObjects/41586_2018_837_Fig1_HTML.png</url></visual><author><name>Ondřej Smetana</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-018-0837-0</link><content><content>&lt;p&gt;&lt;b&gt;High levels of auxin signalling define the stem-cell organizer of the vascular cambium&lt;/b&gt;&lt;/p&gt;&lt;p&gt;High levels of auxin signalling define the stem-cell organizer of the vascular cambium, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0837-0&quot;&gt;doi:10.1038/s41586-018-0837-0&lt;/a&gt;&lt;/p&gt;In the roots of Arabidopsis thaliana, cells with xylem identity and high levels of auxin signalling function as organizer cells that direct neighbouring vascular cambial cells to act as stem cells.</content><direction>ltr</direction></content><commonTopics><item><label>classics</label><id>nlp/f/topic/477</id><probability>0.952</probability></item><item><label>stem cells</label><id>nlp/f/topic/2185</id><probability>0.899</probability></item><item><label>brain</label><id>nlp/f/topic/314</id><probability>0.893</probability></item><item><label>ecology</label><id>nlp/f/topic/725</id><probability>0.87</probability></item><item><label>mp3</label><id>nlp/f/topic/1508</id><probability>0.854</probability></item><item><label>emergency medicine</label><id>nlp/f/topic/764</id><probability>0.829</probability></item><item><label>bioinformatics</label><id>nlp/f/topic/262</id><probability>0.819</probability></item><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.816</probability></item><item><label>rationality</label><id>nlp/f/topic/1895</id><probability>0.774</probability></item><item><label>genetics</label><id>nlp/f/topic/955</id><probability>0.705</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-018-0837-0</originId><description>&lt;p&gt;&lt;b&gt;High levels of auxin signalling define the stem-cell organizer of the vascular cambium&lt;/b&gt;&lt;/p&gt;&lt;p&gt;High levels of auxin signalling define the stem-cell organizer of the vascular cambium, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0837-0&quot;&gt;doi:10.1038/s41586-018-0837-0&lt;/a&gt;&lt;/p&gt;In the roots of Arabidopsis thaliana, cells with xylem identity and high levels of auxin signalling function as organizer cells that direct neighbouring vascular cambial cells to act as stem cells.</description><published>1547020800000</published><engagement>2</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0837-0</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b075:8675cc2c</id><title>High levels of auxin signalling define the stem-cell organizer of the vascular cambium</title><fingerprint>7b7846a3</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08306-x</href></item></canonical><engagement>149</engagement><crawled>1548757739847</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Lennart M. van Maldegem</name></author><visual><height>408</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-08306-x/MediaObjects/41467_2019_8306_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-019-08306-x</link><content><content>&lt;p&gt;&lt;b&gt;Bisnorgammacerane traces predatory pressure and the persistent rise of algal ecosystems after Snowball Earth&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Bisnorgammacerane traces predatory pressure and the persistent rise of algal ecosystems after Snowball Earth, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08306-x&quot;&gt;doi:10.1038/s41467-019-08306-x&lt;/a&gt;&lt;/p&gt;It remains unclear when and why the world’s oceans, once largely occupied by bacteria, became dominated by photosynthetic algae. Here, using fossil lipids in million year old rocks, the authors show that predation after the Snowball Earth glaciations created the opportunity for a global shift to algal ecosystems.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/aCdeBrGO4yo&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-019-08306-x</originId><description>&lt;p&gt;&lt;b&gt;Bisnorgammacerane traces predatory pressure and the persistent rise of algal ecosystems after Snowball Earth&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Bisnorgammacerane traces predatory pressure and the persistent rise of algal ecosystems after Snowball Earth, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08306-x&quot;&gt;doi:10.1038/s41467-019-08306-x&lt;/a&gt;&lt;/p&gt;It remains unclear when and why the world’s oceans, once largely occupied by bacteria, became dominated by photosynthetic algae. Here, using fossil lipids in million year old rocks, the authors show that predation after the Snowball Earth glaciations created the opportunity for a global shift to algal ecosystems.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/aCdeBrGO4yo&quot; height=&quot;1&quot;&gt;</description><engagementRate>29.8</engagementRate><published>1548748800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/aCdeBrGO4yo/s41467-019-08306-x</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1689927a947:1ffc0c:c2ce2e2e</id><title>Bisnorgammacerane traces predatory pressure and the persistent rise of algal ecosystems after Snowball Earth</title><fingerprint>bd704761</fingerprint></item><item><entities><item><label>M.</label><id>nlp/f/entity/en/-/m.</id><mentions><item><text>M.</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Chiu</label><id>nlp/f/entity/en/-/chiu</id><mentions><item><text>Chiu</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Mod</label><id>nlp/f/entity/en/-/mod</id><mentions><item><text>Mod</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Robert H. Thouless</label><id>nlp/f/entity/en/w/Robert H. Thouless</id><mentions><item><text>Thouless</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>C. - K.</label><id>nlp/f/entity/en/-/c. - k.</id><mentions><item><text>C. - K.</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547057114190</crawled><visual><height>311</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0817-4/MediaObjects/41586_2018_817_Fig1_HTML.png</url></visual><author><name>Nathan Schine</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-018-0817-4</link><content><content>&lt;p&gt;&lt;b&gt;Electromagnetic and gravitational responses of photonic Landau levels&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Electromagnetic and gravitational responses of photonic Landau levels, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0817-4&quot;&gt;doi:10.1038/s41586-018-0817-4&lt;/a&gt;&lt;/p&gt;Probing the local response of an integer quantum Hall system enables three different measures of its topology to be explored.</content><direction>ltr</direction></content><commonTopics><item><label>aps</label><id>nlp/f/topic/127</id><probability>0.99</probability></item><item><label>classics</label><id>nlp/f/topic/477</id><probability>0.941</probability></item><item><label>mp3</label><id>nlp/f/topic/1508</id><probability>0.785</probability></item><item><label>quantum</label><id>nlp/f/topic/1873</id><probability>0.736</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-018-0817-4</originId><description>&lt;p&gt;&lt;b&gt;Electromagnetic and gravitational responses of photonic Landau levels&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Electromagnetic and gravitational responses of photonic Landau levels, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0817-4&quot;&gt;doi:10.1038/s41586-018-0817-4&lt;/a&gt;&lt;/p&gt;Probing the local response of an integer quantum Hall system enables three different measures of its topology to be explored.</description><published>1547020800000</published><engagement>44</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0817-4</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b07e:8675cc2c</id><title>Electromagnetic and gravitational responses of photonic Landau levels</title><fingerprint>52673e4b</fingerprint></item><item><entities><item><label>FRB 121102 9,10</label><id>nlp/f/entity/en/-/frb 121102 9,10</id><mentions><item><text>FRB</text></item><item><text>FRB 121102 9,10</text></item><item><text>FRB 121102</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>FRBs</label><id>nlp/f/entity/en/-/frbs</id><mentions><item><text>FRBs</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>FRB 180814.J0422+73</label><id>nlp/f/entity/en/-/frb 180814.j0422+73</id><mentions><item><text>FRB 180814.J0422+73</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Canadian Hydrogen Intensity Mapping Experiment</label><id>nlp/f/entity/en/w/Canadian Hydrogen Intensity Mapping Experiment</id><mentions><item><text>Canadian Hydrogen Intensity Mapping Experiment</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Milky Way</label><id>nlp/f/entity/en/w/Milky Way</id><mentions><item><text>Milky Way</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547057114190</crawled><visual><url>none</url></visual><author><name>M. Amiri</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-018-0864-x</link><content><content>&lt;p&gt;&lt;b&gt;A second source of repeating fast radio bursts&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A second source of repeating fast radio bursts, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0864-x&quot;&gt;doi:10.1038/s41586-018-0864-x&lt;/a&gt;&lt;/p&gt;A second source of repeating fast radio bursts</content><direction>ltr</direction></content><commonTopics><item><label>radio</label><id>nlp/f/topic/1882</id><probability>0.971</probability></item><item><label>economics</label><id>nlp/f/topic/729</id><probability>0.716</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-018-0864-x</originId><description>&lt;p&gt;&lt;b&gt;A second source of repeating fast radio bursts&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A second source of repeating fast radio bursts, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0864-x&quot;&gt;doi:10.1038/s41586-018-0864-x&lt;/a&gt;&lt;/p&gt;A second source of repeating fast radio bursts</description><published>1547020800000</published><engagement>8</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0864-x</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b07d:8675cc2c</id><title>A second source of repeating fast radio bursts</title><fingerprint>ec3f92c8</fingerprint></item><item><entities><item><label>﻿Rare</label><id>nlp/f/entity/en/-/﻿rare</id><mentions><item><text>﻿Rare</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Anna Balazs</label><id>nlp/f/entity/en/-/anna balazs</id><mentions><item><text>Anna Balazs</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>University of Pittsburgh</label><id>nlp/f/entity/en/w/University of Pittsburgh</id><mentions><item><text>University of Pittsburgh</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Pennsylvania</label><id>nlp/f/entity/en/w/Pennsylvania</id><mentions><item><text>Pennsylvania</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547832447142</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00192-z/d41586-019-00192-z_16398754.jpg</url></visual><published>1547798400000</published><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00192-z</link><content><content>&lt;p&gt;&lt;b&gt;﻿Rare whales and seals thrive thanks to controversial US law&lt;/b&gt;&lt;/p&gt;&lt;p&gt;﻿Rare whales and seals thrive thanks to controversial US law, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00192-z&quot;&gt;doi:10.1038/d41586-019-00192-z&lt;/a&gt;&lt;/p&gt;Animals protected by the Endangered Species Act for more than two decades are the most likely to recover.</content><direction>ltr</direction></content><commonTopics><item><label>robotics</label><id>nlp/f/topic/1955</id><probability>0.964</probability></item><item><label>swimming</label><id>nlp/f/topic/2220</id><probability>0.862</probability></item><item><label>biochemistry</label><id>nlp/f/topic/257</id><probability>0.843</probability></item><item><label>ai</label><id>nlp/f/topic/56</id><probability>0.827</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00192-z</originId><description>&lt;p&gt;&lt;b&gt;﻿Rare whales and seals thrive thanks to controversial US law&lt;/b&gt;&lt;/p&gt;&lt;p&gt;﻿Rare whales and seals thrive thanks to controversial US law, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00192-z&quot;&gt;doi:10.1038/d41586-019-00192-z&lt;/a&gt;&lt;/p&gt;Animals protected by the Endangered Species Act for more than two decades are the most likely to recover.</description><author><name>NA</name></author><engagement>20</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00192-z</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1686200d0a6:caad25:c2ce2e2e</id><title>﻿Rare whales and seals thrive thanks to controversial US law</title><fingerprint>456fba4</fingerprint></item><item><crawled>1548820970610</crawled><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><author><name>DeBlasio, D.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/342865v4?rss=1</link><content><content>Computational tools used for genomic analyses are becoming increasingly sophisticated and complex. While these applications provide more accurate results, a new problem is emerging in that these pieces of software have a large number of tunable parameters. The default parameter choices are designed to work well on average across all inputs, but the most interesting experiments are often not &amp;quot;average&amp;quot;. Choosing the wrong parameter values for an application can lead to significant results being overlooked, or false results being reported. This problem is exacerbated when these applications are chained together in analysis pipelines where each step introduces errors due to parameter choices. We take some first steps towards generating a truly automated genomic analysis pipeline by developing a method for automatically choosing input-specific parameter values for reference-based transcript assembly. We apply the parameter advising framework, first developed for multiple sequence alignment, to optimize parameter choices for the Scallop transcript assembler. In doing so, we provide the first method for finding advisor sets for applications with large numbers of tunable parameters. This procedure can be parallelized, meaning it does not add any additional wall time. By choosing parameter values for each input, the area under the curve is increased by 28.9% over using only the default parameter choices on 1595 RNA-seq samples in the Sequence Read Archive. This approach is general, and when applied to StringTie it increases AUC by 13.1% on a set of 65 RNA-seq experiments from ENCODE.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/342865v4?rss=1</originId><description>Computational tools used for genomic analyses are becoming increasingly sophisticated and complex. While these applications provide more accurate results, a new problem is emerging in that these pieces of software have a large number of tunable parameters. The default parameter choices are designed to work well on average across all inputs, but the most interesting experiments are often not &amp;quot;average&amp;quot;. Choosing the wrong parameter values for an application can lead to significant results being overlooked, or false results being reported. This problem is exacerbated when these applications are chained together in analysis pipelines where each step introduces errors due to parameter choices. We take some first steps towards generating a truly automated genomic analysis pipeline by developing a method for automatically choosing input-specific parameter values for reference-based transcript assembly. We apply the parameter advising framework, first developed for multiple sequence alignment, to optimize parameter choices for the Scallop transcript assembler. In doing so, we provide the first method for finding advisor sets for applications with large numbers of tunable parameters. This procedure can be parallelized, meaning it does not add any additional wall time. By choosing parameter values for each input, the area under the curve is increased by 28.9% over using only the default parameter choices on 1595 RNA-seq samples in the Sequence Read Archive. This approach is general, and when applied to StringTie it increases AUC by 13.1% on a set of 65 RNA-seq experiments from ENCODE.</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/342865v4?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689cec7c72:79feb8:c2ce2e2e</id><title>Towards building an automated bioinformatician: more accurate transcript assembly via parameter advising [NEW RESULTS]</title><fingerprint>1097cd0a</fingerprint></item><item><engagement>0</engagement><crawled>1548736218410</crawled><fingerprint>d1ce7f40</fingerprint><author><name>Busia, A.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/353474v2?rss=1</link><content><content>Motivation: Inferring properties of biological sequences--such as determining the species-of-origin of a DNA sequence or the function of an amino-acid sequence--is a core task in many bioinformatics applications. These tasks are often solved using string-matching to map query sequences to labeled database sequences or via Hidden Markov Model-like pattern matching. In the current work we describe and assess an deep learning approach which trains a deep neural network (DNN) to predict database-derived labels directly from query sequences. Results: We demonstrate this DNN performs at state-of-the-art or above levels on a difficult, practically important problem: predicting species-of-origin from short reads of 16S ribosomal DNA. When trained on 16S sequences of over 13,000 distinct species, our DNN achieves read-level species classification accuracy within 2.0% of perfect memorization of training data, and produces more accurate genus-level assignments for reads from held-out species than k-mer, alignment, and taxonomic binning baselines. Moreover, our models exhibit greater robustness than these existing approaches to increasing noise in the query sequences. Finally, we show that these DNNs perform well on experimental 16S mock community dataset. Overall, our results constitute a first step towards our long-term goal of developing a general-purpose deep learning approach to predicting meaningful labels from short biological sequences. Availability: TensorFlow training code is available through GitHub (https://github.com/tensorflow/models/tree/master/research). Data in TensorFlow TFRecord format is available on Google Cloud Storage (gs://brain-genomics-public/research/seq2species/). Contact: seq2species-interest@google.com. Supplementary information: Supplementary data are available in a separate document.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/353474v2?rss=1</originId><description>Motivation: Inferring properties of biological sequences--such as determining the species-of-origin of a DNA sequence or the function of an amino-acid sequence--is a core task in many bioinformatics applications. These tasks are often solved using string-matching to map query sequences to labeled database sequences or via Hidden Markov Model-like pattern matching. In the current work we describe and assess an deep learning approach which trains a deep neural network (DNN) to predict database-derived labels directly from query sequences. Results: We demonstrate this DNN performs at state-of-the-art or above levels on a difficult, practically important problem: predicting species-of-origin from short reads of 16S ribosomal DNA. When trained on 16S sequences of over 13,000 distinct species, our DNN achieves read-level species classification accuracy within 2.0% of perfect memorization of training data, and produces more accurate genus-level assignments for reads from held-out species than k-mer, alignment, and taxonomic binning baselines. Moreover, our models exhibit greater robustness than these existing approaches to increasing noise in the query sequences. Finally, we show that these DNNs perform well on experimental 16S mock community dataset. Overall, our results constitute a first step towards our long-term goal of developing a general-purpose deep learning approach to predicting meaningful labels from short biological sequences. Availability: TensorFlow training code is available through GitHub (https://github.com/tensorflow/models/tree/master/research). Data in TensorFlow TFRecord format is available on Google Cloud Storage (gs://brain-genomics-public/research/seq2species/). Contact: seq2species-interest@google.com. Supplementary information: Supplementary data are available in a separate document.</description><published>1548662400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/353474v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16897df452a:3adf7:ad2b6584</id><title>A deep learning approach to pattern recognition for short DNA sequences [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/353474v2</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37032-5</href></item></canonical><crawled>1547115498266</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Yasmin Mussa</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37032-5</link><content><content>&lt;p&gt;&lt;b&gt;Enhanced Electrochemical performance at high temperature of Cobalt Oxide/Reduced Graphene Oxide Nanocomposites and its application in lithium-ion batteries&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Enhanced Electrochemical performance at high temperature of Cobalt Oxide/Reduced Graphene Oxide Nanocomposites and its application in lithium-ion batteries, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37032-5&quot;&gt;doi:10.1038/s41598-018-37032-5&lt;/a&gt;&lt;/p&gt;Enhanced Electrochemical performance at high temperature of Cobalt Oxide/Reduced Graphene Oxide Nanocomposites and its application in lithium-ion batteries&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/cu6cZU7MJV0&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37032-5</originId><description>&lt;p&gt;&lt;b&gt;Enhanced Electrochemical performance at high temperature of Cobalt Oxide/Reduced Graphene Oxide Nanocomposites and its application in lithium-ion batteries&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Enhanced Electrochemical performance at high temperature of Cobalt Oxide/Reduced Graphene Oxide Nanocomposites and its application in lithium-ion batteries, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37032-5&quot;&gt;doi:10.1038/s41598-018-37032-5&lt;/a&gt;&lt;/p&gt;Enhanced Electrochemical performance at high temperature of Cobalt Oxide/Reduced Graphene Oxide Nanocomposites and its application in lithium-ion batteries&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/cu6cZU7MJV0&quot; height=&quot;1&quot;&gt;</description><published>1547107200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/cu6cZU7MJV0/s41598-018-37032-5</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16837450b1a:120d152:3a104d3b</id><title>Enhanced Electrochemical performance at high temperature of Cobalt Oxide/Reduced Graphene Oxide Nanocomposites and its application in lithium-ion batteries</title><fingerprint>6ba64b3d</fingerprint></item><item><engagement>0</engagement><crawled>1548178984346</crawled><fingerprint>23921502</fingerprint><author><name>Viswanadham, V. V.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/525808v1?rss=1</link><content><content>ATAC-seq exploits the observation that the pattern of transposition of a hyperactive Tn5 transposase in native chromatin mirrors genome-wide chromatin accessibility. It has been suggested that transposition observed around transcription factor binding motifs can be used to assess their occupancy in the form of footprints. However, we show that the vast majority of footprints observed at transcription factor motifs in ATAC-seq data spuriously arise from the intrinsic sequence-dependent transposition site bias of Tn5 and are also observed in naked DNA. We demonstrate that the Tn5 transposition bias can be corrected using existing tools for sequence bias correction and a novel estimate of global occupancy in order to produce more reliable estimates of footprints.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/525808v1?rss=1</originId><description>ATAC-seq exploits the observation that the pattern of transposition of a hyperactive Tn5 transposase in native chromatin mirrors genome-wide chromatin accessibility. It has been suggested that transposition observed around transcription factor binding motifs can be used to assess their occupancy in the form of footprints. However, we show that the vast majority of footprints observed at transcription factor motifs in ATAC-seq data spuriously arise from the intrinsic sequence-dependent transposition site bias of Tn5 and are also observed in naked DNA. We demonstrate that the Tn5 transposition bias can be corrected using existing tools for sequence bias correction and a novel estimate of global occupancy in order to produce more reliable estimates of footprints.</description><published>1548144000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/525808v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16876a88d9a:27114e5:3a104d3b</id><title>A Bayesian approach for correcting Tn5 transposition bias in ATAC-seq footprinting [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/22/525808</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08350-7</href></item></canonical><engagement>0</engagement><crawled>1548325717848</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Liang Chen</name></author><visual><height>586</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-08350-7/MediaObjects/41467_2019_8350_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-019-08350-7</link><content><content>&lt;p&gt;&lt;b&gt;Medial geniculate body and primary auditory cortex differentially contribute to striatal sound representations&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Medial geniculate body and primary auditory cortex differentially contribute to striatal sound representations, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08350-7&quot;&gt;doi:10.1038/s41467-019-08350-7&lt;/a&gt;&lt;/p&gt;The precise role of auditory cortical and thalamic projections in the representation of sound in the auditory striatum is not known. Here, the authors show that silencing thalamic inputs lowers the gain of sound-evoked responses while cortical inputs only affect the best frequency responses of striatal neurons.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/_DAPp16WuG4&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-019-08350-7</originId><description>&lt;p&gt;&lt;b&gt;Medial geniculate body and primary auditory cortex differentially contribute to striatal sound representations&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Medial geniculate body and primary auditory cortex differentially contribute to striatal sound representations, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08350-7&quot;&gt;doi:10.1038/s41467-019-08350-7&lt;/a&gt;&lt;/p&gt;The precise role of auditory cortical and thalamic projections in the representation of sound in the auditory striatum is not known. Here, the authors show that silencing thalamic inputs lowers the gain of sound-evoked responses while cortical inputs only affect the best frequency responses of striatal neurons.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/_DAPp16WuG4&quot; height=&quot;1&quot;&gt;</description><published>1548316800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/_DAPp16WuG4/s41467-019-08350-7</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687f678758:3406955:3a104d3b</id><title>Medial geniculate body and primary auditory cortex differentially contribute to striatal sound representations</title><fingerprint>9ec8baee</fingerprint></item><item><crawled>1548802311194</crawled><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><author><name>Elhassan, R. M.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/534008v1?rss=1</link><content><content>Introduction: Cryptococcosis is a ubiquitous opportunistic fungal disease caused by Cryptococcus neoformans var. grubii. It has high global morbidity and mortality among HIV patients and none-HIV carriers with 99% and 95% respectively. Furthermore, the increasing prevalence of undesired toxicity profile of antifungal, multi-drug resistant organism, and the scarcity of FDA authorized vaccines, where the hallmark in the present days. This study was undertaken to design a reliable multi-epitope peptide vaccine against highly conserved immunodominant heat shock 70KDa protein of Cryptococcus neoformans var. grubii that covers a considerable digit of the world population through implementing computational vaccinology approach. Materials and Methods: A total of 38 Sequences of Cryptococcus neoformans var. grubii heat shock 70KDa protein were retrieved from NCBI protein database. Different prediction tools were used to analyze the aforementioned protein at Immune Epitope Database (IEDB) to discriminate the most promising T-cell and B-cell epitopes. Then the proposed epitopes were subjected to Population coverage analysis tool to compute the global population coverage. Finally, the projected epitopes were ranked based on their scores and binding modes by Moe 2007 program. Outstanding Results and Conclusion: Our prime vaccine candidate was a putative ten promising epitopes (ANYVQASEK, NYVQASEK, KSVEKPAS, TPQQPPAQ, YVYDTRGKL, FYRQGAFEL, FTQLVAAYL, FFGGKVLNF, FDYALVQHF, and FINAQLVDV). Together, these epitopes are forecasted to trigger T lymphocytes, B lymphocytes, and immunological memory with overall population coverage above 90%. Accordingly, our in silico vaccine is expected to be the future multi-epitope peptide vaccine against Cryptococcus neoformans var. grubii heat shock 70KDa protein that covers a significant figure of the entire world citizens. Therefore, there is a definite need for experimental validation for the carefully chosen vaccine candidates in vitro and in vivo to fortify their antigenic and immunogenic potentials. Additionally, further computational studies are needed to be conducted in pathogens-derived Heat shock 70KDa protein family, as it believed to find universal epitopes that might be overlapped with other pathogens derived Hsp70.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/534008v1?rss=1</originId><description>Introduction: Cryptococcosis is a ubiquitous opportunistic fungal disease caused by Cryptococcus neoformans var. grubii. It has high global morbidity and mortality among HIV patients and none-HIV carriers with 99% and 95% respectively. Furthermore, the increasing prevalence of undesired toxicity profile of antifungal, multi-drug resistant organism, and the scarcity of FDA authorized vaccines, where the hallmark in the present days. This study was undertaken to design a reliable multi-epitope peptide vaccine against highly conserved immunodominant heat shock 70KDa protein of Cryptococcus neoformans var. grubii that covers a considerable digit of the world population through implementing computational vaccinology approach. Materials and Methods: A total of 38 Sequences of Cryptococcus neoformans var. grubii heat shock 70KDa protein were retrieved from NCBI protein database. Different prediction tools were used to analyze the aforementioned protein at Immune Epitope Database (IEDB) to discriminate the most promising T-cell and B-cell epitopes. Then the proposed epitopes were subjected to Population coverage analysis tool to compute the global population coverage. Finally, the projected epitopes were ranked based on their scores and binding modes by Moe 2007 program. Outstanding Results and Conclusion: Our prime vaccine candidate was a putative ten promising epitopes (ANYVQASEK, NYVQASEK, KSVEKPAS, TPQQPPAQ, YVYDTRGKL, FYRQGAFEL, FTQLVAAYL, FFGGKVLNF, FDYALVQHF, and FINAQLVDV). Together, these epitopes are forecasted to trigger T lymphocytes, B lymphocytes, and immunological memory with overall population coverage above 90%. Accordingly, our in silico vaccine is expected to be the future multi-epitope peptide vaccine against Cryptococcus neoformans var. grubii heat shock 70KDa protein that covers a significant figure of the entire world citizens. Therefore, there is a definite need for experimental validation for the carefully chosen vaccine candidates in vitro and in vivo to fortify their antigenic and immunogenic potentials. Additionally, further computational studies are needed to be conducted in pathogens-derived Heat shock 70KDa protein family, as it believed to find universal epitopes that might be overlapped with other pathogens derived Hsp70.</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/534008v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689bcfc41a:656952:ad2b6584</id><title>Computational vaccinology approach: Designing an efficient multi-epitope peptide vaccine against Cryptococcus neoformans var. grubii heat shock 70KDa protein [NEW RESULTS]</title><fingerprint>60365af2</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><author><name>Zahn, L. M.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>97976863</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/40-b?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/40-b?rss=1</originId><published>1546540591000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/40-b?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3ab:ad2b6584</id><title>Alzheimer&apos;s disease in admixed people</title><canonicalUrl>http://science.sciencemag.org/content/363/6422/40.2.full</canonicalUrl></item><item><engagement>0</engagement><crawled>1547665791807</crawled><fingerprint>654263d4</fingerprint><author><name>Vella, A., Freeman, J. L. R., Dunn, I., Keller, K., Buse, J. B., Valcarce, C.</name></author><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/475/eaau3441?rss=1</link><content><content>&lt;p&gt;The therapeutic success of interventions targeting glucokinase (GK) activation for the treatment of type 2 diabetes has been limited by hypoglycemia, steatohepatitis, and loss of efficacy over time. The clinical characteristics of patients with GK-activating mutations or GK regulatory protein (GKRP) loss-of-function mutations suggest that a hepatoselective GK activator (GKA) that does not activate GK in β cells or affect the GK-GKRP interaction may reduce hyperglycemia in patients with type 2 diabetes while limiting hypoglycemia and liver-associated adverse effects. Here, we review the rationale for TTP399, an oral hepatoselective GKA, and its progression from preclinical to clinical development, with an emphasis on the results of a randomized, double-blind, placebo- and active-controlled phase 2 study of TTP399 in patients with type 2 diabetes. In this 6-month study, TTP399 (800 mg/day) was associated with a clinically significant and sustained reduction in glycated hemoglobin, with a placebo-subtracted least squares mean HbA&lt;sub&gt;1c&lt;/sub&gt; change from baseline of –0.9% (&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.01). Compared to placebo, TTP399 (800 mg/day) also increased high-density lipoprotein cholesterol (3.2 mg/dl; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05), decreased fasting plasma glucagon (–20 pg/ml; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05), and decreased weight in patients weighing ≥100 kg (–3.4 kg; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05). TTP399 did not cause hypoglycemia, had no detrimental effect on plasma lipids or liver enzymes, and did not increase blood pressure, highlighting the importance of tissue selectivity and preservation of physiological regulation when targeting key metabolic regulators such as GK.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/475/eaau3441?rss=1</originId><description>&lt;p&gt;The therapeutic success of interventions targeting glucokinase (GK) activation for the treatment of type 2 diabetes has been limited by hypoglycemia, steatohepatitis, and loss of efficacy over time. The clinical characteristics of patients with GK-activating mutations or GK regulatory protein (GKRP) loss-of-function mutations suggest that a hepatoselective GK activator (GKA) that does not activate GK in β cells or affect the GK-GKRP interaction may reduce hyperglycemia in patients with type 2 diabetes while limiting hypoglycemia and liver-associated adverse effects. Here, we review the rationale for TTP399, an oral hepatoselective GKA, and its progression from preclinical to clinical development, with an emphasis on the results of a randomized, double-blind, placebo- and active-controlled phase 2 study of TTP399 in patients with type 2 diabetes. In this 6-month study, TTP399 (800 mg/day) was associated with a clinically significant and sustained reduction in glycated hemoglobin, with a placebo-subtracted least squares mean HbA&lt;sub&gt;1c&lt;/sub&gt; change from baseline of –0.9% (&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.01). Compared to placebo, TTP399 (800 mg/day) also increased high-density lipoprotein cholesterol (3.2 mg/dl; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05), decreased fasting plasma glucagon (–20 pg/ml; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05), and decreased weight in patients weighing ≥100 kg (–3.4 kg; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05). TTP399 did not cause hypoglycemia, had no detrimental effect on plasma lipids or liver enzymes, and did not increase blood pressure, highlighting the importance of tissue selectivity and preservation of physiological regulation when targeting key metabolic regulators such as GK.&lt;/p&gt;</description><published>1547664692000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/475/eaau3441?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1685811db3f:3e2669c:3a104d3b</id><title>[Research Articles] Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator</title><canonicalUrl>http://stm.sciencemag.org/content/11/475/eaau3441.full</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0331-0</href></item></canonical><entities><item><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id><mentions><item><text>CSS</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id><mentions><item><text>WEBSITEnature_com</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id><mentions><item><text>Explorer</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id><mentions><item><text>JavaScript</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546877155117</crawled><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><author><name>Hannah Stower</name></author><visual><height>453</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0331-0/MediaObjects/41591_2018_331_Figa_HTML.jpg</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41591-018-0331-0</link><content><content>&lt;p&gt;&lt;b&gt;Full dairy ahead!&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Full dairy ahead!, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0331-0&quot;&gt;doi:10.1038/s41591-018-0331-0&lt;/a&gt;&lt;/p&gt;Full dairy ahead!&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/6WLxAuUiLL4&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>web design</label><id>nlp/f/topic/2461</id><probability>0.933</probability></item><item><label>css</label><id>nlp/f/topic/590</id><probability>0.933</probability></item></commonTopics><originId>https://www.nature.com/articles/s41591-018-0331-0</originId><description>&lt;p&gt;&lt;b&gt;Full dairy ahead!&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Full dairy ahead!, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0331-0&quot;&gt;doi:10.1038/s41591-018-0331-0&lt;/a&gt;&lt;/p&gt;Full dairy ahead!&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/6WLxAuUiLL4&quot; height=&quot;1&quot;&gt;</description><published>1546848000000</published><engagement>6</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/6WLxAuUiLL4/s41591-018-0331-0</href></item></alternate><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_1682910372d:1629689:3a104d3b</id><title>Full dairy ahead!</title><fingerprint>9cb566f7</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01720</href></item></canonical><engagement>0</engagement><crawled>1546277335642</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><author><name>Youtian Hu, Lu Wang, Xu Han, Yueyang Zhou, Tonghui Zhang, Li Wang, Ting Hong, Wei Zhang, Xun-Xiang Guo, Jielin Sun, Yingxin Qi, Jing Yu, Hong Liu, Fang Wu</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01720</link><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01720</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01720/20181231/images/medium/jm-2018-01720v_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01720&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=eV9u8yC1Ldg:uFqqDYrozbA:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/eV9u8yC1Ldg&quot; height=&quot;1&quot;&gt;</description><published>1546232400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/eV9u8yC1Ldg/acs.jmedchem.8b01720</href></item></alternate><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_168054fb25a:ce35f1:56b782f7</id><title>[ASAP] Discovery of a Bioactive Inhibitor with a New Scaffold for Cystathionine ?-Lyase</title><fingerprint>6e2b9f90</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01720/20181231/images/medium/jm-2018-01720v_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01720&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=eV9u8yC1Ldg:uFqqDYrozbA:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/eV9u8yC1Ldg&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00572</href></item></canonical><engagement>0</engagement><crawled>1548422375098</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><author><name>Tiago M. C. Simões, Abel J. P. Gomes</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jcim.8b00572</link><originId>http://dx.doi.org/10.1021/acs.jcim.8b00572</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00572/20190124/images/medium/ci-2018-00572k_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00572&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=JShsQ70Kx9g:BgcDcoasIyk:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/JShsQ70Kx9g&quot; height=&quot;1&quot;&gt;</description><published>1548392400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/JShsQ70Kx9g/acs.jcim.8b00572</href></item></alternate><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_168852a66ba:1121ea7:56b782f7</id><title>[ASAP] CavVis—A Field-of-View Geometric Algorithm for Protein Cavity Detection</title><fingerprint>5ed55455</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00572/20190124/images/medium/ci-2018-00572k_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00572&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=JShsQ70Kx9g:BgcDcoasIyk:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/JShsQ70Kx9g&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08064-2</href></item></canonical><engagement>0</engagement><crawled>1547719533857</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Jason Yi</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>550</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08064-2/MediaObjects/41467_2018_8064_Fig2_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08064-2</link><content><content>&lt;p&gt;&lt;b&gt;TCR microclusters form spatially segregated domains and sequentially assemble in calcium-dependent kinetic steps&lt;/b&gt;&lt;/p&gt;&lt;p&gt;TCR microclusters form spatially segregated domains and sequentially assemble in calcium-dependent kinetic steps, Published online: 17 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08064-2&quot;&gt;doi:10.1038/s41467-018-08064-2&lt;/a&gt;&lt;/p&gt;Engagement of T cell receptors (TCRs) induces the formation of microclusters that mediate the downstream signalling events. Here the authors show, using high resolution TIRF-SIM and live cell imaging, that ZAP70 and LAT are recruited to TCR with distinct kinetics, with the delayed ZAP70-TCR association modulated by TCR-induced calcium flux.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/9p3bKGDgWS0&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08064-2</originId><description>&lt;p&gt;&lt;b&gt;TCR microclusters form spatially segregated domains and sequentially assemble in calcium-dependent kinetic steps&lt;/b&gt;&lt;/p&gt;&lt;p&gt;TCR microclusters form spatially segregated domains and sequentially assemble in calcium-dependent kinetic steps, Published online: 17 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08064-2&quot;&gt;doi:10.1038/s41467-018-08064-2&lt;/a&gt;&lt;/p&gt;Engagement of T cell receptors (TCRs) induces the formation of microclusters that mediate the downstream signalling events. Here the authors show, using high resolution TIRF-SIM and live cell imaging, that ZAP70 and LAT are recruited to TCR with distinct kinetics, with the delayed ZAP70-TCR association modulated by TCR-induced calcium flux.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/9p3bKGDgWS0&quot; height=&quot;1&quot;&gt;</description><published>1547712000000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/9p3bKGDgWS0/s41467-018-08064-2</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1685b45e521:289f40:c2ce2e2e</id><title>TCR microclusters form spatially segregated domains and sequentially assemble in calcium-dependent kinetic steps</title><fingerprint>29264dc1</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/d41573-019-00002-1</href></item></canonical><entities><item><label>Jack Walters</label><id>nlp/f/entity/en/-/jack walters</id><mentions><item><text>Jack Walters</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Alamy</label><id>nlp/f/entity/en/w/Alamy</id><mentions><item><text>Alamy</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>PTX</label><id>nlp/f/entity/en/-/ptx</id><mentions><item><text>PTX</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Cryogenic electron microscopy</label><id>nlp/f/entity/en/w/Cryogenic electron microscopy</id><mentions><item><text>cryo - EM</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>plus GABA</label><id>nlp/f/entity/en/-/plus gaba</id><mentions><item><text>plus GABA</text></item><item><text>GABA</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547124075052</crawled><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><author><name>Megan Cully</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/d41573-019-00002-1</link><content><content>&lt;p&gt;&lt;b&gt;GABA&lt;sub&gt;A&lt;/sub&gt; receptor structures solved&lt;/b&gt;&lt;/p&gt;&lt;p&gt;GABA&amp;lt;sub&gt;A&amp;lt;/sub&gt; receptor structures solved, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00002-1&quot;&gt;doi:10.1038/d41573-019-00002-1&lt;/a&gt;&lt;/p&gt;GABA&lt;sub&gt;A&lt;/sub&gt; receptor structures solved&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/Qx-nEHJQ4aI&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>pharmacology</label><id>nlp/f/topic/1735</id><probability>0.985</probability></item><item><label>drug discovery</label><id>nlp/f/topic/697</id><probability>0.928</probability></item><item><label>med chem</label><id>nlp/f/topic/1428</id><probability>0.796</probability></item><item><label>biochemistry</label><id>nlp/f/topic/257</id><probability>0.715</probability></item></commonTopics><originId>https://www.nature.com/articles/d41573-019-00002-1</originId><description>&lt;p&gt;&lt;b&gt;GABA&lt;sub&gt;A&lt;/sub&gt; receptor structures solved&lt;/b&gt;&lt;/p&gt;&lt;p&gt;GABA&amp;lt;sub&gt;A&amp;lt;/sub&gt; receptor structures solved, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-019-00002-1&quot;&gt;doi:10.1038/d41573-019-00002-1&lt;/a&gt;&lt;/p&gt;GABA&lt;sub&gt;A&lt;/sub&gt; receptor structures solved&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/Qx-nEHJQ4aI&quot; height=&quot;1&quot;&gt;</description><published>1547107200000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/Qx-nEHJQ4aI/d41573-019-00002-1</href></item></alternate><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_16837c7ea2c:12d0a2c:3a104d3b</id><title>GABAA receptor structures solved</title><fingerprint>93198a20</fingerprint></item><item><updateCount>2</updateCount><entities><item><label>NASA</label><id>nlp/f/entity/en/w/NASA</id><mentions><item><text>NASA</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Transiting Exoplanet Survey Satellite</label><id>nlp/f/entity/en/w/Transiting Exoplanet Survey Satellite</id><mentions><item><text>TESS</text></item><item><text>Transiting Exoplanet Survey Satellite</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Massachusetts Institute of Technology</label><id>nlp/f/entity/en/w/Massachusetts Institute of Technology</id><mentions><item><text>Massachusetts Institute of Technology</text></item><item><text>MIT</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Xu Chelsea Huang</label><id>nlp/f/entity/en/-/xu chelsea huang</id><mentions><item><text>Huang</text></item><item><text>Xu Chelsea Huang</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Bill Ricker</label><id>nlp/f/entity/en/w/Bill Ricker</id><mentions><item><text>Ricker</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546910339125</crawled><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><published>1546934400000</published><visual><height>426</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>639</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00071-7/d41586-019-00071-7_16381330.jpg</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><description>&lt;p&gt;&lt;b&gt;NASA exoplanet hunter racks up bizarre worlds and exploding stars&lt;/b&gt;&lt;/p&gt;&lt;p&gt;NASA exoplanet hunter racks up bizarre worlds and exploding stars, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00071-7&quot;&gt;doi:10.1038/d41586-019-00071-7&lt;/a&gt;&lt;/p&gt;The Transiting Exoplanet Survey Satellite has identified at least eight planets, including one with a mass more than 20 times that of Earth.</description><link>https://www.nature.com/articles/d41586-019-00071-7</link><content><content>&lt;p&gt;&lt;b&gt;NASA exoplanet hunter racks up bizarre worlds and exploding stars&lt;/b&gt;&lt;/p&gt;&lt;p&gt;NASA exoplanet hunter racks up bizarre worlds and exploding stars, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00071-7&quot;&gt;doi:10.1038/d41586-019-00071-7&lt;/a&gt;&lt;/p&gt;The Transiting Exoplanet Survey Satellite has identified at least eight planets, including one with a mass more than 20 times that of Earth.</content><direction>ltr</direction></content><commonTopics><item><label>space</label><id>nlp/f/topic/2140</id><probability>1.0</probability></item><item><label>astrophysics</label><id>nlp/f/topic/173</id><probability>0.995</probability></item><item><label>geology</label><id>nlp/f/topic/959</id><probability>0.945</probability></item><item><label>satellite</label><id>nlp/f/topic/2001</id><probability>0.94</probability></item><item><label>science</label><id>nlp/f/topic/2017</id><probability>0.865</probability></item><item><label>physics</label><id>nlp/f/topic/1753</id><probability>0.843</probability></item><item><label>gossip</label><id>nlp/f/topic/989</id><probability>0.819</probability></item><item><label>astrophotography</label><id>nlp/f/topic/172</id><probability>0.776</probability></item><item><label>sports</label><id>nlp/f/topic/2152</id><probability>0.756</probability></item><item><label>culture</label><id>nlp/f/topic/597</id><probability>0.736</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00071-7</originId><author><name>Alexandra Witze</name></author><recrawled>1546951345626</recrawled><engagement>3</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00071-7</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1682b0a9035:255b2:3a104d3b</id><title>NASA exoplanet hunter racks up bizarre worlds and exploding stars</title><fingerprint>1d72ff18</fingerprint></item><item><engagement>343</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Small, D. M., DiFeliceantonio, A. G.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/346?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/346?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6425/346.full</canonicalUrl><published>1548355045000</published><keywords><item>Neuroscience</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/346?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a8d:c2ce2e2e</id><title>Processed foods and food reward</title><fingerprint>8d69a01f</fingerprint></item><item><engagement>0</engagement><crawled>1548294421286</crawled><fingerprint>b77f4404</fingerprint><author><name>Thakkar, N.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/526467v1?rss=1</link><content><content>Repertoire sequencing is enabling deep explorations into the cellular immune response, including the characterization of commonalities and differences among T cell receptor (TCR) repertoires from different individuals, pathologies, and antigen specificities. In seeking to understand the generality of patterns observed in different groups of TCRs, it is necessary to balance how well each pattern represents the diversity among TCRs from one group (sensitivity) vs. how many TCRs from other groups it also represents (specificity). The variable complementarity determining regions (CDRs), particularly the third CDRs (CDR3s) interact with MHC-presented epitopes from putative antigens, and thus encode the determinants of recognition. We here systematically characterize the predictive power that can be obtained from CDR3 sequences, using representative, readily interpretable methods for evaluating CDR sequence similarity and then clustering and classifying sequences based on similarity. An initial analysis of CDR3s of known structure, clustered by structural similarity, helps calibrate the limits of sequence diversity among CDRs that might have a common mode of interaction with presented epitopes. Subsequent analyses demonstrate that this same range of sequence similarity strikes an appropriate specificity/sensitivity balance in distinguishing twins from non-twins based on overall CDR3 repertoires, classifying CDR3 repertoires by antigen specificity, and distinguishing general pathologies. We conclude that within this fairly broad range of sequence similarity, matching CDR3 sequences are likely to share specificities.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/526467v1?rss=1</originId><description>Repertoire sequencing is enabling deep explorations into the cellular immune response, including the characterization of commonalities and differences among T cell receptor (TCR) repertoires from different individuals, pathologies, and antigen specificities. In seeking to understand the generality of patterns observed in different groups of TCRs, it is necessary to balance how well each pattern represents the diversity among TCRs from one group (sensitivity) vs. how many TCRs from other groups it also represents (specificity). The variable complementarity determining regions (CDRs), particularly the third CDRs (CDR3s) interact with MHC-presented epitopes from putative antigens, and thus encode the determinants of recognition. We here systematically characterize the predictive power that can be obtained from CDR3 sequences, using representative, readily interpretable methods for evaluating CDR sequence similarity and then clustering and classifying sequences based on similarity. An initial analysis of CDR3s of known structure, clustered by structural similarity, helps calibrate the limits of sequence diversity among CDRs that might have a common mode of interaction with presented epitopes. Subsequent analyses demonstrate that this same range of sequence similarity strikes an appropriate specificity/sensitivity balance in distinguishing twins from non-twins based on overall CDR3 repertoires, classifying CDR3 repertoires by antigen specificity, and distinguishing general pathologies. We conclude that within this fairly broad range of sequence similarity, matching CDR3 sequences are likely to share specificities.</description><published>1548230400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/526467v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1687d89fb26:3185f49:ad2b6584</id><title>Balancing sensitivity and specificity in distinguishing TCR groups by CDR sequence similarity [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/526467v1</canonicalUrl></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acschembio.8b00972</href></item></canonical><engagement>0</engagement><crawled>1548379954877</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acbcct</streamId><title>ACS Chemical Biology: Latest Articles (ACS Publications)</title></origin><author><name>Patricia R. Feliciano, Catherine L. Drennan, Maria Cristina Nonato</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acschembio.8b00972</link><originId>http://dx.doi.org/10.1021/acschembio.8b00972</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00972/20190124/images/medium/cb-2018-00972g_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00972&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=p80ZNKQGtdo:2dr321GEK7o:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/p80ZNKQGtdo&quot; height=&quot;1&quot;&gt;</description><published>1548306000000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/acbcct/~3/p80ZNKQGtdo/acschembio.8b00972</href></item></alternate><id>ofNPcmQ46PpGzt1nO49W9STAvkUsM7jssLxNXMp09ME=_16882a31ebd:b59e1:875042c9</id><title>[ASAP] Crystal Structures of Fumarate Hydratases from Leishmania major in a Complex with Inhibitor 2-Thiomalate</title><fingerprint>cf760216</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00972/20190124/images/medium/cb-2018-00972g_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00972&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=p80ZNKQGtdo:2dr321GEK7o:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/p80ZNKQGtdo&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08273-9</href></item></canonical><engagement>0</engagement><crawled>1547633219300</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Guodong Xie</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>411</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08273-9/MediaObjects/41467_2018_8273_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08273-9</link><content><content>&lt;p&gt;&lt;b&gt;A conserved dimer interface connects ERH and YTH family proteins to promote gene silencing&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A conserved dimer interface connects ERH and YTH family proteins to promote gene silencing, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08273-9&quot;&gt;doi:10.1038/s41467-018-08273-9&lt;/a&gt;&lt;/p&gt;In fission yeast, Erh1, ortholog of human ERH, interacts with the YTH family RNA binding protein Mmi1 to form the Erh1-Mmi1 complex (EMC), which has been implicated in gene silencing. Here, the authors present the cocrystal structure of Erh1 homodimers interacting with Mmi1 and further characterise the role of EMC in facultative heterochromatin assembly and gene silencing.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/L_6O6O8q1MI&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08273-9</originId><description>&lt;p&gt;&lt;b&gt;A conserved dimer interface connects ERH and YTH family proteins to promote gene silencing&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A conserved dimer interface connects ERH and YTH family proteins to promote gene silencing, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08273-9&quot;&gt;doi:10.1038/s41467-018-08273-9&lt;/a&gt;&lt;/p&gt;In fission yeast, Erh1, ortholog of human ERH, interacts with the YTH family RNA binding protein Mmi1 to form the Erh1-Mmi1 complex (EMC), which has been implicated in gene silencing. Here, the authors present the cocrystal structure of Erh1 homodimers interacting with Mmi1 and further characterise the role of EMC in facultative heterochromatin assembly and gene silencing.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/L_6O6O8q1MI&quot; height=&quot;1&quot;&gt;</description><published>1547625600000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/L_6O6O8q1MI/s41467-018-08273-9</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1685620d6e4:3ad9597:3a104d3b</id><title>A conserved dimer interface connects ERH and YTH family proteins to promote gene silencing</title><fingerprint>ad76b773</fingerprint></item><item><crawled>1548836508002</crawled><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><author><name>Kelly N. Tran, 
Shuqiang Niu, 
Toshiko Ichiye</name></author><visual><height>394</height><processor>feedly-nikon-v3.1</processor><contentType>image/png; charset=UTF-8</contentType><width>388</width><url>https://onlinelibrary.wiley.com/cms/attachment/50a91ce3-2d27-4884-940b-07b893e2d613/jcc25785-toc-0001-m.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25785?af=R</link><content><content>&lt;img alt=&quot;Journal of Computational Chemistry Reduction potential calculations of the Fe–S clusters in Thermus thermophilus respiratory complex I&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/50a91ce3-2d27-4884-940b-07b893e2d613/jcc25785-toc-0001-m.png&quot;&gt;
&lt;p&gt;Characterizing the reduction potentials of the iron–sulfur clusters in respiratory complex I is important for understanding the enzyme&apos;s function. The multitude of iron–sulfur clusters in complex I makes it difficult to unambiguously differentiate the clusters. This article introduces a computational tool to calculate the reduction potentials of the iron–sulfur clusters and the results suggest a dynamic mechanism for electron transfer.
&lt;/p&gt;
&lt;br&gt;
&lt;p&gt;Respiratory complex I facilitates electron transfer from NADH to quinone over ~95 Å through a chain of seven iron–sulfur (Fe–S) clusters in the respiratory chain. In this study, the reduction potentials of the Fe–S clusters in &lt;i&gt;Thermus thermophilus&lt;/i&gt; complex I are calculated using a Density Functional Theory + Poisson–Boltzmann method. Our results indicate that the reduction potentials are influenced by a variety of factors including the clusters being deeply buried in the complex and the protonation state of buried ionizable residues. In addition, as several of the ionizable side chains have predicted pK&lt;sub&gt;a&lt;/sub&gt; values near pH 7, relatively small structural fluctuations could lead to significant (0.2 V) shifts in the reduction potential of several of the Fe–S clusters, suggesting a dynamic mechanism for electron transfer. Moreover, the method used here is a useful computational tool to study other questions about complex I. © 2019 Wiley Periodicals, Inc.&lt;/p&gt;</content><direction>ltr</direction></content><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25785?af=R</originId><description>Characterizing the reduction potentials of the iron–sulfur clusters in respiratory complex I is important for understanding the enzyme&apos;s function. The multitude of iron–sulfur clusters in complex I makes it difficult to unambiguously differentiate the clusters. This article introduces a computational tool to calculate the reduction potentials of the iron–sulfur clusters and the results suggest a dynamic mechanism for electron transfer.
Respiratory complex I facilitates electron transfer from NADH to quinone over ~95 Å through a chain of seven iron–sulfur (Fe–S) clusters in the respiratory chain. In this study, the reduction potentials of the Fe–S clusters in Thermus thermophilus complex I are calculated using a Density Functional Theory + Poisson–Boltzmann method. Our results indicate that the reduction potentials are influenced by a variety of factors including the clusters being deeply buried in the complex and the protonation state of buried ionizable residues. In addition, as several of the ionizable side chains have predicted pKa values near pH 7, relatively small structural fluctuations could lead to significant (0.2 V) shifts in the reduction potential of several of the Fe–S clusters, suggesting a dynamic mechanism for electron transfer. Moreover, the method used here is a useful computational tool to study other questions about complex I. © 2019 Wiley Periodicals, Inc.</description><published>1548777713000</published><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25785?af=R</href></item></alternate><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_1689dd99162:8fcf13:3a104d3b</id><title>Reduction potential calculations of the Fe–S clusters in Thermus thermophilus respiratory complex I</title><fingerprint>c66b8302</fingerprint><summary><content>Characterizing the reduction potentials of the iron–sulfur clusters in respiratory complex I is important for understanding the enzyme&apos;s function. The multitude of iron–sulfur clusters in complex I makes it difficult to unambiguously differentiate the clusters. This article introduces a computational tool to calculate the reduction potentials of the iron–sulfur clusters and the results suggest a dynamic mechanism for electron transfer.
Respiratory complex I facilitates electron transfer from NADH to quinone over ~95 Å through a chain of seven iron–sulfur (Fe–S) clusters in the respiratory chain. In this study, the reduction potentials of the Fe–S clusters in Thermus thermophilus complex I are calculated using a Density Functional Theory + Poisson–Boltzmann method. Our results indicate that the reduction potentials are influenced by a variety of factors including the clusters being deeply buried in the complex and the protonation state of buried ionizable residues. In addition, as several of the ionizable side chains have predicted pKa values near pH 7, relatively small structural fluctuations could lead to significant (0.2 V) shifts in the reduction potential of several of the Fe–S clusters, suggesting a dynamic mechanism for electron transfer. Moreover, the method used here is a useful computational tool to study other questions about complex I. © 2019 Wiley Periodicals, Inc.</content><direction>ltr</direction></summary></item><item><entities><item><label>Albania</label><id>nlp/f/entity/en/w/Albania</id><mentions><item><text>Albanian</text></item><item><text>Albania</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Doctor of Philosophy</label><id>nlp/f/entity/en/w/Doctor of Philosophy</id><mentions><item><text>PhDs</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id><mentions><item><text>Getty</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>AFP</label><id>nlp/f/entity/en/-/afp</id><mentions><item><text>AFP</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Gent Shkullaku</label><id>nlp/f/entity/en/-/gent shkullaku</id><mentions><item><text>Gent Shkullaku</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547653370695</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00144-7/d41586-019-00144-7_16389900.jpg</url></visual><author><name>Altin Raxhimi</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00144-7</link><content><content>&lt;p&gt;&lt;b&gt;Mass student protests bring down Albania’s science minister &lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mass student protests bring down Albania’s science minister , Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00144-7&quot;&gt;doi:10.1038/d41586-019-00144-7&lt;/a&gt;&lt;/p&gt;The government has bowed to pressure to fix the country’s research and higher education — but stopped short of repealing a controversial law.</content><direction>ltr</direction></content><commonTopics><item><label>higher ed</label><id>nlp/f/topic/1063</id><probability>1.0</probability></item><item><label>science policy</label><id>nlp/f/topic/2019</id><probability>0.991</probability></item><item><label>education</label><id>nlp/f/topic/741</id><probability>0.84</probability></item><item><label>academic</label><id>nlp/f/topic/17</id><probability>0.81</probability></item><item><label>international law</label><id>nlp/f/topic/1186</id><probability>0.751</probability></item><item><label>university</label><id>nlp/f/topic/2378</id><probability>0.726</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00144-7</originId><description>&lt;p&gt;&lt;b&gt;Mass student protests bring down Albania’s science minister &lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mass student protests bring down Albania’s science minister , Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00144-7&quot;&gt;doi:10.1038/d41586-019-00144-7&lt;/a&gt;&lt;/p&gt;The government has bowed to pressure to fix the country’s research and higher education — but stopped short of repealing a controversial law.</description><published>1547625600000</published><engagement>11</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00144-7</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857545347:3ca1cb4:c2ce2e2e</id><title>Mass student protests bring down Albania’s science minister</title><fingerprint>e8966b07</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01823</href></item></canonical><engagement>0</engagement><crawled>1546895696291</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><author><name>Liyang Shi, Zhenpeng Zhong, Xitao Li, Yiqing Zhou, Zhengying Pan</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01823</link><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01823</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01823/20190107/images/medium/jm-2018-01823p_0018.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01823&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=DX3W9aXs0UA:4naGnF6Edhw:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/DX3W9aXs0UA&quot; height=&quot;1&quot;&gt;</description><published>1546837200000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/DX3W9aXs0UA/acs.jmedchem.8b01823</href></item></alternate><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1682a2b21a3:16ebe64:56b782f7</id><title>[ASAP] Discovery of an Orally Available Janus Kinase 3 Selective Covalent Inhibitor</title><fingerprint>20fd3d11</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01823/20190107/images/medium/jm-2018-01823p_0018.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01823&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=DX3W9aXs0UA:4naGnF6Edhw:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/DX3W9aXs0UA&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-38422-5</href></item></canonical><engagement>0</engagement><crawled>1548718572786</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Yoichi Kamikoriyama</name></author><visual><height>241</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-38422-5/MediaObjects/41598_2018_38422_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-38422-5</link><content><content>&lt;p&gt;&lt;b&gt;Ambient Aqueous-Phase Synthesis of Copper Nanoparticles and Nanopastes with Low-Temperature Sintering and Ultra-High Bonding Abilities&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ambient Aqueous-Phase Synthesis of Copper Nanoparticles and Nanopastes with Low-Temperature Sintering and Ultra-High Bonding Abilities, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-38422-5&quot;&gt;doi:10.1038/s41598-018-38422-5&lt;/a&gt;&lt;/p&gt;Ambient Aqueous-Phase Synthesis of Copper Nanoparticles and Nanopastes with Low-Temperature Sintering and Ultra-High Bonding Abilities&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/h3iLUl9-fbM&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-38422-5</originId><description>&lt;p&gt;&lt;b&gt;Ambient Aqueous-Phase Synthesis of Copper Nanoparticles and Nanopastes with Low-Temperature Sintering and Ultra-High Bonding Abilities&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ambient Aqueous-Phase Synthesis of Copper Nanoparticles and Nanopastes with Low-Temperature Sintering and Ultra-High Bonding Abilities, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-38422-5&quot;&gt;doi:10.1038/s41598-018-38422-5&lt;/a&gt;&lt;/p&gt;Ambient Aqueous-Phase Synthesis of Copper Nanoparticles and Nanopastes with Low-Temperature Sintering and Ultra-High Bonding Abilities&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/h3iLUl9-fbM&quot; height=&quot;1&quot;&gt;</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/h3iLUl9-fbM/s41598-018-38422-5</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16896d204f2:51217e4:c2ce2e2e</id><title>Ambient Aqueous-Phase Synthesis of Copper Nanoparticles and Nanopastes with Low-Temperature Sintering and Ultra-High Bonding Abilities</title><fingerprint>658ecc11</fingerprint></item><item><engagement>0</engagement><crawled>1547749399792</crawled><fingerprint>790d7d25</fingerprint><author><name>Gruber-Vodicka, H. R.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/521922v1?rss=1</link><content><content>The SSU rRNA gene is the key marker in molecular ecology for all domains of life, but is largely absent from metagenome-assembled genomes that often are the only resource available for environmental microbes. Here we present phyloFlash, a pipeline to overcome this gap with rapid, SSU rRNA-centered taxonomic classification, targeted assembly, and graph-based binning of full metagenomic assemblies. We show that a cleanup of artifacts is pivotal even with a curated reference database. With such a filtered database, the general-purpose mapper BBmap extracts SSU rRNA reads five times faster than the rRNA-specialized tool SortMeRNA with similar sensitivity and higher selectivity on simulated metagenomes. Reference-based targeted assemblers yielded either highly fragmented assemblies or high levels of chimerism, so we employ the general-purpose genomic assembler SPAdes. Our optimized implementation is independent of reference database composition and has satisfactory levels of chimera formation. Using the phyloFlash workflow we could recover the first complete genomes of several enigmatic taxa, including Marinamargulisbacteria from surface ocean seawater. phyloFlash quickly processes Illumina (meta)genomic data, is straightforward to use, even as part of high-throughput quality control, and has user-friendly output reports. The software is available at https://github.com/HRGV/phyloFlash (GPL3 license) and is documented with an online manual.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/521922v1?rss=1</originId><description>The SSU rRNA gene is the key marker in molecular ecology for all domains of life, but is largely absent from metagenome-assembled genomes that often are the only resource available for environmental microbes. Here we present phyloFlash, a pipeline to overcome this gap with rapid, SSU rRNA-centered taxonomic classification, targeted assembly, and graph-based binning of full metagenomic assemblies. We show that a cleanup of artifacts is pivotal even with a curated reference database. With such a filtered database, the general-purpose mapper BBmap extracts SSU rRNA reads five times faster than the rRNA-specialized tool SortMeRNA with similar sensitivity and higher selectivity on simulated metagenomes. Reference-based targeted assemblers yielded either highly fragmented assemblies or high levels of chimerism, so we employ the general-purpose genomic assembler SPAdes. Our optimized implementation is independent of reference database composition and has satisfactory levels of chimera formation. Using the phyloFlash workflow we could recover the first complete genomes of several enigmatic taxa, including Marinamargulisbacteria from surface ocean seawater. phyloFlash quickly processes Illumina (meta)genomic data, is straightforward to use, even as part of high-throughput quality control, and has user-friendly output reports. The software is available at https://github.com/HRGV/phyloFlash (GPL3 license) and is documented with an online manual.</description><published>1547712000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/521922v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1685d0d9cf0:5848d8:ad2b6584</id><title>phyloFlash -- Rapid SSU rRNA profiling and targeted assembly from metagenomes [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/17/521922</canonicalUrl></item><item><updateCount>1</updateCount><entities><item><label>National Science Foundation</label><id>nlp/f/entity/en/w/National Science Foundation</id><mentions><item><text>NSF</text></item><item><text>National Science Foundation</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>wolves of Isle Royale</label><id>nlp/f/entity/en/-/wolves of isle royale</id><mentions><item><text>wolves of Isle Royale</text></item><item><text>wolves</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>NASA</label><id>nlp/f/entity/en/w/NASA</id><mentions><item><text>NASA</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Rolf Peterson</label><id>nlp/f/entity/en/-/rolf peterson</id><mentions><item><text>Rolf Peterson</text></item><item><text>Peterson</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>National Oceanic and Atmospheric Administration</label><id>nlp/f/entity/en/w/National Oceanic and Atmospheric Administration</id><mentions><item><text>NOAA</text></item><item><text>National Oceanic and Atmospheric Administration</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547158640971</crawled><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><published>1547107200000</published><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00082-4/d41586-019-00082-4_16389838.jpg</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><description>&lt;p&gt;&lt;b&gt;Science and the shutdown: 5 things to watch as US impasse drags on&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Science and the shutdown: 5 things to watch as US impasse drags on, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00082-4&quot;&gt;doi:10.1038/d41586-019-00082-4&lt;/a&gt;&lt;/p&gt;A second wave of closures looms as the government funding fight barrels towards a record-breaking fourth week.</description><link>https://www.nature.com/articles/d41586-019-00082-4</link><content><content>&lt;p&gt;&lt;b&gt;Science and the shutdown: 5 things to watch as US impasse drags on&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Science and the shutdown: 5 things to watch as US impasse drags on, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00082-4&quot;&gt;doi:10.1038/d41586-019-00082-4&lt;/a&gt;&lt;/p&gt;A second wave of closures looms as the government funding fight barrels towards a record-breaking fourth week.</content><direction>ltr</direction></content><commonTopics><item><label>ted</label><id>nlp/f/topic/2261</id><probability>0.988</probability></item><item><label>science policy</label><id>nlp/f/topic/2019</id><probability>0.975</probability></item><item><label>surf</label><id>nlp/f/topic/2209</id><probability>0.9</probability></item><item><label>peak oil</label><id>nlp/f/topic/1712</id><probability>0.895</probability></item><item><label>music</label><id>nlp/f/topic/1521</id><probability>0.88</probability></item><item><label>waste</label><id>nlp/f/topic/2453</id><probability>0.863</probability></item><item><label>geology</label><id>nlp/f/topic/959</id><probability>0.83</probability></item><item><label>research</label><id>nlp/f/topic/1931</id><probability>0.802</probability></item><item><label>inspiration</label><id>nlp/f/topic/1173</id><probability>0.799</probability></item><item><label>canada</label><id>nlp/f/topic/375</id><probability>0.769</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00082-4</originId><author><name>Lauren Morello</name></author><recrawled>1547171932776</recrawled><engagement>8</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00082-4</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16839d7594b:160d345:3a104d3b</id><title>Science and the shutdown: 5 things to watch as US impasse drags on</title><fingerprint>bf58b667</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07926-z</href></item></canonical><engagement>126</engagement><crawled>1547028319340</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Janaka Senarathna</name></author><visual><height>615</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07926-z/MediaObjects/41467_2018_7926_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-07926-z</link><content><content>&lt;p&gt;&lt;b&gt;A miniature multi-contrast microscope for functional imaging in freely behaving animals&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A miniature multi-contrast microscope for functional imaging in freely behaving animals, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07926-z&quot;&gt;doi:10.1038/s41467-018-07926-z&lt;/a&gt;&lt;/p&gt;Measuring multiple neurophysiologic variables usually requires bulky benchtop optical systems and working with anesthetized animals. Here the authors present a miniature portable microscope for neurovascular imaging in awake rodents, combining fluorescence, intrinsic optical signals and laser speckle contrast.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/0wJpY_XEm-I&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-07926-z</originId><description>&lt;p&gt;&lt;b&gt;A miniature multi-contrast microscope for functional imaging in freely behaving animals&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A miniature multi-contrast microscope for functional imaging in freely behaving animals, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07926-z&quot;&gt;doi:10.1038/s41467-018-07926-z&lt;/a&gt;&lt;/p&gt;Measuring multiple neurophysiologic variables usually requires bulky benchtop optical systems and working with anesthetized animals. Here the authors present a miniature portable microscope for neurovascular imaging in awake rodents, combining fluorescence, intrinsic optical signals and laser speckle contrast.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/0wJpY_XEm-I&quot; height=&quot;1&quot;&gt;</description><published>1547020800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/0wJpY_XEm-I/s41467-018-07926-z</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1683212cc6c:a75344:8675cc2c</id><title>A miniature multi-contrast microscope for functional imaging in freely behaving animals</title><fingerprint>f4bde6d9</fingerprint></item><item><crawled>1548803603623</crawled><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><author><name>Schreiber, J.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/533273v1?rss=1</link><content><content>Motivation: Recent efforts to describe the human epigenome have yielded thousands of uniformly processed epigenomic and transcriptomic data sets. These data sets characterize a rich variety of biological activity in hundreds of human cell lines and tissues (&amp;quot;biosamples&amp;quot;). Understanding these data sets, and specifically how they differ across biosamples, can help explain many cellular mechanisms, particularly those driving development and disease. However, due primarily to cost, the total number of assays that can be performed is limited. Previously described imputation approaches, such as Avocado, have sought to overcome this limitation by predicting genome-wide epigenomics experiments using learned associations among available epigenomic data sets. However, these previous imputations have focused primarily on measurements of histone modification and chromatin accessibility, despite other biological activity being crucially important. Results: We applied Avocado to a data set of 3,814 tracks of data derived from the ENCODE compendium, spanning 400 human biosamples and 84 assays. The resulting imputations cover measurements of chromatin accessibility, histone modification, transcription, and protein binding. We demonstrate the quality of these imputations by comprehensively evaluating the model&apos;s predictions and by showing significant improvements in protein binding performance compared to the top models in an ENCODE-DREAM challenge. Additionally, we show that the Avocado model allows for efficient addition of new assays and biosamples to a pre-trained model, achieving high accuracy at predicting protein binding, even with only a single track of training data. Availability: Tutorials and source code are available under an Apache 2.0 license at https://github.com/jmschrei/avocado. Contact: william-noble@uw.edu or jmschr@cs.washington.edu</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/533273v1?rss=1</originId><description>Motivation: Recent efforts to describe the human epigenome have yielded thousands of uniformly processed epigenomic and transcriptomic data sets. These data sets characterize a rich variety of biological activity in hundreds of human cell lines and tissues (&amp;quot;biosamples&amp;quot;). Understanding these data sets, and specifically how they differ across biosamples, can help explain many cellular mechanisms, particularly those driving development and disease. However, due primarily to cost, the total number of assays that can be performed is limited. Previously described imputation approaches, such as Avocado, have sought to overcome this limitation by predicting genome-wide epigenomics experiments using learned associations among available epigenomic data sets. However, these previous imputations have focused primarily on measurements of histone modification and chromatin accessibility, despite other biological activity being crucially important. Results: We applied Avocado to a data set of 3,814 tracks of data derived from the ENCODE compendium, spanning 400 human biosamples and 84 assays. The resulting imputations cover measurements of chromatin accessibility, histone modification, transcription, and protein binding. We demonstrate the quality of these imputations by comprehensively evaluating the model&apos;s predictions and by showing significant improvements in protein binding performance compared to the top models in an ENCODE-DREAM challenge. Additionally, we show that the Avocado model allows for efficient addition of new assays and biosamples to a pre-trained model, achieving high accuracy at predicting protein binding, even with only a single track of training data. Availability: Tutorials and source code are available under an Apache 2.0 license at https://github.com/jmschrei/avocado. Contact: william-noble@uw.edu or jmschr@cs.washington.edu</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/533273v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689be37ca7:63deca:c2ce2e2e</id><title>Completing the ENCODE3 compendium yields accurate imputations across a variety of assays and human biosamples [NEW RESULTS]</title><fingerprint>425854cb</fingerprint></item><item><engagement>0</engagement><crawled>1546882373749</crawled><visual><height>324</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>250</width><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14031191/thumb.png</url></visual><published>1546819200000</published><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/A_Practical_and_General_Approach_to_the_Late-Stage_Functionalization_of_Complex_Sulfonamides/7550117</link><originId>https://chemrxiv.org/articles/A_Practical_and_General_Approach_to_the_Late-Stage_Functionalization_of_Complex_Sulfonamides/7550117</originId><description>Herein we describe the development and
application of a method for the mild, late-stage conversion of primary
sulfonamides to several other other functional groups. These reactions occur
via initial reductive deamination of sulfonamides to sulfinates via an
NHC-catalyzed reaction of transiently formed N-sulfonylimines. The method described here is tolerant of nearly
all common functional groups, as exemplified by the late-stage derivatization
of several complex pharmaceutical compounds. Based on the prevalence of
sulfonamide-containing drugs and building blocks, we have developed a method to
enable sulfonamides to be applied as versatile synthetic handles for synthetic
chemsitry.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/A_Practical_and_General_Approach_to_the_Late-Stage_Functionalization_of_Complex_Sulfonamides/7550117</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168295fd875:16acf72:3a104d3b</id><title>A Practical and General Approach to the Late-Stage Functionalization of Complex Sulfonamides</title><fingerprint>93a77763</fingerprint><summary><content>Herein we describe the development and
application of a method for the mild, late-stage conversion of primary
sulfonamides to several other other functional groups. These reactions occur
via initial reductive deamination of sulfonamides to sulfinates via an
NHC-catalyzed reaction of transiently formed N-sulfonylimines. The method described here is tolerant of nearly
all common functional groups, as exemplified by the late-stage derivatization
of several complex pharmaceutical compounds. Based on the prevalence of
sulfonamide-containing drugs and building blocks, we have developed a method to
enable sulfonamides to be applied as versatile synthetic handles for synthetic
chemsitry.</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1547752389672</crawled><visual><url>none</url></visual><author><name>Spinney, L.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6424/213?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6424/213?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6424/213.full</canonicalUrl><published>1547750305000</published><keywords><item>Medicine, Diseases, Scientific Community</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/213?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce0aa:ad2b6584</id><title>In Congo, fighting a virus and a groundswell of fake news</title><fingerprint>208a517e</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Alderton, G.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>292df9e7</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-s?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-s?rss=1</originId><published>1548355045000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-s?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a6e:c2ce2e2e</id><title>Rewarding food</title><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.19.full</canonicalUrl></item><item><engagement>0</engagement><crawled>1546983311492</crawled><visual><url>none</url></visual><author><name>Yingqin Hou, Yu Zhou, Hao Wang, Jialing Sun, Ruijue Wang, Kai Sheng, Jingsong Yuan, Yali Hu, Yu Chao, Zhuang Liu, Hua Lu</name></author><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acscentsci.8b00548</link><originId>http://dx.doi.org/10.1021/acscentsci.8b00548</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00548/20190108/images/medium/oc-2018-00548d_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00548&lt;/div&gt;</description><published>1546923600000</published><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00548</href></item></alternate><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_1682f640884:682b32:b77f238b</id><title>[ASAP] Therapeutic Protein PEPylation: The Helix of Nonfouling Synthetic Polypeptides Minimizes Antidrug Antibody Generation</title><fingerprint>dce50689</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00548/20190108/images/medium/oc-2018-00548d_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00548&lt;/div&gt;</content><direction>ltr</direction></summary></item><item><entities><item><label>Jefferson</label><id>nlp/f/entity/en/-/jefferson</id><mentions><item><text>Jefferson</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>William Thomson, 1st Baron Kelvin</label><id>nlp/f/entity/en/w/William Thomson, 1st Baron Kelvin</id><mentions><item><text>kelvin</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Nature 563</label><id>nlp/f/entity/en/-/nature 563</id><mentions><item><text>Nature 563</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Thomas Jefferson</label><id>nlp/f/entity/en/w/Thomas Jefferson</id><mentions><item><text>Thomas Jefferson</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Robert Patterson</label><id>nlp/f/entity/en/-/robert patterson</id><mentions><item><text>Robert Patterson</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548854231688</crawled><visual><url>none</url></visual><author><name>Steven T. Corneliussen</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00326-3</link><content><content>&lt;p&gt;&lt;b&gt;Units reform harks back to US president Jefferson&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Units reform harks back to US president Jefferson, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00326-3&quot;&gt;doi:10.1038/d41586-019-00326-3&lt;/a&gt;&lt;/p&gt;Units reform harks back to US president Jefferson</content><direction>ltr</direction></content><commonTopics><item><label>conservation</label><id>nlp/f/topic/532</id><probability>0.993</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00326-3</originId><description>&lt;p&gt;&lt;b&gt;Units reform harks back to US president Jefferson&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Units reform harks back to US president Jefferson, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00326-3&quot;&gt;doi:10.1038/d41586-019-00326-3&lt;/a&gt;&lt;/p&gt;Units reform harks back to US president Jefferson</description><published>1548835200000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00326-3</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ee80288:ac1e80:ad2b6584</id><title>Units reform harks back to US president Jefferson</title><fingerprint>2fabb852</fingerprint></item><item><crawled>1546862693437</crawled><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><author><name>Sergei F. Vyboishchikov, 
Alexander A. Voityuk</name></author><visual><height>215</height><processor>feedly-nikon-v3.1</processor><contentType>image/png; charset=UTF-8</contentType><width>395</width><url>https://onlinelibrary.wiley.com/cms/attachment/31ee0e12-03b9-4ddc-bd35-acc7eb031370/jcc25771-toc-0001-m.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25771?af=R</link><content><content>&lt;img alt=&quot;Journal of Computational Chemistry Iterative Atomic Charge Partitioning of Valence Electron Density&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/31ee0e12-03b9-4ddc-bd35-acc7eb031370/jcc25771-toc-0001-m.png&quot;&gt;
&lt;p&gt;An atomic charge scheme, &lt;i&gt;I‐ACP&lt;/i&gt;, is based on partitioning of the valence electron density using a Slater‐type weighting factors &lt;i&gt;c&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt;
&lt;i&gt;r&lt;/i&gt;
&lt;sup&gt;2&lt;i&gt;n–&lt;/i&gt;2&lt;/sup&gt;exp(–&lt;i&gt;α&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt;
&lt;i&gt;r&lt;/i&gt;). I‐ACP produces chemically meaningful atomic charges and accurately reproduces molecular dipole moments.
&lt;/p&gt;
&lt;br&gt;
&lt;p&gt;We propose an atomic charge partitioning scheme, &lt;i&gt;iterative adjusted charge partitioning (I‐ACP)&lt;/i&gt;, belonging to the stockholder family and based on partitioning of the valence molecular electron density. The method uses a Slater‐type weighting factor &lt;i&gt;c&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt;
&lt;i&gt;r&lt;/i&gt;
&lt;sup&gt;2&lt;i&gt;n–&lt;/i&gt;2&lt;/sup&gt;exp(–&lt;i&gt;α&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt;
&lt;i&gt;r&lt;/i&gt;), where &lt;i&gt;α&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt; is a fixed parameter and &lt;i&gt;c&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt; is determined iteratively. The parameters &lt;i&gt;α&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;A&lt;/i&gt;
&lt;/sub&gt; were fitted for 17 main‐group elements. The I‐ACP scheme is shown to produce consistent, chemically meaningful atomic charges. Several stockholder‐type charge‐partitioning are compared. Extensive numerical tests demonstrate that in most cases, I‐ACP surpasses most other methods by reproducing more accurately molecular dipole moments. © 2018 Wiley Periodicals, Inc.&lt;/p&gt;</content><direction>ltr</direction></content><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25771?af=R</originId><description>An atomic charge scheme, I‐ACP, is based on partitioning of the valence electron density using a Slater‐type weighting factors cAr2n–2exp(–αAr). I‐ACP produces chemically meaningful atomic charges and accurately reproduces molecular dipole moments.
We propose an atomic charge partitioning scheme, iterative adjusted charge partitioning (I‐ACP), belonging to the stockholder family and based on partitioning of the valence molecular electron density. The method uses a Slater‐type weighting factor cAr2n–2exp(–αAr), where αA is a fixed parameter and cA is determined iteratively. The parameters αA were fitted for 17 main‐group elements. The I‐ACP scheme is shown to produce consistent, chemically meaningful atomic charges. Several stockholder‐type charge‐partitioning are compared. Extensive numerical tests demonstrate that in most cases, I‐ACP surpasses most other methods by reproducing more accurately molecular dipole moments. © 2018 Wiley Periodicals, Inc.</description><published>1546862073000</published><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25771?af=R</href></item></alternate><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_16828338c3d:14d5d09:3a104d3b</id><title>Iterative Atomic Charge Partitioning of Valence Electron Density</title><fingerprint>2a872ec0</fingerprint><summary><content>An atomic charge scheme, I‐ACP, is based on partitioning of the valence electron density using a Slater‐type weighting factors cAr2n–2exp(–αAr). I‐ACP produces chemically meaningful atomic charges and accurately reproduces molecular dipole moments.
We propose an atomic charge partitioning scheme, iterative adjusted charge partitioning (I‐ACP), belonging to the stockholder family and based on partitioning of the valence molecular electron density. The method uses a Slater‐type weighting factor cAr2n–2exp(–αAr), where αA is a fixed parameter and cA is determined iteratively. The parameters αA were fitted for 17 main‐group elements. The I‐ACP scheme is shown to produce consistent, chemically meaningful atomic charges. Several stockholder‐type charge‐partitioning are compared. Extensive numerical tests demonstrate that in most cases, I‐ACP surpasses most other methods by reproducing more accurately molecular dipole moments. © 2018 Wiley Periodicals, Inc.</content><direction>ltr</direction></summary></item><item><entities><item><label>Nick Sireau</label><id>nlp/f/entity/en/-/nick sireau</id><mentions><item><text>Nick Sireau</text></item><item><text>Nick</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Alkaptonuria</label><id>nlp/f/entity/en/w/Alkaptonuria</id><mentions><item><text>Alkaptonuria</text></item><item><text>alkaptonuria</text></item><item><text>AKU</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>son Julien</label><id>nlp/f/entity/en/-/son julien</id><mentions><item><text>son Julien</text></item><item><text>Julien</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Sonya Mitchell</label><id>nlp/f/entity/en/w/Sonya Mitchell</id><mentions><item><text>Sonya</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Ranga</label><id>nlp/f/entity/en/-/ranga</id><mentions><item><text>Ranga</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547028434691</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00035-x/d41586-019-00035-x_16380782.jpg</url></visual><author><name>David Adam</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00035-x</link><content><content>&lt;p&gt;&lt;b&gt;A father’s fight to help his sons — and fix clinical trials&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A father’s fight to help his sons — and fix clinical trials, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00035-x&quot;&gt;doi:10.1038/d41586-019-00035-x&lt;/a&gt;&lt;/p&gt;Nick Sireau’s quest to give his sons weedkiller could help thousands struggling with rare genetic conditions.</content><direction>ltr</direction></content><commonTopics><item><label>regulatory</label><id>nlp/f/topic/1924</id><probability>0.941</probability></item><item><label>security intel</label><id>nlp/f/topic/2038</id><probability>0.883</probability></item><item><label>medicine</label><id>nlp/f/topic/1433</id><probability>0.823</probability></item><item><label>digital health</label><id>nlp/f/topic/657</id><probability>0.797</probability></item><item><label>drugs</label><id>nlp/f/topic/698</id><probability>0.793</probability></item><item><label>ted</label><id>nlp/f/topic/2261</id><probability>0.787</probability></item><item><label>ehealth</label><id>nlp/f/topic/745</id><probability>0.766</probability></item><item><label>fda</label><id>nlp/f/topic/846</id><probability>0.745</probability></item><item><label>pharmacology</label><id>nlp/f/topic/1735</id><probability>0.722</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00035-x</originId><description>&lt;p&gt;&lt;b&gt;A father’s fight to help his sons — and fix clinical trials&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A father’s fight to help his sons — and fix clinical trials, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00035-x&quot;&gt;doi:10.1038/d41586-019-00035-x&lt;/a&gt;&lt;/p&gt;Nick Sireau’s quest to give his sons weedkiller could help thousands struggling with rare genetic conditions.</description><published>1547020800000</published><engagement>12</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00035-x</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16832148f03:a78421:8675cc2c</id><title>A father’s fight to help his sons — and fix clinical trials</title><fingerprint>f0cda6c3</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00690</href></item></canonical><engagement>0</engagement><crawled>1548682352159</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><author><name>Aleksandra I. Jarmolinska, Qin Zhou, Joanna I. Sulkowska, Faruck Morcos</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jcim.8b00690</link><originId>http://dx.doi.org/10.1021/acs.jcim.8b00690</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00690/20190128/images/medium/ci-2018-00690w_0004.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00690&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=8kG3MgZ6jvA:hkDRMhXpqYc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/8kG3MgZ6jvA&quot; height=&quot;1&quot;&gt;</description><published>1548651600000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/8kG3MgZ6jvA/acs.jcim.8b00690</href></item></alternate><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_16894a9561f:1a7b91:875042c9</id><title>[ASAP] DCA-MOL: A PyMOL Plugin To Analyze Direct Evolutionary Couplings</title><fingerprint>bb169f15</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00690/20190128/images/medium/ci-2018-00690w_0004.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00690&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=8kG3MgZ6jvA:hkDRMhXpqYc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/8kG3MgZ6jvA&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1547654592399</crawled><fingerprint>9a0f6d5c</fingerprint><author><name>Thompson, M.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/521146v1?rss=1</link><content><content>DNA methylation remains one of the most widely studied epigenetic markers. One of the major challenges in population studies of methylation is the presence of global methylation effects that may mask local signals. Such global effects may be due to either technical effects (e.g., batch effects) or biological effects (e.g., cell-type composition, genetics). Many methods have been developed for the detection of such global effects, typically in the context of Epigenome-wide association studies. However, current unsupervised methods do not distinguish between biological and technical effects, resulting in a loss of highly relevant information. Though supervised methods can be used to estimate known biological effects, it remains difficult to identify and estimate unknown biological effects that globally affect the methylome. Here, we propose CONFINED, a reference-free method based on sparse canonical correlation analysis that captures replicable sources of variation--such as age, sex, and cell-type composition--across multiple methylation datasets and distinguishes them from dataset-specific sources of variability (e.g., technical effects). Consequently, we demonstrate through simulated and real data that by leveraging multiple datasets simultaneously, our approach captures several replicable sources of biological variation better than previous reference-free methods and is considerably more robust to technical noise than previous reference-free methods. CONFINED is available as an R package as detailed at https://github.com/cozygene/CONFINED.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/521146v1?rss=1</originId><description>DNA methylation remains one of the most widely studied epigenetic markers. One of the major challenges in population studies of methylation is the presence of global methylation effects that may mask local signals. Such global effects may be due to either technical effects (e.g., batch effects) or biological effects (e.g., cell-type composition, genetics). Many methods have been developed for the detection of such global effects, typically in the context of Epigenome-wide association studies. However, current unsupervised methods do not distinguish between biological and technical effects, resulting in a loss of highly relevant information. Though supervised methods can be used to estimate known biological effects, it remains difficult to identify and estimate unknown biological effects that globally affect the methylome. Here, we propose CONFINED, a reference-free method based on sparse canonical correlation analysis that captures replicable sources of variation--such as age, sex, and cell-type composition--across multiple methylation datasets and distinguishes them from dataset-specific sources of variability (e.g., technical effects). Consequently, we demonstrate through simulated and real data that by leveraging multiple datasets simultaneously, our approach captures several replicable sources of biological variation better than previous reference-free methods and is considerably more robust to technical noise than previous reference-free methods. CONFINED is available as an R package as detailed at https://github.com/cozygene/CONFINED.</description><published>1547625600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/521146v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1685766f78f:3dd0b30:8675cc2c</id><title>Distinguishing biological from technical sources of variation by leveraging multiple methylation datasets [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/16/521146</canonicalUrl></item><item><engagement>0</engagement><crawled>1546371164660</crawled><fingerprint>e34ecf6b</fingerprint><author><name>Banerjee, A.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/332965v4?rss=1</link><content><content>Cryptosporidiosis, a disease marked by diarrhea in adults and stunted growth in children, is associated with the unicellular protozoan pathogen Cryptosporidium; often the species parvum. Cryptopain1, a cysteine protease characterized in the genome of Cryptosporidium parvum, had been earlier shown to be inhibited by a vinyl sulfone compound called K11777 (or K777). Cysteine proteases have long been established as valid drug targets, which can be covalently and selectively inhibited by vinyl sulfones. This computational study was initiated to identify purchasable vinyl sulfone compounds, which could possibly inhibit cryptopain1 with higher efficacy than K11777. Docking simulations screened a number of such possibly better inhibitors. The work was furthered to probe the enzymatic pocket of cryptopain1, through in-silico mutations, to derive a map of receptor-ligand interactions in the docked complexes. The idea was to provide crucial clues to aid the design of inhibitors, which would be able to bind the protease well by making favorable interactions with important residues of the enzyme. The analyses dictated placement of ligands towards the front of the enzymatic cleft, and disfavored interactions deep within. The S1 prime and S2 subsites of the enzyme preferred to remain occupied by polar ligand subgroups. Reasonably distanced ring systems and polar backbones of ligands were desired across the cleft. Large as well as inflexible subgroups were not tolerated. Double ringed systems such as substituted napthalene, especially in S1, were exceptions though. The S2 subsite, which is typically a specificity determinant in papain (C1) family cysteine proteases such as cathepsin L like cryptopain1, can possibly accommodate polar and hydrophobic ligand subgroups alike.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/332965v4?rss=1</originId><description>Cryptosporidiosis, a disease marked by diarrhea in adults and stunted growth in children, is associated with the unicellular protozoan pathogen Cryptosporidium; often the species parvum. Cryptopain1, a cysteine protease characterized in the genome of Cryptosporidium parvum, had been earlier shown to be inhibited by a vinyl sulfone compound called K11777 (or K777). Cysteine proteases have long been established as valid drug targets, which can be covalently and selectively inhibited by vinyl sulfones. This computational study was initiated to identify purchasable vinyl sulfone compounds, which could possibly inhibit cryptopain1 with higher efficacy than K11777. Docking simulations screened a number of such possibly better inhibitors. The work was furthered to probe the enzymatic pocket of cryptopain1, through in-silico mutations, to derive a map of receptor-ligand interactions in the docked complexes. The idea was to provide crucial clues to aid the design of inhibitors, which would be able to bind the protease well by making favorable interactions with important residues of the enzyme. The analyses dictated placement of ligands towards the front of the enzymatic cleft, and disfavored interactions deep within. The S1 prime and S2 subsites of the enzyme preferred to remain occupied by polar ligand subgroups. Reasonably distanced ring systems and polar backbones of ligands were desired across the cleft. Large as well as inflexible subgroups were not tolerated. Double ringed systems such as substituted napthalene, especially in S1, were exceptions though. The S2 subsite, which is typically a specificity determinant in papain (C1) family cysteine proteases such as cathepsin L like cryptopain1, can possibly accommodate polar and hydrophobic ligand subgroups alike.</description><published>1546329600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/332965v4?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1680ae769f4:5c89eec:ad2b6584</id><title>Identification and design of vinyl sulfone inhibitors against Cryptopain1-a cysteine protease from cryptosporidiosis-causing Cryptosporidium parvum [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/01/332965</canonicalUrl></item><item><engagement>0</engagement><crawled>1547094807942</crawled><fingerprint>e285e738</fingerprint><author><name>Lee, M. D.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/512491v4?rss=1</link><content><content>Genome-level evolutionary inference (i.e., phylogenomics) is becoming an increasingly essential step in many biologists&apos; work - such as in the characterization of newly recovered genomes, or in leveraging available reference genomes to guide evolutionary questions. Accordingly, there are several tools available for the major steps in a phylogenomics workflow. But for the biologist whose main focus is not bioinformatics, much of the computational work required - such as accessing genomic data on large scales, integrating genomes from different file formats, performing required filtering, stitching different tools together, etc. - can be prohibitive. Here I introduce GToTree, a command-line tool that can take any combination of fasta files, GenBank files, and/or NCBI assembly accessions as input and outputs an alignment file, estimates of genome completeness and redundancy, and a phylogenomic tree based on the specified single-copy gene (SCG) set. While GToTree can work with any custom hidden Markov Models (HMMs), also included are 13 newly generated SCG-set HMMs for different lineages and levels of resolution, built based on searches of ~12,000 bacterial and archaeal high-quality genomes. GToTree aims to give more researchers the capability to make phylogenomic trees.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/512491v4?rss=1</originId><description>Genome-level evolutionary inference (i.e., phylogenomics) is becoming an increasingly essential step in many biologists&apos; work - such as in the characterization of newly recovered genomes, or in leveraging available reference genomes to guide evolutionary questions. Accordingly, there are several tools available for the major steps in a phylogenomics workflow. But for the biologist whose main focus is not bioinformatics, much of the computational work required - such as accessing genomic data on large scales, integrating genomes from different file formats, performing required filtering, stitching different tools together, etc. - can be prohibitive. Here I introduce GToTree, a command-line tool that can take any combination of fasta files, GenBank files, and/or NCBI assembly accessions as input and outputs an alignment file, estimates of genome completeness and redundancy, and a phylogenomic tree based on the specified single-copy gene (SCG) set. While GToTree can work with any custom hidden Markov Models (HMMs), also included are 13 newly generated SCG-set HMMs for different lineages and levels of resolution, built based on searches of ~12,000 bacterial and archaeal high-quality genomes. GToTree aims to give more researchers the capability to make phylogenomic trees.</description><published>1547020800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/512491v4?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16836095586:108df21:8675cc2c</id><title>GToTree: a user-friendly workflow for phylogenomics [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/09/512491</canonicalUrl></item><item><engagement>0</engagement><crawled>1548631217380</crawled><fingerprint>2c4c6e96</fingerprint><author><name>Mamoshina, P.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/531863v1?rss=1</link><content><content>Transcriptome profiling has been shown really useful in the understanding of the aging process. To date, transcriptomic data is the second most abundant omics data type following genomics. To deconvolute the relationship between transcriptomic changes and aging one needs to conduct an analysis on the comprehensive dataset. At the same time, biological aging clocks constructed for clinical use needs to robustly predict new data without any further retraining. In this paper, we develop a transcriptomic deep-learned age predictor. Deep neural networks (DNN) are trained and tested on more than 6 000 blood gene expression samples from 17 datasets. We apply methods based on output derivatives of DNN to rank input genes by their importance in age prediction and reduce the dimensional of the data. We also show that batch effect in transcriptome datasets of healthy humans is indeed significant, but the existing normalization techniques, while removing technical variation quite effectively, also remove age-associated changes. So robust methods of age prediction are needed.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/531863v1?rss=1</originId><description>Transcriptome profiling has been shown really useful in the understanding of the aging process. To date, transcriptomic data is the second most abundant omics data type following genomics. To deconvolute the relationship between transcriptomic changes and aging one needs to conduct an analysis on the comprehensive dataset. At the same time, biological aging clocks constructed for clinical use needs to robustly predict new data without any further retraining. In this paper, we develop a transcriptomic deep-learned age predictor. Deep neural networks (DNN) are trained and tested on more than 6 000 blood gene expression samples from 17 datasets. We apply methods based on output derivatives of DNN to rank input genes by their importance in age prediction and reduce the dimensional of the data. We also show that batch effect in transcriptome datasets of healthy humans is indeed significant, but the existing normalization techniques, while removing technical variation quite effectively, also remove age-associated changes. So robust methods of age prediction are needed.</description><published>1548576000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/531863v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168919d14e4:49dcc56:c2ce2e2e</id><title>Testing for batch effect through age predictors [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/531863v1</canonicalUrl></item><item><entities><item><label>Greenland</label><id>nlp/f/entity/en/w/Greenland</id><mentions><item><text>Greenland</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Lamarche - Gagnon et al</label><id>nlp/f/entity/en/-/lamarche - gagnon et al</id><mentions><item><text>Lamarche - Gagnon et al</text></item><item><text>Lamarche - Gagnon</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>NASA</label><id>nlp/f/entity/en/w/NASA</id><mentions><item><text>NASA</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Russell Glacier</label><id>nlp/f/entity/en/w/Russell Glacier (Greenland)</id><mentions><item><text>Russell Glacier</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Jeremy Harbeck</label><id>nlp/f/entity/en/-/jeremy harbeck</id><mentions><item><text>Jeremy Harbeck</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546452338856</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07762-7/d41586-018-07762-7_16349128.jpg</url></visual><author><name>Lauren C. Andrews</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07762-7</link><content><content>&lt;p&gt;&lt;b&gt;Methane beneath Greenland’s ice sheet is being released&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Methane beneath Greenland’s ice sheet is being released, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07762-7&quot;&gt;doi:10.1038/d41586-018-07762-7&lt;/a&gt;&lt;/p&gt;Methane produced in sediments beneath the Greenland Ice Sheet is released to the atmosphere by meltwater in the summer. This suggests that glacial melt could be an important global source of this greenhouse gas.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/d41586-018-07762-7</originId><description>&lt;p&gt;&lt;b&gt;Methane beneath Greenland’s ice sheet is being released&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Methane beneath Greenland’s ice sheet is being released, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07762-7&quot;&gt;doi:10.1038/d41586-018-07762-7&lt;/a&gt;&lt;/p&gt;Methane produced in sediments beneath the Greenland Ice Sheet is released to the atmosphere by meltwater in the summer. This suggests that glacial melt could be an important global source of this greenhouse gas.</description><published>1546416000000</published><engagement>21</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07762-7</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680fbe08a8:6162cc8:c2ce2e2e</id><title>Methane beneath Greenland’s ice sheet is being released</title><fingerprint>fa2a7e44</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08151-4</href></item></canonical><engagement>0</engagement><crawled>1547548096718</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Ian C. Fiebelkorn</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>645</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08151-4/MediaObjects/41467_2018_8151_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08151-4</link><content><content>&lt;p&gt;&lt;b&gt;The mediodorsal pulvinar coordinates the macaque fronto-parietal network during rhythmic spatial attention&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The mediodorsal pulvinar coordinates the macaque fronto-parietal network during rhythmic spatial attention, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08151-4&quot;&gt;doi:10.1038/s41467-018-08151-4&lt;/a&gt;&lt;/p&gt;Recent evidence shows that spatial attention is discontinuous over time, sampling locations in rhythmic cycles (3–6 Hz). Here, the authors show that the pulvinar has a role in coordinating this rhythmic sampling, with neural activity propagating from pulvinar to cortex during periods of engagement.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/x-qmjLqkvO8&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08151-4</originId><description>&lt;p&gt;&lt;b&gt;The mediodorsal pulvinar coordinates the macaque fronto-parietal network during rhythmic spatial attention&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The mediodorsal pulvinar coordinates the macaque fronto-parietal network during rhythmic spatial attention, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08151-4&quot;&gt;doi:10.1038/s41467-018-08151-4&lt;/a&gt;&lt;/p&gt;Recent evidence shows that spatial attention is discontinuous over time, sampling locations in rhythmic cycles (3–6 Hz). Here, the authors show that the pulvinar has a role in coordinating this rhythmic sampling, with neural activity propagating from pulvinar to cortex during periods of engagement.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/x-qmjLqkvO8&quot; height=&quot;1&quot;&gt;</description><published>1547539200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/x-qmjLqkvO8/s41467-018-08151-4</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_168510df8ce:3410aeb:8675cc2c</id><title>The mediodorsal pulvinar coordinates the macaque fronto-parietal network during rhythmic spatial attention</title><fingerprint>7c1caa1f</fingerprint></item><item><engagement>0</engagement><crawled>1546881715947</crawled><fingerprint>4d55b71c</fingerprint><author><name>Rey, C.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/513010v1?rss=1</link><content><content>In evolutionary genomics, researchers have taken an interest in identifying in the genomes substitutions that subtend convergent phenotypic adaptations. This is a difficult question to address, because genomes contain billions of sites, many of which have substituted in the lineages where the adaptations took place, and yet are not linked to them. Those extra substitutions may be linked to other adaptations, may be neutral, or may be linked to mutational biases. Furthermore, one can think of various ways of defining substitutions of interest, and various methods that match those definitions have been used, resulting in different sets of candidate substitutions. In this manuscript we first clarify how adaptation to convergent phenotypic evolution can manifest itself in coding sequences. Second, we review methods that have been proposed to detect convergent adaptive evolution in coding sequences and expose the assumptions that underlie them. Finally, we examine their power on simulations of convergent changes, including in the presence of a confounding factor.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/513010v1?rss=1</originId><description>In evolutionary genomics, researchers have taken an interest in identifying in the genomes substitutions that subtend convergent phenotypic adaptations. This is a difficult question to address, because genomes contain billions of sites, many of which have substituted in the lineages where the adaptations took place, and yet are not linked to them. Those extra substitutions may be linked to other adaptations, may be neutral, or may be linked to mutational biases. Furthermore, one can think of various ways of defining substitutions of interest, and various methods that match those definitions have been used, resulting in different sets of candidate substitutions. In this manuscript we first clarify how adaptation to convergent phenotypic evolution can manifest itself in coding sequences. Second, we review methods that have been proposed to detect convergent adaptive evolution in coding sequences and expose the assumptions that underlie them. Finally, we examine their power on simulations of convergent changes, including in the presence of a confounding factor.</description><published>1546848000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/513010v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1682955ceeb:169a114:3a104d3b</id><title>Detecting convergent adaptive amino acid evolution [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/07/513010</canonicalUrl></item><item><engagement>0</engagement><crawled>1548184313415</crawled><visual><url>none</url></visual><author><name>VanHook, A. M.</name></author><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stke.sciencemag.org/cgi/content/short/12/565/eaaw6857?rss=1</link><content><content>&lt;p&gt;Cell compaction induces epithelial cell elimination by reducing ERK activation.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stke.sciencemag.org/cgi/content/short/12/565/eaaw6857?rss=1</originId><description>&lt;p&gt;Cell compaction induces epithelial cell elimination by reducing ERK activation.&lt;/p&gt;</description><canonicalUrl>http://stke.sciencemag.org/content/12/565/eaaw6857.full</canonicalUrl><published>1548182934000</published><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/565/eaaw6857?rss=1</href></item></alternate><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_16876f9de47:2793815:3a104d3b</id><title>Putting the squeeze on ERK signaling</title><fingerprint>1229a99d</fingerprint></item><item><engagement>0</engagement><crawled>1547752389672</crawled><visual><url>none</url></visual><author><name>Alegre, M.-L.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6424/232?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6424/232?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6424/232.full</canonicalUrl><published>1547750305000</published><keywords><item>Immunology</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/232?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce09e:ad2b6584</id><title>B cells, CMV, and stem cell transplant</title><fingerprint>3f7a066a</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37164-8</href></item></canonical><engagement>0</engagement><crawled>1548758002641</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Jenni Kesäniemi</name></author><visual><height>328</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37164-8/MediaObjects/41598_2018_37164_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37164-8</link><content><content>&lt;p&gt;&lt;b&gt;Exposure to environmental radionuclides associates with tissue-specific impacts on telomerase expression and telomere length&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Exposure to environmental radionuclides associates with tissue-specific impacts on telomerase expression and telomere length, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37164-8&quot;&gt;doi:10.1038/s41598-018-37164-8&lt;/a&gt;&lt;/p&gt;Exposure to environmental radionuclides associates with tissue-specific impacts on telomerase expression and telomere length&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/xEpewR6iE1Y&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37164-8</originId><description>&lt;p&gt;&lt;b&gt;Exposure to environmental radionuclides associates with tissue-specific impacts on telomerase expression and telomere length&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Exposure to environmental radionuclides associates with tissue-specific impacts on telomerase expression and telomere length, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37164-8&quot;&gt;doi:10.1038/s41598-018-37164-8&lt;/a&gt;&lt;/p&gt;Exposure to environmental radionuclides associates with tissue-specific impacts on telomerase expression and telomere length&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/xEpewR6iE1Y&quot; height=&quot;1&quot;&gt;</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/xEpewR6iE1Y/s41598-018-37164-8</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168992babd1:22a037:ad2b6584</id><title>Exposure to environmental radionuclides associates with tissue-specific impacts on telomerase expression and telomere length</title><fingerprint>c484b456</fingerprint></item><item><entities><item><label>Italy</label><id>nlp/f/entity/en/w/Italy</id><mentions><item><text>Italian</text></item><item><text>Italy</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>south of Monopoli</label><id>nlp/f/entity/en/-/south of monopoli</id><mentions><item><text>south of Monopoli</text></item><item><text>Monopoli</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Alamy</label><id>nlp/f/entity/en/w/Alamy</id><mentions><item><text>Alamy</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>ROPI</label><id>nlp/f/entity/en/-/ropi</id><mentions><item><text>ROPI</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Facebook</label><id>nlp/f/entity/en/w/Facebook</id><mentions><item><text>Facebook</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548182492487</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00224-8/d41586-019-00224-8_16405556.jpg</url></visual><author><name>Alison Abbott</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00224-8</link><content><content>&lt;p&gt;&lt;b&gt;Thousands turn out to support science in Italy’s stricken olive region&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Thousands turn out to support science in Italy’s stricken olive region, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00224-8&quot;&gt;doi:10.1038/d41586-019-00224-8&lt;/a&gt;&lt;/p&gt;Anti-science sentiment has hampered efforts to contain the spread of a devastating olive-tree disease.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/d41586-019-00224-8</originId><description>&lt;p&gt;&lt;b&gt;Thousands turn out to support science in Italy’s stricken olive region&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Thousands turn out to support science in Italy’s stricken olive region, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00224-8&quot;&gt;doi:10.1038/d41586-019-00224-8&lt;/a&gt;&lt;/p&gt;Anti-science sentiment has hampered efforts to contain the spread of a devastating olive-tree disease.</description><published>1548144000000</published><engagement>12</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00224-8</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16876de1547:27658ed:3a104d3b</id><title>Thousands turn out to support science in Italy’s stricken olive region</title><fingerprint>659bd673</fingerprint></item><item><crawled>1548433431313</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1548374400000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Identify_Similarities_in_Diverse_Polycyclic_Aromatic_Hydrocarbons_of_Asphaltenes_and_Heavy_Oils_Revealed_by_Noncontact_Atomic_Force_Microscopy_Aromaticity_Bonding_and_Implications_in_Reactivity/7624895</link><originId>https://chemrxiv.org/articles/Identify_Similarities_in_Diverse_Polycyclic_Aromatic_Hydrocarbons_of_Asphaltenes_and_Heavy_Oils_Revealed_by_Noncontact_Atomic_Force_Microscopy_Aromaticity_Bonding_and_Implications_in_Reactivity/7624895</originId><description>Heavy
oils are enriched with polycyclic (or polynuclear) aromatic hydrocarbons (PAH
or PNA), but characterization of their chemical structures has been a great
challenge due to their tremendous diversity. Recently, with the advent of
molecular imaging with noncontact Atomic Force Microscopy (nc-AFM), molecular
structures of petroleum has been imaged and a diverse range of novel PAH
structures was revealed. Understanding these structures will help to understand
their chemical reactivities and the mechanisms of their formation or conversion.
Studies on aromaticity and bonding provide means to recognize their intrinsic
structural patterns which is crucial to reconcile a small number of structures
from AFM and to predict infinite number of diverse molecules in bulk. Four types
of PAH structures can be categorized according to their relative stability and reactivity,
and it was found that the most and least stable types are rarely observed in
AFM, with most molecules as intermediate types in a subtle balance of kinetic
reactivity and thermodynamic stability. Local aromaticity was found maximized when
possible for both alternant and nonalternant PAHs revealed by the aromaticity index
NICS (Nucleus-Independent Chemical Shift) values. The unique role of
five-membered rings in disrupting the electron distribution was recognized. Especially,
the presence of partial double bonds in most petroleum PAHs was identified and
their implications in the structure and reactivity of petroleum are discussed.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Identify_Similarities_in_Diverse_Polycyclic_Aromatic_Hydrocarbons_of_Asphaltenes_and_Heavy_Oils_Revealed_by_Noncontact_Atomic_Force_Microscopy_Aromaticity_Bonding_and_Implications_in_Reactivity/7624895</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16885d31b11:3da3144:3a104d3b</id><title>Identify Similarities in Diverse Polycyclic Aromatic Hydrocarbons of Asphaltenes and Heavy Oils Revealed by Noncontact Atomic Force Microscopy: Aromaticity, Bonding, and Implications in Reactivity</title><fingerprint>2d53cf8c</fingerprint><summary><content>Heavy
oils are enriched with polycyclic (or polynuclear) aromatic hydrocarbons (PAH
or PNA), but characterization of their chemical structures has been a great
challenge due to their tremendous diversity. Recently, with the advent of
molecular imaging with noncontact Atomic Force Microscopy (nc-AFM), molecular
structures of petroleum has been imaged and a diverse range of novel PAH
structures was revealed. Understanding these structures will help to understand
their chemical reactivities and the mechanisms of their formation or conversion.
Studies on aromaticity and bonding provide means to recognize their intrinsic
structural patterns which is crucial to reconcile a small number of structures
from AFM and to predict infinite number of diverse molecules in bulk. Four types
of PAH structures can be categorized according to their relative stability and reactivity,
and it was found that the most and least stable types are rarely observed in
AFM, with most molecules as intermediate types in a subtle balance of kinetic
reactivity and thermodynamic stability. Local aromaticity was found maximized when
possible for both alternant and nonalternant PAHs revealed by the aromaticity index
NICS (Nucleus-Independent Chemical Shift) values. The unique role of
five-membered rings in disrupting the electron distribution was recognized. Especially,
the presence of partial double bonds in most petroleum PAHs was identified and
their implications in the structure and reactivity of petroleum are discussed.</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Popkin, G.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/327?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/327?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6425/327.full</canonicalUrl><published>1548355045000</published><keywords><item>Science and Policy</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/327?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a99:c2ce2e2e</id><title>U.S. defenses look to thwart missiles early</title><fingerprint>cd9ea76d</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acschembio.8b00981</href></item></canonical><engagement>0</engagement><crawled>1547760126827</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acbcct</streamId><title>ACS Chemical Biology: Latest Articles (ACS Publications)</title></origin><author><name>Carolyn M. Levinn, Andrea K. Steiger, Michael D. Pluth</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acschembio.8b00981</link><originId>http://dx.doi.org/10.1021/acschembio.8b00981</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00981/20190117/images/medium/cb-2018-00981b_0005.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00981&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=PINyHWhdSeA:QItHssmH_ZE:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/PINyHWhdSeA&quot; height=&quot;1&quot;&gt;</description><published>1547701200000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/acbcct/~3/PINyHWhdSeA/acschembio.8b00981</href></item></alternate><id>ofNPcmQ46PpGzt1nO49W9STAvkUsM7jssLxNXMp09ME=_1685db14b6b:1465990:56b782f7</id><title>[ASAP] Esterase-Triggered Self-Immolative Thiocarbamates Provide Insights into COS Cytotoxicity</title><fingerprint>95a2ef19</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00981/20190117/images/medium/cb-2018-00981b_0005.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00981&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=PINyHWhdSeA:QItHssmH_ZE:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/PINyHWhdSeA&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acschembio.8b00952</href></item></canonical><engagement>0</engagement><crawled>1547661391162</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acbcct</streamId><title>ACS Chemical Biology: Latest Articles (ACS Publications)</title></origin><author><name>Josefine Liljeruhm, Jinfan Wang, Marek Kwiatkowski, Samudra Sabari, Anthony C. Forster</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acschembio.8b00952</link><originId>http://dx.doi.org/10.1021/acschembio.8b00952</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00952/20190115/images/medium/cb-2018-00952s_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00952&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=-IAIKcCic5g:VQlJqZ6CMFA:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/-IAIKcCic5g&quot; height=&quot;1&quot;&gt;</description><published>1547614800000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/acbcct/~3/-IAIKcCic5g/acschembio.8b00952</href></item></alternate><id>ofNPcmQ46PpGzt1nO49W9STAvkUsM7jssLxNXMp09ME=_16857ceb53a:bfaf42:b77f238b</id><title>[ASAP] Kinetics of d-Amino Acid Incorporation in Translation</title><fingerprint>d75596c8</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00952/20190115/images/medium/cb-2018-00952s_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00952&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=-IAIKcCic5g:VQlJqZ6CMFA:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/-IAIKcCic5g&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><entities><item><label>Silvia Purro</label><id>nlp/f/entity/en/-/silvia purro</id><mentions><item><text>Silvia Purro</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>M. Beekes</label><id>nlp/f/entity/en/-/m. beekes</id><mentions><item><text>M. Beekes</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Commission for Hospital Hygiene and Infection Prevention</label><id>nlp/f/entity/en/-/commission for hospital hygiene and infection prevention</id><mentions><item><text>Commission for Hospital Hygiene and Infection Prevention</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>A. Thomzig Nature 531</label><id>nlp/f/entity/en/-/a. thomzig nature 531</id><mentions><item><text>A. Thomzig Nature 531</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>daily Nature Briefing</label><id>nlp/f/entity/en/-/daily nature briefing</id><mentions><item><text>daily Nature Briefing</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548248901536</crawled><visual><url>none</url></visual><author><name>Michael Beekes</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00232-8</link><content><content>&lt;p&gt;&lt;b&gt;Avoid brain contamination from surgery&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Avoid brain contamination from surgery, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00232-8&quot;&gt;doi:10.1038/d41586-019-00232-8&lt;/a&gt;&lt;/p&gt;Avoid brain contamination from surgery</content><direction>ltr</direction></content><commonTopics><item><label>culture</label><id>nlp/f/topic/597</id><probability>0.807</probability></item><item><label>mass spectrometry</label><id>nlp/f/topic/1416</id><probability>0.768</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00232-8</originId><description>&lt;p&gt;&lt;b&gt;Avoid brain contamination from surgery&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Avoid brain contamination from surgery, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00232-8&quot;&gt;doi:10.1038/d41586-019-00232-8&lt;/a&gt;&lt;/p&gt;Avoid brain contamination from surgery</description><published>1548230400000</published><engagement>2</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00232-8</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687ad367a0:2d3ea78:3a104d3b</id><title>Avoid brain contamination from surgery</title><fingerprint>791869d7</fingerprint></item><item><entities><item><label>Earth</label><id>nlp/f/entity/en/w/Earth</id><mentions><item><text>Earth</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Nazca</label><id>nlp/f/entity/en/w/Nazca</id><mentions><item><text>Nazca</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Chen et al</label><id>nlp/f/entity/en/-/chen et al</id><mentions><item><text>Chen et al</text></item><item><text>Chen</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Farallon and Nazca</label><id>nlp/f/entity/en/-/farallon and nazca</id><mentions><item><text>Farallon and Nazca</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Cenozoic</label><id>nlp/f/entity/en/w/Cenozoic</id><mentions><item><text>Cenozoic</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548266506557</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00160-7/d41586-019-00160-7_16408276.jpg</url></visual><author><name>Dietmar  Müller</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00160-7</link><content><content>&lt;p&gt;&lt;b&gt;Lost tectonic history recovered from Earth’s deep mantle&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Lost tectonic history recovered from Earth’s deep mantle, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00160-7&quot;&gt;doi:10.1038/d41586-019-00160-7&lt;/a&gt;&lt;/p&gt;Tectonic plates lost to the deep mantle carry a record of ancient surface tectonic processes. A method for retrieving such records has been developed that could clarify the links between tectonics and mountain building.</content><direction>ltr</direction></content><commonTopics><item><label>geology</label><id>nlp/f/topic/959</id><probability>0.988</probability></item><item><label>paleontology</label><id>nlp/f/topic/1683</id><probability>0.924</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00160-7</originId><description>&lt;p&gt;&lt;b&gt;Lost tectonic history recovered from Earth’s deep mantle&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Lost tectonic history recovered from Earth’s deep mantle, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00160-7&quot;&gt;doi:10.1038/d41586-019-00160-7&lt;/a&gt;&lt;/p&gt;Tectonic plates lost to the deep mantle carry a record of ancient surface tectonic processes. A method for retrieving such records has been developed that could clarify the links between tectonics and mountain building.</description><published>1548230400000</published><engagement>5</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00160-7</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687be0093d:2e2c1b8:c2ce2e2e</id><title>Lost tectonic history recovered from Earth’s deep mantle</title><fingerprint>59d45328</fingerprint></item><item><engagement>0</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><published>1546540591000</published><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/8?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/8?rss=1</originId><fingerprint>e1829fc5</fingerprint><author><name>NA</name></author><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/8?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3d3:ad2b6584</id><title>What&apos;s coming up in 2019</title><canonicalUrl>http://science.sciencemag.org/content/363/6422/8.full</canonicalUrl></item><item><engagement>0</engagement><crawled>1548082829214</crawled><visual><height>324</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>250</width><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14127158/thumb.png</url></visual><published>1548028800000</published><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Small_Molecule_Isotope_Resolved_Formula_Enumerator_a_Tool_for_Assigning_Isotopologues_and_Metabolites_in_Fourier_Transform_Mass_Spectra/7609205</link><originId>https://chemrxiv.org/articles/Small_Molecule_Isotope_Resolved_Formula_Enumerator_a_Tool_for_Assigning_Isotopologues_and_Metabolites_in_Fourier_Transform_Mass_Spectra/7609205</originId><description>Improvements in Fourier Transform Mass Spectrometry (FT-MS) enable increasingly more complex experiments in the field of metabolomics. What is directly detected in FT-MS spectra are spectral features (peaks) that correspond to sets of adducted and charged forms of specific molecules in the sample. The robust assignment of these features is an essential step for MS-based metabolomics experiments, but the sheer complexity of what is detected and a variety of analytically-introduced variance, errors, and artifacts has hindered the systematic analysis of complex patterns of observed peaks with respect to isotope content. We have devel-oped a method called SMIRFE that detect small biomolecules and determines their elemental molecular formula (EMF) using de-tected sets of isotopologue peaks sharing the same EMF. SMIRFE does not use a database of known metabolite formulas, instead a nearly comprehensive search space of all isotopologues within a mass range is constructed and used for assignment. This search space can be tailored for different isotope labeling patterns expected in different stable isotope tracing experiments. Using consumer-level computing equipment, a large search space of 2000 daltons was constructed and assignment performance was evaluated and validated using verified assignments on a pair of peak lists derived from spectra containing unlabeled and 15N-labeled versions of amino acids derivatized using ethylchloroformate. SMIRFE identified 18 of 18 predicted derivatized EMFs and each assignment was evaluated statistically and assigned an e-value representing the probability to occur by chance.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Small_Molecule_Isotope_Resolved_Formula_Enumerator_a_Tool_for_Assigning_Isotopologues_and_Metabolites_in_Fourier_Transform_Mass_Spectra/7609205</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16870ed579e:1e27bd5:c2ce2e2e</id><title>Small Molecule Isotope Resolved Formula Enumerator: a Tool for Assigning Isotopologues and Metabolites in Fourier Transform Mass Spectra</title><fingerprint>5a0b9885</fingerprint><summary><content>Improvements in Fourier Transform Mass Spectrometry (FT-MS) enable increasingly more complex experiments in the field of metabolomics. What is directly detected in FT-MS spectra are spectral features (peaks) that correspond to sets of adducted and charged forms of specific molecules in the sample. The robust assignment of these features is an essential step for MS-based metabolomics experiments, but the sheer complexity of what is detected and a variety of analytically-introduced variance, errors, and artifacts has hindered the systematic analysis of complex patterns of observed peaks with respect to isotope content. We have devel-oped a method called SMIRFE that detect small biomolecules and determines their elemental molecular formula (EMF) using de-tected sets of isotopologue peaks sharing the same EMF. SMIRFE does not use a database of known metabolite formulas, instead a nearly comprehensive search space of all isotopologues within a mass range is constructed and used for assignment. This search space can be tailored for different isotope labeling patterns expected in different stable isotope tracing experiments. Using consumer-level computing equipment, a large search space of 2000 daltons was constructed and assignment performance was evaluated and validated using verified assignments on a pair of peak lists derived from spectra containing unlabeled and 15N-labeled versions of amino acids derivatized using ethylchloroformate. SMIRFE identified 18 of 18 predicted derivatized EMFs and each assignment was evaluated statistically and assigned an e-value representing the probability to occur by chance.</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1547214631244</crawled><visual><url>none</url></visual><author><name>Edmund C. M. Tse, Theodore J. Zwang, Sebastian Bedoya, Jacqueline K. Barton</name></author><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acscentsci.8b00566</link><originId>http://dx.doi.org/10.1021/acscentsci.8b00566</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00566/20181112/images/medium/oc-2018-005666_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00566&lt;/div&gt;</description><published>1547182800000</published><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00566</href></item></alternate><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_1683d2db14c:1c81a6:875042c9</id><title>[ASAP] Effective Distance for DNA-Mediated Charge Transport between Repair Proteins</title><fingerprint>7d3e137a</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00566/20181112/images/medium/oc-2018-005666_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00566&lt;/div&gt;</content><direction>ltr</direction></summary></item><item><updateCount>1</updateCount><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006679</href></item></canonical><crawled>1546283731268</crawled><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><published>1546293600000</published><link>10.1371/journal.pcbi.1006679</link><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><description>&lt;p&gt;by Michael Moutoussis, Edward T. Bullmore, Ian M. Goodyer, Peter Fonagy, Peter B. Jones, Raymond J. Dolan, Peter Dayan, on behalf of The Neuroscience in Psychiatry Network Research Consortium &lt;/p&gt;
Pavlovian influences are important in guiding decision-making across health and psychopathology. There is an increasing interest in using concise computational tasks to parametrise such influences in large populations, and especially to track their evolution during development and changes in mental health. However, the developmental course of Pavlovian influences is uncertain, a problem compounded by the unclear psychometric properties of the relevant measurements. We assessed Pavlovian influences in a longitudinal sample using a well characterised and widely used Go-NoGo task. We hypothesized that the strength of Pavlovian influences and other ‘psychomarkers’ guiding decision-making would behave like traits. As reliance on Pavlovian influence is not as profitable as precise instrumental decision-making in this Go-NoGo task, we expected this influence to decrease with higher IQ and age. Additionally, we hypothesized it would correlate with expressions of psychopathology. We found that Pavlovian effects had weak temporal stability, while model-fit was more stable. In terms of external validity, Pavlovian effects decreased with increasing IQ and experience within the task, in line with normative expectations. However, Pavlovian effects were poorly correlated with age or psychopathology. Thus, although this computational construct did correlate with important aspects of development, it does not meet conventional requirements for tracking individual development. We suggest measures that might improve psychometric properties of task-derived Pavlovian measures for future studies.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/JoPyq3Wkq5c&quot; height=&quot;1&quot;&gt;</description><updated>1546293600000</updated><content><content>&lt;p&gt;by Michael Moutoussis, Edward T. Bullmore, Ian M. Goodyer, Peter Fonagy, Peter B. Jones, Raymond J. Dolan, Peter Dayan, on behalf of The Neuroscience in Psychiatry Network Research Consortium &lt;/p&gt;
Pavlovian influences are important in guiding decision-making across health and psychopathology. There is an increasing interest in using concise computational tasks to parametrise such influences in large populations, and especially to track their evolution during development and changes in mental health. However, the developmental course of Pavlovian influences is uncertain, a problem compounded by the unclear psychometric properties of the relevant measurements. We assessed Pavlovian influences in a longitudinal sample using a well characterised and widely used Go-NoGo task. We hypothesized that the strength of Pavlovian influences and other ‘psychomarkers’ guiding decision-making would behave like traits. As reliance on Pavlovian influence is not as profitable as precise instrumental decision-making in this Go-NoGo task, we expected this influence to decrease with higher IQ and age. Additionally, we hypothesized it would correlate with expressions of psychopathology. We found that Pavlovian effects had weak temporal stability, while model-fit was more stable. In terms of external validity, Pavlovian effects decreased with increasing IQ and experience within the task, in line with normative expectations. However, Pavlovian effects were poorly correlated with age or psychopathology. Thus, although this computational construct did correlate with important aspects of development, it does not meet conventional requirements for tracking individual development. We suggest measures that might improve psychometric properties of task-derived Pavlovian measures for future studies.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/JoPyq3Wkq5c&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>10.1371/journal.pcbi.1006679</originId><author><name>Michael Moutoussis</name></author><recrawled>1546291629611</recrawled><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/JoPyq3Wkq5c/article</href></item></alternate><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_16805b14944:d457d0:b77f238b</id><title>Change, stability, and instability in the Pavlovian guidance of behaviour from adolescence to young adulthood</title><fingerprint>f32fba68</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Vinson, V.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>782445f</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/361-f?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/361-f?rss=1</originId><published>1548355045000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/361-f?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a65:c2ce2e2e</id><title>Turning on the clock</title><canonicalUrl>http://science.sciencemag.org/content/363/6425/361.6.full</canonicalUrl></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00565</href></item></canonical><engagement>0</engagement><crawled>1547127666028</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><author><name>Angelo Spinello, Elena Vecile, Antonio Abbate, Aldo Dobrina, Alessandra Magistrato</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jcim.8b00565</link><originId>http://dx.doi.org/10.1021/acs.jcim.8b00565</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00565/20190109/images/medium/ci-2018-005653_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00565&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=Oj9MBpI6xAo:PrxDiqpVh7U:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/Oj9MBpI6xAo&quot; height=&quot;1&quot;&gt;</description><published>1547096400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/Oj9MBpI6xAo/acs.jcim.8b00565</href></item></alternate><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_16837feb56c:1299695:56b782f7</id><title>[ASAP] How Can Interleukin-1 Receptor Antagonist Modulate Distinct Cell Death Pathways?</title><fingerprint>48f605b7</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00565/20190109/images/medium/ci-2018-005653_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00565&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=Oj9MBpI6xAo:PrxDiqpVh7U:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/Oj9MBpI6xAo&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><entities><item><label>Ethiopia</label><id>nlp/f/entity/en/w/Ethiopia</id><mentions><item><text>Ethiopian</text></item><item><text>Ethiopia</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Alemayehu Wassie</label><id>nlp/f/entity/en/-/alemayehu wassie</id><mentions><item><text>Wassie</text></item><item><text>Alemayehu Wassie</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Kieran Dodds</label><id>nlp/f/entity/en/-/kieran dodds</id><mentions><item><text>Kieran Dodds</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Panos Pictures</label><id>nlp/f/entity/en/w/Panos Pictures</id><mentions><item><text>Panos Pictures</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>South Gonder</label><id>nlp/f/entity/en/-/south gonder</id><mentions><item><text>South Gonder</text></item></mentions><salienceLevel>about</salienceLevel></item></entities><crawled>1548783285770</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00275-x/d41586-019-00275-x_16423422.jpg</url></visual><author><name>Alison Abbott</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00275-x</link><content><content>&lt;p&gt;&lt;b&gt;Ethiopia’s church forests are a last refuge for dwindling biodiversity&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ethiopia’s church forests are a last refuge for dwindling biodiversity, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00275-x&quot;&gt;doi:10.1038/d41586-019-00275-x&lt;/a&gt;&lt;/p&gt;Ecologists are working with the nation’s Tewahedo churches to preserve these pockets of lush, wild habitat.</content><direction>ltr</direction></content><commonTopics><item><label>conservation</label><id>nlp/f/topic/532</id><probability>1.0</probability></item><item><label>wildlife</label><id>nlp/f/topic/2486</id><probability>0.972</probability></item><item><label>religion</label><id>nlp/f/topic/1928</id><probability>0.875</probability></item><item><label>global health</label><id>nlp/f/topic/977</id><probability>0.822</probability></item><item><label>environment</label><id>nlp/f/topic/780</id><probability>0.791</probability></item><item><label>science</label><id>nlp/f/topic/2017</id><probability>0.76</probability></item><item><label>orthodox</label><id>nlp/f/topic/1657</id><probability>0.734</probability></item><item><label>children</label><id>nlp/f/topic/444</id><probability>0.719</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00275-x</originId><description>&lt;p&gt;&lt;b&gt;Ethiopia’s church forests are a last refuge for dwindling biodiversity&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ethiopia’s church forests are a last refuge for dwindling biodiversity, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00275-x&quot;&gt;doi:10.1038/d41586-019-00275-x&lt;/a&gt;&lt;/p&gt;Ecologists are working with the nation’s Tewahedo churches to preserve these pockets of lush, wild habitat.</description><engagementRate>0.86</engagementRate><published>1548748800000</published><engagement>6</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00275-x</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689aad760a:46d46a:c2ce2e2e</id><title>Ethiopia’s church forests are a last refuge for dwindling biodiversity</title><fingerprint>5812e1d3</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01631</href></item></canonical><engagement>0</engagement><crawled>1547157993731</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><author><name>Xin Han, Chao Wang, Chong Qin, Weiguo Xiang, Ester Fernandez-Salas, Chao-Yie Yang, Mi Wang, Lijie Zhao, Tianfeng Xu, Krishnapriya Chinnaswamy, James Delproposto, Jeanne Stuckey, Shaomeng Wang</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01631</link><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01631</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01631/20190110/images/medium/jm-2018-01631v_0027.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01631&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=A6OABMe2Xzs:4wRDyxOEfms:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/A6OABMe2Xzs&quot; height=&quot;1&quot;&gt;</description><published>1547096400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/A6OABMe2Xzs/acs.jmedchem.8b01631</href></item></alternate><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_16839cd7903:17713b:875042c9</id><title>[ASAP] Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer</title><fingerprint>74a4c16</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01631/20190110/images/medium/jm-2018-01631v_0027.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01631&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=A6OABMe2Xzs:4wRDyxOEfms:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/A6OABMe2Xzs&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><engagement>13</engagement><crawled>1546617637260</crawled><fingerprint>a9d6c66b</fingerprint><author><name>Srinivasan, S.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/511626v1?rss=1</link><content><content>Single-cell RNA sequencing (scRNA-seq) is a recent technology that enables fine-grained discovery of cellular subtypes and specific cell states. It routinely uses machine learning methods, such as feature learning, clustering, and classification, to assist in uncovering novel information from scRNA-seq data. However, current methods are not well suited to deal with the substantial amounts of noise that is created by the experiments or the variation that occurs due to differences in the cells of the same type. Here, we develop a new hybrid approach, Deep Unsupervised Single-cell Clustering (DUSC), that integrates feature generation based on a deep learning architecture with a model-based clustering algorithm, to find a compact and informative representation of the single-cell transcriptomic data generating robust clusters. We also include a technique to estimate an efficient number of latent features in the deep learning model. Our method outperforms both classical and state-of-the-art feature learning and clustering methods, approaching the accuracy of supervised learning. The method is freely available to the community and will hopefully facilitate our understanding of the cellular atlas of living organisms as well as provide the means to improve patient diagnostics and treatment.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/511626v1?rss=1</originId><description>Single-cell RNA sequencing (scRNA-seq) is a recent technology that enables fine-grained discovery of cellular subtypes and specific cell states. It routinely uses machine learning methods, such as feature learning, clustering, and classification, to assist in uncovering novel information from scRNA-seq data. However, current methods are not well suited to deal with the substantial amounts of noise that is created by the experiments or the variation that occurs due to differences in the cells of the same type. Here, we develop a new hybrid approach, Deep Unsupervised Single-cell Clustering (DUSC), that integrates feature generation based on a deep learning architecture with a model-based clustering algorithm, to find a compact and informative representation of the single-cell transcriptomic data generating robust clusters. We also include a technique to estimate an efficient number of latent features in the deep learning model. Our method outperforms both classical and state-of-the-art feature learning and clustering methods, approaching the accuracy of supervised learning. The method is freely available to the community and will hopefully facilitate our understanding of the cellular atlas of living organisms as well as provide the means to improve patient diagnostics and treatment.</description><published>1546588800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/511626v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1681998498c:49e4e3:ad2b6584</id><title>A Hybrid Deep Clustering Approach for Robust Cell Type Profiling Using Single-cell RNA-seq Data [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/04/511626</canonicalUrl></item><item><engagement>163</engagement><crawled>1546456541947</crawled><fingerprint>7bb71e8f</fingerprint><author><name>Yang, W., Warrington, N. M., Taylor, S. J., Whitmire, P., Carrasco, E., Singleton, K. W., Wu, N., Lathia, J. D., Berens, M. E., Kim, A. H., Barnholtz-Sloan, J. S., Swanson, K. R., Luo, J., Rubin, J. B.</name></author><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/473/eaao5253?rss=1</link><content><content>&lt;p&gt;Sex differences in the incidence and outcome of human disease are broadly recognized but, in most cases, not sufficiently understood to enable sex-specific approaches to treatment. Glioblastoma (GBM), the most common malignant brain tumor, provides a case in point. Despite well-established differences in incidence and emerging indications of differences in outcome, there are few insights that distinguish male and female GBM at the molecular level or allow specific targeting of these biological differences. Here, using a quantitative imaging–based measure of response, we found that standard therapy is more effective in female compared with male patients with GBM. We then applied a computational algorithm to linked GBM transcriptome and outcome data and identified sex-specific molecular subtypes of GBM in which cell cycle and integrin signaling are the critical determinants of survival for male and female patients, respectively. The clinical relevance of cell cycle and integrin signaling pathway signatures was further established through correlations between gene expression and in vitro chemotherapy sensitivity in a panel of male and female patient-derived GBM cell lines. Together, these results suggest that greater precision in GBM molecular subtyping can be achieved through sex-specific analyses and that improved outcomes for all patients might be accomplished by tailoring treatment to sex differences in molecular mechanisms.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/473/eaao5253?rss=1</originId><description>&lt;p&gt;Sex differences in the incidence and outcome of human disease are broadly recognized but, in most cases, not sufficiently understood to enable sex-specific approaches to treatment. Glioblastoma (GBM), the most common malignant brain tumor, provides a case in point. Despite well-established differences in incidence and emerging indications of differences in outcome, there are few insights that distinguish male and female GBM at the molecular level or allow specific targeting of these biological differences. Here, using a quantitative imaging–based measure of response, we found that standard therapy is more effective in female compared with male patients with GBM. We then applied a computational algorithm to linked GBM transcriptome and outcome data and identified sex-specific molecular subtypes of GBM in which cell cycle and integrin signaling are the critical determinants of survival for male and female patients, respectively. The clinical relevance of cell cycle and integrin signaling pathway signatures was further established through correlations between gene expression and in vitro chemotherapy sensitivity in a panel of male and female patient-derived GBM cell lines. Together, these results suggest that greater precision in GBM molecular subtyping can be achieved through sex-specific analyses and that improved outcomes for all patients might be accomplished by tailoring treatment to sex differences in molecular mechanisms.&lt;/p&gt;</description><published>1546455083000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/473/eaao5253?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1680ffe2afb:62a4633:ad2b6584</id><title>[Research Articles] Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data</title><canonicalUrl>http://stm.sciencemag.org/content/11/473/eaao5253.full</canonicalUrl></item><item><engagement>0</engagement><crawled>1548184313415</crawled><fingerprint>b00857dd</fingerprint><author><name>Dobson, T. H. W., Tao, R.-H., Swaminathan, J., Maegawa, S., Shaik, S., Bravo-Alegria, J., Sharma, A., Kennis, B., Yang, Y., Callegari, K., Haltom, A. R., Taylor, P., Kogiso, M., Qi, L., Khatua, S., Goldman, S., Lulla, R. R., Fangusaro, J., MacDonald, T. J., Li, X.-N., Hawkins, C., Rajaram, V., Gopalakrishnan, V.</name></author><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stke.sciencemag.org/cgi/content/short/12/565/eaan8680?rss=1</link><content><content>&lt;p&gt;In medulloblastomas (MBs), the expression and activity of RE1-silencing transcription factor (REST) is increased in tumors driven by the sonic hedgehog (SHH) pathway, specifically the SHH-α (children 3 to 16 years) and SHH-β (infants) subgroups. Neuronal maturation is greater in SHH-β than SHH-α tumors, but both correlate with poor overall patient survival. We studied the contribution of REST to MB using a transgenic mouse model (&lt;i&gt;RESTTG&lt;/i&gt;&lt;sup&gt;&lt;/sup&gt;) wherein conditional &lt;i&gt;NeuroD2&lt;/i&gt;-controlled &lt;i&gt;REST&lt;/i&gt; transgene expression in lineage-committed &lt;i&gt;Ptch1&lt;/i&gt;&lt;sup&gt;+/–&lt;/sup&gt; cerebellar granule neuron progenitors (CGNPs) accelerated tumorigenesis and increased penetrance and infiltrative disease. This model revealed a neuronal maturation context–specific antagonistic interplay between the transcriptional repressor REST and the activator GLI1 at &lt;i&gt;Ptch1&lt;/i&gt;. Expression of &lt;i&gt;Arrb1&lt;/i&gt;, which encodes β-arrestin1 (a GLI1 inhibitor), was substantially reduced in proliferating and, to a lesser extent, lineage-committed &lt;i&gt;RESTTG&lt;/i&gt;&lt;sup&gt;&lt;/sup&gt; cells compared with wild-type proliferating CGNPs. Lineage-committed &lt;i&gt;REST&lt;sup&gt;TG&lt;/sup&gt;&lt;/i&gt; cells also had decreased GLI1 activity and increased histone H3K9 methylation at the &lt;i&gt;Ptch1&lt;/i&gt; locus, which correlated with premature silencing of &lt;i&gt;Ptch1&lt;/i&gt;. These cells also had decreased expression of &lt;i&gt;Pten&lt;/i&gt;, which encodes a negative regulator of the kinase AKT. Expression of &lt;i&gt;PTCH1&lt;/i&gt; and &lt;i&gt;GLI1&lt;/i&gt; were less, and &lt;i&gt;ARRB1&lt;/i&gt; was somewhat greater, in patient SHH-β than SHH-α MBs, whereas that of &lt;i&gt;PTEN&lt;/i&gt; was similarly lower in both subtypes than in others. Inhibition of histone modifiers or AKT reduced proliferation and induced apoptosis, respectively, in cultured REST-high MB cells. Our findings linking REST to differentiation-specific chromatin remodeling, &lt;i&gt;PTCH1&lt;/i&gt; silencing, and AKT activation in MB tissues reveal potential subgroup-specific therapeutic targets for MB patients.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stke.sciencemag.org/cgi/content/short/12/565/eaan8680?rss=1</originId><description>&lt;p&gt;In medulloblastomas (MBs), the expression and activity of RE1-silencing transcription factor (REST) is increased in tumors driven by the sonic hedgehog (SHH) pathway, specifically the SHH-α (children 3 to 16 years) and SHH-β (infants) subgroups. Neuronal maturation is greater in SHH-β than SHH-α tumors, but both correlate with poor overall patient survival. We studied the contribution of REST to MB using a transgenic mouse model (&lt;i&gt;RESTTG&lt;/i&gt;&lt;sup&gt;&lt;/sup&gt;) wherein conditional &lt;i&gt;NeuroD2&lt;/i&gt;-controlled &lt;i&gt;REST&lt;/i&gt; transgene expression in lineage-committed &lt;i&gt;Ptch1&lt;/i&gt;&lt;sup&gt;+/–&lt;/sup&gt; cerebellar granule neuron progenitors (CGNPs) accelerated tumorigenesis and increased penetrance and infiltrative disease. This model revealed a neuronal maturation context–specific antagonistic interplay between the transcriptional repressor REST and the activator GLI1 at &lt;i&gt;Ptch1&lt;/i&gt;. Expression of &lt;i&gt;Arrb1&lt;/i&gt;, which encodes β-arrestin1 (a GLI1 inhibitor), was substantially reduced in proliferating and, to a lesser extent, lineage-committed &lt;i&gt;RESTTG&lt;/i&gt;&lt;sup&gt;&lt;/sup&gt; cells compared with wild-type proliferating CGNPs. Lineage-committed &lt;i&gt;REST&lt;sup&gt;TG&lt;/sup&gt;&lt;/i&gt; cells also had decreased GLI1 activity and increased histone H3K9 methylation at the &lt;i&gt;Ptch1&lt;/i&gt; locus, which correlated with premature silencing of &lt;i&gt;Ptch1&lt;/i&gt;. These cells also had decreased expression of &lt;i&gt;Pten&lt;/i&gt;, which encodes a negative regulator of the kinase AKT. Expression of &lt;i&gt;PTCH1&lt;/i&gt; and &lt;i&gt;GLI1&lt;/i&gt; were less, and &lt;i&gt;ARRB1&lt;/i&gt; was somewhat greater, in patient SHH-β than SHH-α MBs, whereas that of &lt;i&gt;PTEN&lt;/i&gt; was similarly lower in both subtypes than in others. Inhibition of histone modifiers or AKT reduced proliferation and induced apoptosis, respectively, in cultured REST-high MB cells. Our findings linking REST to differentiation-specific chromatin remodeling, &lt;i&gt;PTCH1&lt;/i&gt; silencing, and AKT activation in MB tissues reveal potential subgroup-specific therapeutic targets for MB patients.&lt;/p&gt;</description><published>1548182934000</published><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/565/eaan8680?rss=1</href></item></alternate><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_16876f9de47:2793813:3a104d3b</id><title>Transcriptional repressor REST drives lineage stage-specific chromatin compaction at Ptch1 and increases AKT activation in a mouse model of medulloblastoma</title><canonicalUrl>http://stke.sciencemag.org/content/12/565/eaan8680.full</canonicalUrl></item><item><entities><item><label>Jacey</label><id>nlp/f/entity/en/-/jacey</id><mentions><item><text>Jacey</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Gen - 1</label><id>nlp/f/entity/en/-/gen - 1</id><mentions><item><text>Gen - 1</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>kwuh</label><id>nlp/f/entity/en/-/kwuh</id><mentions><item><text>kwuh</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Nature Futures</label><id>nlp/f/entity/en/-/nature futures</id><mentions><item><text>Nature Futures</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Mars Council</label><id>nlp/f/entity/en/-/mars council</id><mentions><item><text>Mars Council</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546434278506</crawled><visual><height>512</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07850-8/d41586-018-07850-8_16355506.jpg</url></visual><author><name>Laurence Raphael Brothers</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07850-8</link><content><content>&lt;p&gt;&lt;b&gt;Cold memories&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cold memories, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07850-8&quot;&gt;doi:10.1038/d41586-018-07850-8&lt;/a&gt;&lt;/p&gt;Time to go home?</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/d41586-018-07850-8</originId><description>&lt;p&gt;&lt;b&gt;Cold memories&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cold memories, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07850-8&quot;&gt;doi:10.1038/d41586-018-07850-8&lt;/a&gt;&lt;/p&gt;Time to go home?</description><published>1546416000000</published><engagement>1</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07850-8</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680eaa746a:60d06e6:3a104d3b</id><title>Cold memories</title><fingerprint>77a4b4f7</fingerprint></item><item><engagement>0</engagement><crawled>1546276574064</crawled><fingerprint>6b84dc43</fingerprint><author><name>Suderman, M.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/508556v1?rss=1</link><content><content>A differentially methylated region (DMR) is a genomic region in which DNA methylation is consistently positively or negatively associated with a phenotype or exposure. We demonstrate that existing algorithms for identifying DMRs either fail to consistently control false positive rates (comb-p and DMRcate), suffer from low power (bumphunter) or lack modeling flexibility (seqlm). We introduce a new method, dmrff, that overcomes these shortcomings and can additionally be used to meta-analyze multiple datasets. When applied to investigate associations of age in multiple datasets, dmrff identifies novel DMRs near genes previously linked to age. An R implementation is available on Github (http://github.com/perishky/dmrff).</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/508556v1?rss=1</originId><description>A differentially methylated region (DMR) is a genomic region in which DNA methylation is consistently positively or negatively associated with a phenotype or exposure. We demonstrate that existing algorithms for identifying DMRs either fail to consistently control false positive rates (comb-p and DMRcate), suffer from low power (bumphunter) or lack modeling flexibility (seqlm). We introduce a new method, dmrff, that overcomes these shortcomings and can additionally be used to meta-analyze multiple datasets. When applied to investigate associations of age in multiple datasets, dmrff identifies novel DMRs near genes previously linked to age. An R implementation is available on Github (http://github.com/perishky/dmrff).</description><published>1546243200000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/508556v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16805441370:56b1f36:3a104d3b</id><title>dmrff: identifying differentially methylated regions efficiently with power and control [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2018/12/31/508556</canonicalUrl></item><item><engagement>0</engagement><crawled>1548618511165</crawled><fingerprint>a21e0126</fingerprint><author><name>Osato, N.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/290825v11?rss=1</link><content><content>Chromatin interactions have important roles for enhancer-promoter interactions (EPI) and regulating the transcription of genes. CTCF and cohesin proteins are located at the anchors of chromatin interactions, forming their loop structures. CTCF has insulator function limiting the activity of enhancers into the loops. DNA binding sequences of CTCF indicate their orientation bias at chromatin interaction anchors - forward-reverse (FR) orientation is frequently observed. DNA binding sequences of CTCF were found in open chromatin regions at about 40% - 80% of chromatin interaction anchors in Hi-C and in situ Hi-C experimental data. Though the number of chromatin interactions was about seventy thousand in Hi-C at 50kb resolution, about twenty millions of chromatin interactions were recently identified by HiChIP at 5kb resolution. It has been reported that long range of chromatin interactions tends to include less CTCF at their anchors. It is still unclear what proteins are associated with chromatin interactions. To find DNA binding motif sequences of transcription factors (TF), such as CTCF, and repeat DNA sequences affecting the interaction between enhancers and promoters of genes and their expression, first I predicted TF bound in enhancers and promoters using DNA motif sequences of TF and experimental data of open chromatin regions in monocytes and other cell types, which were obtained from public and commercial databases. Second, transcriptional target genes of each TF were predicted based on enhancer-promoter association (EPA). EPA was shortened at the genomic locations of FR or reverse-forward (RF) orientation of DNA motif sequence of a TF, which were supposed to be at chromatin interaction anchors and acted as insulator sites like CTCF. Then, the expression levels of the transcriptional target genes predicted based on the EPA were compared with those predicted from only promoters. Total 287 biased orientation of DNA motifs (159 FR and 153 RF orientation, the reverse complement sequences of some DNA motifs were also registered in databases, so the total number was smaller than the number of FR and RF) affected the expression level of putative transcriptional target genes significantly in CD14+ monocytes of four people in common. The same analysis was conducted in CD4+ T cells of four people. DNA motif sequences of CTCF, cohesin and other transcription factors involved in chromatin interactions were found to be a biased orientation. Transposon sequences, which are known to be involved in insulators and enhancers, showed a biased orientation. The biased orientation of DNA motif sequences tended to be co-localized in the same open chromatin regions. Moreover, for 85% of FR and RF orientations of DNA motif sequences, EPI predicted from EPA that were shortened at the genomic locations of the biased orientation of DNA motif sequence were overlapped with chromatin interaction data (Hi-C and HiChIP) significantly more than other types of EPAs.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/290825v11?rss=1</originId><description>Chromatin interactions have important roles for enhancer-promoter interactions (EPI) and regulating the transcription of genes. CTCF and cohesin proteins are located at the anchors of chromatin interactions, forming their loop structures. CTCF has insulator function limiting the activity of enhancers into the loops. DNA binding sequences of CTCF indicate their orientation bias at chromatin interaction anchors - forward-reverse (FR) orientation is frequently observed. DNA binding sequences of CTCF were found in open chromatin regions at about 40% - 80% of chromatin interaction anchors in Hi-C and in situ Hi-C experimental data. Though the number of chromatin interactions was about seventy thousand in Hi-C at 50kb resolution, about twenty millions of chromatin interactions were recently identified by HiChIP at 5kb resolution. It has been reported that long range of chromatin interactions tends to include less CTCF at their anchors. It is still unclear what proteins are associated with chromatin interactions. To find DNA binding motif sequences of transcription factors (TF), such as CTCF, and repeat DNA sequences affecting the interaction between enhancers and promoters of genes and their expression, first I predicted TF bound in enhancers and promoters using DNA motif sequences of TF and experimental data of open chromatin regions in monocytes and other cell types, which were obtained from public and commercial databases. Second, transcriptional target genes of each TF were predicted based on enhancer-promoter association (EPA). EPA was shortened at the genomic locations of FR or reverse-forward (RF) orientation of DNA motif sequence of a TF, which were supposed to be at chromatin interaction anchors and acted as insulator sites like CTCF. Then, the expression levels of the transcriptional target genes predicted based on the EPA were compared with those predicted from only promoters. Total 287 biased orientation of DNA motifs (159 FR and 153 RF orientation, the reverse complement sequences of some DNA motifs were also registered in databases, so the total number was smaller than the number of FR and RF) affected the expression level of putative transcriptional target genes significantly in CD14+ monocytes of four people in common. The same analysis was conducted in CD4+ T cells of four people. DNA motif sequences of CTCF, cohesin and other transcription factors involved in chromatin interactions were found to be a biased orientation. Transposon sequences, which are known to be involved in insulators and enhancers, showed a biased orientation. The biased orientation of DNA motif sequences tended to be co-localized in the same open chromatin regions. Moreover, for 85% of FR and RF orientations of DNA motif sequences, EPI predicted from EPA that were shortened at the genomic locations of the biased orientation of DNA motif sequence were overlapped with chromatin interaction data (Hi-C and HiChIP) significantly more than other types of EPAs.</description><published>1548576000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/290825v11?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16890db333d:4a33a9c:ad2b6584</id><title>Discovery of biased orientation of human DNA motif sequences affecting enhancer-promoter interactions and transcription of genes [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/290825v11</canonicalUrl></item><item><entities><item><label>Japan</label><id>nlp/f/entity/en/w/Japan</id><mentions><item><text>Japan</text></item><item><text>Japanese</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Europe</label><id>nlp/f/entity/en/w/Europe</id><mentions><item><text>Europeans</text></item><item><text>Europe</text></item><item><text>European</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>CBS</label><id>nlp/f/entity/en/w/CBS</id><mentions><item><text>CBS</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>RIKEN CBS Summer Program</label><id>nlp/f/entity/en/-/riken cbs summer program</id><mentions><item><text>RIKEN CBS Summer Program</text></item><item><text>RIKEN CBS</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Riken</label><id>nlp/f/entity/en/w/Riken</id><mentions><item><text>RIKEN</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548440214528</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07869-x/d41586-018-07869-x_16411716.jpg</url></visual><author><name>Magdalena Śmiech</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07869-x</link><content><content>&lt;p&gt;&lt;b&gt;Dispatch: a visit to Japan from Europe&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dispatch: a visit to Japan from Europe, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07869-x&quot;&gt;doi:10.1038/d41586-018-07869-x&lt;/a&gt;&lt;/p&gt;PhD student Magdalena Śmiech describes her experience of switching continents and cultures.</content><direction>ltr</direction></content><commonTopics><item><label>japan</label><id>nlp/f/topic/1222</id><probability>1.0</probability></item><item><label>anime</label><id>nlp/f/topic/104</id><probability>0.996</probability></item><item><label>science policy</label><id>nlp/f/topic/2019</id><probability>0.903</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-018-07869-x</originId><description>&lt;p&gt;&lt;b&gt;Dispatch: a visit to Japan from Europe&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dispatch: a visit to Japan from Europe, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07869-x&quot;&gt;doi:10.1038/d41586-018-07869-x&lt;/a&gt;&lt;/p&gt;PhD student Magdalena Śmiech describes her experience of switching continents and cultures.</description><engagementRate>2.45</engagementRate><published>1548403200000</published><engagement>27</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07869-x</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168863a9c00:3e51601:3a104d3b</id><title>Dispatch: a visit to Japan from Europe</title><fingerprint>d936f49a</fingerprint></item><item><engagement>0</engagement><crawled>1547147463250</crawled><visual><url>none</url></visual><author><name>Ray, L. B.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6423/137-h?rss=1</link><entities><item><label>American Association for the Advancement of Science</label><id>nlp/f/entity/en/w/American Association for the Advancement of Science</id><mentions><item><text>AAAS</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Science</label><id>nlp/f/entity/en/w/Science</id><mentions><item><text>Science</text></item></mentions><salienceLevel>about</salienceLevel></item></entities><commonTopics><item><label>neuroscience</label><id>nlp/f/topic/1565</id><probability>0.994</probability></item></commonTopics><originId>http://science.sciencemag.org/cgi/content/short/363/6423/137-h?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6423/137.8.full</canonicalUrl><published>1547145461000</published><keywords><item>Neuroscience</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/137-h?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708b2:8675cc2c</id><title>Astrocytes can drive the master clock in the brain</title><fingerprint>64ef3002</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08230-6</href></item></canonical><engagement>28</engagement><crawled>1547719533857</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Woo-Jeong Jeong</name></author><visual><height>390</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08230-6/MediaObjects/41467_2018_8230_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08230-6</link><content><content>&lt;p&gt;&lt;b&gt;WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation, Published online: 17 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08230-6&quot;&gt;doi:10.1038/s41467-018-08230-6&lt;/a&gt;&lt;/p&gt;Overexpression of RAS proteins is frequently observed in patients with hepatocellular carcinoma. Here, the authors identify an HRAS binding protein, the E3 ubiquitin ligase WDR76, which promotes HRAS degradation, thus functioning as a tumour suppressor in liver cancer&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/TStMQngbYQY&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08230-6</originId><description>&lt;p&gt;&lt;b&gt;WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation, Published online: 17 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08230-6&quot;&gt;doi:10.1038/s41467-018-08230-6&lt;/a&gt;&lt;/p&gt;Overexpression of RAS proteins is frequently observed in patients with hepatocellular carcinoma. Here, the authors identify an HRAS binding protein, the E3 ubiquitin ligase WDR76, which promotes HRAS degradation, thus functioning as a tumour suppressor in liver cancer&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/TStMQngbYQY&quot; height=&quot;1&quot;&gt;</description><published>1547712000000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/TStMQngbYQY/s41467-018-08230-6</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1685b45e521:289f3c:c2ce2e2e</id><title>WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation</title><fingerprint>9cf2c7b0</fingerprint></item><item><crawled>1546542450273</crawled><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><author><name>Gebbie, G., Huybers, P.</name></author><engagement>161</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/70?rss=1</link><content><content>&lt;p&gt;Proxy records show that before the onset of modern anthropogenic warming, globally coherent cooling occurred from the Medieval Warm Period to the Little Ice Age. The long memory of the ocean suggests that these historical surface anomalies are associated with ongoing deep-ocean temperature adjustments. Combining an ocean model with modern and paleoceanographic data leads to a prediction that the deep Pacific is still adjusting to the cooling going into the Little Ice Age, whereas temperature trends in the surface ocean and deep Atlantic reflect modern warming. This prediction is corroborated by temperature changes identified between the HMS Challenger expedition of the 1870s and modern hydrography. The implied heat loss in the deep ocean since 1750 CE offsets one-fourth of the global heat gain in the upper ocean.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://science.sciencemag.org/cgi/content/short/363/6422/70?rss=1</originId><description>&lt;p&gt;Proxy records show that before the onset of modern anthropogenic warming, globally coherent cooling occurred from the Medieval Warm Period to the Little Ice Age. The long memory of the ocean suggests that these historical surface anomalies are associated with ongoing deep-ocean temperature adjustments. Combining an ocean model with modern and paleoceanographic data leads to a prediction that the deep Pacific is still adjusting to the cooling going into the Little Ice Age, whereas temperature trends in the surface ocean and deep Atlantic reflect modern warming. This prediction is corroborated by temperature changes identified between the HMS Challenger expedition of the 1870s and modern hydrography. The implied heat loss in the deep ocean since 1750 CE offsets one-fourth of the global heat gain in the upper ocean.&lt;/p&gt;</description><canonicalUrl>http://science.sciencemag.org/content/363/6422/70.full</canonicalUrl><published>1546540591000</published><keywords><item>Oceanography</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/70?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b39f:ad2b6584</id><title>The Little Ice Age and 20th-century deep Pacific cooling</title><fingerprint>ed6141a7</fingerprint></item><item><engagement>2</engagement><crawled>1547814721219</crawled><fingerprint>af8cdfa9</fingerprint><author><name>Tsai, H.-F.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/524041v1?rss=1</link><content><content>Stain-free, single-cell segmentation and tracking is tantamount to the holy grail of microscopic cell migration analysis. Phase contrast microscopy (PCM) images with cells at high density are notoriously difficult to segment accurately; thus, manual segmentation remains the de facto standard practice. In this work, we introduce Usiigaci, an all-in-one, semi-automated pipeline to segment, track, and visualize cell movement and morphological changes in PCM. Stain-free, instance-aware segmentation is accomplished using a mask regional convolutional neural network (Mask R-CNN). A Trackpy-based cell tracker with a graphical user interface is developed for cell tracking and data verification. The performance of Usiigaci is validated with electrotaxis of NIH/3T3 fibroblasts. Usiigaci provides highly accurate cell movement and morphological information for quantitative cell migration analysis.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/524041v1?rss=1</originId><description>Stain-free, single-cell segmentation and tracking is tantamount to the holy grail of microscopic cell migration analysis. Phase contrast microscopy (PCM) images with cells at high density are notoriously difficult to segment accurately; thus, manual segmentation remains the de facto standard practice. In this work, we introduce Usiigaci, an all-in-one, semi-automated pipeline to segment, track, and visualize cell movement and morphological changes in PCM. Stain-free, instance-aware segmentation is accomplished using a mask regional convolutional neural network (Mask R-CNN). A Trackpy-based cell tracker with a graphical user interface is developed for cell tracking and data verification. The performance of Usiigaci is validated with electrotaxis of NIH/3T3 fibroblasts. Usiigaci provides highly accurate cell movement and morphological information for quantitative cell migration analysis.</description><published>1547798400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/524041v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16860f256c3:afab1b:ad2b6584</id><title>Usiigaci: Instance-aware cell tracking in stain-free phase contrast microscopy enabled by machine learning [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/18/524041</canonicalUrl></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01365</href></item></canonical><engagement>0</engagement><crawled>1547142035363</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><author><name>Kelly A. Bachovchin, Amrita Sharma, Seema Bag, Dana M. Klug, Katherine M. Schneider, Baljinder Singh, Hitesh B. Jalani, Melissa J. Buskes, Naimee Mehta, Scott Tanghe, Jeremiah D. Momper, Richard J. Sciotti, Ana Rodriguez, Kojo Mensa-Wilmot, Michael P. Pollastri, Lori Ferrins</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01365</link><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01365</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01365/20190110/images/medium/jm-2018-01365z_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01365&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=tyX6Acjzcac:JZuqcqfJQns:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/tyX6Acjzcac&quot; height=&quot;1&quot;&gt;</description><published>1547096400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/tyX6Acjzcac/acs.jmedchem.8b01365</href></item></alternate><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_16838d9f7a3:1402b0c:b77f238b</id><title>[ASAP] Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development</title><fingerprint>31b52c4</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01365/20190110/images/medium/jm-2018-01365z_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01365&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=tyX6Acjzcac:JZuqcqfJQns:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/tyX6Acjzcac&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1548466077488</crawled><visual><url>none</url></visual><author><name>Eugene Lih, Wooram Park, Ki Wan Park, So Young Chun, Hyuncheol Kim, Yoon Ki Joung, Tae Gyun Kwon, Jeffrey A. Hubbell, Dong Keun Han</name></author><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acscentsci.8b00812</link><originId>http://dx.doi.org/10.1021/acscentsci.8b00812</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00812/20190125/images/medium/oc-2018-008122_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00812&lt;/div&gt;</description><published>1548392400000</published><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00812</href></item></alternate><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_16887c53f30:14e8d1d:56b782f7</id><title>[ASAP] A Bioinspired Scaffold with Anti-Inflammatory Magnesium Hydroxide and Decellularized Extracellular Matrix for Renal Tissue Regeneration</title><fingerprint>6a63555d</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00812/20190125/images/medium/oc-2018-008122_0006.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00812&lt;/div&gt;</content><direction>ltr</direction></summary></item><item><engagement>88</engagement><crawled>1546281669362</crawled><fingerprint>dcfdd90b</fingerprint><author><name>Tan, Y.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/508085v1?rss=1</link><content><content>Single cell RNA-Seq has emerged as a powerful tool in diverse applications, ranging from determining the cell-type composition of tissues to uncovering the regulators of developmental programs. A near-universal step in the analysis of single cell RNA-Seq data is to hypothesize the identity of each cell. Often, this is achieved by finding cells that express combinations of marker genes that had previously been implicated as being cell-type specific, an approach that is not quantitative and does not explicitly take advantage of other single cell RNA-Seq studies. Here, we describe our tool, SingleCellNet, which addresses these issues and enables the classification of query single cell RNA-Seq data in comparison to reference single cell RNA-Seq data. SingleCellNet compares favorably to other methods, and it is notably able to make sensitive and accurate classifications across platforms and species. We demonstrate how SingleCellNet can be used to classify previously undetermined cells, and how it can be used to assess the outcome of cell fate engineering experiments.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/508085v1?rss=1</originId><description>Single cell RNA-Seq has emerged as a powerful tool in diverse applications, ranging from determining the cell-type composition of tissues to uncovering the regulators of developmental programs. A near-universal step in the analysis of single cell RNA-Seq data is to hypothesize the identity of each cell. Often, this is achieved by finding cells that express combinations of marker genes that had previously been implicated as being cell-type specific, an approach that is not quantitative and does not explicitly take advantage of other single cell RNA-Seq studies. Here, we describe our tool, SingleCellNet, which addresses these issues and enables the classification of query single cell RNA-Seq data in comparison to reference single cell RNA-Seq data. SingleCellNet compares favorably to other methods, and it is notably able to make sensitive and accurate classifications across platforms and species. We demonstrate how SingleCellNet can be used to classify previously undetermined cells, and how it can be used to assess the outcome of cell fate engineering experiments.</description><published>1546243200000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/508085v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1680591d2f2:5631eab:c2ce2e2e</id><title>SingleCellNet: a computational tool to classify single cell RNA-Seq data across platforms and across species [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2018/12/31/508085</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08159-w</href></item></canonical><engagement>1</engagement><crawled>1548152582796</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Amanda M. Barberio</name></author><visual><height>506</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08159-w/MediaObjects/41467_2018_8159_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08159-w</link><content><content>&lt;p&gt;&lt;b&gt;Central body fatness is a stronger predictor of cancer risk than overall body size&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Central body fatness is a stronger predictor of cancer risk than overall body size, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08159-w&quot;&gt;doi:10.1038/s41467-018-08159-w&lt;/a&gt;&lt;/p&gt;Obesity is linked to increased cancer risk but the impact of body size versus weight distribution in determining the increased risk is unclear. Here the authors examined body mass index, waist circumference, and waist to hip ratio in relation to all-cancer incidence and incidence of seven individual cancers in a population of approximately 26,000 individual and conclude that central adiposity appears to be a stronger predictor of all-cancer risk than body size.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/x_8avhkaywc&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08159-w</originId><description>&lt;p&gt;&lt;b&gt;Central body fatness is a stronger predictor of cancer risk than overall body size&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Central body fatness is a stronger predictor of cancer risk than overall body size, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08159-w&quot;&gt;doi:10.1038/s41467-018-08159-w&lt;/a&gt;&lt;/p&gt;Obesity is linked to increased cancer risk but the impact of body size versus weight distribution in determining the increased risk is unclear. Here the authors examined body mass index, waist circumference, and waist to hip ratio in relation to all-cancer incidence and incidence of seven individual cancers in a population of approximately 26,000 individual and conclude that central adiposity appears to be a stronger predictor of all-cancer risk than body size.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/x_8avhkaywc&quot; height=&quot;1&quot;&gt;</description><published>1548144000000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/x_8avhkaywc/s41467-018-08159-w</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687515b28c:246a92d:3a104d3b</id><title>Central body fatness is a stronger predictor of cancer risk than overall body size</title><fingerprint>4753342d</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Berg, J.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>e234eb37</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/355-b?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/355-b?rss=1</originId><published>1548355045000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/355-b?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a85:c2ce2e2e</id><title>Editor&apos;s note</title><canonicalUrl>http://science.sciencemag.org/content/363/6425/355.2.full</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08172-z</href></item></canonical><engagement>0</engagement><crawled>1548066469662</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Nicola Fenderico</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>496</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08172-z/MediaObjects/41467_2018_8172_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08172-z</link><content><content>&lt;p&gt;&lt;b&gt;Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08172-z&quot;&gt;doi:10.1038/s41467-018-08172-z&lt;/a&gt;&lt;/p&gt;Enhanced Wnt receptor activity is a major cause of cancer development. Here the authors identify camelid single-domain antibody fragments (VHHs) that bind to the Wnt receptor LRP5/6 ectodomain, determine the crystal structures and show that these VHHs selectively inhibit Wnt3- mediated cellular responses and block the growth of mutant Wnt-hypersensitive intestinal tumor organoids.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/8pjq12ql1hM&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08172-z</originId><description>&lt;p&gt;&lt;b&gt;Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08172-z&quot;&gt;doi:10.1038/s41467-018-08172-z&lt;/a&gt;&lt;/p&gt;Enhanced Wnt receptor activity is a major cause of cancer development. Here the authors identify camelid single-domain antibody fragments (VHHs) that bind to the Wnt receptor LRP5/6 ectodomain, determine the crystal structures and show that these VHHs selectively inhibit Wnt3- mediated cellular responses and block the growth of mutant Wnt-hypersensitive intestinal tumor organoids.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/8pjq12ql1hM&quot; height=&quot;1&quot;&gt;</description><published>1548057600000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/8pjq12ql1hM/s41467-018-08172-z</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1686ff3b71e:1d335eb:ad2b6584</id><title>Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells</title><fingerprint>ed91e88e</fingerprint></item><item><engagement>0</engagement><crawled>1547652036135</crawled><fingerprint>c6b1e6ad</fingerprint><author><name>Gur, T.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/520841v1?rss=1</link><content><content>Due to their nature, bioinformatics datasets are often closely related to each other. For this reason, search, mapping and visualization of these relations are often performed manual or programmatically via identifiers or special keywords such as gene symbols. Although various tools exist for these situations, the growing volume of bioinformatics datasets, emerging new software tools and approaches motivates new solutions. To provide a new tool for these current cases, I present the Biobtree bioinformatics tool. Biobtree effectively fetches and indexes identifiers and special keywords with their related identifiers from supported datasets, optionally with user pre-defined datasets and provides a web interface, web services and direct B+ tree data structure based single uniform database output. Biobtree can handle billions of identifiers and runs via a single executable file with no installation and dependency required. It also aims to provide a relatively small codebase for easy maintenance, addition of new features and extension to larger datasets. Biobtree is available to download at https://www.github.com/tamerh/biobtree.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/520841v1?rss=1</originId><description>Due to their nature, bioinformatics datasets are often closely related to each other. For this reason, search, mapping and visualization of these relations are often performed manual or programmatically via identifiers or special keywords such as gene symbols. Although various tools exist for these situations, the growing volume of bioinformatics datasets, emerging new software tools and approaches motivates new solutions. To provide a new tool for these current cases, I present the Biobtree bioinformatics tool. Biobtree effectively fetches and indexes identifiers and special keywords with their related identifiers from supported datasets, optionally with user pre-defined datasets and provides a web interface, web services and direct B+ tree data structure based single uniform database output. Biobtree can handle billions of identifiers and runs via a single executable file with no installation and dependency required. It also aims to provide a relatively small codebase for easy maintenance, addition of new features and extension to larger datasets. Biobtree is available to download at https://www.github.com/tamerh/biobtree.</description><published>1547625600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/520841v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168573ff627:3d8c806:8675cc2c</id><title>Biobtree: A tool to search, map and visualize bioinformatics identifiers and special keywords [CONFIRMATORY RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/16/520841</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36475-0</href></item></canonical><engagement>0</engagement><crawled>1548066000055</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Sahabjada Siddiqui</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>564</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36475-0/MediaObjects/41598_2018_36475_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36475-0</link><content><content>&lt;p&gt;&lt;b&gt;Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36475-0&quot;&gt;doi:10.1038/s41598-018-36475-0&lt;/a&gt;&lt;/p&gt;Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/hCaEkj5nA34&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36475-0</originId><description>&lt;p&gt;&lt;b&gt;Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36475-0&quot;&gt;doi:10.1038/s41598-018-36475-0&lt;/a&gt;&lt;/p&gt;Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/hCaEkj5nA34&quot; height=&quot;1&quot;&gt;</description><published>1548057600000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/hCaEkj5nA34/s41598-018-36475-0</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1686fec8cb7:1d0f712:3a104d3b</id><title>Cytostatic and Anti-tumor Potential of Ajwa Date Pulp against Human Hepatocellular Carcinoma HepG2 Cells</title><fingerprint>a39b590</fingerprint></item><item><engagement>1</engagement><crawled>1548218028434</crawled><fingerprint>1017f38f</fingerprint><author><name>Giorgi, J.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/526244v1?rss=1</link><content><content>Motivation: Automatic biomedical named entity recognition (BioNER) is a key task in biomedical information extraction (IE). For some time, state-of-the-art BioNER has been dominated by machine learning methods, particularly conditional random fields (CRFs), with a recent focus on deep learning. However, recent work has suggested that the high performance of CRFs for BioNER may not generalize to corpora other than the one it was trained on. In our analysis, we find that a popular deep learning-based approach to BioNER, known as bidirectional long short-term memory network-conditional random field (BiLSTM-CRF), is correspondingly poor at generalizing - often dramatically overfitting the corpus it was trained on. To address this, we evaluate three modifications of BiLSTM-CRF for BioNER to alleviate overfitting and improve generalization: improved regularization via variational dropout, transfer learning, and multi-task learning. Results: We measure the effect that each strategy has when training/testing on the same corpus (&amp;quot;in-corpus&amp;quot; performance) and when training on one corpus and evaluating on another (&amp;quot;out-of-corpus&amp;quot; performance), our measure of the models ability to generalize. We found that variational dropout improves out-of-corpus performance by an average of 4.62%, transfer learning by 6.48% and multi-task learning by 8.42%. The maximal increase we identified combines multi-task learning and variational dropout, which boosts out-of-corpus performance by 10.75%. Furthermore, we make available a new open-source tool, called Saber, that implements our best BioNER models. Availability: Source code for our biomedical IE tool is available at https://github.com/BaderLab/saber. Corpora and other resources used in this study are available at https://github.com/BaderLab/Towards- reliable-BioNER.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/526244v1?rss=1</originId><description>Motivation: Automatic biomedical named entity recognition (BioNER) is a key task in biomedical information extraction (IE). For some time, state-of-the-art BioNER has been dominated by machine learning methods, particularly conditional random fields (CRFs), with a recent focus on deep learning. However, recent work has suggested that the high performance of CRFs for BioNER may not generalize to corpora other than the one it was trained on. In our analysis, we find that a popular deep learning-based approach to BioNER, known as bidirectional long short-term memory network-conditional random field (BiLSTM-CRF), is correspondingly poor at generalizing - often dramatically overfitting the corpus it was trained on. To address this, we evaluate three modifications of BiLSTM-CRF for BioNER to alleviate overfitting and improve generalization: improved regularization via variational dropout, transfer learning, and multi-task learning. Results: We measure the effect that each strategy has when training/testing on the same corpus (&amp;quot;in-corpus&amp;quot; performance) and when training on one corpus and evaluating on another (&amp;quot;out-of-corpus&amp;quot; performance), our measure of the models ability to generalize. We found that variational dropout improves out-of-corpus performance by an average of 4.62%, transfer learning by 6.48% and multi-task learning by 8.42%. The maximal increase we identified combines multi-task learning and variational dropout, which boosts out-of-corpus performance by 10.75%. Furthermore, we make available a new open-source tool, called Saber, that implements our best BioNER models. Availability: Source code for our biomedical IE tool is available at https://github.com/BaderLab/saber. Corpora and other resources used in this study are available at https://github.com/BaderLab/Towards- reliable-BioNER.</description><published>1548144000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/526244v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16878fc5192:2aa56d6:ad2b6584</id><title>Towards reliable named entity recognition in the biomedical domain [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/526244v1</canonicalUrl></item><item><engagement>0</engagement><crawled>1546975262889</crawled><visual><url>none</url></visual><author><name>Ferrarelli, L. K.</name></author><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stke.sciencemag.org/cgi/content/short/12/563/eaaw5563?rss=1</link><content><content>&lt;p&gt;For combination therapy, knowing the &amp;quot;how&amp;quot; and &amp;quot;when&amp;quot; is just as important as knowing the &amp;quot;what.&amp;quot;&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stke.sciencemag.org/cgi/content/short/12/563/eaaw5563?rss=1</originId><description>&lt;p&gt;For combination therapy, knowing the &amp;quot;how&amp;quot; and &amp;quot;when&amp;quot; is just as important as knowing the &amp;quot;what.&amp;quot;&lt;/p&gt;</description><canonicalUrl>http://stke.sciencemag.org/content/12/563/eaaw5563.full</canonicalUrl><published>1546973708000</published><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/563/eaaw5563?rss=1</href></item></alternate><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_1682ee938a9:5d2d1d:3a104d3b</id><title>Combination therapy is a game of strategy</title><fingerprint>8308542f</fingerprint></item><item><engagement>0</engagement><crawled>1548740888728</crawled><fingerprint>b28b2d20</fingerprint><author><name>Luo, R.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/311985v2?rss=1</link><content><content>Motivation: Many rare diseases and cancers are fundamentally diseases of the genome. In the past several years, genome sequencing has become one of the most important tools in clinical practice for rare disease diagnosis and targeted cancer therapy. However, variant interpretation remains the bottleneck as is not yet automated and may take a specialist several hours of work per patient. On average, one-fifth of this time is spent on visually confirming the authenticity of the candidate variants. Results: We developed Skyhawk, an artificial neural network-based discriminator that mimics the process of expert review on clinically significant genomics variants. Skyhawk runs in less than one minute to review ten thousand variants, and about 30 minutes to review all variants in a typical whole-genome sequencing sample. Among the false positive singletons identified by GATK HaplotypeCaller, UnifiedGenotyper and 16GT in the HG005 GIAB sample, 79.7% were rejected by Skyhawk. Worked on the Variants with Unknown Significance (VUS), Skyhawk marked most of the false positive variants for manual review and most of the true positive variants no need for review. Availability: Skyhawk is easy to use and freely available at https://github.com/aquaskyline/Skyhawk</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/311985v2?rss=1</originId><description>Motivation: Many rare diseases and cancers are fundamentally diseases of the genome. In the past several years, genome sequencing has become one of the most important tools in clinical practice for rare disease diagnosis and targeted cancer therapy. However, variant interpretation remains the bottleneck as is not yet automated and may take a specialist several hours of work per patient. On average, one-fifth of this time is spent on visually confirming the authenticity of the candidate variants. Results: We developed Skyhawk, an artificial neural network-based discriminator that mimics the process of expert review on clinically significant genomics variants. Skyhawk runs in less than one minute to review ten thousand variants, and about 30 minutes to review all variants in a typical whole-genome sequencing sample. Among the false positive singletons identified by GATK HaplotypeCaller, UnifiedGenotyper and 16GT in the HG005 GIAB sample, 79.7% were rejected by Skyhawk. Worked on the Variants with Unknown Significance (VUS), Skyhawk marked most of the false positive variants for manual review and most of the true positive variants no need for review. Availability: Skyhawk is easy to use and freely available at https://github.com/aquaskyline/Skyhawk</description><published>1548662400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/311985v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16898268898:9ae29:ad2b6584</id><title>Skyhawk: An Artificial Neural Network-based discriminator for reviewing clinically significant genomic variants [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/311985v2</canonicalUrl></item><item><crawled>1548704875737</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1548633600000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Ni-Catalyzed_Deamination_Cross-Electrophile_Coupling_of_Katritzky_Salts_with_Halides_via_C_N_Bond_Activation/7638164</link><originId>https://chemrxiv.org/articles/Ni-Catalyzed_Deamination_Cross-Electrophile_Coupling_of_Katritzky_Salts_with_Halides_via_C_N_Bond_Activation/7638164</originId><description>This work describes the first Ni-catalyzed cross-electrophile coupling of alkylpyridinium salts, derived from the corresponding amines, with aryl iodide, bromoalkyne or bromoalkyl coupling partners. C(sp)-C(sp3), C(sp2)-C(sp3) and C(sp3)-C(sp3) bond formation was achieved to afford a variety of synthetically useful arenes, alkynes and alkanes in good yields from2-33. The advantages of the methodology are showcased in the two-step synthesis of the key lactonic moiety of (+)-Compactin and (+)-Mevinolin from commercially available starting materials. A one-pot procedure without isolation of alkylpyridinium tetrafluoroborate salt was also demonstrated to be successful. This work represents a new strategy for the cross-coupling reaction of two electrophiles, and also provides a complementary and highly valuable vista for the current methodologies of alkyl arene/alkyne/alkane synthesis.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Ni-Catalyzed_Deamination_Cross-Electrophile_Coupling_of_Katritzky_Salts_with_Halides_via_C_N_Bond_Activation/7638164</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168960104d9:5102118:3a104d3b</id><title>Ni-Catalyzed Deamination Cross-Electrophile Coupling of Katritzky Salts with Halides via C–N Bond Activation</title><fingerprint>2681596</fingerprint><summary><content>This work describes the first Ni-catalyzed cross-electrophile coupling of alkylpyridinium salts, derived from the corresponding amines, with aryl iodide, bromoalkyne or bromoalkyl coupling partners. C(sp)-C(sp3), C(sp2)-C(sp3) and C(sp3)-C(sp3) bond formation was achieved to afford a variety of synthetically useful arenes, alkynes and alkanes in good yields from2-33. The advantages of the methodology are showcased in the two-step synthesis of the key lactonic moiety of (+)-Compactin and (+)-Mevinolin from commercially available starting materials. A one-pot procedure without isolation of alkylpyridinium tetrafluoroborate salt was also demonstrated to be successful. This work represents a new strategy for the cross-coupling reaction of two electrophiles, and also provides a complementary and highly valuable vista for the current methodologies of alkyl arene/alkyne/alkane synthesis.</content><direction>ltr</direction></summary></item><item><engagement>178</engagement><crawled>1547752389672</crawled><visual><url>none</url></visual><author><name>Reese, A.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6424/218?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6424/218?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6424/218.full</canonicalUrl><published>1547750305000</published><keywords><item>Ecology, Scientific Community</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/218?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce0a6:ad2b6584</id><title>The bones of Bears Ears</title><fingerprint>757b609b</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><author><name>Maroso, M.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>c142b3d2</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/39-i?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/39-i?rss=1</originId><published>1546540591000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/39-i?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3b9:ad2b6584</id><title>A long-lasting poison scavenger</title><canonicalUrl>http://science.sciencemag.org/content/363/6422/39.9.full</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08193-8</href></item></canonical><engagement>2</engagement><crawled>1547202509590</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Elisa Vergari</name></author><visual><height>421</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08193-8/MediaObjects/41467_2018_8193_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08193-8</link><content><content>&lt;p&gt;&lt;b&gt;Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion, Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08193-8&quot;&gt;doi:10.1038/s41467-018-08193-8&lt;/a&gt;&lt;/p&gt;Impaired glucagon secretion in patients with diabetes causes hypoglycemia. Here the authors show that therapeutic concentrations of insulin inhibit alpha-cell glucagon secretion by stimulating delta-cell insulin receptor and the release of somatostatin. Blocking somatostatin secretion or action ameliorates this effect.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/szCdOe4rEYc&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08193-8</originId><description>&lt;p&gt;&lt;b&gt;Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion, Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08193-8&quot;&gt;doi:10.1038/s41467-018-08193-8&lt;/a&gt;&lt;/p&gt;Impaired glucagon secretion in patients with diabetes causes hypoglycemia. Here the authors show that therapeutic concentrations of insulin inhibit alpha-cell glucagon secretion by stimulating delta-cell insulin receptor and the release of somatostatin. Blocking somatostatin secretion or action ameliorates this effect.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/szCdOe4rEYc&quot; height=&quot;1&quot;&gt;</description><published>1547193600000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/szCdOe4rEYc/s41467-018-08193-8</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1683c74bb16:1a14ef1:8675cc2c</id><title>Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion</title><fingerprint>19d2a439</fingerprint></item><item><engagement>0</engagement><crawled>1548358609694</crawled><fingerprint>e9e84187</fingerprint><author><name>Sun, Y.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/528216v1?rss=1</link><content><content>Motivation: Cancer is a major cause of death worldwide, and an early diagnosis is required for a favorable prognosis. Histological examination is the gold standard for cancer identification; however, there is a large amount of inter-observer variability in histological diagnosis. Numerous studies have shown that cancer genesis is accompanied by an accumulation of harmful mutations within patients genome, potentiating the identification of cancer based on genomic information. We have proposed a method, GDL (genome deep learning), to study the relationship between genomic variations and traits based on deep neural networks with multiple hidden layers and nonlinear transformations. Result: We analyzed 6,083 samples from 12 cancer types obtained from the TCGA (The Cancer Genome Atlas) and 1,991 healthy samples from the 1000 Genomes project(Genomes Project, et al., 2010). We constructed 12 specific models to distinguish between certain types of cancers and healthy tissues, a specific model that can identify healthy vs diseased tissues, and a mixture model to distinguish between all 12 types of cancer based on GDL. We present the success obtained with GDL when applied to the challenging problem of cancer based on genomic variations and demonstrate state-of-the-art results (97%, 70.08% and 94.70%) for cancer identification. The mixture model achieved a comparable performance. With the development of new molecular and sequencing technologies, we can now collect circulating tumor DNA (ctDNA) from blood and monitor the cancer risk in real time, and using our model, we can also target cancerous tissue that may develop in the future. We developed a new and efficient method for the identification of cancer based on genomic information that offers a new direction for disease diagnosis while providing a new method to predict traits based on that information.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/528216v1?rss=1</originId><description>Motivation: Cancer is a major cause of death worldwide, and an early diagnosis is required for a favorable prognosis. Histological examination is the gold standard for cancer identification; however, there is a large amount of inter-observer variability in histological diagnosis. Numerous studies have shown that cancer genesis is accompanied by an accumulation of harmful mutations within patients genome, potentiating the identification of cancer based on genomic information. We have proposed a method, GDL (genome deep learning), to study the relationship between genomic variations and traits based on deep neural networks with multiple hidden layers and nonlinear transformations. Result: We analyzed 6,083 samples from 12 cancer types obtained from the TCGA (The Cancer Genome Atlas) and 1,991 healthy samples from the 1000 Genomes project(Genomes Project, et al., 2010). We constructed 12 specific models to distinguish between certain types of cancers and healthy tissues, a specific model that can identify healthy vs diseased tissues, and a mixture model to distinguish between all 12 types of cancer based on GDL. We present the success obtained with GDL when applied to the challenging problem of cancer based on genomic variations and demonstrate state-of-the-art results (97%, 70.08% and 94.70%) for cancer identification. The mixture model achieved a comparable performance. With the development of new molecular and sequencing technologies, we can now collect circulating tumor DNA (ctDNA) from blood and monitor the cancer risk in real time, and using our model, we can also target cancerous tissue that may develop in the future. We developed a new and efficient method for the identification of cancer based on genomic information that offers a new direction for disease diagnosis while providing a new method to predict traits based on that information.</description><published>1548316800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/528216v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168815d6b1e:3637c8e:c2ce2e2e</id><title>Identification of 12 cancer types through genome deep learning [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/528216v1</canonicalUrl></item><item><crawled>1548875250003</crawled><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><author><name>Wolf, M. T., Ganguly, S., Wang, T. L., Anderson, C. W., Sadtler, K., Narain, R., Cherry, C., Parrillo, A. J., Park, B. V., Wang, G., Pan, F., Sukumar, S., Pardoll, D. M., Elisseeff, J. H.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/477/eaat7973?rss=1</link><content><content>&lt;p&gt;Biomaterials in regenerative medicine are designed to mimic and modulate tissue environments to promote repair. Biologic scaffolds (derived from decellularized tissue extracellular matrix) promote a wound-healing (proregenerative) immune phenotype and are used clinically to treat tissue loss, including in the context of tumor resection. It is unknown whether a biomaterial microenvironment that encourages tissue formation may also promote tumor development. We implanted a urinary bladder matrix (UBM) scaffold, which is used clinically for wound management, with syngeneic cancer cell lines in mice to study how wound-healing immune responses affect tumor formation and sensitivity to immune checkpoint blockade. The UBM scaffold created an immune microenvironment that inhibited B16-F10 melanoma tumor formation in a CD4&lt;sup&gt;+&lt;/sup&gt; T cell–dependent and macrophage-dependent manner. In-depth immune characterization revealed an activated type 2–like immune response that was distinct from the classical tumor microenvironment, including activated type 2 T helper T cells, a unique macrophage phenotype, eosinophil infiltration, angiogenic factors, and complement. Tumor growth inhibition by PD-1 and PD-L1 checkpoint blockade was potentiated in the UBM scaffold immune microenvironment. Engineering the local tumor microenvironment to promote a type 2 wound-healing immune signature may serve as a therapeutic target to improve immunotherapy efficacy.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/477/eaat7973?rss=1</originId><description>&lt;p&gt;Biomaterials in regenerative medicine are designed to mimic and modulate tissue environments to promote repair. Biologic scaffolds (derived from decellularized tissue extracellular matrix) promote a wound-healing (proregenerative) immune phenotype and are used clinically to treat tissue loss, including in the context of tumor resection. It is unknown whether a biomaterial microenvironment that encourages tissue formation may also promote tumor development. We implanted a urinary bladder matrix (UBM) scaffold, which is used clinically for wound management, with syngeneic cancer cell lines in mice to study how wound-healing immune responses affect tumor formation and sensitivity to immune checkpoint blockade. The UBM scaffold created an immune microenvironment that inhibited B16-F10 melanoma tumor formation in a CD4&lt;sup&gt;+&lt;/sup&gt; T cell–dependent and macrophage-dependent manner. In-depth immune characterization revealed an activated type 2–like immune response that was distinct from the classical tumor microenvironment, including activated type 2 T helper T cells, a unique macrophage phenotype, eosinophil infiltration, angiogenic factors, and complement. Tumor growth inhibition by PD-1 and PD-L1 checkpoint blockade was potentiated in the UBM scaffold immune microenvironment. Engineering the local tumor microenvironment to promote a type 2 wound-healing immune signature may serve as a therapeutic target to improve immunotherapy efficacy.&lt;/p&gt;</description><published>1548874208000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/477/eaat7973?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_168a028b953:cc891b:3a104d3b</id><title>[Research Articles] A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy</title><fingerprint>69b7fe5</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07964-7</href></item></canonical><engagement>1</engagement><crawled>1546943421546</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Nikolay P. Kandul</name></author><visual><height>528</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07964-7/MediaObjects/41467_2018_7964_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-07964-7</link><content><content>&lt;p&gt;&lt;b&gt;Transforming insect population control with precision guided sterile males with demonstration in flies&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Transforming insect population control with precision guided sterile males with demonstration in flies, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07964-7&quot;&gt;doi:10.1038/s41467-018-07964-7&lt;/a&gt;&lt;/p&gt;Sterile Insect Technique (SIT) is used to suppress wild populations. Here the authors integrate CRISPR-based technology and SIT to develop a precision guided SIT (pgSIT), and demonstrate its proof-of-principle by generating 100% sterile males.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/viauZsWVBug&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-07964-7</originId><description>&lt;p&gt;&lt;b&gt;Transforming insect population control with precision guided sterile males with demonstration in flies&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Transforming insect population control with precision guided sterile males with demonstration in flies, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07964-7&quot;&gt;doi:10.1038/s41467-018-07964-7&lt;/a&gt;&lt;/p&gt;Sterile Insect Technique (SIT) is used to suppress wild populations. Here the authors integrate CRISPR-based technology and SIT to develop a precision guided SIT (pgSIT), and demonstrate its proof-of-principle by generating 100% sterile males.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/viauZsWVBug&quot; height=&quot;1&quot;&gt;</description><published>1546934400000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/viauZsWVBug/s41467-018-07964-7</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1682d035c6a:2a73e2:c2ce2e2e</id><title>Transforming insect population control with precision guided sterile males with demonstration in flies</title><fingerprint>8a46bba7</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36537-3</href></item></canonical><engagement>43</engagement><crawled>1548152137226</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Elena Pedrazzini</name></author><visual><height>309</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36537-3/MediaObjects/41598_2018_36537_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36537-3</link><content><content>&lt;p&gt;&lt;b&gt;Damage to the right temporoparietal junction, but not lateral prefrontal or insular cortex, amplifies the role of goal-directed attention&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Damage to the right temporoparietal junction, but not lateral prefrontal or insular cortex, amplifies the role of goal-directed attention, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36537-3&quot;&gt;doi:10.1038/s41598-018-36537-3&lt;/a&gt;&lt;/p&gt;Damage to the right temporoparietal junction, but not lateral prefrontal or insular cortex, amplifies the role of goal-directed attention&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/iWQ3M-x3BIQ&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36537-3</originId><description>&lt;p&gt;&lt;b&gt;Damage to the right temporoparietal junction, but not lateral prefrontal or insular cortex, amplifies the role of goal-directed attention&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Damage to the right temporoparietal junction, but not lateral prefrontal or insular cortex, amplifies the role of goal-directed attention, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36537-3&quot;&gt;doi:10.1038/s41598-018-36537-3&lt;/a&gt;&lt;/p&gt;Damage to the right temporoparietal junction, but not lateral prefrontal or insular cortex, amplifies the role of goal-directed attention&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/iWQ3M-x3BIQ&quot; height=&quot;1&quot;&gt;</description><published>1548144000000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/iWQ3M-x3BIQ/s41598-018-36537-3</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168750ee60a:23b88bb:c2ce2e2e</id><title>Damage to the right temporoparietal junction, but not lateral prefrontal or insular cortex, amplifies the role of goal-directed attention</title><fingerprint>9bda81b</fingerprint></item><item><entities><item><label>Brexit</label><id>nlp/f/entity/en/w/Brexit</id><mentions><item><text>Brexit</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Lassa fever</label><id>nlp/f/entity/en/w/Lassa fever</id><mentions><item><text>Lassa</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>European Union</label><id>nlp/f/entity/en/w/European Union</id><mentions><item><text>EU</text></item><item><text>European Union</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>European Medicines Agency</label><id>nlp/f/entity/en/w/European Medicines Agency</id><mentions><item><text>European Medicines Agency</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>South Korean icebreaker Araon</label><id>nlp/f/entity/en/-/south korean icebreaker araon</id><mentions><item><text>Araon</text></item><item><text>South Korean icebreaker Araon</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548854231688</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00283-x/d41586-019-00283-x_16426654.jpg</url></visual><published>1548835200000</published><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00283-x</link><content><content>&lt;p&gt;&lt;b&gt;Brexit impacts, quitting coal and Lassa-fever outbreak&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Brexit impacts, quitting coal and Lassa-fever outbreak, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00283-x&quot;&gt;doi:10.1038/d41586-019-00283-x&lt;/a&gt;&lt;/p&gt;The week in science: 25–31 January 2019.</content><direction>ltr</direction></content><commonTopics><item><label>europe</label><id>nlp/f/topic/807</id><probability>0.958</probability></item><item><label>open access</label><id>nlp/f/topic/1636</id><probability>0.939</probability></item><item><label>science policy</label><id>nlp/f/topic/2019</id><probability>0.922</probability></item><item><label>global health</label><id>nlp/f/topic/977</id><probability>0.905</probability></item><item><label>research</label><id>nlp/f/topic/1931</id><probability>0.896</probability></item><item><label>phd</label><id>nlp/f/topic/1737</id><probability>0.806</probability></item><item><label>germany</label><id>nlp/f/topic/964</id><probability>0.796</probability></item><item><label>academic</label><id>nlp/f/topic/17</id><probability>0.766</probability></item><item><label>africa</label><id>nlp/f/topic/47</id><probability>0.741</probability></item><item><label>epidemiology</label><id>nlp/f/topic/783</id><probability>0.736</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00283-x</originId><description>&lt;p&gt;&lt;b&gt;Brexit impacts, quitting coal and Lassa-fever outbreak&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Brexit impacts, quitting coal and Lassa-fever outbreak, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00283-x&quot;&gt;doi:10.1038/d41586-019-00283-x&lt;/a&gt;&lt;/p&gt;The week in science: 25–31 January 2019.</description><author><name>NA</name></author><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00283-x</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ee80288:ac1e7c:ad2b6584</id><title>Brexit impacts, quitting coal and Lassa-fever outbreak</title><fingerprint>9733ec25</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37482-x</href></item></canonical><engagement>4</engagement><crawled>1547461245387</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Diba Emal</name></author><visual><height>172</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37482-x/MediaObjects/41598_2018_37482_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37482-x</link><content><content>&lt;p&gt;&lt;b&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37482-x&quot;&gt;doi:10.1038/s41598-018-37482-x&lt;/a&gt;&lt;/p&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/yLhA3-x1tbk&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37482-x</originId><description>&lt;p&gt;&lt;b&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37482-x&quot;&gt;doi:10.1038/s41598-018-37482-x&lt;/a&gt;&lt;/p&gt;Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/yLhA3-x1tbk&quot; height=&quot;1&quot;&gt;</description><published>1547452800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/yLhA3-x1tbk/s41598-018-37482-x</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1684be0b9cb:2b4c869:c2ce2e2e</id><title>Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection</title><fingerprint>b91c1539</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08271-x</href></item></canonical><engagement>6</engagement><crawled>1548411385568</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Jun Yan</name></author><visual><height>550</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08271-x/MediaObjects/41467_2018_8271_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08271-x</link><content><content>&lt;p&gt;&lt;b&gt;FGL2 promotes tumor progression in the CNS by suppressing CD103&lt;sup&gt;+&lt;/sup&gt; dendritic cell differentiation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;FGL2 promotes tumor progression in the CNS by suppressing CD103&amp;lt;sup&gt;+&amp;lt;/sup&gt; dendritic cell differentiation, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08271-x&quot;&gt;doi:10.1038/s41467-018-08271-x&lt;/a&gt;&lt;/p&gt;Fibrinogen-like protein 2 (FGL2) mediates immune suppression in glioblastoma (GBM). Here, the authors show that FGL-2 expressed by GBM cancer cells acts by suppressing the differentiation of CD103+ DC cells required to activate the anti-tumor CD8+ T cell response via blocking GM-CSF signalling at NFKB, STAT1/5 and p38 level.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/gDnM-4ypUnk&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08271-x</originId><description>&lt;p&gt;&lt;b&gt;FGL2 promotes tumor progression in the CNS by suppressing CD103&lt;sup&gt;+&lt;/sup&gt; dendritic cell differentiation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;FGL2 promotes tumor progression in the CNS by suppressing CD103&amp;lt;sup&gt;+&amp;lt;/sup&gt; dendritic cell differentiation, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08271-x&quot;&gt;doi:10.1038/s41467-018-08271-x&lt;/a&gt;&lt;/p&gt;Fibrinogen-like protein 2 (FGL2) mediates immune suppression in glioblastoma (GBM). Here, the authors show that FGL-2 expressed by GBM cancer cells acts by suppressing the differentiation of CD103+ DC cells required to activate the anti-tumor CD8+ T cell response via blocking GM-CSF signalling at NFKB, STAT1/5 and p38 level.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/gDnM-4ypUnk&quot; height=&quot;1&quot;&gt;</description><engagementRate>0.6</engagementRate><published>1548403200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/gDnM-4ypUnk/s41467-018-08271-x</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1688482b6e0:3b9c08e:3a104d3b</id><title>FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation</title><fingerprint>d2ad563c</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36384-2</href></item></canonical><engagement>0</engagement><crawled>1547806500228</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>J. Sean Doody</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>459</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36384-2/MediaObjects/41598_2018_36384_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36384-2</link><content><content>&lt;p&gt;&lt;b&gt;Novel habitat causes a shift to diurnal activity in a nocturnal species&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Novel habitat causes a shift to diurnal activity in a nocturnal species, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36384-2&quot;&gt;doi:10.1038/s41598-018-36384-2&lt;/a&gt;&lt;/p&gt;Novel habitat causes a shift to diurnal activity in a nocturnal species&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/clIOSjuX58Q&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36384-2</originId><description>&lt;p&gt;&lt;b&gt;Novel habitat causes a shift to diurnal activity in a nocturnal species&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Novel habitat causes a shift to diurnal activity in a nocturnal species, Published online: 18 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36384-2&quot;&gt;doi:10.1038/s41598-018-36384-2&lt;/a&gt;&lt;/p&gt;Novel habitat causes a shift to diurnal activity in a nocturnal species&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/clIOSjuX58Q&quot; height=&quot;1&quot;&gt;</description><published>1547798400000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/clIOSjuX58Q/s41598-018-36384-2</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1686074e584:a7a824:3a104d3b</id><title>Novel habitat causes a shift to diurnal activity in a nocturnal species</title><fingerprint>c86274fe</fingerprint></item><item><engagement>1</engagement><crawled>1548261812092</crawled><visual><height>324</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>250</width><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14147681/thumb.png</url></visual><published>1548201600000</published><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Diacylfuroxans_Are_Masked_Nitrile_Oxides_That_Inhibit_GPX4_Covalently/7617884</link><originId>https://chemrxiv.org/articles/Diacylfuroxans_Are_Masked_Nitrile_Oxides_That_Inhibit_GPX4_Covalently/7617884</originId><description>GPX4 represents a promising yet difficult-to-drug therapeutic target for the treatment of, among others, drug-resistant cancers. While most GPX4 inhibitors rely on a chloroacetamide moiety to modify covalently the protein’s catalytic selenocysteine residue, the discovery and mechanistic elucidation of structurally diverse GPX4-inhibiting molecules has uncovered novel electrophilic warheads that bind and inhibit GPX4. Here we report our discovery that diacylfuroxans can act as masked nitrile oxides that inhibit GPX4 covalently. These observations illuminate a novel molecular mechanism of action for biologically active furoxans and also suggest that nitrile oxides may be uniquely suited to targeting GPX4.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Diacylfuroxans_Are_Masked_Nitrile_Oxides_That_Inhibit_GPX4_Covalently/7617884</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1687b98677c:2e85407:3a104d3b</id><title>Diacylfuroxans Are Masked Nitrile Oxides That Inhibit GPX4 Covalently</title><fingerprint>d169ff08</fingerprint><summary><content>GPX4 represents a promising yet difficult-to-drug therapeutic target for the treatment of, among others, drug-resistant cancers. While most GPX4 inhibitors rely on a chloroacetamide moiety to modify covalently the protein’s catalytic selenocysteine residue, the discovery and mechanistic elucidation of structurally diverse GPX4-inhibiting molecules has uncovered novel electrophilic warheads that bind and inhibit GPX4. Here we report our discovery that diacylfuroxans can act as masked nitrile oxides that inhibit GPX4 covalently. These observations illuminate a novel molecular mechanism of action for biologically active furoxans and also suggest that nitrile oxides may be uniquely suited to targeting GPX4.</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1547656706058</crawled><fingerprint>c30b1b93</fingerprint><author><name>Mukherjee, S.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/521518v1?rss=1</link><content><content>Salmonella enterica serovar typhi is the causative agent of typhoid fever in human. The available vaccine lacks the effectiveness and further overuse of the antibiotics throughout the past decades lead to the emergence of antibiotic-resistant strains. To reduce the spread of antibiotic resistance, it is essential to develop new vaccines. In this study using an extensive bioinformatic analysis based on reverse vaccinology and subtractive genomics-based approach, we searched the genome of S typhi. We found that two outermost membrane proteins LptD and LptE, which are responsible for the final transport of the LPS across the membrane having most of the essential signature for being vaccine target. Both of these proteins are found highly conserved and possess shared surface epitopes among several species of Salmonella pathogens. This indicates that these two proteins could be the potential target for vaccine development, which could be effective for a broad range of Salmonella pathogens.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/521518v1?rss=1</originId><description>Salmonella enterica serovar typhi is the causative agent of typhoid fever in human. The available vaccine lacks the effectiveness and further overuse of the antibiotics throughout the past decades lead to the emergence of antibiotic-resistant strains. To reduce the spread of antibiotic resistance, it is essential to develop new vaccines. In this study using an extensive bioinformatic analysis based on reverse vaccinology and subtractive genomics-based approach, we searched the genome of S typhi. We found that two outermost membrane proteins LptD and LptE, which are responsible for the final transport of the LPS across the membrane having most of the essential signature for being vaccine target. Both of these proteins are found highly conserved and possess shared surface epitopes among several species of Salmonella pathogens. This indicates that these two proteins could be the potential target for vaccine development, which could be effective for a broad range of Salmonella pathogens.</description><published>1547625600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/521518v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1685787380a:3d2f043:3a104d3b</id><title>Identification of potential new vaccine candidates in Salmonella typhi using reverse vaccinology and subtractive genomics-based approach [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/16/521518</canonicalUrl></item><item><crawled>1548357093757</crawled><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><author><name>Zhang, X., Ren, J., Tan, S. M., Tan, D., Lee, R., Tan, C.-H.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/400?rss=1</link><content><content>&lt;p&gt;Bimolecular nucleophilic substitution (S&lt;sub&gt;N&lt;/sub&gt;2) plays a central role in organic chemistry. In the conventionally accepted mechanism, the nucleophile displaces a carbon-bound leaving group X, often a halogen, by attacking the carbon face opposite the C–X bond. A less common variant, the halogenophilic S&lt;sub&gt;N&lt;/sub&gt;2X reaction, involves initial nucleophilic attack of the X group from the front and as such is less sensitive to backside steric hindrance. Herein, we report an enantioconvergent substitution reaction of activated tertiary bromides by thiocarboxylates or azides that, on the basis of experimental and computational mechanistic studies, appears to proceed via the unusual S&lt;sub&gt;N&lt;/sub&gt;2X pathway. The proposed electrophilic intermediates, benzoylsulfenyl bromide and bromine azide, were independently synthesized and shown to be effective.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://science.sciencemag.org/cgi/content/short/363/6425/400?rss=1</originId><description>&lt;p&gt;Bimolecular nucleophilic substitution (S&lt;sub&gt;N&lt;/sub&gt;2) plays a central role in organic chemistry. In the conventionally accepted mechanism, the nucleophile displaces a carbon-bound leaving group X, often a halogen, by attacking the carbon face opposite the C–X bond. A less common variant, the halogenophilic S&lt;sub&gt;N&lt;/sub&gt;2X reaction, involves initial nucleophilic attack of the X group from the front and as such is less sensitive to backside steric hindrance. Herein, we report an enantioconvergent substitution reaction of activated tertiary bromides by thiocarboxylates or azides that, on the basis of experimental and computational mechanistic studies, appears to proceed via the unusual S&lt;sub&gt;N&lt;/sub&gt;2X pathway. The proposed electrophilic intermediates, benzoylsulfenyl bromide and bromine azide, were independently synthesized and shown to be effective.&lt;/p&gt;</description><canonicalUrl>http://science.sciencemag.org/content/363/6425/400.full</canonicalUrl><published>1548355045000</published><keywords><item>Chemistry</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/400?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a5c:c2ce2e2e</id><title>An enantioconvergent halogenophilic nucleophilic substitution (SN2X) reaction</title><fingerprint>8e94a3bb</fingerprint></item><item><crawled>1547831320797</crawled><engagement>6</engagement><unread>True</unread><link>http://blogs.sciencemag.org/pipeline/?p=14116</link><commonTopics><item><label>ip</label><id>nlp/f/topic/1200</id><probability>0.991</probability></item><item><label>pharma</label><id>nlp/f/topic/1734</id><probability>0.722</probability></item></commonTopics><alternate><item><type>text/html</type><href>http://blogs.sciencemag.org/pipeline/archives/2019/01/18/automated-route-finding-and-patent-busting</href></item></alternate><title>Automated Route Finding (and Patent Busting)</title><canonicalUrl>http://blogs.sciencemag.org/pipeline/archives/2019/01/18/automated-route-finding-and-patent-busting</canonicalUrl><updateCount>4</updateCount><entities><item><label>Route Finding</label><id>nlp/f/entity/en/-/route finding</id><mentions><item><text>Route Finding</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Patent Busting</label><id>nlp/f/entity/en/-/patent busting</id><mentions><item><text>Patent Busting</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Momenta v. Teva</label><id>nlp/f/entity/en/-/momenta v. teva</id><mentions><item><text>Momenta v. Teva</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>United States</label><id>nlp/f/entity/en/w/United States</id><mentions><item><text>US</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><origin><htmlUrl>http://blogs.sciencemag.org/pipeline</htmlUrl><streamId>feed/http://blogs.sciencemag.org/pipeline/feed</streamId><title>Sciencemag</title></origin><published>1547830850000</published><visual><height>452</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1594</width><url>http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Linez.jpg</url></visual><fingerprint>ada14e9</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><content><content>&lt;p&gt;&lt;a href=&quot;https://www.sciencedirect.com/science/article/pii/S2451929418305679&quot;&gt;Here’s another look&lt;/a&gt; at retrosynthesis software, building on the &lt;a href=&quot;http://blogs.sciencemag.org/pipeline/archives/2018/03/06/retrosynthesis-here-it-comes&quot;&gt;earlier Chematica paper&lt;/a&gt; that looked at generating new routes to known compounds. This is a more detailed look at the same idea, using the software to both analyze the existing routes to marketed drugs (and the patent landscape around them) and to come up with new ones that would slip through those existing patents.&lt;/p&gt;
&lt;p&gt;As anyone who’s had to do this sort of analysis can tell you, a small-molecule drug can have a forest of patent filings around it. Many of these will be around the chemical matter itself (and associated things like formulations and dosage methods for it), and others will be process patents for useful ways to prepare it. Some of these may have “product by process” claims, where you’re indirectly claiming the final drug substance itself (when made by the specified route). But others will be direct claims for the process itself, not the chemical matter it produces. In many jurisdictions, the burden of proof is on the potential violator of such patents, and they have to show that they’re not infringing a patented route. Under US law, importing a drug substance that’s made outside the country via a US-patented route can constitute infringement itself (as clarified in &lt;a href=&quot;https://ocpatentlawyer.com/process-patent-blocks-importation-of-product/&quot;&gt;&lt;em&gt;Momenta v. Teva&lt;/em&gt;&lt;/a&gt; a few years ago). So there’s a pretty strong incentive to find new routes.&lt;/p&gt;
&lt;p&gt;I have to say, it looks like the software does a pretty nice job of it (both the analysis and the new-route-finding). The latter is done by analyzing the existing route for the key bonds that are being formed, and then forcing the software to consider other options. Without such constraints, it tends to come up with routes that are similar or identical to the already-patented ones (which speaks well of it, actually). But if you tell it “No, I don’t want anything where that ring gets formed as part of the sequence” or the like, then it goes off-roading and comes up with something new.&lt;/p&gt;
&lt;p&gt;&lt;img sizes=&quot;(max-width: 1024px) 100vw, 1024px&quot; src=&quot;http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Linez-1024x290.jpg&quot; alt=&quot;&quot; width=&quot;1024&quot; srcset=&quot;http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Linez-1024x290.jpg 1024w, http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Linez-300x85.jpg 300w, http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Linez-768x218.jpg 768w, http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Linez-1280x363.jpg 1280w, http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/Linez.jpg 1594w&quot; class=&quot;wp-image-14117&quot; height=&quot;290&quot;&gt;&lt;/p&gt;
&lt;p&gt;&lt;img sizes=&quot;(max-width: 300px) 100vw, 300px&quot; src=&quot;http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/linez2-300x273.jpg&quot; alt=&quot;&quot; width=&quot;300&quot; srcset=&quot;http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/linez2-300x273.jpg 300w, http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/linez2-768x699.jpg 768w, http://blogs.sciencemag.org/pipeline/wp-content/uploads/sites/2/2019/01/linez2.jpg 1002w&quot; class=&quot;wp-image-14118&quot; height=&quot;273&quot;&gt;&lt;/p&gt;
&lt;p&gt;For example, shown above is the program’s analysis of the patented routes to &lt;a href=&quot;https://en.wikipedia.org/wiki/Linezolid&quot;&gt;linezolid&lt;/a&gt;. A common theme is the synthesis of the oxazolidinone ring (and to be sure, most organic chemists would think the same way). But making those bonds “protected” makes the program come up with a different set of potential routes (shown at right). Now, this is not the most difficult synthetic problem in the world, but that looks like a perfectly creditable job of it, and the program is also spitting out literature precedents for all of these steps along with the analysis. You can certainly do this by hand, but &lt;em&gt;why would you&lt;/em&gt;? That’s the question that such programs force us to ask, and it’s the same question that other labor-saving devices have made people ask over the years. And that’s what this and the other programs like it are: labor-saving devices. The labor in this case is not hauling laundry or digging holes, but rather the mental exertion in thinking up these pathways and the time spent in coming up with plausible procedures and precedents. The work is taking place between your ears (well, and with your fingers at the keyboard) but it’s still work.&lt;/p&gt;
&lt;p&gt;The paper shows similar analyses for &lt;a href=&quot;https://en.wikipedia.org/wiki/Sitagliptin&quot;&gt;sitagliptin&lt;/a&gt; and &lt;a href=&quot;https://en.wikipedia.org/wiki/Panobinostat&quot;&gt;panobinostat&lt;/a&gt;, all of which are (I would say) solid representatives of the kinds of structures and syntheses that we work with in med-chem. The former ends up being a chiral-pool synthesis rather than depending on a chiral reduction, and the latter comes up with two different approaches, depending on whether or not you allow a Pd-catalyzed coupling reaction. It would not surprise me to find that the process chemists at the various companies (both the originators and generic competition) have considered these general schemes already, of course. But they probably took a lot longer to do it!&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;</content><direction>ltr</direction></content><originId>http://blogs.sciencemag.org/pipeline/?p=14116</originId><description>Here’s another look at retrosynthesis software, building on the earlier Chematica paper that looked at generating new routes to known compounds. This is a more detailed look at the same idea, using the software to both analyze the existing routes to marketed drugs (and the patent landscape around them) and to come up with new</description><author><name>Derek Lowe</name></author><keywords><item>Chemical News</item><item>Patents and IP</item></keywords><id>2k24/TFePIh3MUUJr/vqRk++EkKG/RZ2TtOvsKiJXX4=_16861efa0dd:ce5b04:3a104d3b</id><recrawled>1548782024101</recrawled><summary><content>Here’s another look at retrosynthesis software, building on the earlier Chematica paper that looked at generating new routes to known compounds. This is a more detailed look at the same idea, using the software to both analyze the existing routes to marketed drugs (and the patent landscape around them) and to come up with new</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08562-x</href></item></canonical><engagement>0</engagement><crawled>1548757739847</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Chia-Yu Chung</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-019-08562-x</link><content><content>&lt;p&gt;&lt;b&gt;Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08562-x&quot;&gt;doi:10.1038/s41467-019-08562-x&lt;/a&gt;&lt;/p&gt;Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/Cfs6XAUHFgc&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-019-08562-x</originId><description>&lt;p&gt;&lt;b&gt;Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08562-x&quot;&gt;doi:10.1038/s41467-019-08562-x&lt;/a&gt;&lt;/p&gt;Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/Cfs6XAUHFgc&quot; height=&quot;1&quot;&gt;</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/Cfs6XAUHFgc/s41467-019-08562-x</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1689927a947:1ffc0d:c2ce2e2e</id><title>Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity</title><fingerprint>ac118bde</fingerprint></item><item><engagement>0</engagement><crawled>1548863862787</crawled><visual><height>324</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>250</width><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14203601/thumb.png</url></visual><published>1548806400000</published><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Modular_Stereocontrolled_C_H_C_C_Activation_of_Alkyl_Carboxylic_Acids/7645115</link><originId>https://chemrxiv.org/articles/Modular_Stereocontrolled_C_H_C_C_Activation_of_Alkyl_Carboxylic_Acids/7645115</originId><description>The union of two powerful transformations, directed C–H activation and decarboxylative cross-coupling, for the
enantioselective synthesis of vicinally functionalized alkyl, carbocyclic, and heterocyclic compounds is described. Starting from
simple carboxylic acid building blocks, this modular sequence exploits the residual directing group to access more than 50 scaffolds
that would be otherwise extremely difficult to prepare. The tactical use of these two transformations accomplishes a formal vicinal
difunctionalization of carbon centers in a way that is modular and thus amenable to rapid diversity incorporation. A simplification of
routes to known preclinical drug candidates is presented along with the rapid diversification of an antimalarial compound series.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Modular_Stereocontrolled_C_H_C_C_Activation_of_Alkyl_Carboxylic_Acids/7645115</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1689f7af803:bb2f21:ad2b6584</id><title>Modular, Stereocontrolled Cβ–H/Cα–C Activation of Alkyl Carboxylic Acids</title><fingerprint>7f365948</fingerprint><summary><content>The union of two powerful transformations, directed C–H activation and decarboxylative cross-coupling, for the
enantioselective synthesis of vicinally functionalized alkyl, carbocyclic, and heterocyclic compounds is described. Starting from
simple carboxylic acid building blocks, this modular sequence exploits the residual directing group to access more than 50 scaffolds
that would be otherwise extremely difficult to prepare. The tactical use of these two transformations accomplishes a formal vicinal
difunctionalization of carbon centers in a way that is modular and thus amenable to rapid diversity incorporation. A simplification of
routes to known preclinical drug candidates is presented along with the rapid diversification of an antimalarial compound series.</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/d41591-019-00001-0</href></item></canonical><entities><item><label>Ingrid Fleming</label><id>nlp/f/entity/en/-/ingrid fleming</id><mentions><item><text>Ingrid Fleming</text></item><item><text>Fleming</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>CSE</label><id>nlp/f/entity/en/-/cse</id><mentions><item><text>CSE</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Cystathionine gamma-lyase</label><id>nlp/f/entity/en/w/Cystathionine gamma-lyase</id><mentions><item><text>cystathionine - gamma - lyase</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Goethe University Frankfurt</label><id>nlp/f/entity/en/w/Goethe University Frankfurt</id><mentions><item><text>Goethe University Frankfurt</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Suowen Xu</label><id>nlp/f/entity/en/-/suowen xu</id><mentions><item><text>Suowen Xu</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547481499128</crawled><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><author><name>Colin Barras</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/d41591-019-00001-0</link><content><content>&lt;p&gt;&lt;b&gt;&lt;i&gt;Smelly gas protects against clogged arteries&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;Smelly gas protects against clogged arteries&amp;lt;/i&gt;, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41591-019-00001-0&quot;&gt;doi:10.1038/d41591-019-00001-0&lt;/a&gt;&lt;/p&gt;Mice given a hydrogen-sulfide-generating drug had less plaque buildup&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/yhgC8NU7KWE&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>oil</label><id>nlp/f/topic/1627</id><probability>0.987</probability></item><item><label>medical devices</label><id>nlp/f/topic/1430</id><probability>0.85</probability></item><item><label>pharmacology</label><id>nlp/f/topic/1735</id><probability>0.794</probability></item><item><label>biohacking</label><id>nlp/f/topic/261</id><probability>0.79</probability></item><item><label>health</label><id>nlp/f/topic/1045</id><probability>0.77</probability></item><item><label>ted</label><id>nlp/f/topic/2261</id><probability>0.708</probability></item><item><label>maritime</label><id>nlp/f/topic/1407</id><probability>0.705</probability></item></commonTopics><originId>https://www.nature.com/articles/d41591-019-00001-0</originId><description>&lt;p&gt;&lt;b&gt;&lt;i&gt;Smelly gas protects against clogged arteries&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;Smelly gas protects against clogged arteries&amp;lt;/i&gt;, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41591-019-00001-0&quot;&gt;doi:10.1038/d41591-019-00001-0&lt;/a&gt;&lt;/p&gt;Mice given a hydrogen-sulfide-generating drug had less plaque buildup&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/yhgC8NU7KWE&quot; height=&quot;1&quot;&gt;</description><published>1547452800000</published><engagement>22</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/yhgC8NU7KWE/d41591-019-00001-0</href></item></alternate><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_1684d15c5f8:2e536fc:8675cc2c</id><title>Smelly gas protects against clogged arteries</title><fingerprint>50217dac</fingerprint></item><item><entities><item><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id><mentions><item><text>CSS</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id><mentions><item><text>Explorer</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id><mentions><item><text>JavaScript</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id><mentions><item><text>WEBSITEnature_com</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546530511732</crawled><visual><url>none</url></visual><author><name>Laura DeFrancesco</name></author><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><link>https://www.nature.com/articles/nbt0119-9b</link><content><content>&lt;p&gt;&lt;b&gt;Not &apos;fake&apos; meat but &apos;clean&apos;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Not &apos;fake&apos; meat but &apos;clean&apos;, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt0119-9b&quot;&gt;doi:10.1038/nbt0119-9b&lt;/a&gt;&lt;/p&gt;Not &apos;fake&apos; meat but &apos;clean&apos;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/nbt0119-9b</originId><description>&lt;p&gt;&lt;b&gt;Not &apos;fake&apos; meat but &apos;clean&apos;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Not &apos;fake&apos; meat but &apos;clean&apos;, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt0119-9b&quot;&gt;doi:10.1038/nbt0119-9b&lt;/a&gt;&lt;/p&gt;Not &apos;fake&apos; meat but &apos;clean&apos;</description><published>1546502400000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/nbt0119-9b</href></item></alternate><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_1681466db74:68a3835:3a104d3b</id><title>Not &apos;fake&apos; meat but &apos;clean&apos;</title><fingerprint>f1be1322</fingerprint></item><item><updateCount>1</updateCount><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006267</href></item></canonical><engagement>0</engagement><crawled>1546627430109</crawled><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><published>1546639200000</published><link>10.1371/journal.pcbi.1006267</link><visual><height>195</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>320</width><url>https://journals.plos.org/ploscompbiol/article/figure/image?size=inline&amp;id=10.1371/journal.pcbi.1006267.g001</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><description>&lt;p&gt;by Anna C. Sales, Karl J. Friston, Matthew W. Jones, Anthony E. Pickering, Rosalyn J. Moran&lt;/p&gt;
The locus coeruleus (LC) in the pons is the major source of noradrenaline (NA) in the brain. Two modes of LC firing have been associated with distinct cognitive states: changes in tonic rates of firing are correlated with global levels of arousal and behavioural flexibility, whilst phasic LC responses are evoked by salient stimuli. Here, we unify these two modes of firing by modelling the response of the LC as a correlate of a prediction error when inferring states for action planning under Active Inference (AI). We simulate a classic Go/No-go reward learning task and a three-arm ‘explore/exploit’ task and show that, if LC activity is considered to reflect the magnitude of high level ‘state-action’ prediction errors, then both tonic and phasic modes of firing are emergent features of belief updating. We also demonstrate that when contingencies change, AI agents can update their internal models more quickly by feeding back this state-action prediction error–reflected in LC firing and noradrenaline release–to optimise learning rate, enabling large adjustments over short timescales. We propose that such prediction errors are mediated by cortico-LC connections, whilst ascending input from LC to cortex modulates belief updating in anterior cingulate cortex (ACC). In short, we characterise the LC/ NA system within a general theory of brain function. In doing so, we show that contrasting, behaviour-dependent firing patterns are an emergent property of the LC that translates state-action prediction errors into an optimal balance between plasticity and stability.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/A_rbYMuEoU0&quot; height=&quot;1&quot;&gt;</description><updated>1546639200000</updated><content><content>&lt;p&gt;by Anna C. Sales, Karl J. Friston, Matthew W. Jones, Anthony E. Pickering, Rosalyn J. Moran&lt;/p&gt;
The locus coeruleus (LC) in the pons is the major source of noradrenaline (NA) in the brain. Two modes of LC firing have been associated with distinct cognitive states: changes in tonic rates of firing are correlated with global levels of arousal and behavioural flexibility, whilst phasic LC responses are evoked by salient stimuli. Here, we unify these two modes of firing by modelling the response of the LC as a correlate of a prediction error when inferring states for action planning under Active Inference (AI). We simulate a classic Go/No-go reward learning task and a three-arm ‘explore/exploit’ task and show that, if LC activity is considered to reflect the magnitude of high level ‘state-action’ prediction errors, then both tonic and phasic modes of firing are emergent features of belief updating. We also demonstrate that when contingencies change, AI agents can update their internal models more quickly by feeding back this state-action prediction error–reflected in LC firing and noradrenaline release–to optimise learning rate, enabling large adjustments over short timescales. We propose that such prediction errors are mediated by cortico-LC connections, whilst ascending input from LC to cortex modulates belief updating in anterior cingulate cortex (ACC). In short, we characterise the LC/ NA system within a general theory of brain function. In doing so, we show that contrasting, behaviour-dependent firing patterns are an emergent property of the LC that translates state-action prediction errors into an optimal balance between plasticity and stability.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/A_rbYMuEoU0&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>10.1371/journal.pcbi.1006267</originId><author><name>Anna C. Sales</name></author><recrawled>1546637233906</recrawled><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/A_rbYMuEoU0/article</href></item></alternate><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_1681a2db6dd:4d2cc9:56b782f7</id><title>Locus Coeruleus tracking of prediction errors optimises cognitive flexibility: An Active Inference model</title><fingerprint>75af9c9b</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01158</href></item></canonical><engagement>0</engagement><crawled>1547228855250</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><author><name>Yi Zheng, Samuel Obeng, Huiqun Wang, Abdulmajeed M. Jali, Bharath Peddibhotla, Dwight A. Williams, Chuanchun Zou, David L. Stevens, William L. Dewey, Hamid I. Akbarali, Dana E. Selley, Yan Zhang</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01158</link><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01158</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01158/20190110/images/medium/jm-2018-01158g_0013.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01158&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=qFqDtQJgE3k:Ai3TuFekHCk:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/qFqDtQJgE3k&quot; height=&quot;1&quot;&gt;</description><published>1547182800000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/qFqDtQJgE3k/acs.jmedchem.8b01158</href></item></alternate><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_1683e06bbd2:1b419a5:b77f238b</id><title>[ASAP] Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14ß-dihydroxy-4,5a-epoxy-6ß-[(4&apos;-pyridyl)carboxamido]morphinan (NAP) Derivatives as µ/? Opioid Receptor Dual Selective Ligands</title><fingerprint>c33d71f8</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01158/20190110/images/medium/jm-2018-01158g_0013.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01158&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=qFqDtQJgE3k:Ai3TuFekHCk:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/qFqDtQJgE3k&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08312-z</href></item></canonical><engagement>0</engagement><crawled>1548152582796</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Adam Kim</name></author><visual><height>653</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-08312-z/MediaObjects/41467_2019_8312_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-019-08312-z</link><content><content>&lt;p&gt;&lt;b&gt;&lt;i&gt;Plasmodium vivax&lt;/i&gt; transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;Plasmodium vivax&amp;lt;/i&gt; transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08312-z&quot;&gt;doi:10.1038/s41467-019-08312-z&lt;/a&gt;&lt;/p&gt;Plasmodium vivax biology is not well understood, due to a lack of in vitro culture systems and difficulties associated with studying clinical blood samples. Here, Kim et al. use gene expression profiles from P. vivax infected patient blood and show stage-specific chloroquine response and differential regulation of male and female gametocytes.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/57ZLqdXgj2E&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-019-08312-z</originId><description>&lt;p&gt;&lt;b&gt;&lt;i&gt;Plasmodium vivax&lt;/i&gt; transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;Plasmodium vivax&amp;lt;/i&gt; transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08312-z&quot;&gt;doi:10.1038/s41467-019-08312-z&lt;/a&gt;&lt;/p&gt;Plasmodium vivax biology is not well understood, due to a lack of in vitro culture systems and difficulties associated with studying clinical blood samples. Here, Kim et al. use gene expression profiles from P. vivax infected patient blood and show stage-specific chloroquine response and differential regulation of male and female gametocytes.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/57ZLqdXgj2E&quot; height=&quot;1&quot;&gt;</description><published>1548144000000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/57ZLqdXgj2E/s41467-019-08312-z</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687515b28c:246a930:3a104d3b</id><title>Plasmodium vivax transcriptomes reveal stage-specific chloroquine response and differential regulation of male and female gametocytes</title><fingerprint>d7548bbd</fingerprint></item><item><crawled>1548079190592</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1548028800000</published><engagement>2</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Making_Better_Decisions_During_Synthetic_Route_Design_Leveraging_Prediction_to_Achieve_Greenness-by-Design/7599926</link><originId>https://chemrxiv.org/articles/Making_Better_Decisions_During_Synthetic_Route_Design_Leveraging_Prediction_to_Achieve_Greenness-by-Design/7599926</originId><description>This paper expands our work predicting Process Mass Intensity (PMI), as a methodology for exploring the potential efficiency of proposed synthetic routes. In the present work, we integrate a method for predicting the PMI contributions of high complexity reagents, needed to enable certain transformations. We focus on ligands for metal catalyzed reactions - and develop an approach for predicting which ligands may function in CN couplings - as a proof of concept. We leverage this to enable the integration of the PMI contribution of the ligands into a predictions of a routes efficiency, enabling an understanding of the holistic impact of a route decision..</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Making_Better_Decisions_During_Synthetic_Route_Design_Leveraging_Prediction_to_Achieve_Greenness-by-Design/7599926</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16870b5d240:1dd4d95:c2ce2e2e</id><title>Making Better Decisions During Synthetic Route Design: Leveraging Prediction to Achieve Greenness-by-Design</title><fingerprint>38b32daa</fingerprint><summary><content>This paper expands our work predicting Process Mass Intensity (PMI), as a methodology for exploring the potential efficiency of proposed synthetic routes. In the present work, we integrate a method for predicting the PMI contributions of high complexity reagents, needed to enable certain transformations. We focus on ligands for metal catalyzed reactions - and develop an approach for predicting which ligands may function in CN couplings - as a proof of concept. We leverage this to enable the integration of the PMI contribution of the ligands into a predictions of a routes efficiency, enabling an understanding of the holistic impact of a route decision..</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1547653736591</crawled><fingerprint>f26d2621</fingerprint><author><name>Behsaz, B.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/521872v1?rss=1</link><content><content>Cyclic and branch cyclic peptides (cyclopeptides) represent an important class of bioactive natural products that include many antibiotics and anti-tumor compounds. However, little is known about cyclopeptides in the human gut, despite the fact that humans are constantly exposed to them. To address this bottleneck, we developed the CycloNovo algorithm for de novo cyclopeptide sequencing that employs de Bruijn graphs, the workhorse of DNA sequencing algorithms. CycloNovo reconstructed many new cyclopeptides that we validated with transcriptome, metagenome, and genome mining analyses. Our benchmarking revealed a vast hidden cyclopeptidome in the human gut and other environments and suggested that CycloNovo offers a much-needed step-change for cyclopeptide discovery. Furthermore, CycloNovo revealed a wealth of anti-microbial cyclopeptides from food that survive the complete human gastrointestinal tract, raising the question of how these cyclopeptides might affect the human microbiome.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/521872v1?rss=1</originId><description>Cyclic and branch cyclic peptides (cyclopeptides) represent an important class of bioactive natural products that include many antibiotics and anti-tumor compounds. However, little is known about cyclopeptides in the human gut, despite the fact that humans are constantly exposed to them. To address this bottleneck, we developed the CycloNovo algorithm for de novo cyclopeptide sequencing that employs de Bruijn graphs, the workhorse of DNA sequencing algorithms. CycloNovo reconstructed many new cyclopeptides that we validated with transcriptome, metagenome, and genome mining analyses. Our benchmarking revealed a vast hidden cyclopeptidome in the human gut and other environments and suggested that CycloNovo offers a much-needed step-change for cyclopeptide discovery. Furthermore, CycloNovo revealed a wealth of anti-microbial cyclopeptides from food that survive the complete human gastrointestinal tract, raising the question of how these cyclopeptides might affect the human microbiome.</description><published>1547625600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/521872v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1685759e88f:3db9a38:8675cc2c</id><title>De Novo Peptide Sequencing Reveals a Vast Cyclopeptidome in Human Gut and Other Environments [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/16/521872</canonicalUrl></item><item><unread>True</unread><engagement>0</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><author><name>Degroot, D.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>28c71bb0</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/37?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/37?rss=1</originId><published>1546540591000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/37?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3c3:ad2b6584</id><title>A military alliance goes green</title><canonicalUrl>http://science.sciencemag.org/content/363/6422/37.full</canonicalUrl></item><item><crawled>1548770522424</crawled><engagementRate>0.13</engagementRate><engagement>2</engagement><unread>True</unread><link>http://blogs.sciencemag.org/pipeline/?p=14134</link><commonTopics><item><label>chemistry</label><id>nlp/f/topic/437</id><probability>1.0</probability></item><item><label>drug discovery</label><id>nlp/f/topic/697</id><probability>0.989</probability></item><item><label>rsc</label><id>nlp/f/topic/1967</id><probability>0.988</probability></item><item><label>pharma</label><id>nlp/f/topic/1734</id><probability>0.838</probability></item><item><label>acs</label><id>nlp/f/topic/26</id><probability>0.83</probability></item><item><label>biochemistry</label><id>nlp/f/topic/257</id><probability>0.76</probability></item></commonTopics><alternate><item><type>text/html</type><href>https://blogs.sciencemag.org/pipeline/archives/2019/01/29/defending-drug-synthesis</href></item></alternate><title>Defending Drug Synthesis</title><updateCount>1</updateCount><entities><item><label>Science</label><id>nlp/f/entity/en/w/Science</id><mentions><item><text>Science</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Science and Nature</label><id>nlp/f/entity/en/-/science and nature</id><mentions><item><text>Science and Nature</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Photoredox</label><id>nlp/f/entity/en/-/photoredox</id><mentions><item><text>Photoredox</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>The Importance of Synthetic Chemistry in the Pharmaceutical Industry</label><id>nlp/f/entity/en/-/the importance of synthetic chemistry in the pharmaceutical industry</id><mentions><item><text>The Importance of Synthetic Chemistry in the Pharmaceutical Industry</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Hoffmann-La Roche</label><id>nlp/f/entity/en/w/Hoffmann-La Roche</id><mentions><item><text>Roche</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><origin><htmlUrl>https://blogs.sciencemag.org/pipeline</htmlUrl><streamId>feed/http://blogs.sciencemag.org/pipeline/feed</streamId><title>Sciencemag</title></origin><published>1548770397000</published><fingerprint>f6f9703d</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><content><content>&lt;p&gt;&lt;a href=&quot;http://science.sciencemag.org/content/363/6424/eaat0805&quot;&gt;This article&lt;/a&gt; from &lt;em&gt;Science&lt;/em&gt; is a good look at the scientific state of organic synthesis in the pharmaceutical industry. It covers a range of topics which will be familiar to regular readers of this blog as well: synthetic advances such as late-stage functionalization, new bond-forming techniques (photoredox chemistry in particular), the intersection of biomolecules with synthetic chemistry (both engineered enzymes as reagents and the use of organic chemistry on other biomolecules in turn), high-throughput experimentation for discovery of both new analogs and new reactions, and others. These are all solid topics and definitely represent where organic synthesis is in drug discovery, and I would particularly recommend the article to academic chemists who’d like to know what’s going on in this side of the business.&lt;/p&gt;
&lt;p&gt;Reading through the paper and thinking about the times I’ve written about these topics, though, it occurred to me that not one of them has come up without some grumbling in the comments section here – grumbling, it must be noted, from some chemists in the audience themselves. Photoredox is a prime example – I don’t think I’ve written about it once over the last few years without at least a few orange peels, beer bottles, and half-eaten hot dog buns descending from the stands. Comments get made about “it’s all a bunch of stuff to get into &lt;em&gt;Science&lt;/em&gt; and &lt;em&gt;Nature&lt;/em&gt;“, or how it’s just an academic toy, or it will never be actually useful, or a sort of general sense that isn’t it awful that people do this stuff instead of &lt;em&gt;real&lt;/em&gt; chemistry? Meanwhile, other chemists have been quietly taking it up, and it’s now used all the way up to large scale because it allows for bond formations that you just can’t get anywhere else. That’s going to continue, too, because new reactions just keep getting discovered.&lt;/p&gt;
&lt;p&gt;Now, blog comments are hardly representative of an entire field (the great majority of readers here never comment at all). And the ticked-off commenters aren’t even representative of the comments section in general, but they’re always present. My own take is that it’s a longing for How Things Used to Be, and that’s only partly for the chemistry of yore. Everyone has their own idea of when the Old Days were, but in general it apparently was the time when lots of real analogs and real SAR compounds were made with real chemistry. . .by lots of real chemists. And I think that last part is a key. People remember days when chemistry departments were larger, and somehow felt more central to the whole business, and employment in them was easier to obtain and easier to hold on to. That remembered era (whose doom was heralded, in retrospect, with the big Roche layoffs of 1985) gets mixed together with all its other features of the time, down to the kinds of chemistry being done. Later techniques and developments pick up a smell of outsourcing, layoffs, mergers, and job uncertainty just because of when they occurred.&lt;/p&gt;
&lt;p&gt;Now for the “centrality” part. I’ve seen a couple of comments about the &lt;em&gt;Science&lt;/em&gt; article to the effect that making the case that chemistry is important seemed a bit defensive. The paper’s title, “The Importance of Synthetic Chemistry in the Pharmaceutical Industry” does seem that way, and the first paragraph makes it explicit:&lt;/p&gt;
&lt;div title=&quot;Page 2&quot;&gt;
&lt;div&gt;
&lt;div&gt;
&lt;div&gt;
&lt;blockquote&gt;&lt;p&gt;&lt;em&gt;. . .In recent years, many pharmaceutical companies have chosen to reduce their R&amp;amp;D investment in chemistry, viewing synthetic chemistry more as a mature technology and less as a driver of innovation in drug discovery. Contrary to this opinion, we believe that excellence and innovation in synthetic chemistry continues to be critical to success in all phases of drug discovery and development.&lt;/em&gt;&lt;/p&gt;&lt;/blockquote&gt;
&lt;p&gt;Well, it’s a mature technology compared to several areas in biology, and suffers by comparison. I think one of the underlying problems, though, is &lt;a href=&quot;https://www.chemistryworld.com/opinion/what-are-the-rate-limiting-steps-in-drug-discovery/3009996.article&quot;&gt;this argument&lt;/a&gt; that I was making in &lt;em&gt;Chemistry World&lt;/em&gt;: that synthetic chemistry is rarely, if ever, a rate-determining step in drug discovery. The real killer in this business is the near-ninety-per-cent failure rate in human clinical trials, and that’s down to target selection and to toxicity. Synthetic organic chemistry doesn’t directly attack either of those; they’re tangles of complex biology that we don’t understand well enough to ameliorate yet.&lt;/p&gt;
&lt;p&gt;Chemistry has a lot of contributions to make – the &lt;em&gt;Science&lt;/em&gt; article is certainly right about that and it does a clear job of laying out the state of the art. But better, cleaner, faster ways to produce totally new types of chemical matter and to quickly home in on active, selective molecules (which is what all these synthetic advances are aiming for) . . .all of that is for naught when you find out that the mechanism of action isn’t actually enough to provide a clinical benefit. Or that it was the wrong target completely. Or that some other pathway that you’d never heard of and never thought to counterscreen against has kicked in and given you show-stopping toxicity out what was a clear blue sky. Projects have died &lt;a href=&quot;https://theplaystheblog.wordpress.com/2012/12/09/men-have-died-from-time-to-time-and-worms-have-eaten-them-but-not-for-love/&quot;&gt;from time to time&lt;/a&gt; and cost accountants have eaten them, but not for chemistry.&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</content><direction>ltr</direction></content><originId>http://blogs.sciencemag.org/pipeline/?p=14134</originId><description>This article from Science is a good look at the scientific state of organic synthesis in the pharmaceutical industry. It covers a range of topics which will be familiar to regular readers of this blog as well: synthetic advances such as late-stage functionalization, new bond-forming techniques (photoredox chemistry in particular), the intersection of biomolecules with</description><author><name>Derek Lowe</name></author><keywords><item>Chemical News</item><item>Drug Development</item><item>Drug Industry History</item></keywords><id>2k24/TFePIh3MUUJr/vqRk++EkKG/RZ2TtOvsKiJXX4=_16899eab538:32ef87:c2ce2e2e</id><recrawled>1548859785603</recrawled><summary><content>This article from Science is a good look at the scientific state of organic synthesis in the pharmaceutical industry. It covers a range of topics which will be familiar to regular readers of this blog as well: synthetic advances such as late-stage functionalization, new bond-forming techniques (photoredox chemistry in particular), the intersection of biomolecules with</content><direction>ltr</direction></summary></item><item><crawled>1546529934154</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1546473600000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Combining_Polarizable_Embedding_with_the_Frenkel_Exciton_Model_Applications_to_Absorption_Spectra_with_Overlapping_Solute-Solvent_Bands/7504697</link><originId>https://chemrxiv.org/articles/Combining_Polarizable_Embedding_with_the_Frenkel_Exciton_Model_Applications_to_Absorption_Spectra_with_Overlapping_Solute-Solvent_Bands/7504697</originId><description>Modeling of spectral properties of extended chemical systems, such as the case of a solute in a solvent, is often performed based on so-called hybrid models in which only part of the complete system is given a quantum chemical description. The remaining part of the system is represented by an embedding potential treating the environment either by a discrete or continuum model. In order to successfully make use of minimally sized quantum chemical regions, theembedding potential should represent the environment as authentic as possible. Here, the importance of exactly such an accurate description of the embedding potential is investigated by comparing the performance of the Polarizable Embedding scheme against larger sized full quantum mechanical calculations. Our main conclusion is that as long as the solute and solvent do not overlap in their absorption spectra, the Polarizable Embedding approach shows results consistent with full quantum chemical calculations. For partly overlapping absorption spectra the Polarizable Embedding approach can furthermore successfully be expanded within a Frenkel exciton approach based on only economical monomeric quantum chemical calculations. Thus, by extending the Polarizable Embedding scheme to the exciton picture it is possible to cover computations of the whole absorption spectrum andstill reduce the computational cost compared to costly cluster calculations.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Combining_Polarizable_Embedding_with_the_Frenkel_Exciton_Model_Applications_to_Absorption_Spectra_with_Overlapping_Solute-Solvent_Bands/7504697</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168145e0b4a:6871446:ad2b6584</id><title>Combining Polarizable Embedding with the Frenkel Exciton Model: Applications to Absorption Spectra with Overlapping Solute-Solvent Bands</title><fingerprint>bebf11aa</fingerprint><summary><content>Modeling of spectral properties of extended chemical systems, such as the case of a solute in a solvent, is often performed based on so-called hybrid models in which only part of the complete system is given a quantum chemical description. The remaining part of the system is represented by an embedding potential treating the environment either by a discrete or continuum model. In order to successfully make use of minimally sized quantum chemical regions, theembedding potential should represent the environment as authentic as possible. Here, the importance of exactly such an accurate description of the embedding potential is investigated by comparing the performance of the Polarizable Embedding scheme against larger sized full quantum mechanical calculations. Our main conclusion is that as long as the solute and solvent do not overlap in their absorption spectra, the Polarizable Embedding approach shows results consistent with full quantum chemical calculations. For partly overlapping absorption spectra the Polarizable Embedding approach can furthermore successfully be expanded within a Frenkel exciton approach based on only economical monomeric quantum chemical calculations. Thus, by extending the Polarizable Embedding scheme to the exciton picture it is possible to cover computations of the whole absorption spectrum andstill reduce the computational cost compared to costly cluster calculations.</content><direction>ltr</direction></summary></item><item><crawled>1547752389672</crawled><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><author><name>Welin, E. R., Ngamnithiporn, A., Klatte, M., Lapointe, G., Pototschnig, G. M., McDermott, M. S. J., Conklin, D., Gilmore, C. D., Tadross, P. M., Haley, C. K., Negoro, K., Glibstrup, E., Grünanger, C. U., Allan, K. M., Virgil, S. C., Slamon, D. J., Stoltz, B. M.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6424/270?rss=1</link><content><content>&lt;p&gt;The bis-tetrahydroisoquinoline (bis-THIQ) natural products have been studied intensively over the past four decades for their exceptionally potent anticancer activity, in addition to strong Gram-positive and Gram-negative antibiotic character. Synthetic strategies toward these complex polycyclic compounds have relied heavily on electrophilic aromatic chemistry, such as the Pictet–Spengler reaction, that mimics their biosynthetic pathways. Herein, we report an approach to two bis-THIQ natural products, jorunnamycin A and jorumycin, that instead harnesses the power of modern transition-metal catalysis for the three major bond-forming events and proceeds with high efficiency (15 and 16 steps, respectively). By breaking from biomimicry, this strategy allows for the preparation of a more diverse set of nonnatural analogs.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://science.sciencemag.org/cgi/content/short/363/6424/270?rss=1</originId><description>&lt;p&gt;The bis-tetrahydroisoquinoline (bis-THIQ) natural products have been studied intensively over the past four decades for their exceptionally potent anticancer activity, in addition to strong Gram-positive and Gram-negative antibiotic character. Synthetic strategies toward these complex polycyclic compounds have relied heavily on electrophilic aromatic chemistry, such as the Pictet–Spengler reaction, that mimics their biosynthetic pathways. Herein, we report an approach to two bis-THIQ natural products, jorunnamycin A and jorumycin, that instead harnesses the power of modern transition-metal catalysis for the three major bond-forming events and proceeds with high efficiency (15 and 16 steps, respectively). By breaking from biomimicry, this strategy allows for the preparation of a more diverse set of nonnatural analogs.&lt;/p&gt;</description><canonicalUrl>http://science.sciencemag.org/content/363/6424/270.full</canonicalUrl><published>1547750305000</published><keywords><item>Chemistry</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/270?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce076:ad2b6584</id><title>Concise total syntheses of (-)-jorunnamycin A and (-)-jorumycin enabled by asymmetric catalysis</title><fingerprint>42f90ad3</fingerprint></item><item><entities><item><label>UC</label><id>nlp/f/entity/en/-/uc</id><mentions><item><text>UC</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>CRISPR</label><id>nlp/f/entity/en/w/CRISPR</id><mentions><item><text>CRISPR</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id><mentions><item><text>CSS</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id><mentions><item><text>WEBSITEnature_com</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id><mentions><item><text>Explorer</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546530511732</crawled><visual><url>none</url></visual><author><name>Charlotte Harrison</name></author><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><link>https://www.nature.com/articles/nbt0119-6</link><content><content>&lt;p&gt;&lt;b&gt;UC&apos;s latest CRISPR patent&lt;/b&gt;&lt;/p&gt;&lt;p&gt;UC&apos;s latest CRISPR patent, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt0119-6&quot;&gt;doi:10.1038/nbt0119-6&lt;/a&gt;&lt;/p&gt;UC&apos;s latest CRISPR patent</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/nbt0119-6</originId><description>&lt;p&gt;&lt;b&gt;UC&apos;s latest CRISPR patent&lt;/b&gt;&lt;/p&gt;&lt;p&gt;UC&apos;s latest CRISPR patent, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt0119-6&quot;&gt;doi:10.1038/nbt0119-6&lt;/a&gt;&lt;/p&gt;UC&apos;s latest CRISPR patent</description><published>1546502400000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/nbt0119-6</href></item></alternate><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_1681466db74:68a3830:3a104d3b</id><title>UC&apos;s latest CRISPR patent</title><fingerprint>e2fc7c99</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36426-9</href></item></canonical><engagement>0</engagement><crawled>1547201635151</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>César Parra-Rojas</name></author><visual><height>572</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36426-9/MediaObjects/41598_2018_36426_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36426-9</link><content><content>&lt;p&gt;&lt;b&gt;Adjuvanted influenza vaccine dynamics&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Adjuvanted influenza vaccine dynamics, Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36426-9&quot;&gt;doi:10.1038/s41598-018-36426-9&lt;/a&gt;&lt;/p&gt;Adjuvanted influenza vaccine dynamics&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/4jgzlbl9gv0&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36426-9</originId><description>&lt;p&gt;&lt;b&gt;Adjuvanted influenza vaccine dynamics&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Adjuvanted influenza vaccine dynamics, Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36426-9&quot;&gt;doi:10.1038/s41598-018-36426-9&lt;/a&gt;&lt;/p&gt;Adjuvanted influenza vaccine dynamics&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/4jgzlbl9gv0&quot; height=&quot;1&quot;&gt;</description><published>1547193600000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/4jgzlbl9gv0/s41598-018-36426-9</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1683c67634f:19fe6b9:8675cc2c</id><title>Adjuvanted influenza vaccine dynamics</title><fingerprint>5745fd9f</fingerprint></item><item><engagement>13</engagement><crawled>1547665791807</crawled><visual><url>none</url></visual><author><name>Chonghaile, T. N.</name></author><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/475/eaaw5311?rss=1</link><content><content>&lt;p&gt;Specific MCL-1 inhibitor kills multiple myeloma and acute myeloid leukemia cells.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/475/eaaw5311?rss=1</originId><description>&lt;p&gt;Specific MCL-1 inhibitor kills multiple myeloma and acute myeloid leukemia cells.&lt;/p&gt;</description><canonicalUrl>http://stm.sciencemag.org/content/11/475/eaaw5311.full</canonicalUrl><published>1547664692000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/475/eaaw5311?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1685811db3f:3e2669a:3a104d3b</id><title>[Editors&apos; Choice] BH3 mimetics: Weapons of cancer cell destruction</title><fingerprint>dc6070b</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36909-9</href></item></canonical><engagement>8</engagement><crawled>1548238772764</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Antonia Rujia Sun</name></author><visual><height>616</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36909-9/MediaObjects/41598_2018_36909_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36909-9</link><content><content>&lt;p&gt;&lt;b&gt;Pro-resolving lipid mediator ameliorates obesity induced osteoarthritis by regulating synovial macrophage polarisation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Pro-resolving lipid mediator ameliorates obesity induced osteoarthritis by regulating synovial macrophage polarisation, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36909-9&quot;&gt;doi:10.1038/s41598-018-36909-9&lt;/a&gt;&lt;/p&gt;Pro-resolving lipid mediator ameliorates obesity induced osteoarthritis by regulating synovial macrophage polarisation&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/4a3cNSCPN2A&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36909-9</originId><description>&lt;p&gt;&lt;b&gt;Pro-resolving lipid mediator ameliorates obesity induced osteoarthritis by regulating synovial macrophage polarisation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Pro-resolving lipid mediator ameliorates obesity induced osteoarthritis by regulating synovial macrophage polarisation, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36909-9&quot;&gt;doi:10.1038/s41598-018-36909-9&lt;/a&gt;&lt;/p&gt;Pro-resolving lipid mediator ameliorates obesity induced osteoarthritis by regulating synovial macrophage polarisation&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/4a3cNSCPN2A&quot; height=&quot;1&quot;&gt;</description><published>1548230400000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/4a3cNSCPN2A/s41598-018-36909-9</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1687a38da1c:2c4c17e:3a104d3b</id><title>Pro-resolving lipid mediator ameliorates obesity induced osteoarthritis by regulating synovial macrophage polarisation</title><fingerprint>f7da4ecb</fingerprint></item><item><engagement>0</engagement><crawled>1546983311492</crawled><visual><url>none</url></visual><author><name>Soyoung E. Seo, Martin Girard, Monica Olvera de la Cruz, Chad A. Mirkin</name></author><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acscii</streamId><title>ACS Central Science: Latest Articles (ACS Publications)</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acscentsci.8b00826</link><originId>http://dx.doi.org/10.1021/acscentsci.8b00826</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00826/20190108/images/medium/oc-2018-00826z_0005.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00826&lt;/div&gt;</description><published>1546923600000</published><alternate><item><type>text/html</type><href>http://dx.doi.org/10.1021/acscentsci.8b00826</href></item></alternate><id>1TYkl+7D2jbCAjv6kqe9qy39+K76tsp7YKV/mQVt7ps=_1682f640884:682b2f:b77f238b</id><title>[ASAP] The Importance of Salt-Enhanced Electrostatic Repulsion in Colloidal Crystal Engineering with DNA</title><fingerprint>6508dba1</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acscii/0/acscii.ahead-of-print/acscentsci.8b00826/20190108/images/medium/oc-2018-00826z_0005.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Central Science&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acscentsci.8b00826&lt;/div&gt;</content><direction>ltr</direction></summary></item><item><entities><item><label>Anna Balazs</label><id>nlp/f/entity/en/-/anna balazs</id><mentions><item><text>Anna Balazs</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>University of Pittsburgh</label><id>nlp/f/entity/en/w/University of Pittsburgh</id><mentions><item><text>University of Pittsburgh</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Pennsylvania</label><id>nlp/f/entity/en/w/Pennsylvania</id><mentions><item><text>Pennsylvania</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547482794053</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00134-9/d41586-019-00134-9_16391972.jpg</url></visual><published>1547452800000</published><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00134-9</link><content><content>&lt;p&gt;&lt;b&gt;City gardens are a boon for threatened bees&lt;/b&gt;&lt;/p&gt;&lt;p&gt;City gardens are a boon for threatened bees, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00134-9&quot;&gt;doi:10.1038/d41586-019-00134-9&lt;/a&gt;&lt;/p&gt;Expanding allotment space and allowing weeds to grow in public parks could help city pollinators to thrive.</content><direction>ltr</direction></content><commonTopics><item><label>robotics</label><id>nlp/f/topic/1955</id><probability>0.964</probability></item><item><label>swimming</label><id>nlp/f/topic/2220</id><probability>0.862</probability></item><item><label>biochemistry</label><id>nlp/f/topic/257</id><probability>0.843</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00134-9</originId><description>&lt;p&gt;&lt;b&gt;City gardens are a boon for threatened bees&lt;/b&gt;&lt;/p&gt;&lt;p&gt;City gardens are a boon for threatened bees, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00134-9&quot;&gt;doi:10.1038/d41586-019-00134-9&lt;/a&gt;&lt;/p&gt;Expanding allotment space and allowing weeds to grow in public parks could help city pollinators to thrive.</description><author><name>NA</name></author><engagement>11</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00134-9</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1684d298845:2e7a786:8675cc2c</id><title>City gardens are a boon for threatened bees</title><fingerprint>123c6e15</fingerprint></item><item><unread>True</unread><engagement>22</engagement><crawled>1547147463250</crawled><visual><url>none</url></visual><author><name>Smith, H. J.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>5e8a7b2e</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6423/138-a?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6423/138-a?rss=1</originId><published>1547145461000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/138-a?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708a2:8675cc2c</id><title>The meteorological future is here</title><canonicalUrl>http://science.sciencemag.org/content/363/6423/138.1.full</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0324-z</href></item></canonical><entities><item><label>C. R.</label><id>nlp/f/entity/en/-/c. r.</id><mentions><item><text>C. R.</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>John Milton</label><id>nlp/f/entity/en/w/John Milton</id><mentions><item><text>J.</text></item><item><text>J. M.</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>S. et al</label><id>nlp/f/entity/en/-/s. et al</id><mentions><item><text>S. et al</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>National Academies</label><id>nlp/f/entity/en/-/national academies</id><mentions><item><text>National Academies</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Sicherer</label><id>nlp/f/entity/en/-/sicherer</id><mentions><item><text>Sicherer</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547482787868</crawled><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><author><name>Taylor Feehley</name></author><visual><height>168</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0324-z/MediaObjects/41591_2018_324_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41591-018-0324-z</link><content><content>&lt;p&gt;&lt;b&gt;Healthy infants harbor intestinal bacteria that protect against food allergy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Healthy infants harbor intestinal bacteria that protect against food allergy, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0324-z&quot;&gt;doi:10.1038/s41591-018-0324-z&lt;/a&gt;&lt;/p&gt;Specific members of the gut microbiota are critical for regulating allergic responses to dietary antigens.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/6pH9ZeAEJkw&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.982</probability></item><item><label>classics</label><id>nlp/f/topic/477</id><probability>0.978</probability></item><item><label>allergy</label><id>nlp/f/topic/77</id><probability>0.968</probability></item><item><label>bioinformatics</label><id>nlp/f/topic/262</id><probability>0.942</probability></item><item><label>brain</label><id>nlp/f/topic/314</id><probability>0.941</probability></item><item><label>emergency medicine</label><id>nlp/f/topic/764</id><probability>0.894</probability></item><item><label>rationality</label><id>nlp/f/topic/1895</id><probability>0.876</probability></item><item><label>mp3</label><id>nlp/f/topic/1508</id><probability>0.852</probability></item><item><label>ecology</label><id>nlp/f/topic/725</id><probability>0.851</probability></item><item><label>data science</label><id>nlp/f/topic/618</id><probability>0.781</probability></item></commonTopics><originId>https://www.nature.com/articles/s41591-018-0324-z</originId><description>&lt;p&gt;&lt;b&gt;Healthy infants harbor intestinal bacteria that protect against food allergy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Healthy infants harbor intestinal bacteria that protect against food allergy, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0324-z&quot;&gt;doi:10.1038/s41591-018-0324-z&lt;/a&gt;&lt;/p&gt;Specific members of the gut microbiota are critical for regulating allergic responses to dietary antigens.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/6pH9ZeAEJkw&quot; height=&quot;1&quot;&gt;</description><published>1547452800000</published><engagement>19</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/6pH9ZeAEJkw/s41591-018-0324-z</href></item></alternate><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_1684d29701c:2d435a6:c2ce2e2e</id><title>Healthy infants harbor intestinal bacteria that protect against food allergy</title><fingerprint>67626f2a</fingerprint></item><item><crawled>1546452174256</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1546387200000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Computational_Insights_into_the_Mechanism_of_the_Selective_Catalytic_Reduction_of_NOx_Fe-_Versus_Cu-Doped_Zeolite_Catalysts/7538720</link><originId>https://chemrxiv.org/articles/Computational_Insights_into_the_Mechanism_of_the_Selective_Catalytic_Reduction_of_NOx_Fe-_Versus_Cu-Doped_Zeolite_Catalysts/7538720</originId><description>We computationally investigate the mechanism of the reduction half-cycle of the
selective catalytic reduction (SCR) of nitrogen oxides with ammonia. We compare
both Fe- and Cu-doped zeolite catalysts and aim at exploring all accessible reaction
pathways. From our calculations, a comprehensive picture emerges that unifies sev-
eral previous mechanistic proposals. We find that both for Fe and for Cu catalysts,
different reaction pathways are feasible, but some of the possible reaction pathways
differ in these two cases. Our computational results provide a basis for the inter-
pretation of in situ spectroscopic investigations that can possibly distinguish the
different mechanistic pathways.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Computational_Insights_into_the_Mechanism_of_the_Selective_Catalytic_Reduction_of_NOx_Fe-_Versus_Cu-Doped_Zeolite_Catalysts/7538720</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1680fbb85b0:615f867:c2ce2e2e</id><title>Computational Insights into the Mechanism of the Selective Catalytic Reduction of NOx: Fe- Versus Cu-Doped Zeolite Catalysts</title><fingerprint>e0d17cc7</fingerprint><summary><content>We computationally investigate the mechanism of the reduction half-cycle of the
selective catalytic reduction (SCR) of nitrogen oxides with ammonia. We compare
both Fe- and Cu-doped zeolite catalysts and aim at exploring all accessible reaction
pathways. From our calculations, a comprehensive picture emerges that unifies sev-
eral previous mechanistic proposals. We find that both for Fe and for Cu catalysts,
different reaction pathways are feasible, but some of the possible reaction pathways
differ in these two cases. Our computational results provide a basis for the inter-
pretation of in situ spectroscopic investigations that can possibly distinguish the
different mechanistic pathways.</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36506-w</href></item></canonical><engagement>0</engagement><crawled>1548412119508</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Henri J. van de Vrugt</name></author><visual><height>474</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36506-w/MediaObjects/41598_2018_36506_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36506-w</link><content><content>&lt;p&gt;&lt;b&gt;Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36506-w&quot;&gt;doi:10.1038/s41598-018-36506-w&lt;/a&gt;&lt;/p&gt;Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Yf5HDondyf8&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36506-w</originId><description>&lt;p&gt;&lt;b&gt;Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair, Published online: 25 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36506-w&quot;&gt;doi:10.1038/s41598-018-36506-w&lt;/a&gt;&lt;/p&gt;Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Yf5HDondyf8&quot; height=&quot;1&quot;&gt;</description><published>1548403200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/Yf5HDondyf8/s41598-018-36506-w</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168848de9d4:3bb2479:ad2b6584</id><title>Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair</title><fingerprint>def953ed</fingerprint></item><item><engagement>194</engagement><crawled>1547147463250</crawled><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><author><name>Yano, K., Itoh, Y., Araoka, F., Watanabe, G., Hikima, T., Aida, T.</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6423/161?rss=1</link><content><content>&lt;p&gt;Disk- and rod-shaped molecules are incompatible in coassembly, as the former tend to stack one-dimensionally whereas the latter tend to align in parallel. Because this type of incompatibility can be more pronounced in condensed phases, different-shaped molecules generally exclude one another. We report that supramolecular polymerization of a disk-shaped chiral monomer in nematic liquid crystals comprising rod-shaped molecules results in order-increasing mesophase transition into a single mesophase with a core-shell columnar geometry. This liquid crystalline material responds quickly to an applied electric field, resulting in unidirectional columnar ordering. Moreover, it can be modularly customized to be optoelectrically responsive simply by using a photoisomerizable rod-shaped module. The modular strategy allows for cooperative integration of different functions into elaborate dynamic architectures.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://science.sciencemag.org/cgi/content/short/363/6423/161?rss=1</originId><description>&lt;p&gt;Disk- and rod-shaped molecules are incompatible in coassembly, as the former tend to stack one-dimensionally whereas the latter tend to align in parallel. Because this type of incompatibility can be more pronounced in condensed phases, different-shaped molecules generally exclude one another. We report that supramolecular polymerization of a disk-shaped chiral monomer in nematic liquid crystals comprising rod-shaped molecules results in order-increasing mesophase transition into a single mesophase with a core-shell columnar geometry. This liquid crystalline material responds quickly to an applied electric field, resulting in unidirectional columnar ordering. Moreover, it can be modularly customized to be optoelectrically responsive simply by using a photoisomerizable rod-shaped module. The modular strategy allows for cooperative integration of different functions into elaborate dynamic architectures.&lt;/p&gt;</description><canonicalUrl>http://science.sciencemag.org/content/363/6423/161.full</canonicalUrl><published>1547145461000</published><keywords><item>Chemistry, Materials Science</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/161?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:1570896:8675cc2c</id><title>Nematic-to-columnar mesophase transition by in situ supramolecular polymerization</title><fingerprint>2af3b3a1</fingerprint></item><item><entities><item><label>Julie Gould</label><id>nlp/f/entity/en/-/julie gould</id><mentions><item><text>Julie Gould</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Elizabeth Pier</label><id>nlp/f/entity/en/-/elizabeth pier</id><mentions><item><text>Elizabeth</text></item><item><text>Elizabeth Pier</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Anne Marie Coriat</label><id>nlp/f/entity/en/-/anne marie coriat</id><mentions><item><text>Anne Marie Coriat</text></item><item><text>Anne Marie</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>ERC</label><id>nlp/f/entity/en/-/erc</id><mentions><item><text>ERC</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Peter Gorsuch</label><id>nlp/f/entity/en/-/peter gorsuch</id><mentions><item><text>Peter</text></item><item><text>Peter Gorsuch</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547198336489</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00103-2/d41586-019-00103-2_16389468.jpg</url></visual><author><name>Julie Gould</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00103-2</link><content><content>&lt;p&gt;&lt;b&gt;Working Scientist podcast: How to plan a successful grant application &lt;/b&gt;&lt;/p&gt;&lt;p&gt;Working Scientist podcast: How to plan a successful grant application , Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00103-2&quot;&gt;doi:10.1038/d41586-019-00103-2&lt;/a&gt;&lt;/p&gt;Julie Gould investigates the importance of advance planning when you&apos;re preparing a funding application.</content><direction>ltr</direction></content><commonTopics><item><label>academic</label><id>nlp/f/topic/17</id><probability>0.791</probability></item><item><label>science policy</label><id>nlp/f/topic/2019</id><probability>0.773</probability></item><item><label>lifestyle</label><id>nlp/f/topic/1339</id><probability>0.726</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00103-2</originId><description>&lt;p&gt;&lt;b&gt;Working Scientist podcast: How to plan a successful grant application &lt;/b&gt;&lt;/p&gt;&lt;p&gt;Working Scientist podcast: How to plan a successful grant application , Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00103-2&quot;&gt;doi:10.1038/d41586-019-00103-2&lt;/a&gt;&lt;/p&gt;Julie Gould investigates the importance of advance planning when you&apos;re preparing a funding application.</description><published>1547193600000</published><engagement>23</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00103-2</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1683c350de9:18f329c:c2ce2e2e</id><title>Working Scientist podcast: How to plan a successful grant application</title><fingerprint>16728149</fingerprint></item><item><entities><item><label>Bristol-Myers Squibb</label><id>nlp/f/entity/en/w/Bristol-Myers Squibb</id><mentions><item><text>Bristol - Myers Squibb</text></item><item><text>Giovanni Caforio</text></item><item><text>BMS</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Celgene</label><id>nlp/f/entity/en/w/Celgene</id><mentions><item><text>Celgene</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Lenalidomide</label><id>nlp/f/entity/en/w/Lenalidomide</id><mentions><item><text>lenalidomide</text></item><item><text>Revlimid</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Nivolumab</label><id>nlp/f/entity/en/w/Nivolumab</id><mentions><item><text>nivolumab</text></item><item><text>Opdivo</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Chimeric antigen receptor</label><id>nlp/f/entity/en/w/Chimeric antigen receptor</id><mentions><item><text>CAR - T</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546963668138</crawled><visual><url>none</url></visual><author><name>Chris Morrison</name></author><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><link>https://www.nature.com/articles/d41587-019-00003-w</link><content><content>&lt;p&gt;&lt;b&gt;Biotech shockwaves follow BMS’s $74 billion Celgene buyout&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Biotech shockwaves follow BMS’s $74 billion Celgene buyout, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41587-019-00003-w&quot;&gt;doi:10.1038/d41587-019-00003-w&lt;/a&gt;&lt;/p&gt;An oncology behemoth is born but small biotechs lose an active acquirer and alliance maker</content><direction>ltr</direction></content><commonTopics><item><label>pharma</label><id>nlp/f/topic/1734</id><probability>0.99</probability></item><item><label>ma</label><id>nlp/f/topic/1376</id><probability>0.803</probability></item></commonTopics><originId>https://www.nature.com/articles/d41587-019-00003-w</originId><description>&lt;p&gt;&lt;b&gt;Biotech shockwaves follow BMS’s $74 billion Celgene buyout&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Biotech shockwaves follow BMS’s $74 billion Celgene buyout, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41587-019-00003-w&quot;&gt;doi:10.1038/d41587-019-00003-w&lt;/a&gt;&lt;/p&gt;An oncology behemoth is born but small biotechs lose an active acquirer and alliance maker</description><published>1546934400000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41587-019-00003-w</href></item></alternate><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_1682e384caa:488229:c2ce2e2e</id><title>Biotech shockwaves follow BMS’s $74 billion Celgene buyout</title><fingerprint>607ed173</fingerprint></item><item><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Yeston, J.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-p?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-p?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.16.full</canonicalUrl><published>1548355045000</published><keywords><item>Chemistry</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-p?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a71:c2ce2e2e</id><title>Attack from the front</title><fingerprint>122afee8</fingerprint></item><item><crawled>1548875250003</crawled><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><author><name>Berkhout, L. C., lAmi, M. J., Ruwaard, J., Hart, M. H., Heer, P. O.-d., Bloem, K., Nurmohamed, M. T., van Vollenhoven, R. F., Boers, M., Alvarez, D. F., Smith, C. H., Wolbink, G. J., Rispens, T.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/477/eaat3356?rss=1</link><content><content>&lt;p&gt;Patients with rheumatoid arthritis (RA) can be successfully treated with tumor necrosis factor (TNF) inhibitors, including the monoclonal antibody adalimumab. Once in remission, a proportion of patients can successfully discontinue treatment, indicating that blocking TNF is no longer required for disease control. To explore the dynamics of circulating TNF during adalimumab treatment, we developed a competition enzyme-linked immunosorbent assay that can quantify TNF in the presence of large amounts of TNF inhibitor, i.e., a &amp;quot;drug-tolerant&amp;quot; assay. In 193 consecutive adalimumab-treated patients with RA, we demonstrated that circulating TNF increased in average of &gt;50-fold upon treatment and reached a stable concentration in time for most patients. A similar increase in TNF was found in 30 healthy volunteers after one dose of adalimumab. This implies that TNF in circulation during anti-TNF treatment is not primarily associated with disease activity. During treatment, TNF was in complex with adalimumab and could be recovered as inactive 3:1 adalimumab-TNF complexes. No quantitative association was found between TNF and adalimumab concentrations. Low TNF concentrations at week 4 were associated with a higher frequency of antidrug antibodies (ADAs) at subsequent time points, less frequent methotrexate use at baseline, and less frequent remission after 52 weeks. Also in healthy volunteers, early low TNF concentrations are associated with ADAs. In conclusion, longitudinal TNF concentrations are mostly stable during adalimumab treatment and may therefore not predict successful treatment discontinuation. However, early low TNF is strongly associated with ADA formation and may be used as timely predictor of nonresponse toward adalimumab treatment.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/477/eaat3356?rss=1</originId><description>&lt;p&gt;Patients with rheumatoid arthritis (RA) can be successfully treated with tumor necrosis factor (TNF) inhibitors, including the monoclonal antibody adalimumab. Once in remission, a proportion of patients can successfully discontinue treatment, indicating that blocking TNF is no longer required for disease control. To explore the dynamics of circulating TNF during adalimumab treatment, we developed a competition enzyme-linked immunosorbent assay that can quantify TNF in the presence of large amounts of TNF inhibitor, i.e., a &amp;quot;drug-tolerant&amp;quot; assay. In 193 consecutive adalimumab-treated patients with RA, we demonstrated that circulating TNF increased in average of &gt;50-fold upon treatment and reached a stable concentration in time for most patients. A similar increase in TNF was found in 30 healthy volunteers after one dose of adalimumab. This implies that TNF in circulation during anti-TNF treatment is not primarily associated with disease activity. During treatment, TNF was in complex with adalimumab and could be recovered as inactive 3:1 adalimumab-TNF complexes. No quantitative association was found between TNF and adalimumab concentrations. Low TNF concentrations at week 4 were associated with a higher frequency of antidrug antibodies (ADAs) at subsequent time points, less frequent methotrexate use at baseline, and less frequent remission after 52 weeks. Also in healthy volunteers, early low TNF concentrations are associated with ADAs. In conclusion, longitudinal TNF concentrations are mostly stable during adalimumab treatment and may therefore not predict successful treatment discontinuation. However, early low TNF is strongly associated with ADA formation and may be used as timely predictor of nonresponse toward adalimumab treatment.&lt;/p&gt;</description><published>1548874208000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/477/eaat3356?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_168a028b953:cc8920:3a104d3b</id><title>[Research Articles] Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay</title><fingerprint>16ef121f</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Alderton, G.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>7c205a5b</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-r?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-r?rss=1</originId><published>1548355045000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-r?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a6f:c2ce2e2e</id><title>Biomaterials in tissue repair</title><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.18.full</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41573-018-0009-9</href></item></canonical><entities><item><label>X</label><id>nlp/f/entity/en/-/x</id><mentions><item><text>X</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>O</label><id>nlp/f/entity/en/-/o</id><mentions><item><text>O</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Nat</label><id>nlp/f/entity/en/-/nat</id><mentions><item><text>Nat</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Proc</label><id>nlp/f/entity/en/-/proc</id><mentions><item><text>Proc</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>R.</label><id>nlp/f/entity/en/-/r.</id><mentions><item><text>R.</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548328056878</crawled><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><author><name>Joseph H. Nadeau</name></author><visual><height>365</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41573-018-0009-9/MediaObjects/41573_2018_9_Figa_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41573-018-0009-9</link><content><content>&lt;p&gt;&lt;b&gt;The virtuous cycle of human genetics and mouse models in drug discovery&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The virtuous cycle of human genetics and mouse models in drug discovery, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41573-018-0009-9&quot;&gt;doi:10.1038/s41573-018-0009-9&lt;/a&gt;&lt;/p&gt;Understanding the genetic and phenotypic architecture of health and disease is vital to the identification of novel therapeutic targets and therapies. Here, Nadeau and Auwerx review the fundamentals of genotype–phenotype relations in mouse models and discuss how the integration of human and mouse genetic research remains essential to understanding disease pathogenesis, identifying potential therapeutic targets and developing new therapies&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/fNuzybtkZZI&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>cell</label><id>nlp/f/topic/403</id><probability>1.0</probability></item><item><label>brain</label><id>nlp/f/topic/314</id><probability>1.0</probability></item><item><label>genetics</label><id>nlp/f/topic/955</id><probability>0.998</probability></item><item><label>stem cells</label><id>nlp/f/topic/2185</id><probability>0.996</probability></item><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.98</probability></item><item><label>neuroscience</label><id>nlp/f/topic/1565</id><probability>0.978</probability></item><item><label>pharmacology</label><id>nlp/f/topic/1735</id><probability>0.966</probability></item><item><label>hbd</label><id>nlp/f/topic/1042</id><probability>0.889</probability></item><item><label>neurology</label><id>nlp/f/topic/1563</id><probability>0.879</probability></item><item><label>ecology</label><id>nlp/f/topic/725</id><probability>0.834</probability></item></commonTopics><originId>https://www.nature.com/articles/s41573-018-0009-9</originId><description>&lt;p&gt;&lt;b&gt;The virtuous cycle of human genetics and mouse models in drug discovery&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The virtuous cycle of human genetics and mouse models in drug discovery, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41573-018-0009-9&quot;&gt;doi:10.1038/s41573-018-0009-9&lt;/a&gt;&lt;/p&gt;Understanding the genetic and phenotypic architecture of health and disease is vital to the identification of novel therapeutic targets and therapies. Here, Nadeau and Auwerx review the fundamentals of genotype–phenotype relations in mouse models and discuss how the integration of human and mouse genetic research remains essential to understanding disease pathogenesis, identifying potential therapeutic targets and developing new therapies&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/fNuzybtkZZI&quot; height=&quot;1&quot;&gt;</description><published>1548316800000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/fNuzybtkZZI/s41573-018-0009-9</href></item></alternate><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_1687f8b382e:335e325:c2ce2e2e</id><title>The virtuous cycle of human genetics and mouse models in drug discovery</title><fingerprint>bec028d2</fingerprint></item><item><crawled>1548822666211</crawled><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><author><name>Clarke, E. L.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/326363v4?rss=1</link><content><content>Background: Analysis of mixed microbial communities using metagenomic sequencing experiments requires multiple preprocessing and analytical steps to interpret the microbial and genetic composition of samples. Analytical steps include quality control, adapter trimming, host decontamination, metagenomic classification, read assembly, and alignment to reference genomes. Results: We present a modular and user-extensible pipeline called Sunbeam that performs these steps in a consistent and reproducible fashion. It can be installed in a single step, does not require administrative access to the host computer system, and can work with most cluster computing frameworks. We also introduce Komplexity, a software tool to eliminate potentially problematic, low-complexity nucleotide sequences from metagenomic data. Unique components of the Sunbeam pipeline include direct analysis of data from NCBI SRA and an easy-to-use extension framework that enables users to add custom processing or analysis steps directly to the workflow. The pipeline and its extension framework are well documented, in routine use, and regularly updated. Conclusions: Sunbeam provides a foundation to build more in-depth analyses and to enable comparisons in metagenomic sequencing experiments by removing problematic low complexity reads and standardizing post-processing and analytical steps. Sunbeam is written in Python using the Snakemake workflow management software and is freely available at github.com/sunbeam-labs/sunbeam under the GPLv3.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/326363v4?rss=1</originId><description>Background: Analysis of mixed microbial communities using metagenomic sequencing experiments requires multiple preprocessing and analytical steps to interpret the microbial and genetic composition of samples. Analytical steps include quality control, adapter trimming, host decontamination, metagenomic classification, read assembly, and alignment to reference genomes. Results: We present a modular and user-extensible pipeline called Sunbeam that performs these steps in a consistent and reproducible fashion. It can be installed in a single step, does not require administrative access to the host computer system, and can work with most cluster computing frameworks. We also introduce Komplexity, a software tool to eliminate potentially problematic, low-complexity nucleotide sequences from metagenomic data. Unique components of the Sunbeam pipeline include direct analysis of data from NCBI SRA and an easy-to-use extension framework that enables users to add custom processing or analysis steps directly to the workflow. The pipeline and its extension framework are well documented, in routine use, and regularly updated. Conclusions: Sunbeam provides a foundation to build more in-depth analyses and to enable comparisons in metagenomic sequencing experiments by removing problematic low complexity reads and standardizing post-processing and analytical steps. Sunbeam is written in Python using the Snakemake workflow management software and is freely available at github.com/sunbeam-labs/sunbeam under the GPLv3.</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/326363v4?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689d065be3:7e7a31:3a104d3b</id><title>Sunbeam: an extensible pipeline for analyzing metagenomic sequencing experiments [NEW RESULTS]</title><fingerprint>7c500cb0</fingerprint></item><item><entities><item><label>United Kingdom</label><id>nlp/f/entity/en/w/United Kingdom</id><mentions><item><text>UK</text></item><item><text>United Kingdom</text></item><item><text>Britain</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>European Union</label><id>nlp/f/entity/en/w/European Union</id><mentions><item><text>EU</text></item><item><text>European Union</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Brexit</label><id>nlp/f/entity/en/w/Brexit</id><mentions><item><text>Brexit</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Russell Group</label><id>nlp/f/entity/en/w/Russell Group</id><mentions><item><text>Russell Group</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Shutterstock</label><id>nlp/f/entity/en/w/Shutterstock</id><mentions><item><text>Shutterstock</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548257899528</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00240-8/d41586-019-00240-8_16408684.jpg</url></visual><author><name>Declan Butler</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00240-8</link><content><content>&lt;p&gt;&lt;b&gt;Number of EU research students in Britain drops from pre-referendum high&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Number of EU research students in Britain drops from pre-referendum high, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00240-8&quot;&gt;doi:10.1038/d41586-019-00240-8&lt;/a&gt;&lt;/p&gt;Downward trend in postgraduate enrolment stokes fears of a brain drain in the country&apos;s pipeline of promising young scientists.</content><direction>ltr</direction></content><commonTopics><item><label>science policy</label><id>nlp/f/topic/2019</id><probability>0.997</probability></item><item><label>academic</label><id>nlp/f/topic/17</id><probability>0.995</probability></item><item><label>higher ed</label><id>nlp/f/topic/1063</id><probability>0.993</probability></item><item><label>phd</label><id>nlp/f/topic/1737</id><probability>0.942</probability></item><item><label>university</label><id>nlp/f/topic/2378</id><probability>0.939</probability></item><item><label>research</label><id>nlp/f/topic/1931</id><probability>0.915</probability></item><item><label>europe</label><id>nlp/f/topic/807</id><probability>0.905</probability></item><item><label>market research</label><id>nlp/f/topic/1408</id><probability>0.884</probability></item><item><label>sociology</label><id>nlp/f/topic/2122</id><probability>0.837</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00240-8</originId><description>&lt;p&gt;&lt;b&gt;Number of EU research students in Britain drops from pre-referendum high&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Number of EU research students in Britain drops from pre-referendum high, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00240-8&quot;&gt;doi:10.1038/d41586-019-00240-8&lt;/a&gt;&lt;/p&gt;Downward trend in postgraduate enrolment stokes fears of a brain drain in the country&apos;s pipeline of promising young scientists.</description><published>1548230400000</published><engagement>4</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00240-8</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687b5cb408:2d57e3d:c2ce2e2e</id><title>Number of EU research students in Britain drops from pre-referendum high</title><fingerprint>3404706f</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36483-0</href></item></canonical><crawled>1548152137226</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Itxaso Montánchez</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36483-0</link><content><content>&lt;p&gt;&lt;b&gt;Analysis of &lt;i&gt;Vibrio harveyi&lt;/i&gt; adaptation in sea water microcosms at elevated temperature provides insights into the putative mechanisms of its persistence and spread in the time of global warming&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Analysis of &amp;lt;i&gt;Vibrio harveyi&amp;lt;/i&gt; adaptation in sea water microcosms at elevated temperature provides insights into the putative mechanisms of its persistence and spread in the time of global warming, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36483-0&quot;&gt;doi:10.1038/s41598-018-36483-0&lt;/a&gt;&lt;/p&gt;Analysis of &lt;i&gt;Vibrio harveyi&lt;/i&gt; adaptation in sea water microcosms at elevated temperature provides insights into the putative mechanisms of its persistence and spread in the time of global warming&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/GK8lPDv3x_s&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36483-0</originId><description>&lt;p&gt;&lt;b&gt;Analysis of &lt;i&gt;Vibrio harveyi&lt;/i&gt; adaptation in sea water microcosms at elevated temperature provides insights into the putative mechanisms of its persistence and spread in the time of global warming&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Analysis of &amp;lt;i&gt;Vibrio harveyi&amp;lt;/i&gt; adaptation in sea water microcosms at elevated temperature provides insights into the putative mechanisms of its persistence and spread in the time of global warming, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36483-0&quot;&gt;doi:10.1038/s41598-018-36483-0&lt;/a&gt;&lt;/p&gt;Analysis of &lt;i&gt;Vibrio harveyi&lt;/i&gt; adaptation in sea water microcosms at elevated temperature provides insights into the putative mechanisms of its persistence and spread in the time of global warming&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/GK8lPDv3x_s&quot; height=&quot;1&quot;&gt;</description><published>1548144000000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/GK8lPDv3x_s/s41598-018-36483-0</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_168750ee60a:23b88b8:c2ce2e2e</id><title>Analysis of Vibrio harveyi adaptation in sea water microcosms at elevated temperature provides insights into the putative mechanisms of its persistence and spread in the time of global warming</title><fingerprint>c8f8fda4</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08021-z</href></item></canonical><engagement>11</engagement><crawled>1547461729544</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Ingerid J. Hagen</name></author><visual><height>339</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08021-z/MediaObjects/41467_2018_8021_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08021-z</link><content><content>&lt;p&gt;&lt;b&gt;Supplementary stocking selects for domesticated genotypes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Supplementary stocking selects for domesticated genotypes, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08021-z&quot;&gt;doi:10.1038/s41467-018-08021-z&lt;/a&gt;&lt;/p&gt;Stocking of hatchery produced fish is widely used to supplement wild fish populations. Here, the authors show that supplementary stocking can unintentionally favour introgressed individuals with domestic genotypes and compromise the fitness of a wild population of Atlantic salmon.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/iDfCu3wFqp8&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08021-z</originId><description>&lt;p&gt;&lt;b&gt;Supplementary stocking selects for domesticated genotypes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Supplementary stocking selects for domesticated genotypes, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08021-z&quot;&gt;doi:10.1038/s41467-018-08021-z&lt;/a&gt;&lt;/p&gt;Stocking of hatchery produced fish is widely used to supplement wild fish populations. Here, the authors show that supplementary stocking can unintentionally favour introgressed individuals with domestic genotypes and compromise the fitness of a wild population of Atlantic salmon.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/iDfCu3wFqp8&quot; height=&quot;1&quot;&gt;</description><published>1547452800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/iDfCu3wFqp8/s41467-018-08021-z</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1684be81d08:2c839b7:8675cc2c</id><title>Supplementary stocking selects for domesticated genotypes</title><fingerprint>9148164e</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08279-3</href></item></canonical><engagement>1</engagement><crawled>1548325717848</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Daniel Felsky</name></author><visual><height>518</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08279-3/MediaObjects/41467_2018_8279_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08279-3</link><content><content>&lt;p&gt;&lt;b&gt;Neuropathological correlates and genetic architecture of microglial activation in elderly human brain&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Neuropathological correlates and genetic architecture of microglial activation in elderly human brain, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08279-3&quot;&gt;doi:10.1038/s41467-018-08279-3&lt;/a&gt;&lt;/p&gt;The consequences of microglial activation in the aging human brain remain unknown. This study quantified microglial morphology and density in the elderly human brain to show that cortical microglial activation strongly associates with AD pathogenesis and may be an upstream contributor to cognitive decline via the accumulation of tau pathology.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/VvFIXl_Ft74&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08279-3</originId><description>&lt;p&gt;&lt;b&gt;Neuropathological correlates and genetic architecture of microglial activation in elderly human brain&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Neuropathological correlates and genetic architecture of microglial activation in elderly human brain, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08279-3&quot;&gt;doi:10.1038/s41467-018-08279-3&lt;/a&gt;&lt;/p&gt;The consequences of microglial activation in the aging human brain remain unknown. This study quantified microglial morphology and density in the elderly human brain to show that cortical microglial activation strongly associates with AD pathogenesis and may be an upstream contributor to cognitive decline via the accumulation of tau pathology.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/VvFIXl_Ft74&quot; height=&quot;1&quot;&gt;</description><engagementRate>0.09</engagementRate><published>1548316800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/VvFIXl_Ft74/s41467-018-08279-3</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687f678758:3406957:3a104d3b</id><title>Neuropathological correlates and genetic architecture of microglial activation in elderly human brain</title><fingerprint>5756725f</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><author><name>Szuromi, P.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>a153231c</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/39-n?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/39-n?rss=1</originId><published>1546540591000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/39-n?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3b4:ad2b6584</id><title>Nanographenes on oxides</title><canonicalUrl>http://science.sciencemag.org/content/363/6422/39.14.full</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36338-8</href></item></canonical><engagement>0</engagement><crawled>1548066000055</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Karine F. Ferri-Lagneau</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>439</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36338-8/MediaObjects/41598_2018_36338_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36338-8</link><content><content>&lt;p&gt;&lt;b&gt;Rescue of hematopoietic stem/progenitor cells formation in &lt;i&gt;plcg1&lt;/i&gt; zebrafish mutant&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Rescue of hematopoietic stem/progenitor cells formation in &amp;lt;i&gt;plcg1&amp;lt;/i&gt; zebrafish mutant, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36338-8&quot;&gt;doi:10.1038/s41598-018-36338-8&lt;/a&gt;&lt;/p&gt;Rescue of hematopoietic stem/progenitor cells formation in &lt;i&gt;plcg1&lt;/i&gt; zebrafish mutant&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/8ikzz7dbICw&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36338-8</originId><description>&lt;p&gt;&lt;b&gt;Rescue of hematopoietic stem/progenitor cells formation in &lt;i&gt;plcg1&lt;/i&gt; zebrafish mutant&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Rescue of hematopoietic stem/progenitor cells formation in &amp;lt;i&gt;plcg1&amp;lt;/i&gt; zebrafish mutant, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36338-8&quot;&gt;doi:10.1038/s41598-018-36338-8&lt;/a&gt;&lt;/p&gt;Rescue of hematopoietic stem/progenitor cells formation in &lt;i&gt;plcg1&lt;/i&gt; zebrafish mutant&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/8ikzz7dbICw&quot; height=&quot;1&quot;&gt;</description><published>1548057600000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/8ikzz7dbICw/s41598-018-36338-8</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1686fec8cb7:1d0f713:3a104d3b</id><title>Rescue of hematopoietic stem/progenitor cells formation in plcg1 zebrafish mutant</title><fingerprint>bdb37d7e</fingerprint></item><item><entities><item><label>Edward Barbier</label><id>nlp/f/entity/en/-/edward barbier</id><mentions><item><text>Barbier</text></item><item><text>Edward Barbier</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Overcoming the Global Crisis in Water Management Edward B. Barbier Yale University Press</label><id>nlp/f/entity/en/-/overcoming the global crisis in water management edward b. barbier yale university press</id><mentions><item><text>Overcoming the Global Crisis in Water Management Edward B. Barbier Yale University Press</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Karl August Wittfogel</label><id>nlp/f/entity/en/w/Karl August Wittfogel</id><mentions><item><text>Karl Wittfogel</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>P. Ball Nature 564</label><id>nlp/f/entity/en/-/p. ball nature 564</id><mentions><item><text>P. Ball Nature 564</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>discord</label><id>nlp/f/entity/en/-/discord</id><mentions><item><text>discord</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548080657657</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00214-w/d41586-019-00214-w_16386772.jpg</url></visual><author><name>Margaret Catley-Carlson</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00214-w</link><content><content>&lt;p&gt;&lt;b&gt;The non-stop waste of water&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The non-stop waste of water, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00214-w&quot;&gt;doi:10.1038/d41586-019-00214-w&lt;/a&gt;&lt;/p&gt;Margaret Catley-Carlson reflects on millennia of resource mismanagement.</content><direction>ltr</direction></content><commonTopics><item><label>waste</label><id>nlp/f/topic/2453</id><probability>1.0</probability></item><item><label>environment</label><id>nlp/f/topic/780</id><probability>0.885</probability></item><item><label>geology</label><id>nlp/f/topic/959</id><probability>0.84</probability></item><item><label>peak oil</label><id>nlp/f/topic/1712</id><probability>0.799</probability></item><item><label>kayak</label><id>nlp/f/topic/1254</id><probability>0.788</probability></item><item><label>economics</label><id>nlp/f/topic/729</id><probability>0.75</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00214-w</originId><description>&lt;p&gt;&lt;b&gt;The non-stop waste of water&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The non-stop waste of water, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00214-w&quot;&gt;doi:10.1038/d41586-019-00214-w&lt;/a&gt;&lt;/p&gt;Margaret Catley-Carlson reflects on millennia of resource mismanagement.</description><published>1548057600000</published><engagement>4</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00214-w</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16870cc34f9:1e657d7:3a104d3b</id><title>The non-stop waste of water</title><fingerprint>b1d2964</fingerprint></item><item><engagement>0</engagement><crawled>1548179409624</crawled><fingerprint>3d2eda2</fingerprint><author><name>Lopez, C. A.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/527630v1?rss=1</link><content><content>Phase separation in mixed lipid systems has been extensively studied both experimentally and theoretically because of its biological importance. A detailed description of such complex systems undoubtedly requires novel mathematical frameworks that are capable to decompose and categorize the evolution of thousands if not millions of lipids involved in the phenomenon. The interpretation and analysis of Molecular Dynamics (MD) simulations representing temporal and spatial changes in such systems is still a challenging task. Here, we present a new unsupervised machine learning approach based on Nonnegative Matrix Factorization, called NMFk, that successfully extracts physically meaningful features from neighborhood profiles derived from coarse-grained MD simulations of ternary lipid mixture. Our results demonstrate that leveraging NMFk can (a) determine the role of different lipid molecules in phase separation, (b) characterize the formation of nano-domains of lipids, (c) determine the timescales of interest and (d) extract physically meaningful features that uniquely describe the phase separation with broad implications.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/527630v1?rss=1</originId><description>Phase separation in mixed lipid systems has been extensively studied both experimentally and theoretically because of its biological importance. A detailed description of such complex systems undoubtedly requires novel mathematical frameworks that are capable to decompose and categorize the evolution of thousands if not millions of lipids involved in the phenomenon. The interpretation and analysis of Molecular Dynamics (MD) simulations representing temporal and spatial changes in such systems is still a challenging task. Here, we present a new unsupervised machine learning approach based on Nonnegative Matrix Factorization, called NMFk, that successfully extracts physically meaningful features from neighborhood profiles derived from coarse-grained MD simulations of ternary lipid mixture. Our results demonstrate that leveraging NMFk can (a) determine the role of different lipid molecules in phase separation, (b) characterize the formation of nano-domains of lipids, (c) determine the timescales of interest and (d) extract physically meaningful features that uniquely describe the phase separation with broad implications.</description><published>1548144000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/527630v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16876af0ad8:2668624:c2ce2e2e</id><title>Unsupervised Machine Learning for Analysis of Coexisting Lipid Phases and Domain Growth in Biological Membranes [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/22/527630</canonicalUrl></item><item><unread>True</unread><engagement>0</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><author><name>Hines, P. J.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>b549470</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/39-m?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/39-m?rss=1</originId><published>1546540591000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/39-m?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3b5:ad2b6584</id><title>Fixing photosynthetic inefficiencies</title><canonicalUrl>http://science.sciencemag.org/content/363/6422/39.13.full</canonicalUrl></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acschembio.8b00937</href></item></canonical><engagement>0</engagement><crawled>1546983030301</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acbcct</streamId><title>ACS Chemical Biology: Latest Articles (ACS Publications)</title></origin><author><name>Megan Garland, Brett M. Babin, Shin-Ichiro Miyashita, Sebastian Loscher, Yi Shen, Min Dong, Matthew Bogyo</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acschembio.8b00937</link><originId>http://dx.doi.org/10.1021/acschembio.8b00937</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00937/20190108/images/medium/cb-2018-009376_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00937&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=6TNem6oKZBs:x7W60-G4-tY:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/6TNem6oKZBs&quot; height=&quot;1&quot;&gt;</description><published>1546923600000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/acbcct/~3/6TNem6oKZBs/acschembio.8b00937</href></item></alternate><id>ofNPcmQ46PpGzt1nO49W9STAvkUsM7jssLxNXMp09ME=_1682f5fbe1d:67b6cc:b77f238b</id><title>[ASAP] Covalent Modifiers of Botulinum Neurotoxin Counteract Toxin Persistence</title><fingerprint>e97607a4</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b00937/20190108/images/medium/cb-2018-009376_0008.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b00937&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=6TNem6oKZBs:x7W60-G4-tY:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/6TNem6oKZBs&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acschembio.8b01098</href></item></canonical><engagement>0</engagement><crawled>1546292673607</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acbcct</streamId><title>ACS Chemical Biology: Latest Articles (ACS Publications)</title></origin><author><name>Bishnu P. Joshi, Joseph Hardie, Michael A. Mingroni, Abdulrahman O. Basabrain, Aammar Paracha, Michelle E. Farkas</name></author><visual><height>283</height><processor>feedly-nikon-v3.1</processor><contentType>image/png; charset=UTF-8</contentType><width>560</width><url>https://pubs.acs.org/templates/jsp/_style2/_achs/images/CoverImages_2by1Scaled/acbcct.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acschembio.8b01098</link><originId>http://dx.doi.org/10.1021/acschembio.8b01098</originId><description>&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b01098&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=Gemv7DXOTt0:Zhz7Qb0rjNM:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/Gemv7DXOTt0&quot; height=&quot;1&quot;&gt;</description><published>1546232400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/acbcct/~3/Gemv7DXOTt0/acschembio.8b01098</href></item></alternate><id>ofNPcmQ46PpGzt1nO49W9STAvkUsM7jssLxNXMp09ME=_1680639bc47:dc7665:b77f238b</id><title>[ASAP] Correction to “Surface-Modified Macrophages Facilitate Tracking of Breast Cancer-Immune Interactions”</title><fingerprint>756a8803</fingerprint><summary><content>&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b01098&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=Gemv7DXOTt0:Zhz7Qb0rjNM:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/Gemv7DXOTt0&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><engagement>404</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Alley, R. B., Emanuel, K. A., Zhang, F.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/342?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/342?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6425/342.full</canonicalUrl><published>1548355045000</published><keywords><item>Geochemistry, Geophysics</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/342?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a8f:c2ce2e2e</id><title>Advances in weather prediction</title><fingerprint>9cd44027</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1548357093757</crawled><visual><url>none</url></visual><author><name>Kline, R.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>fd023af3</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6425/360-a?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6425/360-a?rss=1</originId><published>1548355045000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6425/360-a?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1688146497d:3614a80:c2ce2e2e</id><title>A robot quickly learns to use its legs</title><canonicalUrl>http://science.sciencemag.org/content/363/6425/360.1.full</canonicalUrl></item><item><engagement>0</engagement><crawled>1546555595508</crawled><fingerprint>6e04a941</fingerprint><author><name>Osato, N.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/290825v9?rss=1</link><content><content>Chromatin interactions have important roles for enhancer-promoter interactions (EPI) and regulating the transcription of genes. CTCF and cohesin proteins are located at the anchors of chromatin interactions, forming their loop structures. CTCF has insulator function limiting the activity of enhancers into the loops. DNA binding sequences of CTCF indicate their orientation bias at chromatin interaction anchors - forward-reverse (FR) orientation is frequently observed. DNA binding sequences of CTCF were found in open chromatin regions at about 40% - 80% of chromatin interaction anchors in Hi-C and in situ Hi-C experimental data. It has been reported that long range of chromatin interactions tends to include less CTCF at their anchors. It is still unclear what proteins are associated with chromatin interactions. To find DNA binding motif sequences of transcription factors (TF), such as CTCF, and repeat DNA sequences affecting the interaction between enhancers and promoters of genes and their expression, first I predicted TF bound in enhancers and promoters using DNA motif sequences of TF and experimental data of open chromatin regions in monocytes and other cell types, which were obtained from public and commercial databases. Second, transcriptional target genes of each TF were predicted based on enhancer-promoter association (EPA). EPA was shortened at the genomic locations of FR or reverse-forward (RF) orientation of DNA motif sequence of a TF, which were supposed to be at chromatin interaction anchors and acted as insulator sites like CTCF. The expression levels of the transcriptional target genes predicted based on the EPA were compared with those predicted from only promoters. Total 287 biased orientation of DNA motifs (159 FR and 153 RF orientation, the reverse complement sequences of some DNA motifs were also registered in databases, so the total number was smaller than the number of FR and RF) affected the expression level of putative transcriptional target genes significantly in CD14+ monocytes of four people in common. The same analysis was conducted in CD4+ T cells of four people. DNA motif sequences of CTCF, cohesin and other transcription factors involved in chromatin interactions were found to be a biased orientation. Transposon sequences, which are known to be involved in insulators and enhancers, showed a biased orientation. The biased orientation of DNA motif sequences tended to be co-localized in the same open chromatin regions. Moreover, for ~85% of FR and RF orientations of DNA motif sequences, EPI predicted from EPA that were shortened at the genomic locations of the biased orientation of DNA motif sequence were overlapped with chromatin interaction data (Hi-C and HiChIP) significantly more than other types of EPAs.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/290825v9?rss=1</originId><description>Chromatin interactions have important roles for enhancer-promoter interactions (EPI) and regulating the transcription of genes. CTCF and cohesin proteins are located at the anchors of chromatin interactions, forming their loop structures. CTCF has insulator function limiting the activity of enhancers into the loops. DNA binding sequences of CTCF indicate their orientation bias at chromatin interaction anchors - forward-reverse (FR) orientation is frequently observed. DNA binding sequences of CTCF were found in open chromatin regions at about 40% - 80% of chromatin interaction anchors in Hi-C and in situ Hi-C experimental data. It has been reported that long range of chromatin interactions tends to include less CTCF at their anchors. It is still unclear what proteins are associated with chromatin interactions. To find DNA binding motif sequences of transcription factors (TF), such as CTCF, and repeat DNA sequences affecting the interaction between enhancers and promoters of genes and their expression, first I predicted TF bound in enhancers and promoters using DNA motif sequences of TF and experimental data of open chromatin regions in monocytes and other cell types, which were obtained from public and commercial databases. Second, transcriptional target genes of each TF were predicted based on enhancer-promoter association (EPA). EPA was shortened at the genomic locations of FR or reverse-forward (RF) orientation of DNA motif sequence of a TF, which were supposed to be at chromatin interaction anchors and acted as insulator sites like CTCF. The expression levels of the transcriptional target genes predicted based on the EPA were compared with those predicted from only promoters. Total 287 biased orientation of DNA motifs (159 FR and 153 RF orientation, the reverse complement sequences of some DNA motifs were also registered in databases, so the total number was smaller than the number of FR and RF) affected the expression level of putative transcriptional target genes significantly in CD14+ monocytes of four people in common. The same analysis was conducted in CD4+ T cells of four people. DNA motif sequences of CTCF, cohesin and other transcription factors involved in chromatin interactions were found to be a biased orientation. Transposon sequences, which are known to be involved in insulators and enhancers, showed a biased orientation. The biased orientation of DNA motif sequences tended to be co-localized in the same open chromatin regions. Moreover, for ~85% of FR and RF orientations of DNA motif sequences, EPI predicted from EPA that were shortened at the genomic locations of the biased orientation of DNA motif sequence were overlapped with chromatin interaction data (Hi-C and HiChIP) significantly more than other types of EPAs.</description><published>1546502400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/290825v9?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16815e59af4:69d1be9:c2ce2e2e</id><title>Discovery of biased orientation of human DNA motif sequences affecting enhancer-promoter interactions and transcription of genes [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/03/290825</canonicalUrl></item><item><entities><item><label>Hubble Space Telescope</label><id>nlp/f/entity/en/w/Hubble Space Telescope</id><mentions><item><text>Hubble Space Telescope</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Stockholm University</label><id>nlp/f/entity/en/w/Stockholm University</id><mentions><item><text>Stockholm University</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Jesper Sollerman</label><id>nlp/f/entity/en/-/jesper sollerman</id><mentions><item><text>Jesper Sollerman</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548087918595</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00226-6/d41586-019-00226-6_16400128.jpg</url></visual><published>1548057600000</published><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00226-6</link><content><content>&lt;p&gt;&lt;b&gt;Gigantic stellar cluster may have dwarfish roots&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Gigantic stellar cluster may have dwarfish roots, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00226-6&quot;&gt;doi:10.1038/d41586-019-00226-6&lt;/a&gt;&lt;/p&gt;The shape of one of the Milky Way’s largest star clusters hints at independent past.</content><direction>ltr</direction></content><commonTopics><item><label>astrophysics</label><id>nlp/f/topic/173</id><probability>0.952</probability></item><item><label>space</label><id>nlp/f/topic/2140</id><probability>0.924</probability></item><item><label>gossip</label><id>nlp/f/topic/989</id><probability>0.804</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00226-6</originId><description>&lt;p&gt;&lt;b&gt;Gigantic stellar cluster may have dwarfish roots&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Gigantic stellar cluster may have dwarfish roots, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00226-6&quot;&gt;doi:10.1038/d41586-019-00226-6&lt;/a&gt;&lt;/p&gt;The shape of one of the Milky Way’s largest star clusters hints at independent past.</description><author><name>NA</name></author><engagement>1</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00226-6</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168713b0003:1f2a85d:ad2b6584</id><title>Gigantic stellar cluster may have dwarfish roots</title><fingerprint>e10944c9</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0299-9</href></item></canonical><entities><item><label>Cannabinoid receptor type 1</label><id>nlp/f/entity/en/w/Cannabinoid receptor type 1</id><mentions><item><text>Cannabinoid CB1</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Nat</label><id>nlp/f/entity/en/-/nat</id><mentions><item><text>Nat</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>O</label><id>nlp/f/entity/en/-/o</id><mentions><item><text>O</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>X</label><id>nlp/f/entity/en/-/x</id><mentions><item><text>X</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>M.</label><id>nlp/f/entity/en/-/m.</id><mentions><item><text>M.</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547494725217</crawled><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><author><name>Chen-Jie Shen</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>510</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0299-9/MediaObjects/41591_2018_299_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41591-018-0299-9</link><content><content>&lt;p&gt;&lt;b&gt;Cannabinoid CB&lt;sub&gt;1&lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cannabinoid CB&amp;lt;sub&gt;1&amp;lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0299-9&quot;&gt;doi:10.1038/s41591-018-0299-9&lt;/a&gt;&lt;/p&gt;Activating cannabinoid receptors in a newly identified neural circuit ameliorates depressive-like behaviors in mice.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/gyLGW83PsWU&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>classics</label><id>nlp/f/topic/477</id><probability>0.983</probability></item><item><label>brain</label><id>nlp/f/topic/314</id><probability>0.954</probability></item><item><label>mp3</label><id>nlp/f/topic/1508</id><probability>0.898</probability></item><item><label>neuroscience</label><id>nlp/f/topic/1565</id><probability>0.875</probability></item><item><label>emergency medicine</label><id>nlp/f/topic/764</id><probability>0.837</probability></item><item><label>rationality</label><id>nlp/f/topic/1895</id><probability>0.754</probability></item><item><label>fat</label><id>nlp/f/topic/842</id><probability>0.727</probability></item><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.727</probability></item><item><label>nlp</label><id>nlp/f/topic/1585</id><probability>0.703</probability></item></commonTopics><originId>https://www.nature.com/articles/s41591-018-0299-9</originId><description>&lt;p&gt;&lt;b&gt;Cannabinoid CB&lt;sub&gt;1&lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Cannabinoid CB&amp;lt;sub&gt;1&amp;lt;/sub&gt; receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior, Published online: 14 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0299-9&quot;&gt;doi:10.1038/s41591-018-0299-9&lt;/a&gt;&lt;/p&gt;Activating cannabinoid receptors in a newly identified neural circuit ameliorates depressive-like behaviors in mice.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/gyLGW83PsWU&quot; height=&quot;1&quot;&gt;</description><published>1547452800000</published><engagement>2</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/gyLGW83PsWU/s41591-018-0299-9</href></item></alternate><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_1684ddf9661:2e69f25:c2ce2e2e</id><title>Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior</title><fingerprint>301bfbbc</fingerprint></item><item><entities><item><label>Hubble Space Telescope</label><id>nlp/f/entity/en/w/Hubble Space Telescope</id><mentions><item><text>Hubble Space Telescope</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Stockholm University</label><id>nlp/f/entity/en/w/Stockholm University</id><mentions><item><text>Stockholm University</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Jesper Sollerman</label><id>nlp/f/entity/en/-/jesper sollerman</id><mentions><item><text>Jesper Sollerman</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548692369000</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00306-7/d41586-019-00306-7_16423298.jpg</url></visual><published>1548662400000</published><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00306-7</link><content><content>&lt;p&gt;&lt;b&gt;Children glued to screens show delays in key skills&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Children glued to screens show delays in key skills, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00306-7&quot;&gt;doi:10.1038/d41586-019-00306-7&lt;/a&gt;&lt;/p&gt;Greater screen time at age two corresponds to poorer scores on developmental test at age three.</content><direction>ltr</direction></content><commonTopics><item><label>astrophysics</label><id>nlp/f/topic/173</id><probability>0.982</probability></item><item><label>entertainment</label><id>nlp/f/topic/777</id><probability>0.912</probability></item><item><label>space</label><id>nlp/f/topic/2140</id><probability>0.89</probability></item><item><label>tv</label><id>nlp/f/topic/2349</id><probability>0.802</probability></item><item><label>astrophotography</label><id>nlp/f/topic/172</id><probability>0.753</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00306-7</originId><description>&lt;p&gt;&lt;b&gt;Children glued to screens show delays in key skills&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Children glued to screens show delays in key skills, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00306-7&quot;&gt;doi:10.1038/d41586-019-00306-7&lt;/a&gt;&lt;/p&gt;Greater screen time at age two corresponds to poorer scores on developmental test at age three.</description><engagementRate>0.67</engagementRate><author><name>NA</name></author><engagement>6</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00306-7</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16895422e68:4feedee:ad2b6584</id><title>Children glued to screens show delays in key skills</title><fingerprint>a31ae427</fingerprint></item><item><entities><item><label>M.</label><id>nlp/f/entity/en/-/m.</id><mentions><item><text>M.</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>J. Immunol</label><id>nlp/f/entity/en/-/j. immunol</id><mentions><item><text>Immunol</text></item><item><text>J. Immunol</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Nat</label><id>nlp/f/entity/en/-/nat</id><mentions><item><text>Nat</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Panduro</label><id>nlp/f/entity/en/-/panduro</id><mentions><item><text>Panduro</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Li</label><id>nlp/f/entity/en/-/li</id><mentions><item><text>Li</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546452338856</crawled><visual><height>598</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0824-5/MediaObjects/41586_2018_824_Fig1_HTML.png</url></visual><author><name>Minako Ito</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-018-0824-5</link><content><content>&lt;p&gt;&lt;b&gt;Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0824-5&quot;&gt;doi:10.1038/s41586-018-0824-5&lt;/a&gt;&lt;/p&gt;In a mouse model of ischaemic stroke, regulatory T cells infiltrate the injured brain in response to the chemokines CCL1 and CCL20 and suppress excessive astrogliosis via the production of amphiregulin.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41586-018-0824-5</originId><description>&lt;p&gt;&lt;b&gt;Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0824-5&quot;&gt;doi:10.1038/s41586-018-0824-5&lt;/a&gt;&lt;/p&gt;In a mouse model of ischaemic stroke, regulatory T cells infiltrate the injured brain in response to the chemokines CCL1 and CCL20 and suppress excessive astrogliosis via the production of amphiregulin.</description><published>1546416000000</published><engagement>3</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0824-5</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680fbe08a8:6162ccc:c2ce2e2e</id><title>Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery</title><fingerprint>7c6a40e8</fingerprint></item><item><crawled>1546529934154</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1546473600000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Inorganic_Co-Crystal_Formation_and_Thermal_Disproportionation_in_a_Dicyanometallate_Superperovskite_/7533407</link><originId>https://chemrxiv.org/articles/Inorganic_Co-Crystal_Formation_and_Thermal_Disproportionation_in_a_Dicyanometallate_Superperovskite_/7533407</originId><description>We report the synthesis, crystal structure, and thermally-
driven phase transformation of the dicyanometallate super-
perovskite co-crystal [NBu4]Mn[Au(CN)2]3·[NBu4]ClO4. This
phase is understandable in terms of the conventional ABX3
perovskite structure type, but with the NBu+4 A-site cation
displaced onto the perovskite cage face and 1-dimensional
AX′ chains included within framework pores opened up by
these displacements. On heating to 380K, the co-crystal
disproportionates into its two inorganic components: a
bcs-structured ABX3 phase and [NBu4 ]ClO4 . This system
illustrates a new type of structural and phase complexity
accessible to dicyanometallate perovskites.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Inorganic_Co-Crystal_Formation_and_Thermal_Disproportionation_in_a_Dicyanometallate_Superperovskite_/7533407</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168145e0b4a:6871447:ad2b6584</id><title>Inorganic Co-Crystal Formation and Thermal Disproportionation in a Dicyanometallate &apos;Superperovskite&apos;</title><fingerprint>969c18d8</fingerprint><summary><content>We report the synthesis, crystal structure, and thermally-
driven phase transformation of the dicyanometallate super-
perovskite co-crystal [NBu4]Mn[Au(CN)2]3·[NBu4]ClO4. This
phase is understandable in terms of the conventional ABX3
perovskite structure type, but with the NBu+4 A-site cation
displaced onto the perovskite cage face and 1-dimensional
AX′ chains included within framework pores opened up by
these displacements. On heating to 380K, the co-crystal
disproportionates into its two inorganic components: a
bcs-structured ABX3 phase and [NBu4 ]ClO4 . This system
illustrates a new type of structural and phase complexity
accessible to dicyanometallate perovskites.</content><direction>ltr</direction></summary></item><item><crawled>1547133666920</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1547078400000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Introducing_QUBE_Quantum_Mechanical_Bespoke_Force_Fields_for_Protein_Simulations/7565222</link><originId>https://chemrxiv.org/articles/Introducing_QUBE_Quantum_Mechanical_Bespoke_Force_Fields_for_Protein_Simulations/7565222</originId><description>Molecular mechanics force field parameters for macromolecules, such as proteins, are traditionally fit to reproduce experimental properties of small molecules, and thus they neglect system-specific polarization. In this paper, we introduce a complete QUantum mechanical BEspoke (QUBE) protein force field, which derives non-bonded parameters directly from the electron density of the specific protein under study. The main backbone and sidechain protein torsional parameters are re-derived in this work by fitting to quantum mechanical dihedral scans for compatibibility with QUBE non-bonded parameters. Software is provided for the preparation of QUBE input files. The accuracy of the new force field, and the derived torsional parameters, are tested by comparing the conformational preferences of a range of peptides and proteins with experimental measurements. Accurate backbone and sidechain conformations are obtained in molecular dynamics simulations of dipeptides, with NMR J coupling errors comparable to the widely-used OPLS force field. In simulations of five folded proteins, the secondary structure is generally retained and the NMR J coupling errors are similar to standard transferable force fields, although some loss of the experimental structure is observed in certain regions of the proteins. Overall, with several avenues for further development, the use of system-specific non-bonded force field parameters is a promising approach for next-generation simulations of biological molecules.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Introducing_QUBE_Quantum_Mechanical_Bespoke_Force_Fields_for_Protein_Simulations/7565222</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_168385a4668:136b962:c2ce2e2e</id><title>Introducing QUBE: Quantum Mechanical Bespoke Force Fields for Protein Simulations</title><fingerprint>99092cf2</fingerprint><summary><content>Molecular mechanics force field parameters for macromolecules, such as proteins, are traditionally fit to reproduce experimental properties of small molecules, and thus they neglect system-specific polarization. In this paper, we introduce a complete QUantum mechanical BEspoke (QUBE) protein force field, which derives non-bonded parameters directly from the electron density of the specific protein under study. The main backbone and sidechain protein torsional parameters are re-derived in this work by fitting to quantum mechanical dihedral scans for compatibibility with QUBE non-bonded parameters. Software is provided for the preparation of QUBE input files. The accuracy of the new force field, and the derived torsional parameters, are tested by comparing the conformational preferences of a range of peptides and proteins with experimental measurements. Accurate backbone and sidechain conformations are obtained in molecular dynamics simulations of dipeptides, with NMR J coupling errors comparable to the widely-used OPLS force field. In simulations of five folded proteins, the secondary structure is generally retained and the NMR J coupling errors are similar to standard transferable force fields, although some loss of the experimental structure is observed in certain regions of the proteins. Overall, with several avenues for further development, the use of system-specific non-bonded force field parameters is a promising approach for next-generation simulations of biological molecules.</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00785</href></item></canonical><engagement>0</engagement><crawled>1548349958870</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><author><name>Jan Wenzel, Hans Matter, Friedemann Schmidt</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jcim.8b00785</link><originId>http://dx.doi.org/10.1021/acs.jcim.8b00785</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00785/20190124/images/medium/ci-2018-00785s_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00785&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=LG4o_YmCgKs:u0dCckJSN0E:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/LG4o_YmCgKs&quot; height=&quot;1&quot;&gt;</description><published>1548306000000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/LG4o_YmCgKs/acs.jcim.8b00785</href></item></alternate><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_16880d96ad6:94795:875042c9</id><title>[ASAP] Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets</title><fingerprint>c0c85d1e</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00785/20190124/images/medium/ci-2018-00785s_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00785&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=LG4o_YmCgKs:u0dCckJSN0E:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/LG4o_YmCgKs&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><engagement>1</engagement><crawled>1547815581176</crawled><fingerprint>fcb50c70</fingerprint><author><name>Li, F.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/523308v1?rss=1</link><content><content>Motivation: Post-translational modifications (PTMs) play very important roles in various cell signalling pathways and biological process. Due to PTMs&apos; extremely important roles, many major PTMs have been thoroughly studied, while the functional and mechanical characterization of major PTMs is well-documented in several databases. However, currently available databases only focus on protein sequences, while the real 3D structures of PTMs have been largely ignored. Therefore, studies of PTMs 3D structural signatures have been severely limited by the deficiency of the data. Results: Here, we developed PRISM, a novel publicly available and free 3D structure-based database for PTMs. PRISM provides comprehensive and interactive online knowledge focused on 3D structural information of PTM proteins. The first version of PRISM encompasses 17,145 non-redundant modification sites on 3,919 related protein 3D structure entries pertaining to 37 different types of PTMs. Our entry web page organizes in a comprehensive manner detailed PTM annotation on the 3D structure and biological information in terms of mutations affecting PTMs information, secondary structural features and residue accessibility features of PTM sites, domain context information, predicted disordered regions and sequence alignments. In addition, high-definition JavaScript packages are employed to enhance information visualization in PRISM. PRISM equips a variety of interactive and customizable search options and data browsing functions; these capabilities allow users to access data via keyword, ID, and advanced options combination search in an efficient and user-friendly way. A download page is also provided to enable users to download the SQL file, computational structural features, and PTM sites&apos; data. We anticipate PRISM will swiftly become an invaluable online resource, assisting both biologists and bioinformaticians to conduct experiments and develop applications supporting discovery efforts in the sequence-structural-functional relationship of PTMs and providing important insight into mutations and PTM sites interaction mechanisms.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/523308v1?rss=1</originId><description>Motivation: Post-translational modifications (PTMs) play very important roles in various cell signalling pathways and biological process. Due to PTMs&apos; extremely important roles, many major PTMs have been thoroughly studied, while the functional and mechanical characterization of major PTMs is well-documented in several databases. However, currently available databases only focus on protein sequences, while the real 3D structures of PTMs have been largely ignored. Therefore, studies of PTMs 3D structural signatures have been severely limited by the deficiency of the data. Results: Here, we developed PRISM, a novel publicly available and free 3D structure-based database for PTMs. PRISM provides comprehensive and interactive online knowledge focused on 3D structural information of PTM proteins. The first version of PRISM encompasses 17,145 non-redundant modification sites on 3,919 related protein 3D structure entries pertaining to 37 different types of PTMs. Our entry web page organizes in a comprehensive manner detailed PTM annotation on the 3D structure and biological information in terms of mutations affecting PTMs information, secondary structural features and residue accessibility features of PTM sites, domain context information, predicted disordered regions and sequence alignments. In addition, high-definition JavaScript packages are employed to enhance information visualization in PRISM. PRISM equips a variety of interactive and customizable search options and data browsing functions; these capabilities allow users to access data via keyword, ID, and advanced options combination search in an efficient and user-friendly way. A download page is also provided to enable users to download the SQL file, computational structural features, and PTM sites&apos; data. We anticipate PRISM will swiftly become an invaluable online resource, assisting both biologists and bioinformaticians to conduct experiments and develop applications supporting discovery efforts in the sequence-structural-functional relationship of PTMs and providing important insight into mutations and PTM sites interaction mechanisms.</description><published>1547798400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/523308v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16860ff75f8:b1130f:ad2b6584</id><title>PRISM: a comprehensive 3D structure database for post-translational modifications and mutations with functional impact [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/18/523308</canonicalUrl></item><item><engagement>0</engagement><crawled>1546816728293</crawled><fingerprint>a89a238c</fingerprint><author><name>Hussien, A.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/505859v1?rss=1</link><content><content>Background: ABCB1 (MDR1) is a transporter glycoprotein that has a major role in drug effluxes and resistance. Single nucleotide polymorphisms (SNPs) in ABCB1gene may affect protein expression, disease susceptibility and drug response, side effects and pharmacokinetics. The functional impact of most non-synonymous (ns) SNPs is still unclear. This study adopted a Structural bioinformatics approach to predict the effects of nsSNPs on ABCB1 structure and function. Methodology: The effects of coding nsSNPs were predicted by SIFT, PolyPhen-2, PANTHER, SNAP, PROVEAN, PhD-SNP and SNPs &amp;amp; GO. Prediction of protein stability changes was analyzed by I-Mutant. The conservation of amino acid positions in a protein was predicted by Consurf. NetSurfP was used to predict the surface accessibility of amino acid residue in protein structure. The impact of substitutions in protein was analyzed using Hope. Chimera was used to visualize changes in the protein 3D structure due to deleterious nsSNPs. Results: The nsSNPs of ABCB1 gene were retrieved from dbSNP database. nsSNPs were analyzed using SIFT and PolyPhen-2. To increase the accuracy of predictions, results of SIFT and PolyPhen-2 were joined and nsSNPs with PolyPhen score&gt; 0.90 and SIFT&amp;lt; 0.05 were selected. Accordingly, three nsSNPs were classified as deleterious/damaging (rs28381902 (E566K), rs1128501 (G185V) and rs9282565 (A80E)). PANTHER, SNPs &amp;amp; GO, PhD-SNP, SNAP and PROVEAN confirmed the damaging effects of the first two nsSNPs, while the damaging effect of the third one was predicted only by PhD-SNP and SNAP. These three nsSNPs were predicted by I-Mutant as significantly decreasing the stability of the protein. ConSurf revealed that the three deleterious nsSNPs were located in intermediately/highly conserved regions. Conclusion: Structural bioinformatics approach proved capable of identifying the most damaging nsSNPs. This study predicted three nsSNPs in the ABCB1 gene as the most damaging. These nsSNPs, to the best of our knowledge, have not yet been investigated and therefore may be considered as candidates for association with diseases and drug response.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/505859v1?rss=1</originId><description>Background: ABCB1 (MDR1) is a transporter glycoprotein that has a major role in drug effluxes and resistance. Single nucleotide polymorphisms (SNPs) in ABCB1gene may affect protein expression, disease susceptibility and drug response, side effects and pharmacokinetics. The functional impact of most non-synonymous (ns) SNPs is still unclear. This study adopted a Structural bioinformatics approach to predict the effects of nsSNPs on ABCB1 structure and function. Methodology: The effects of coding nsSNPs were predicted by SIFT, PolyPhen-2, PANTHER, SNAP, PROVEAN, PhD-SNP and SNPs &amp;amp; GO. Prediction of protein stability changes was analyzed by I-Mutant. The conservation of amino acid positions in a protein was predicted by Consurf. NetSurfP was used to predict the surface accessibility of amino acid residue in protein structure. The impact of substitutions in protein was analyzed using Hope. Chimera was used to visualize changes in the protein 3D structure due to deleterious nsSNPs. Results: The nsSNPs of ABCB1 gene were retrieved from dbSNP database. nsSNPs were analyzed using SIFT and PolyPhen-2. To increase the accuracy of predictions, results of SIFT and PolyPhen-2 were joined and nsSNPs with PolyPhen score&gt; 0.90 and SIFT&amp;lt; 0.05 were selected. Accordingly, three nsSNPs were classified as deleterious/damaging (rs28381902 (E566K), rs1128501 (G185V) and rs9282565 (A80E)). PANTHER, SNPs &amp;amp; GO, PhD-SNP, SNAP and PROVEAN confirmed the damaging effects of the first two nsSNPs, while the damaging effect of the third one was predicted only by PhD-SNP and SNAP. These three nsSNPs were predicted by I-Mutant as significantly decreasing the stability of the protein. ConSurf revealed that the three deleterious nsSNPs were located in intermediately/highly conserved regions. Conclusion: Structural bioinformatics approach proved capable of identifying the most damaging nsSNPs. This study predicted three nsSNPs in the ABCB1 gene as the most damaging. These nsSNPs, to the best of our knowledge, have not yet been investigated and therefore may be considered as candidates for association with diseases and drug response.</description><published>1546761600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/505859v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16825762ce5:11b117b:c2ce2e2e</id><title>In Silico Screening and Analysis of SNPs in Human ABCB1 (MDR1) Gene [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/06/505859</canonicalUrl></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01742</href></item></canonical><engagement>0</engagement><crawled>1548465334845</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><author><name>Xin-Ya Xu, Siu Wai Tsang, Yi-Fu Guan, Kang-Lun Liu, Wen-Hui Pan, Chu Shing Lam, Kwan Ming Lee, Yi-Xuan Xia, Wen-Jian Xie, Wing Yan Wong, Magnolia Muk Lan Lee, William Chi Shing Tai, Hong-Jie Zhang</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01742</link><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01742</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01742/20190125/images/medium/jm-2018-01742c_0012.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01742&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=b_pIWvqB_00:YSsjj0WBa7g:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/b_pIWvqB_00&quot; height=&quot;1&quot;&gt;</description><published>1548392400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/b_pIWvqB_00/acs.jmedchem.8b01742</href></item></alternate><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_16887b9ea3d:14c8792:b77f238b</id><title>[ASAP] In Vitro and in Vivo Antitumor Effects of Plant-Derived Miliusanes and Their Induction of Cellular Senescence</title><fingerprint>5e9cb43d</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01742/20190125/images/medium/jm-2018-01742c_0012.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01742&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=b_pIWvqB_00:YSsjj0WBa7g:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/b_pIWvqB_00&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><engagement>1</engagement><crawled>1548306361935</crawled><fingerprint>84d6cbef</fingerprint><author><name>Bauer, A.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/527184v1?rss=1</link><content><content>Aerial imagery is regularly used by farmers and growers to monitor crops during the growing season. To extract meaningful phenotypic information from large-scale aerial images collected regularly from the field, high-throughput analytic solutions are required, which not only produce high-quality measures of key crop traits, but also support agricultural practitioners to make reliable management decisions of their crops. Here, we report AirSurf-Lettuce, an automated and open-source aerial image analysis platform that combines modern computer vision, up-to-date machine learning, and modular software engineering to measure yield-related phenotypes of millions of lettuces across the field. Utilising ultra-large normalized difference vegetation index (NDVI) images acquired by fixed-wing light aircrafts together with a deep-learning classifier trained with over 100,000 labelled lettuce signals, the platform is capable of scoring and categorising iceberg lettuces with high accuracy (&gt;98%). Furthermore, novel analysis functions have been developed to map lettuce size distribution in the field, based on which global positioning system (GPS) tagged harvest regions can be derived to enable growers and farmers&apos; precise harvest strategies and marketability estimates before the harvest.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/527184v1?rss=1</originId><description>Aerial imagery is regularly used by farmers and growers to monitor crops during the growing season. To extract meaningful phenotypic information from large-scale aerial images collected regularly from the field, high-throughput analytic solutions are required, which not only produce high-quality measures of key crop traits, but also support agricultural practitioners to make reliable management decisions of their crops. Here, we report AirSurf-Lettuce, an automated and open-source aerial image analysis platform that combines modern computer vision, up-to-date machine learning, and modular software engineering to measure yield-related phenotypes of millions of lettuces across the field. Utilising ultra-large normalized difference vegetation index (NDVI) images acquired by fixed-wing light aircrafts together with a deep-learning classifier trained with over 100,000 labelled lettuce signals, the platform is capable of scoring and categorising iceberg lettuces with high accuracy (&gt;98%). Furthermore, novel analysis functions have been developed to map lettuce size distribution in the field, based on which global positioning system (GPS) tagged harvest regions can be derived to enable growers and farmers&apos; precise harvest strategies and marketability estimates before the harvest.</description><published>1548230400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/527184v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1687e402e4f:3285582:ad2b6584</id><title>AirSurf-Lettuce: an aerial image analysis platform for ultra-scale field phenotyping and precision agriculture using computer vision and deep learning [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/527184v1</canonicalUrl></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00761</href></item></canonical><engagement>0</engagement><crawled>1546276326732</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><author><name>Ruxi Qi, Ray Luo</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jcim.8b00761</link><originId>http://dx.doi.org/10.1021/acs.jcim.8b00761</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00761/20181231/images/medium/ci-2018-007614_0010.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00761&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=vE6e1bEzfPY:iElDfUiU5Ms:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/vE6e1bEzfPY&quot; height=&quot;1&quot;&gt;</description><published>1546232400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/vE6e1bEzfPY/acs.jcim.8b00761</href></item></alternate><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_16805404d4c:9591e:875042c9</id><title>[ASAP] Robustness and Efficiency of Poisson–Boltzmann Modeling on Graphics Processing Units</title><fingerprint>abacc9b0</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00761/20181231/images/medium/ci-2018-007614_0010.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00761&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=vE6e1bEzfPY:iElDfUiU5Ms:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/vE6e1bEzfPY&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><crawled>1548859251226</crawled><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><author><name>Zhang, Y.-z.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/503649v3?rss=1</link><content><content>Structure variants (SVs) are complex genomic alterations with affected genome sizes larger than 50 nucleotides. They have been found in both healthy individuals and patients, which contribute to phenotypic traits and are highly correlated with diseases, such as cancer. With the advance of sequencing technologies, more precise profiling of SVs becomes available. It is still a challenging task to determine SVs in nucleotide-resolution with satisfying both high accuracy and coverage for a single sample. In this paper, we proposed a novel nucleotide-resolution SV detection method for determining SV fragments inside of bin with base-pair read-depth (RD) information. Distinguished from traditional RD based SV detectors, which usually require grouping and smoothing RD signals at the scale of a bin, we used a U-net model to directly process base-pair RD signals inside of a bin and learn feature representations for intra-bin SV segmentation. The proposed method can be used solely for searching target SVs with RD signature or integrated with previous bin-based SV detection methods to exceed the bin-size limitation. We did a systematic evaluation of the method using WGS data from 1000 Genomes Project. In both single-sample and cross-sample experiments, the U-net model achieves significantly better performances on detecting intra-bin SV fragments when compared with convolutional neural networks (CNN). Furthermore, the model shows a good ability to detect specific SV subtypes, such as ALU deletion.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/503649v3?rss=1</originId><description>Structure variants (SVs) are complex genomic alterations with affected genome sizes larger than 50 nucleotides. They have been found in both healthy individuals and patients, which contribute to phenotypic traits and are highly correlated with diseases, such as cancer. With the advance of sequencing technologies, more precise profiling of SVs becomes available. It is still a challenging task to determine SVs in nucleotide-resolution with satisfying both high accuracy and coverage for a single sample. In this paper, we proposed a novel nucleotide-resolution SV detection method for determining SV fragments inside of bin with base-pair read-depth (RD) information. Distinguished from traditional RD based SV detectors, which usually require grouping and smoothing RD signals at the scale of a bin, we used a U-net model to directly process base-pair RD signals inside of a bin and learn feature representations for intra-bin SV segmentation. The proposed method can be used solely for searching target SVs with RD signature or integrated with previous bin-based SV detection methods to exceed the bin-size limitation. We did a systematic evaluation of the method using WGS data from 1000 Genomes Project. In both single-sample and cross-sample experiments, the U-net model achieves significantly better performances on detecting intra-bin SV fragments when compared with convolutional neural networks (CNN). Furthermore, the model shows a good ability to detect specific SV subtypes, such as ALU deletion.</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/503649v3?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689f349a1a:b3e16d:ad2b6584</id><title>Intra-bin structural variant segmentation for whole-genome sequencing data using U-net [NEW RESULTS]</title><fingerprint>1082515b</fingerprint></item><item><entities><item><label>Carl Linnaeus</label><id>nlp/f/entity/en/w/Carl Linnaeus</id><mentions><item><text>L.</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>J.</label><id>nlp/f/entity/en/-/j.</id><mentions><item><text>J.</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>CTR</label><id>nlp/f/entity/en/-/ctr</id><mentions><item><text>CTR</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Nuckolls</label><id>nlp/f/entity/en/-/nuckolls</id><mentions><item><text>Nuckolls</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Nat</label><id>nlp/f/entity/en/-/nat</id><mentions><item><text>Nat</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548872162027</crawled><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>591</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0877-0/MediaObjects/41586_2019_877_Fig1_HTML.png</url></visual><author><name>V. Gopalaswamy</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-019-0877-0</link><content><content>&lt;p&gt;&lt;b&gt;Tripled yield in direct-drive laser fusion through statistical modelling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Tripled yield in direct-drive laser fusion through statistical modelling, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0877-0&quot;&gt;doi:10.1038/s41586-019-0877-0&lt;/a&gt;&lt;/p&gt;A statistical approach to designing and predicting the fusion yield of cryogenic deuterium–tritium implosions leads to tripled yield in direct-drive laser fusion of deuterium–tritium layered targets.</content><direction>ltr</direction></content><commonTopics><item><label>physics</label><id>nlp/f/topic/1753</id><probability>0.903</probability></item><item><label>aps</label><id>nlp/f/topic/127</id><probability>0.823</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-019-0877-0</originId><description>&lt;p&gt;&lt;b&gt;Tripled yield in direct-drive laser fusion through statistical modelling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Tripled yield in direct-drive laser fusion through statistical modelling, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0877-0&quot;&gt;doi:10.1038/s41586-019-0877-0&lt;/a&gt;&lt;/p&gt;A statistical approach to designing and predicting the fusion yield of cryogenic deuterium–tritium implosions leads to tripled yield in direct-drive laser fusion of deuterium–tritium layered targets.</description><published>1548835200000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0877-0</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac4e:3a104d3b</id><title>Tripled yield in direct-drive laser fusion through statistical modelling</title><fingerprint>a918696b</fingerprint></item><item><entities><item><label>Google</label><id>nlp/f/entity/en/w/Google</id><mentions><item><text>Google</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Mirko Zimic</label><id>nlp/f/entity/en/-/mirko zimic</id><mentions><item><text>Mirko Zimic</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Bast</label><id>nlp/f/entity/en/-/bast</id><mentions><item><text>Bast</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Amazon</label><id>nlp/f/entity/en/w/Amazon (company)</id><mentions><item><text>Amazon</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Cayetano Heredia University</label><id>nlp/f/entity/en/w/Cayetano Heredia University</id><mentions><item><text>Cayetano Heredia University</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548769962156</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00290-y/d41586-019-00290-y_16417538.jpg</url></visual><author><name>Gabriel Popkin</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00290-y</link><content><content>&lt;p&gt;&lt;b&gt;How scientists can team up with big tech&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How scientists can team up with big tech, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00290-y&quot;&gt;doi:10.1038/d41586-019-00290-y&lt;/a&gt;&lt;/p&gt;Technology companies are attracting researchers through funding and partnership opportunities.</content><direction>ltr</direction></content><commonTopics><item><label>research</label><id>nlp/f/topic/1931</id><probability>0.993</probability></item><item><label>ai</label><id>nlp/f/topic/56</id><probability>0.987</probability></item><item><label>academic</label><id>nlp/f/topic/17</id><probability>0.953</probability></item><item><label>phd</label><id>nlp/f/topic/1737</id><probability>0.937</probability></item><item><label>science policy</label><id>nlp/f/topic/2019</id><probability>0.93</probability></item><item><label>strategy</label><id>nlp/f/topic/2192</id><probability>0.924</probability></item><item><label>market research</label><id>nlp/f/topic/1408</id><probability>0.915</probability></item><item><label>tech</label><id>nlp/f/topic/2256</id><probability>0.881</probability></item><item><label>singularity</label><id>nlp/f/topic/2074</id><probability>0.876</probability></item><item><label>biochemistry</label><id>nlp/f/topic/257</id><probability>0.852</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00290-y</originId><description>&lt;p&gt;&lt;b&gt;How scientists can team up with big tech&lt;/b&gt;&lt;/p&gt;&lt;p&gt;How scientists can team up with big tech, Published online: 29 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00290-y&quot;&gt;doi:10.1038/d41586-019-00290-y&lt;/a&gt;&lt;/p&gt;Technology companies are attracting researchers through funding and partnership opportunities.</description><engagementRate>1.25</engagementRate><published>1548748800000</published><engagement>10</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00290-y</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16899e228ac:34a854:ad2b6584</id><title>How scientists can team up with big tech</title><fingerprint>74b98bd6</fingerprint></item><item><engagement>0</engagement><crawled>1548717777002</crawled><fingerprint>238f04a</fingerprint><author><name>Yi, X.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/532143v1?rss=1</link><content><content>Within the family of super-resolution (SR) fluorescence microscopy, single-molecule localization microscopies (PALM[1], STORM[2] and their derivatives) afford among the highest spatial resolution (approximately 5 to 10 nm), but often with moderate temporal resolution. The high spatial resolution relies on the adequate accumulation of precise localizations of bright fluorophores, which requires the bright fluorophores to possess a relatively low spatial density. Several methods have demonstrated localization at higher densities in both two dimensions (2D)[3, 4] and three dimensions (3D)[5-7]. Additionally, with further advancements, such as functional super-resolution[8, 9] and point spread function (PSF) engineering with[8-11] or without[12] multi-channel observations, extra information (spectra, dipole orientation) can be encoded and recovered at the single molecule level. However, such advancements are not fully extended for high-density localizations in 3D. In this work, we adopt sparse recovery using simple matrix/vector operations, and propose a systematic progressive refinement method (dubbed as PRIS) for 3D high-density reconstruction. Our method allows for localization reconstruction using experimental PSFs that include the spatial aberrations and fingerprint patterns of the PSFs[13]. We generalized the method for PSF engineering, multi-channel and multi-species observations using different forms of matrix concatenations. Reconstructions with both double-helix and astigmatic PSFs, for both single and biplane settings are demonstrated, together with the recovery capability for a mixture of two different color species.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/532143v1?rss=1</originId><description>Within the family of super-resolution (SR) fluorescence microscopy, single-molecule localization microscopies (PALM[1], STORM[2] and their derivatives) afford among the highest spatial resolution (approximately 5 to 10 nm), but often with moderate temporal resolution. The high spatial resolution relies on the adequate accumulation of precise localizations of bright fluorophores, which requires the bright fluorophores to possess a relatively low spatial density. Several methods have demonstrated localization at higher densities in both two dimensions (2D)[3, 4] and three dimensions (3D)[5-7]. Additionally, with further advancements, such as functional super-resolution[8, 9] and point spread function (PSF) engineering with[8-11] or without[12] multi-channel observations, extra information (spectra, dipole orientation) can be encoded and recovered at the single molecule level. However, such advancements are not fully extended for high-density localizations in 3D. In this work, we adopt sparse recovery using simple matrix/vector operations, and propose a systematic progressive refinement method (dubbed as PRIS) for 3D high-density reconstruction. Our method allows for localization reconstruction using experimental PSFs that include the spatial aberrations and fingerprint patterns of the PSFs[13]. We generalized the method for PSF engineering, multi-channel and multi-species observations using different forms of matrix concatenations. Reconstructions with both double-helix and astigmatic PSFs, for both single and biplane settings are demonstrated, together with the recovery capability for a mixture of two different color species.</description><published>1548662400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/532143v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16896c5e06a:52475e8:ad2b6584</id><title>3D super-resolution imaging using a generalized and scalable progressive refinement method on sparse recovery (PRIS) [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/532143v1</canonicalUrl></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jcim.8b00738</href></item></canonical><engagement>0</engagement><crawled>1546982196788</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jcisd8</streamId><title>Journal of Chemical Information and Modeling: Latest Articles (ACS Publications)</title></origin><author><name>Afshan Mohajeri, Akbar Omidvar, Hengameh Setoodeh</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jcim.8b00738</link><originId>http://dx.doi.org/10.1021/acs.jcim.8b00738</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00738/20190108/images/medium/ci-2018-007383_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00738&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=FhXtxEGstfw:OI8mIRFOBuA:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/FhXtxEGstfw&quot; height=&quot;1&quot;&gt;</description><published>1546923600000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jcisd8/~3/FhXtxEGstfw/acs.jcim.8b00738</href></item></alternate><id>bE0mPve90xtDW7Mgx9+xm/gIKXt54qktoOvefuUy0ZI=_1682f530634:677b42:56b782f7</id><title>[ASAP] Fine Structural Tuning of Thieno[3,2-b] Pyrrole Donor for Designing Banana-Shaped Semiconductors Relevant to Organic Field Effect Transistors</title><fingerprint>ff415017</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jcisd8/0/jcisd8.ahead-of-print/acs.jcim.8b00738/20190108/images/medium/ci-2018-007383_0009.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Chemical Information and Modeling&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jcim.8b00738&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?a=FhXtxEGstfw:OI8mIRFOBuA:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jcisd8?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jcisd8/~4/FhXtxEGstfw&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01757</href></item></canonical><engagement>0</engagement><crawled>1546277335642</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><author><name>Torben Heise, Johan F. A. Pijnenborg, Christian Büll, Niek van Hilten, Esther D. Kers-Rebel, Natasja Balneger, Hidde Elferink, Gosse J. Adema, Thomas J. Boltje</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01757</link><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01757</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01757/20181231/images/medium/jm-2018-01757b_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01757&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=kRrDM4QW-d4:nOiCe-YiIgc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/kRrDM4QW-d4&quot; height=&quot;1&quot;&gt;</description><published>1546232400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/kRrDM4QW-d4/acs.jmedchem.8b01757</href></item></alternate><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_168054fb25a:ce35f0:56b782f7</id><title>[ASAP] Potent Metabolic Sialylation Inhibitors Based on C-5-Modified Fluorinated Sialic Acids</title><fingerprint>247f0553</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01757/20181231/images/medium/jm-2018-01757b_0007.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01757&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=kRrDM4QW-d4:nOiCe-YiIgc:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/kRrDM4QW-d4&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><crawled>1548797631192</crawled><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><author><name>Bremges, A.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/532473v1?rss=1</link><content><content>The number of microbial genome sequences is growing exponentially, also thanks to recent advances in recovering complete or near-complete genomes from metagenomes and single cells. Assigning reliable taxon labels to genomes is key and often a prerequisite for downstream analyses. We introduce CAMITAX, a scalable and reproducible workflow for the taxonomic labelling of microbial genomes recovered from isolates, single cells, and metagenomes. CAMITAX combines genome distance-, 16S rRNA gene-, and gene homology-based taxonomic assignments with phylogenetic placement. It uses Nextflow to orchestrate reference databases and software containers, and thus combines ease of installation and use with computational reproducibility. We evaluated the method on several hundred metagenome-assembled genomes with high-quality taxonomic annotations from the TARA Oceans project, and show that the ensemble classification method in CAMITAX improved on all individual methods across tested ranks. While we initially developed CAMITAX to aid the Critical Assessment of Metagenome Interpretation (CAMI) initiative, it evolved into a comprehensive software to reliably assign taxon labels to microbial genomes. CAMITAX is available under the Apache License 2.0 at: https://github.com/CAMI-challenge/CAMITAX</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/532473v1?rss=1</originId><description>The number of microbial genome sequences is growing exponentially, also thanks to recent advances in recovering complete or near-complete genomes from metagenomes and single cells. Assigning reliable taxon labels to genomes is key and often a prerequisite for downstream analyses. We introduce CAMITAX, a scalable and reproducible workflow for the taxonomic labelling of microbial genomes recovered from isolates, single cells, and metagenomes. CAMITAX combines genome distance-, 16S rRNA gene-, and gene homology-based taxonomic assignments with phylogenetic placement. It uses Nextflow to orchestrate reference databases and software containers, and thus combines ease of installation and use with computational reproducibility. We evaluated the method on several hundred metagenome-assembled genomes with high-quality taxonomic annotations from the TARA Oceans project, and show that the ensemble classification method in CAMITAX improved on all individual methods across tested ranks. While we initially developed CAMITAX to aid the Critical Assessment of Metagenome Interpretation (CAMI) initiative, it evolved into a comprehensive software to reliably assign taxon labels to microbial genomes. CAMITAX is available under the Apache License 2.0 at: https://github.com/CAMI-challenge/CAMITAX</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/532473v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689b885ad8:5bced6:c2ce2e2e</id><title>CAMITAX: Taxon labels for microbial genomes [NEW RESULTS]</title><fingerprint>8efca333</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><author><name>Mao, S.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>ac8bbb94</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/39-h?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/39-h?rss=1</originId><published>1546540591000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/39-h?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3ba:ad2b6584</id><title>Additional, diverse CRISPR systems</title><canonicalUrl>http://science.sciencemag.org/content/363/6422/39.8.full</canonicalUrl></item><item><engagement>0</engagement><crawled>1548626978214</crawled><fingerprint>d2578421</fingerprint><author><name>Sturm, G.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/463828v3?rss=1</link><content><content>Motivation: The composition and density of immune cells in the tumor microenvironment profoundly influence tumor progression and success of anti-cancer therapies. Flow cytometry, immunohistochemistry staining, or single-cell sequencing is often unavailable such that we rely on computational methods to estimate the immune-cell composition from bulk RNA-sequencing (RNA-seq) data. Various methods have been proposed recently, yet their capabilities and limitations have not been evaluated systematically. A general guideline leading the research community through cell type deconvolution is missing. Results: We developed a systematic approach for benchmarking such computational methods and assessed the accuracy of tools at estimating nine different immune- and stromal cells from bulk RNA-seq samples. We used a single-cell RNA-seq dataset of ~11,000 cells from the tumor microenvironment to simulate bulk samples of known cell type proportions, and validated the results using independent, publicly available gold-standard estimates. This allowed us to analyze and condense the results of more than a hundred thousand predictions to provide an exhaustive evaluation across seven computational methods over nine cell types and ~1,800 samples from five simulated and real-world datasets. We demonstrate that computational deconvolution performs at high accuracy for well-defined cell-type signatures and propose how fuzzy cell-type signatures can be improved. We suggest that future efforts should be dedicated to refining cell population definitions and finding reliable signatures. Availability: A snakemake pipeline to reproduce the benchmark is available at https://github.com/grst/immune_deconvolution_benchmark. An R package allows the community to perform integrated deconvolution using different methods (https://grst.github.io/immunedeconv).</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/463828v3?rss=1</originId><description>Motivation: The composition and density of immune cells in the tumor microenvironment profoundly influence tumor progression and success of anti-cancer therapies. Flow cytometry, immunohistochemistry staining, or single-cell sequencing is often unavailable such that we rely on computational methods to estimate the immune-cell composition from bulk RNA-sequencing (RNA-seq) data. Various methods have been proposed recently, yet their capabilities and limitations have not been evaluated systematically. A general guideline leading the research community through cell type deconvolution is missing. Results: We developed a systematic approach for benchmarking such computational methods and assessed the accuracy of tools at estimating nine different immune- and stromal cells from bulk RNA-seq samples. We used a single-cell RNA-seq dataset of ~11,000 cells from the tumor microenvironment to simulate bulk samples of known cell type proportions, and validated the results using independent, publicly available gold-standard estimates. This allowed us to analyze and condense the results of more than a hundred thousand predictions to provide an exhaustive evaluation across seven computational methods over nine cell types and ~1,800 samples from five simulated and real-world datasets. We demonstrate that computational deconvolution performs at high accuracy for well-defined cell-type signatures and propose how fuzzy cell-type signatures can be improved. We suggest that future efforts should be dedicated to refining cell population definitions and finding reliable signatures. Availability: A snakemake pipeline to reproduce the benchmark is available at https://github.com/grst/immune_deconvolution_benchmark. An R package allows the community to perform integrated deconvolution using different methods (https://grst.github.io/immunedeconv).</description><published>1548576000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/463828v3?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168915c65a6:4ab327d:3a104d3b</id><title>Comprehensive evaluation of computational cell-type quantification methods for immuno-oncology [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/10.1101/463828v3</canonicalUrl></item><item><engagement>35</engagement><crawled>1548270343644</crawled><visual><url>none</url></visual><author><name>Kaeberlein, M., Galvan, V.</name></author><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/476/eaar4289?rss=1</link><content><content>&lt;p&gt;The drug rapamycin has beneficial effects in a number of animal models of neurodegeneration and aging including mouse models of Alzheimer’s disease. Despite its compelling preclinical record, no clinical trials have tested rapamycin or other mTOR inhibitors in patients with Alzheimer’s disease. We argue that such clinical trials should be undertaken.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/476/eaar4289?rss=1</originId><description>&lt;p&gt;The drug rapamycin has beneficial effects in a number of animal models of neurodegeneration and aging including mouse models of Alzheimer’s disease. Despite its compelling preclinical record, no clinical trials have tested rapamycin or other mTOR inhibitors in patients with Alzheimer’s disease. We argue that such clinical trials should be undertaken.&lt;/p&gt;</description><canonicalUrl>http://stm.sciencemag.org/content/11/476/eaar4289.full</canonicalUrl><published>1548269442000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/476/eaar4289?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1687c1a95dc:2f6433e:ad2b6584</id><title>[Perspectives] Rapamycin and Alzheimers disease: Time for a clinical trial?</title><fingerprint>f99b1d26</fingerprint></item><item><crawled>1548836508002</crawled><origin><htmlUrl>https://onlinelibrary.wiley.com/journal/1096987x?af=R</htmlUrl><streamId>feed/https://onlinelibrary.wiley.com/action/showFeed?jc=1096987x&amp;type=etoc&amp;feed=rss</streamId><title>Wiley: Journal of Computational Chemistry: Table of Contents</title></origin><author><name>Laura J. S. Lopes, 
Tony Lelièvre</name></author><visual><height>394</height><processor>feedly-nikon-v3.1</processor><contentType>image/png; charset=UTF-8</contentType><width>394</width><url>https://onlinelibrary.wiley.com/cms/attachment/d352a250-5b8c-4d72-a1c2-b1c59d0a289b/jcc25778-toc-0001-m.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25778?af=R</link><content><content>&lt;img alt=&quot;Journal of Computational Chemistry Analysis of the adaptive multilevel splitting method on the isomerization of alanine dipeptide&quot; src=&quot;https://onlinelibrary.wiley.com/cms/attachment/d352a250-5b8c-4d72-a1c2-b1c59d0a289b/jcc25778-toc-0001-m.png&quot;&gt;
&lt;p&gt;Rare events in molecular dynamics, which include processes like ligand‐protein unbinding, have been an important field of research. The low probability of occurrence entails the need to use adapted methods to simulate these processes. In this article, we apply the adaptive multilevel splitting method to the isomerization of alanine dipeptide. Some properties of the algorithm are numerically illustrated, and the method is then used to obtain the transition time between the two stable structures.
&lt;/p&gt;
&lt;br&gt;
&lt;p&gt;We apply the adaptive multilevel splitting (AMS) method to the &lt;span&gt;
&lt;i&gt;C&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;eq&lt;/i&gt;
&lt;/sub&gt; → &lt;i&gt;C&lt;/i&gt;
&lt;sub&gt;
&lt;i&gt;ax&lt;/i&gt;
&lt;/sub&gt;
&lt;/span&gt; transition of alanine dipeptide in vacuum. Some properties of the algorithm are numerically illustrated, such as the unbiasedness of the probability estimator and the robustness of the method with respect to the reaction coordinate. We also calculate the transition time obtained via the probability estimator, using an appropriate ensemble of initial conditions. Finally, we show how the AMS method can be used to compute an approximation of the committor function. © 2019 Wiley Periodicals, Inc.&lt;/p&gt;</content><direction>ltr</direction></content><originId>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25778?af=R</originId><description>Rare events in molecular dynamics, which include processes like ligand‐protein unbinding, have been an important field of research. The low probability of occurrence entails the need to use adapted methods to simulate these processes. In this article, we apply the adaptive multilevel splitting method to the isomerization of alanine dipeptide. Some properties of the algorithm are numerically illustrated, and the method is then used to obtain the transition time between the two stable structures.
We apply the adaptive multilevel splitting (AMS) method to the C
eq → C
ax transition of alanine dipeptide in vacuum. Some properties of the algorithm are numerically illustrated, such as the unbiasedness of the probability estimator and the robustness of the method with respect to the reaction coordinate. We also calculate the transition time obtained via the probability estimator, using an appropriate ensemble of initial conditions. Finally, we show how the AMS method can be used to compute an approximation of the committor function. © 2019 Wiley Periodicals, Inc.</description><published>1548777760000</published><alternate><item><type>text/html</type><href>https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.25778?af=R</href></item></alternate><id>6wY2EtDmLbeMr9WopopAzS1SKiHs2ogsOuunEriW7zs=_1689dd99162:8fcf14:3a104d3b</id><title>Analysis of the adaptive multilevel splitting method on the isomerization of alanine dipeptide</title><fingerprint>21dc846d</fingerprint><summary><content>Rare events in molecular dynamics, which include processes like ligand‐protein unbinding, have been an important field of research. The low probability of occurrence entails the need to use adapted methods to simulate these processes. In this article, we apply the adaptive multilevel splitting method to the isomerization of alanine dipeptide. Some properties of the algorithm are numerically illustrated, and the method is then used to obtain the transition time between the two stable structures.
We apply the adaptive multilevel splitting (AMS) method to the C
eq → C
ax transition of alanine dipeptide in vacuum. Some properties of the algorithm are numerically illustrated, such as the unbiasedness of the probability estimator and the robustness of the method with respect to the reaction coordinate. We also calculate the transition time obtained via the probability estimator, using an appropriate ensemble of initial conditions. Finally, we show how the AMS method can be used to compute an approximation of the committor function. © 2019 Wiley Periodicals, Inc.</content><direction>ltr</direction></summary></item><item><entities><item><label>SRP</label><id>nlp/f/entity/en/-/srp</id><mentions><item><text>SRP</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>SEC62</label><id>nlp/f/entity/en/w/SEC62</id><mentions><item><text>Sec62</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>SEC63</label><id>nlp/f/entity/en/w/SEC63</id><mentions><item><text>Sec63</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>U.S. Securities and Exchange Commission</label><id>nlp/f/entity/en/w/U.S. Securities and Exchange Commission</id><mentions><item><text>Sec</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>BiP</label><id>nlp/f/entity/en/-/bip</id><mentions><item><text>BiP</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546272877376</crawled><visual><url>none</url></visual><author><name>Xudong Wu</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-018-0856-x</link><content><content>&lt;p&gt;&lt;b&gt;Structure of the post-translational protein translocation machinery of the ER membrane&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Structure of the post-translational protein translocation machinery of the ER membrane, Published online: 31 December 2018; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0856-x&quot;&gt;doi:10.1038/s41586-018-0856-x&lt;/a&gt;&lt;/p&gt;Structure of the post-translational protein translocation machinery of the ER membrane</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41586-018-0856-x</originId><description>&lt;p&gt;&lt;b&gt;Structure of the post-translational protein translocation machinery of the ER membrane&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Structure of the post-translational protein translocation machinery of the ER membrane, Published online: 31 December 2018; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0856-x&quot;&gt;doi:10.1038/s41586-018-0856-x&lt;/a&gt;&lt;/p&gt;Structure of the post-translational protein translocation machinery of the ER membrane</description><published>1546243200000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0856-x</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168050bab40:558f52b:c2ce2e2e</id><title>Structure of the post-translational protein translocation machinery of the ER membrane</title><fingerprint>79d6326c</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07898-0</href></item></canonical><engagement>0</engagement><crawled>1546597817290</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Adam Shahine</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>509</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07898-0/MediaObjects/41467_2018_7898_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-07898-0</link><content><content>&lt;p&gt;&lt;b&gt;A T-cell receptor escape channel allows broad T-cell response to CD1b and membrane phospholipids&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A T-cell receptor escape channel allows broad T-cell response to CD1b and membrane phospholipids, Published online: 04 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07898-0&quot;&gt;doi:10.1038/s41467-018-07898-0&lt;/a&gt;&lt;/p&gt;CD1 proteins present lipid antigens to T cells via the T cell receptor. Here the authors describe T cell reactivity to human membrane lipid moieties and provide structural data to define a molecular mechanism of promiscuous recognition of self-derived phospholipids.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/eucz3fNb4_0&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-07898-0</originId><description>&lt;p&gt;&lt;b&gt;A T-cell receptor escape channel allows broad T-cell response to CD1b and membrane phospholipids&lt;/b&gt;&lt;/p&gt;&lt;p&gt;A T-cell receptor escape channel allows broad T-cell response to CD1b and membrane phospholipids, Published online: 04 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07898-0&quot;&gt;doi:10.1038/s41467-018-07898-0&lt;/a&gt;&lt;/p&gt;CD1 proteins present lipid antigens to T cells via the T cell receptor. Here the authors describe T cell reactivity to human membrane lipid moieties and provide structural data to define a molecular mechanism of promiscuous recognition of self-derived phospholipids.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/eucz3fNb4_0&quot; height=&quot;1&quot;&gt;</description><published>1546588800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/eucz3fNb4_0/s41467-018-07898-0</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1681869dbca:2e6725:ad2b6584</id><title>A T-cell receptor escape channel allows broad T-cell response to CD1b and membrane phospholipids</title><fingerprint>a064baa1</fingerprint></item><item><engagement>0</engagement><crawled>1546882139798</crawled><fingerprint>43974156</fingerprint><author><name>Marchet, C.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/512889v1?rss=1</link><content><content>Motivation: In the last few years, third generation sequencing error rates have been capped above 5%, including many insertions and deletions. Thereby, an increasing number of long reads correction methods have been proposed to reduce the noise in these sequences. Whether hybrid or self-correction methods, there exist multiple approaches to correct long reads data. As the quality of the error correction has huge impacts on downstream processes, developing methods allowing to evaluate error correction tools with precise and reliable statistics is therefore a crucial need. Since error correction is often a resource bottleneck in long reads pipelines. A key feature of assessment methods is therefore to be efficient, in order to allow the fast comparison of different tools. Results: We propose ELECTOR, a reliable and efficient tool to evaluate long reads correction, that enables the evaluation of hybrid and self-correction methods. Our tool provides a complete and relevant set of metrics to assess the read quality improvement after correction and scales to large datasets. ELECTOR is directly compatible with a wide range of state-of-the-art error correction tools, using whether simulated or real long reads. We show that ELECTOR displays a wider range of metrics than the state-of-the-art tool, LRCstats, and additionally importantly decreases the runtime needed for assessment on most datasets.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/512889v1?rss=1</originId><description>Motivation: In the last few years, third generation sequencing error rates have been capped above 5%, including many insertions and deletions. Thereby, an increasing number of long reads correction methods have been proposed to reduce the noise in these sequences. Whether hybrid or self-correction methods, there exist multiple approaches to correct long reads data. As the quality of the error correction has huge impacts on downstream processes, developing methods allowing to evaluate error correction tools with precise and reliable statistics is therefore a crucial need. Since error correction is often a resource bottleneck in long reads pipelines. A key feature of assessment methods is therefore to be efficient, in order to allow the fast comparison of different tools. Results: We propose ELECTOR, a reliable and efficient tool to evaluate long reads correction, that enables the evaluation of hybrid and self-correction methods. Our tool provides a complete and relevant set of metrics to assess the read quality improvement after correction and scales to large datasets. ELECTOR is directly compatible with a wide range of state-of-the-art error correction tools, using whether simulated or real long reads. We show that ELECTOR displays a wider range of metrics than the state-of-the-art tool, LRCstats, and additionally importantly decreases the runtime needed for assessment on most datasets.</description><published>1546848000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/512889v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168295c4696:16a7e4d:ad2b6584</id><title>ELECTOR: Evaluator for long reads correction methods [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/07/512889</canonicalUrl></item><item><engagement>123</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><author><name>Eisenhut, M., Weber, A. P. M.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/32?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/32?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6422/32.full</canonicalUrl><published>1546540591000</published><keywords><item>Botany, Ecology</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/32?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3c6:ad2b6584</id><title>Improving crop yield</title><fingerprint>3187d026</fingerprint></item><item><unread>True</unread><engagement>0</engagement><crawled>1547752389672</crawled><visual><url>none</url></visual><author><name>Junior, H. M., Martelli, D. R., Silva, A. C. S. e., Oliveira, M. C. L., Oliveira, E. A.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>62123a57</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6424/240-a?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6424/240-a?rss=1</originId><published>1547750305000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/240-a?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce099:ad2b6584</id><title>Brazil&apos;s endangered postgraduate system</title><canonicalUrl>http://science.sciencemag.org/content/363/6424/240.1.full</canonicalUrl></item><item><entities><item><label>Moody&apos;s Investors Service</label><id>nlp/f/entity/en/w/Moody&apos;s Investors Service</id><mentions><item><text>Moody</text></item><item><text>Moody &apos;s Investors Service</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id><mentions><item><text>Getty</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Gabriel Serna</label><id>nlp/f/entity/en/-/gabriel serna</id><mentions><item><text>Serna</text></item><item><text>Gabriel Serna</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>US Council of Graduate Schools</label><id>nlp/f/entity/en/-/us council of graduate schools</id><mentions><item><text>US Council of Graduate Schools</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Institute of International Education</label><id>nlp/f/entity/en/w/Institute of International Education</id><mentions><item><text>Institute of International Education</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546530920355</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07889-7/d41586-018-07889-7_16369682.jpg</url></visual><author><name>Chris Woolston</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07889-7</link><content><content>&lt;p&gt;&lt;b&gt;Falling tuition revenues could pinch US universities&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Falling tuition revenues could pinch US universities, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07889-7&quot;&gt;doi:10.1038/d41586-018-07889-7&lt;/a&gt;&lt;/p&gt;Report predicts that public institutions could face recruitment and retention struggles.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/d41586-018-07889-7</originId><description>&lt;p&gt;&lt;b&gt;Falling tuition revenues could pinch US universities&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Falling tuition revenues could pinch US universities, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07889-7&quot;&gt;doi:10.1038/d41586-018-07889-7&lt;/a&gt;&lt;/p&gt;Report predicts that public institutions could face recruitment and retention struggles.</description><published>1546502400000</published><engagement>9</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07889-7</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168146d17a3:68af069:3a104d3b</id><title>Falling tuition revenues could pinch US universities</title><fingerprint>6eb3cde1</fingerprint></item><item><engagement>1</engagement><crawled>1547419411014</crawled><fingerprint>c45e614f</fingerprint><author><name>Zhang, X. A.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/519231v1?rss=1</link><content><content>Electronic Health Record (EHR) systems typically define laboratory test results using the Laboratory Observation Identifier Names and Codes (LOINC) and can transmit them using Fast Healthcare Interoperability Resource (FHIR) standards. LOINC has not yet been semantically integrated with computational resources for phenotype analysis. Here, we provide a method for mapping LOINC-encoded laboratory test results transmitted in FHIR standards to the Human Phenotype Ontology (HPO) terms. We annotated the medical implications of 2421 commonly used laboratory tests with HPO terms. Using these annotations, a software assesses laboratory test results and converts each into an HPO term. We validated our approach with EHR data from 15,681 patients with respiratory complaints and identified known biomarkers for asthma. Finally, we provide a freely available SMART on FHIR application that can be used within EHR systems. Our approach allows reusing readily available laboratory tests in EHR for deep phenotyping and using the hierarchical structure of HPO for association studies with medical outcomes and genomics.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/519231v1?rss=1</originId><description>Electronic Health Record (EHR) systems typically define laboratory test results using the Laboratory Observation Identifier Names and Codes (LOINC) and can transmit them using Fast Healthcare Interoperability Resource (FHIR) standards. LOINC has not yet been semantically integrated with computational resources for phenotype analysis. Here, we provide a method for mapping LOINC-encoded laboratory test results transmitted in FHIR standards to the Human Phenotype Ontology (HPO) terms. We annotated the medical implications of 2421 commonly used laboratory tests with HPO terms. Using these annotations, a software assesses laboratory test results and converts each into an HPO term. We validated our approach with EHR data from 15,681 patients with respiratory complaints and identified known biomarkers for asthma. Finally, we provide a freely available SMART on FHIR application that can be used within EHR systems. Our approach allows reusing readily available laboratory tests in EHR for deep phenotyping and using the hierarchical structure of HPO for association studies with medical outcomes and genomics.</description><published>1547366400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/519231v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16849626246:298d05c:8675cc2c</id><title>Semantic Integration of Clinical Laboratory Tests from Electronic Health Records for Deep Phenotyping and Biomarker Discovery [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/13/519231</canonicalUrl></item><item><crawled>1548703072665</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1548633600000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Halide_Ion_Micro-Hydration_Structure_Energetics_and_Spectroscopy_of_Small_Halide_Water_Clusters/7636004</link><originId>https://chemrxiv.org/articles/Halide_Ion_Micro-Hydration_Structure_Energetics_and_Spectroscopy_of_Small_Halide_Water_Clusters/7636004</originId><description>Replica exchange molecular dynamics simulations and vibrational spectroscopy calculations
are performed using halide-water many-body potential energy functions to provide a bottom-up
analysis of the structures, energetics, and hydrogen-bonding arrangements in X−(H2O)n=3−6
clusters, with X = F, Cl, Br, and I. Independently of the cluster size, it is found that all four
halides prefer surface-type structures in which they occupy one of the vertices in the underlying three-dimensional hydrogen-bond networks. For fluoride-water clusters, this is in contrast
with previous reports suggesting that fluoride prefers interior-type arrangements, where the ion
is fully hydrated. These differences can be ascribed to the variability in how various molecular
models are capable to reproduce the subtle interplay between halide-water and water-water interactions. Our results thus emphasize the importance of a correct representation of individual
many-body contributions to the molecular interactions for a quantitative description of halide
ion hydration.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Halide_Ion_Micro-Hydration_Structure_Energetics_and_Spectroscopy_of_Small_Halide_Water_Clusters/7636004</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16895e58199:510237a:ad2b6584</id><title>Halide Ion Micro-Hydration: Structure, Energetics, and Spectroscopy of Small Halide–Water Clusters</title><fingerprint>db8cd520</fingerprint><summary><content>Replica exchange molecular dynamics simulations and vibrational spectroscopy calculations
are performed using halide-water many-body potential energy functions to provide a bottom-up
analysis of the structures, energetics, and hydrogen-bonding arrangements in X−(H2O)n=3−6
clusters, with X = F, Cl, Br, and I. Independently of the cluster size, it is found that all four
halides prefer surface-type structures in which they occupy one of the vertices in the underlying three-dimensional hydrogen-bond networks. For fluoride-water clusters, this is in contrast
with previous reports suggesting that fluoride prefers interior-type arrangements, where the ion
is fully hydrated. These differences can be ascribed to the variability in how various molecular
models are capable to reproduce the subtle interplay between halide-water and water-water interactions. Our results thus emphasize the importance of a correct representation of individual
many-body contributions to the molecular interactions for a quantitative description of halide
ion hydration.</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0334-x</href></item></canonical><entities><item><label>Lo</label><id>nlp/f/entity/en/-/lo</id><mentions><item><text>Lo</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Genet</label><id>nlp/f/entity/en/-/genet</id><mentions><item><text>Genet</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Dar</label><id>nlp/f/entity/en/-/dar</id><mentions><item><text>Dar</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Norton</label><id>nlp/f/entity/en/-/norton</id><mentions><item><text>Norton</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Prenat</label><id>nlp/f/entity/en/-/prenat</id><mentions><item><text>Prenat</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548691718069</crawled><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><author><name>Jinglan Zhang</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>611</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0334-x/MediaObjects/41591_2018_334_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41591-018-0334-x</link><content><content>&lt;p&gt;&lt;b&gt;Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0334-x&quot;&gt;doi:10.1038/s41591-018-0334-x&lt;/a&gt;&lt;/p&gt;A non-invasive prenatal test utilizing cell-free DNA simultaneously detects mutations in 30 genes frequently associated with dominant monogenic diseases and demonstrates high accuracy in human clinical samples.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/3MXKRtXsE7M&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>brain</label><id>nlp/f/topic/314</id><probability>1.0</probability></item><item><label>cell</label><id>nlp/f/topic/403</id><probability>1.0</probability></item><item><label>bioinformatics</label><id>nlp/f/topic/262</id><probability>0.999</probability></item><item><label>neurology</label><id>nlp/f/topic/1563</id><probability>0.987</probability></item><item><label>genetics</label><id>nlp/f/topic/955</id><probability>0.962</probability></item><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.961</probability></item><item><label>stem cells</label><id>nlp/f/topic/2185</id><probability>0.958</probability></item><item><label>dna</label><id>nlp/f/topic/679</id><probability>0.94</probability></item><item><label>hematology</label><id>nlp/f/topic/1058</id><probability>0.716</probability></item></commonTopics><originId>https://www.nature.com/articles/s41591-018-0334-x</originId><description>&lt;p&gt;&lt;b&gt;Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0334-x&quot;&gt;doi:10.1038/s41591-018-0334-x&lt;/a&gt;&lt;/p&gt;A non-invasive prenatal test utilizing cell-free DNA simultaneously detects mutations in 30 genes frequently associated with dominant monogenic diseases and demonstrates high accuracy in human clinical samples.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/3MXKRtXsE7M&quot; height=&quot;1&quot;&gt;</description><engagementRate>1.09</engagementRate><published>1548662400000</published><engagement>12</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/3MXKRtXsE7M/s41591-018-0334-x</href></item></alternate><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_16895383fb5:4fc2f1f:3a104d3b</id><title>Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA</title><fingerprint>7c61f517</fingerprint></item><item><crawled>1548778946509</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1548720000000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Adsorption_of_Amino_Acids_on_Graphene_Assessment_of_Current_Force_Fields/7640489</link><originId>https://chemrxiv.org/articles/Adsorption_of_Amino_Acids_on_Graphene_Assessment_of_Current_Force_Fields/7640489</originId><description>We compare the free energies of adsorption (∆Aads) and the structural preferences of amino
acids obtained using the force fields — Amberff99SB-ILDN/TIP3P, CHARMM36/modified-TIP3P,
OPLS-AA/M/TIP3P, and Amber03w/TIP4P/2005. The amino acid–graphene interactions are favorable irrespective of the force field. While the magnitudes of ∆Aads differ between the force
fields, the trends in the free energy of adsorption with amino acids are similar across the studied
force fields. ∆Aads positively correlates with amino acid–graphene and negatively correlates with
graphene–water interaction energies. Using a combination of principal component analysis and
density-based clustering technique, we grouped the structures observed in the graphene adsorbed
state. The resulting population of clusters, and the conformation in each cluster indicate that the
structures of the amino acid in the graphene adsorbed state vary across force fields. The differences
in the conformations of amino acids are more severe in the graphene adsorbed state compared to the
bulk state for all the force fields. Our findings suggest that while the thermodynamics of adsorption
of proteins and peptides would be described consistently across different force fields, the structural
preferences of peptides and proteins on graphene will be force field dependent.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Adsorption_of_Amino_Acids_on_Graphene_Assessment_of_Current_Force_Fields/7640489</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1689a6b3fcd:435e80:ad2b6584</id><title>Adsorption of Amino Acids on Graphene: Assessment of Current Force Fields</title><fingerprint>e6375b8b</fingerprint><summary><content>We compare the free energies of adsorption (∆Aads) and the structural preferences of amino
acids obtained using the force fields — Amberff99SB-ILDN/TIP3P, CHARMM36/modified-TIP3P,
OPLS-AA/M/TIP3P, and Amber03w/TIP4P/2005. The amino acid–graphene interactions are favorable irrespective of the force field. While the magnitudes of ∆Aads differ between the force
fields, the trends in the free energy of adsorption with amino acids are similar across the studied
force fields. ∆Aads positively correlates with amino acid–graphene and negatively correlates with
graphene–water interaction energies. Using a combination of principal component analysis and
density-based clustering technique, we grouped the structures observed in the graphene adsorbed
state. The resulting population of clusters, and the conformation in each cluster indicate that the
structures of the amino acid in the graphene adsorbed state vary across force fields. The differences
in the conformations of amino acids are more severe in the graphene adsorbed state compared to the
bulk state for all the force fields. Our findings suggest that while the thermodynamics of adsorption
of proteins and peptides would be described consistently across different force fields, the structural
preferences of peptides and proteins on graphene will be force field dependent.</content><direction>ltr</direction></summary></item><item><engagement>1</engagement><crawled>1547147463250</crawled><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><author><name>Bruelheide, H., Chen, Y., Huang, Y., Ma, K., Niklaus, P. A., Schmid, B.</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6423/eaav9863?rss=1</link><content><content>&lt;p&gt;Yang &lt;i&gt;et al&lt;/i&gt;. have raised criticism that the results reported by us would not be relevant for natural forests. We argue that productivity is positively related to species richness also in subtropical natural forests, and that both the species pools and the range of tree species richness used in our experiment are representative of many natural forests of this biome.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://science.sciencemag.org/cgi/content/short/363/6423/eaav9863?rss=1</originId><description>&lt;p&gt;Yang &lt;i&gt;et al&lt;/i&gt;. have raised criticism that the results reported by us would not be relevant for natural forests. We argue that productivity is positively related to species richness also in subtropical natural forests, and that both the species pools and the range of tree species richness used in our experiment are representative of many natural forests of this biome.&lt;/p&gt;</description><canonicalUrl>http://science.sciencemag.org/content/363/6423/eaav9863.full</canonicalUrl><published>1547145461000</published><keywords><item>Ecology</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/eaav9863?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:1570885:8675cc2c</id><title>Response to Comment on &quot;Impacts of species richness on productivity in a large-scale subtropical forest experiment&quot;</title><fingerprint>ed000153</fingerprint></item><item><entities><item><label>min</label><id>nlp/f/entity/en/-/min</id><mentions><item><text>min</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Hello Nature</label><id>nlp/f/entity/en/-/hello nature</id><mentions><item><text>Hello Nature</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Ebola virus disease</label><id>nlp/f/entity/en/w/Ebola virus disease</id><mentions><item><text>Ebola</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>CERN</label><id>nlp/f/entity/en/w/CERN</id><mentions><item><text>CERN</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>European Space Agency</label><id>nlp/f/entity/en/w/European Space Agency</id><mentions><item><text>ESA</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547659798027</crawled><visual><height>393</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00188-9/d41586-019-00188-9_16112928.jpg</url></visual><author><name>Flora Graham</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00188-9</link><content><content>&lt;p&gt;&lt;b&gt;Daily briefing: WHO calls out ‘vaccine hesitancy’ as top 10 health threat&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Daily briefing: WHO calls out ‘vaccine hesitancy’ as top 10 health threat, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00188-9&quot;&gt;doi:10.1038/d41586-019-00188-9&lt;/a&gt;&lt;/p&gt;Anti-vaccination sentiment up there with deadly air pollution, Ebola and antibiotic resistance. Plus: the Milky Way is awesome and there’s a plant growing on the Moon.</content><direction>ltr</direction></content><commonTopics><item><label>global health</label><id>nlp/f/topic/977</id><probability>0.962</probability></item><item><label>conservation</label><id>nlp/f/topic/532</id><probability>0.961</probability></item><item><label>charlotte mason</label><id>nlp/f/topic/427</id><probability>0.714</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00188-9</originId><description>&lt;p&gt;&lt;b&gt;Daily briefing: WHO calls out ‘vaccine hesitancy’ as top 10 health threat&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Daily briefing: WHO calls out ‘vaccine hesitancy’ as top 10 health threat, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00188-9&quot;&gt;doi:10.1038/d41586-019-00188-9&lt;/a&gt;&lt;/p&gt;Anti-vaccination sentiment up there with deadly air pollution, Ebola and antibiotic resistance. Plus: the Milky Way is awesome and there’s a plant growing on the Moon.</description><published>1547625600000</published><engagement>12</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00188-9</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857b6660b:3d7ff05:3a104d3b</id><title>Daily briefing: WHO calls out ‘vaccine hesitancy’ as top 10 health threat</title><fingerprint>ad6f5b10</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acschembio.8b01022</href></item></canonical><engagement>0</engagement><crawled>1548869080861</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/acbcct</streamId><title>ACS Chemical Biology: Latest Articles (ACS Publications)</title></origin><author><name>Nilkamal Mahanta, D. Miklos Szantai-Kis, E. James Petersson, Douglas A. Mitchell</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acschembio.8b01022</link><originId>http://dx.doi.org/10.1021/acschembio.8b01022</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b01022/20190129/images/medium/cb-2018-01022v_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b01022&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=R17vQDz5Mgs:RS2Zfi1nx1o:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/R17vQDz5Mgs&quot; height=&quot;1&quot;&gt;</description><published>1548824400000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/acbcct/~3/R17vQDz5Mgs/acschembio.8b01022</href></item></alternate><id>ofNPcmQ46PpGzt1nO49W9STAvkUsM7jssLxNXMp09ME=_1689fca971d:4bbf46:56b782f7</id><title>[ASAP] Biosynthesis and Chemical Applications of Thioamides</title><fingerprint>e023d098</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/acbcct/0/acbcct.ahead-of-print/acschembio.8b01022/20190129/images/medium/cb-2018-01022v_0017.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;ACS Chemical Biology&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acschembio.8b01022&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?a=R17vQDz5Mgs:RS2Zfi1nx1o:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/acbcct?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/acbcct/~4/R17vQDz5Mgs&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><entities><item><label>Ernest Lawrence</label><id>nlp/f/entity/en/w/Ernest Lawrence</id><mentions><item><text>Lawrence</text></item><item><text>Ernest Lawrence</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Emilio Segrè</label><id>nlp/f/entity/en/w/Emilio Segrè</id><mentions><item><text>Emilio Segrè</text></item><item><text>Segrè</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Dmitri Mendeleev</label><id>nlp/f/entity/en/w/Dmitri Mendeleev</id><mentions><item><text>Mendeleev</text></item><item><text>Dmitri Mendeleev</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Enrico Fermi</label><id>nlp/f/entity/en/w/Enrico Fermi</id><mentions><item><text>Enrico Fermi</text></item><item><text>Fermi</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>eka - manganese</label><id>nlp/f/entity/en/-/eka - manganese</id><mentions><item><text>eka - manganese</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548684673217</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00236-4/d41586-019-00236-4_16417034.jpg</url></visual><author><name>Kit Chapman</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00236-4</link><content><content>&lt;p&gt;&lt;b&gt;The first synthetic element&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The first synthetic element, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00236-4&quot;&gt;doi:10.1038/d41586-019-00236-4&lt;/a&gt;&lt;/p&gt;When Mendeleev proposed his periodic table in 1869, element 43 was unknown. In 1937, it became the first element to be discovered by synthesis in a laboratory — paving the way to the atomic age.</content><direction>ltr</direction></content><commonTopics><item><label>browsers</label><id>nlp/f/topic/334</id><probability>0.976</probability></item><item><label>css</label><id>nlp/f/topic/590</id><probability>0.973</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00236-4</originId><description>&lt;p&gt;&lt;b&gt;The first synthetic element&lt;/b&gt;&lt;/p&gt;&lt;p&gt;The first synthetic element, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00236-4&quot;&gt;doi:10.1038/d41586-019-00236-4&lt;/a&gt;&lt;/p&gt;When Mendeleev proposed his periodic table in 1869, element 43 was unknown. In 1937, it became the first element to be discovered by synthesis in a laboratory — paving the way to the atomic age.</description><engagementRate>2.56</engagementRate><published>1548662400000</published><engagement>23</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00236-4</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16894ccc0c1:4f1a4fb:3a104d3b</id><title>The first synthetic element</title><fingerprint>56abb3fe</fingerprint></item><item><entities><item><label>CRISPR</label><id>nlp/f/entity/en/w/CRISPR</id><mentions><item><text>CRISPR</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Xinhua News Agency</label><id>nlp/f/entity/en/w/Xinhua News Agency</id><mentions><item><text>Xinhua</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Guangdong health ministry</label><id>nlp/f/entity/en/-/guangdong health ministry</id><mentions><item><text>Guangdong health ministry</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id><mentions><item><text>Getty</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Guandong province</label><id>nlp/f/entity/en/-/guandong province</id><mentions><item><text>Guandong province</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548185912505</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00246-2/d41586-019-00246-2_16411326.jpg</url></visual><author><name>David Cyranoski</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00246-2</link><content><content>&lt;p&gt;&lt;b&gt;CRISPR-baby scientist fired by university&lt;/b&gt;&lt;/p&gt;&lt;p&gt;CRISPR-baby scientist fired by university, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00246-2&quot;&gt;doi:10.1038/d41586-019-00246-2&lt;/a&gt;&lt;/p&gt;Investigation by Chinese authorities finds He Jiankui broke national regulations in his controversial work on gene-edited babies.</content><direction>ltr</direction></content><commonTopics><item><label>health</label><id>nlp/f/topic/1045</id><probability>0.775</probability></item><item><label>stem cells</label><id>nlp/f/topic/2185</id><probability>0.734</probability></item><item><label>hiv</label><id>nlp/f/topic/1069</id><probability>0.714</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00246-2</originId><description>&lt;p&gt;&lt;b&gt;CRISPR-baby scientist fired by university&lt;/b&gt;&lt;/p&gt;&lt;p&gt;CRISPR-baby scientist fired by university, Published online: 22 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00246-2&quot;&gt;doi:10.1038/d41586-019-00246-2&lt;/a&gt;&lt;/p&gt;Investigation by Chinese authorities finds He Jiankui broke national regulations in his controversial work on gene-edited babies.</description><published>1548144000000</published><engagement>8</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00246-2</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_168771244b9:270e015:c2ce2e2e</id><title>CRISPR-baby scientist fired by university</title><fingerprint>ddb348f2</fingerprint></item><item><unread>True</unread><engagement>2</engagement><crawled>1547147463250</crawled><visual><url>none</url></visual><published>1547145461000</published><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>deb03a4d</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6423/106?rss=1</link><entities><item><label>American Association for the Advancement of Science</label><id>nlp/f/entity/en/w/American Association for the Advancement of Science</id><mentions><item><text>AAAS</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Science</label><id>nlp/f/entity/en/w/Science</id><mentions><item><text>Science</text></item></mentions><salienceLevel>about</salienceLevel></item></entities><originId>http://science.sciencemag.org/cgi/content/short/363/6423/106?rss=1</originId><author><name>NA</name></author><keywords><item>Scientific Community</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/106?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708cd:8675cc2c</id><title>News at a glance</title><canonicalUrl>http://science.sciencemag.org/content/363/6423/106.full</canonicalUrl></item><item><engagement>0</engagement><crawled>1547217063092</crawled><fingerprint>cc7f6d5f</fingerprint><author><name>Chen, D.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/217257v3?rss=1</link><content><content>The growing number of annotated biological sequences available makes it possible to learn genotype-phenotype relationships from data with increasingly high accuracy. When large quantities of labeled samples are available for training a model, convolutional neural networks can be used to predict the phenotype of unannotated sequences with good accuracy. Unfortunately, their performance with medium- or small-scale datasets is mitigated, which requires inventing new data-efficient approaches. In this paper, we introduce a hybrid approach between convolutional neural networks and kernel methods to model biological sequences. Our method enjoys the ability of convolutional neural networks to learn data representations that are adapted to a specific task, while the kernel point of view yields algorithms that perform significantly better when the amount of training data is small. We illustrate these advantages for transcription factor binding prediction and protein homology detection, and we demonstrate that our model is also simple to interpret, which is crucial for discovering predictive motifs in sequences. The source code is freely available at https://gitlab.inria.fr/dchen/CKN-seq.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/217257v3?rss=1</originId><description>The growing number of annotated biological sequences available makes it possible to learn genotype-phenotype relationships from data with increasingly high accuracy. When large quantities of labeled samples are available for training a model, convolutional neural networks can be used to predict the phenotype of unannotated sequences with good accuracy. Unfortunately, their performance with medium- or small-scale datasets is mitigated, which requires inventing new data-efficient approaches. In this paper, we introduce a hybrid approach between convolutional neural networks and kernel methods to model biological sequences. Our method enjoys the ability of convolutional neural networks to learn data representations that are adapted to a specific task, while the kernel point of view yields algorithms that perform significantly better when the amount of training data is small. We illustrate these advantages for transcription factor binding prediction and protein homology detection, and we demonstrate that our model is also simple to interpret, which is crucial for discovering predictive motifs in sequences. The source code is freely available at https://gitlab.inria.fr/dchen/CKN-seq.</description><published>1547193600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/217257v3?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1683d52ccb4:1b6cb3b:8675cc2c</id><title>Biological Sequence Modeling with Convolutional Kernel Networks [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/11/217257</canonicalUrl></item><item><engagement>0</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><author><name>Peha, J.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/38?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/38?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6422/38.full</canonicalUrl><published>1546540591000</published><keywords><item>Economics</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/38?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3c2:ad2b6584</id><title>Robots, telework, and the jobs of the future</title><fingerprint>5d41a6bb</fingerprint></item><item><engagement>0</engagement><crawled>1547654158809</crawled><fingerprint>26a33bad</fingerprint><author><name>Alsamman, A. M.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/522045v1?rss=1</link><content><content>The integration of known nucleotide variations in breeding programs and medical assessments demands the ability to scan and validate thousands of gene-affected SNPs. Designing PCR primers targeting these SNPs require computational tools could generate accurate and target-specific primers using multidisciplinary data types with high accuracy. KASP-Hedgehog is a local-installation, simple and routine tool for allele-specific PCR primer design. KASP-Hedgehog gives user the ability to design KASP primer from a variety of genomic data, extract bi-allelic SNPs for genomic sequences with unknown nucleotide variations and select SNPs with potential effect depending on gene annotation. This tool can use user-provided or self-produced SNPs database to create allele-specific primers with degenerate structure in order to enhance PCR assay selectivity and increase amplification reaction. Additionally, it run an in silico PCR test for designed primers against provided FASTA sequences in order to increase primers selectivity and provide user more information. Moreover, it has interactive and user-friendly graphical user interface (GUI) in addition to a command-line package could be integrated in different bioinformatics pipelines.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/522045v1?rss=1</originId><description>The integration of known nucleotide variations in breeding programs and medical assessments demands the ability to scan and validate thousands of gene-affected SNPs. Designing PCR primers targeting these SNPs require computational tools could generate accurate and target-specific primers using multidisciplinary data types with high accuracy. KASP-Hedgehog is a local-installation, simple and routine tool for allele-specific PCR primer design. KASP-Hedgehog gives user the ability to design KASP primer from a variety of genomic data, extract bi-allelic SNPs for genomic sequences with unknown nucleotide variations and select SNPs with potential effect depending on gene annotation. This tool can use user-provided or self-produced SNPs database to create allele-specific primers with degenerate structure in order to enhance PCR assay selectivity and increase amplification reaction. Additionally, it run an in silico PCR test for designed primers against provided FASTA sequences in order to increase primers selectivity and provide user more information. Moreover, it has interactive and user-friendly graphical user interface (GUI) in addition to a command-line package could be integrated in different bioinformatics pipelines.</description><published>1547625600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/522045v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168576059d9:3dc57e8:8675cc2c</id><title>KASP-Hedgehog: Efficient and routine tool for allele specific primer design using multidisciplinary data types. [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/16/522045</canonicalUrl></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36871-6</href></item></canonical><engagement>0</engagement><crawled>1548325060903</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Ana F. Almeida-Santos</name></author><visual><height>362</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36871-6/MediaObjects/41598_2018_36871_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36871-6</link><content><content>&lt;p&gt;&lt;b&gt;Social isolation impairs the persistence of social recognition memory by disturbing the glutamatergic tonus and the olfactory bulb-dorsal hippocampus coupling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Social isolation impairs the persistence of social recognition memory by disturbing the glutamatergic tonus and the olfactory bulb-dorsal hippocampus coupling, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36871-6&quot;&gt;doi:10.1038/s41598-018-36871-6&lt;/a&gt;&lt;/p&gt;Social isolation impairs the persistence of social recognition memory by disturbing the glutamatergic tonus and the olfactory bulb-dorsal hippocampus coupling&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/mIIU0PtC0Ws&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36871-6</originId><description>&lt;p&gt;&lt;b&gt;Social isolation impairs the persistence of social recognition memory by disturbing the glutamatergic tonus and the olfactory bulb-dorsal hippocampus coupling&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Social isolation impairs the persistence of social recognition memory by disturbing the glutamatergic tonus and the olfactory bulb-dorsal hippocampus coupling, Published online: 24 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36871-6&quot;&gt;doi:10.1038/s41598-018-36871-6&lt;/a&gt;&lt;/p&gt;Social isolation impairs the persistence of social recognition memory by disturbing the glutamatergic tonus and the olfactory bulb-dorsal hippocampus coupling&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/mIIU0PtC0Ws&quot; height=&quot;1&quot;&gt;</description><published>1548316800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/mIIU0PtC0Ws/s41598-018-36871-6</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1687f5d8127:341e611:ad2b6584</id><title>Social isolation impairs the persistence of social recognition memory by disturbing the glutamatergic tonus and the olfactory bulb-dorsal hippocampus coupling</title><fingerprint>1e5ee323</fingerprint></item><item><crawled>1548805713296</crawled><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><author><name>Marcais, G.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/534446v1?rss=1</link><content><content>Motivation: Sequence alignment is a central operation in bioinformatics pipeline and, despite many improvements, remains a computationally challenging problem. Locality Sensitive Hashing (LSH) is one method used to estimate the likelihood of two sequences to have a proper alignment. Using an LSH, it is possible to separate, with high probability and relatively low computation, the pairs of sequences that do not have an alignment from those that may have an alignment. Therefore, an LSH reduces in the overall computational requirement while not introducing many false negatives (i.e., omitting to report a valid alignment). However, current LSH methods treat sequences as a bag of k-mers and do not take into account the relative ordering of k-mers in sequences. And due to the lack of a practical LSH method for edit distance, in practice, LSH methods for Jaccard similarity or Hamming distance are used as a proxy. Results: We present an LSH method, called Order Min Hash (OMH), for the edit distance. This method is a refinement of the minHash LSH used to approximate the Jaccard similarity, in that OMH is not only sensitive to the k-mer contents of the sequences but also to the relative order of the k-mers in the sequences. We present theoretical guarantees of the OMH as a gapped LSH.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/534446v1?rss=1</originId><description>Motivation: Sequence alignment is a central operation in bioinformatics pipeline and, despite many improvements, remains a computationally challenging problem. Locality Sensitive Hashing (LSH) is one method used to estimate the likelihood of two sequences to have a proper alignment. Using an LSH, it is possible to separate, with high probability and relatively low computation, the pairs of sequences that do not have an alignment from those that may have an alignment. Therefore, an LSH reduces in the overall computational requirement while not introducing many false negatives (i.e., omitting to report a valid alignment). However, current LSH methods treat sequences as a bag of k-mers and do not take into account the relative ordering of k-mers in sequences. And due to the lack of a practical LSH method for edit distance, in practice, LSH methods for Jaccard similarity or Hamming distance are used as a proxy. Results: We present an LSH method, called Order Min Hash (OMH), for the edit distance. This method is a refinement of the minHash LSH used to approximate the Jaccard similarity, in that OMH is not only sensitive to the k-mer contents of the sequences but also to the relative order of the k-mers in the sequences. We present theoretical guarantees of the OMH as a gapped LSH.</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/534446v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689c03ad90:689578:3a104d3b</id><title>Locality sensitive hashing for the edit distance [NEW RESULTS]</title><fingerprint>5fb97847</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-019-08338-3</href></item></canonical><engagement>0</engagement><crawled>1547548096718</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Matteo Rosati</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-019-08338-3</link><content><content>&lt;p&gt;&lt;b&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08338-3&quot;&gt;doi:10.1038/s41467-019-08338-3&lt;/a&gt;&lt;/p&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/kaQTXvfT7nU&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-019-08338-3</originId><description>&lt;p&gt;&lt;b&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-019-08338-3&quot;&gt;doi:10.1038/s41467-019-08338-3&lt;/a&gt;&lt;/p&gt;Author Correction: Narrow bounds for the quantum capacity of thermal attenuators&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/kaQTXvfT7nU&quot; height=&quot;1&quot;&gt;</description><published>1547539200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/kaQTXvfT7nU/s41467-019-08338-3</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_168510df8ce:3410aee:8675cc2c</id><title>Author Correction: Narrow bounds for the quantum capacity of thermal attenuators</title><fingerprint>b320a15a</fingerprint></item><item><crawled>1548804025103</crawled><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><author><name>Song, F.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/533372v1?rss=1</link><content><content>Despite their widespread applications, single-cell RNA-sequencing (scRNA-seq) experiments are still plagued by batch effects and dropout events. Although the completely randomized experimental design has frequently been advocated to control for batch effects, it is rarely implemented in real applications due to time and budget constraints. Here, we mathematically prove that under two more flexible and realistic experimental designs--the &amp;quot;reference panel&amp;quot; and the &amp;quot;chain-type&amp;quot; designs--true biological variability can also be separated from batch effects. We develop Batch effects correction with Unknown Subtypes for scRNA-seq data (BUSseq), which is an interpretable Bayesian hierarchical model that closely follows the data-generating mechanism of scRNA-seq experiments. BUSseq can simultaneously correct batch effects, cluster cell types, impute missing data caused by dropout events, and detect differentially expressed genes without requiring a preliminary normalization step. We demonstrate that BUSseq outperforms existing methods with simulated and real data.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/533372v1?rss=1</originId><description>Despite their widespread applications, single-cell RNA-sequencing (scRNA-seq) experiments are still plagued by batch effects and dropout events. Although the completely randomized experimental design has frequently been advocated to control for batch effects, it is rarely implemented in real applications due to time and budget constraints. Here, we mathematically prove that under two more flexible and realistic experimental designs--the &amp;quot;reference panel&amp;quot; and the &amp;quot;chain-type&amp;quot; designs--true biological variability can also be separated from batch effects. We develop Batch effects correction with Unknown Subtypes for scRNA-seq data (BUSseq), which is an interpretable Bayesian hierarchical model that closely follows the data-generating mechanism of scRNA-seq experiments. BUSseq can simultaneously correct batch effects, cluster cell types, impute missing data caused by dropout events, and detect differentially expressed genes without requiring a preliminary normalization step. We demonstrate that BUSseq outperforms existing methods with simulated and real data.</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/533372v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689be9eb0f:67b8d1:ad2b6584</id><title>Flexible Experimental Designs for Valid Single-cell RNA-sequencing Experiments Allowing Batch Effects Correction [NEW RESULTS]</title><fingerprint>856319da</fingerprint></item><item><entities><item><label>Hubble Space Telescope</label><id>nlp/f/entity/en/w/Hubble Space Telescope</id><mentions><item><text>Hubble Space Telescope</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Stockholm University</label><id>nlp/f/entity/en/w/Stockholm University</id><mentions><item><text>Stockholm University</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Jesper Sollerman</label><id>nlp/f/entity/en/-/jesper sollerman</id><mentions><item><text>Jesper Sollerman</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548202590607</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00227-5/d41586-019-00227-5_16411400.jpg</url></visual><published>1548230400000</published><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00227-5</link><content><content>&lt;p&gt;&lt;b&gt;Ants build superhighways without bosses or blueprints&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ants build superhighways without bosses or blueprints, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00227-5&quot;&gt;doi:10.1038/d41586-019-00227-5&lt;/a&gt;&lt;/p&gt;Hard-working insects ﻿achieve engineering marvels despite lack of cooperation.</content><direction>ltr</direction></content><commonTopics><item><label>astrophysics</label><id>nlp/f/topic/173</id><probability>0.952</probability></item><item><label>space</label><id>nlp/f/topic/2140</id><probability>0.924</probability></item><item><label>gossip</label><id>nlp/f/topic/989</id><probability>0.804</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00227-5</originId><description>&lt;p&gt;&lt;b&gt;Ants build superhighways without bosses or blueprints&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Ants build superhighways without bosses or blueprints, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00227-5&quot;&gt;doi:10.1038/d41586-019-00227-5&lt;/a&gt;&lt;/p&gt;Hard-working insects ﻿achieve engineering marvels despite lack of cooperation.</description><author><name>NA</name></author><engagement>3</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00227-5</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687810c18f:28a8953:c2ce2e2e</id><title>Ants build superhighways without bosses or blueprints</title><fingerprint>8e13ffaf</fingerprint></item><item><engagement>0</engagement><crawled>1547665791807</crawled><fingerprint>895ec62a</fingerprint><author><name>Chan, R., Buckley, P. T., OMalley, A., Sause, W. E., Alonzo, F., Lubkin, A., Boguslawski, K. M., Payne, A., Fernandez, J., Strohl, W. R., Whitaker, B., Lynch, A. S., Torres, V. J.</name></author><origin><htmlUrl>http://stm.sciencemag.org</htmlUrl><streamId>feed/http://stm.sciencemag.org/rss/current.xml</streamId><title>Science Translational Medicine current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stm.sciencemag.org/cgi/content/short/11/475/eaat0882?rss=1</link><content><content>&lt;p&gt;A key aspect underlying the severity of infections caused by &lt;i&gt;Staphylococcus aureus&lt;/i&gt; is the abundance of virulence factors that the pathogen uses to thwart critical components of the human immune response. One such mechanism involves the destruction of host immune cells by cytolytic toxins secreted by &lt;i&gt;S. aureus&lt;/i&gt;, including five bicomponent leukocidins: PVL, HlgAB, HlgCB, LukED, and LukAB. Purified leukocidins can lyse immune cells ex vivo, and systemic injections of purified LukED or HlgAB can acutely kill mice. Here, we describe the generation and characterization of centyrins that bind &lt;i&gt;S. aureus&lt;/i&gt; leukocidins with high affinity and protect primary human immune cells from toxin-mediated cytolysis. Centyrins are small protein scaffolds derived from the fibronectin type III–binding domain of the human protein tenascin-C. Although centyrins are potent in tissue culture assays, their short serum half-lives limit their efficacies in vivo. By extending the serum half-lives of centyrins through their fusion to an albumin-binding consensus domain, we demonstrate the in vivo efficacy of these biologics in a murine intoxication model and in models of both prophylactic and therapeutic treatment of live &lt;i&gt;S. aureus&lt;/i&gt; systemic infections. These biologics that target &lt;i&gt;S. aureus&lt;/i&gt; virulence factors have potential for treating and preventing serious staphylococcal infections.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stm.sciencemag.org/cgi/content/short/11/475/eaat0882?rss=1</originId><description>&lt;p&gt;A key aspect underlying the severity of infections caused by &lt;i&gt;Staphylococcus aureus&lt;/i&gt; is the abundance of virulence factors that the pathogen uses to thwart critical components of the human immune response. One such mechanism involves the destruction of host immune cells by cytolytic toxins secreted by &lt;i&gt;S. aureus&lt;/i&gt;, including five bicomponent leukocidins: PVL, HlgAB, HlgCB, LukED, and LukAB. Purified leukocidins can lyse immune cells ex vivo, and systemic injections of purified LukED or HlgAB can acutely kill mice. Here, we describe the generation and characterization of centyrins that bind &lt;i&gt;S. aureus&lt;/i&gt; leukocidins with high affinity and protect primary human immune cells from toxin-mediated cytolysis. Centyrins are small protein scaffolds derived from the fibronectin type III–binding domain of the human protein tenascin-C. Although centyrins are potent in tissue culture assays, their short serum half-lives limit their efficacies in vivo. By extending the serum half-lives of centyrins through their fusion to an albumin-binding consensus domain, we demonstrate the in vivo efficacy of these biologics in a murine intoxication model and in models of both prophylactic and therapeutic treatment of live &lt;i&gt;S. aureus&lt;/i&gt; systemic infections. These biologics that target &lt;i&gt;S. aureus&lt;/i&gt; virulence factors have potential for treating and preventing serious staphylococcal infections.&lt;/p&gt;</description><published>1547664692000</published><alternate><item><type>text/html</type><href>http://stm.sciencemag.org/cgi/content/short/11/475/eaat0882?rss=1</href></item></alternate><id>wnkrsZvJ/I8FcpnJN66aQJEbdeWdw7Fc0LoIj490v/0=_1685811db3f:3e2669e:3a104d3b</id><title>[Research Articles] Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus</title><canonicalUrl>http://stm.sciencemag.org/content/11/475/eaat0882.full</canonicalUrl></item><item><entities><item><label>min</label><id>nlp/f/entity/en/-/min</id><mentions><item><text>min</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Hello Nature</label><id>nlp/f/entity/en/-/hello nature</id><mentions><item><text>Hello Nature</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>European Union</label><id>nlp/f/entity/en/w/European Union</id><mentions><item><text>EU</text></item><item><text>European Union</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Brexit</label><id>nlp/f/entity/en/w/Brexit</id><mentions><item><text>Brexit</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Getty Images</label><id>nlp/f/entity/en/w/Getty Images</id><mentions><item><text>Getty</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547140252095</crawled><visual><height>393</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00109-w/d41586-019-00109-w_16112928.jpg</url></visual><author><name>Flora Graham</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00109-w</link><content><content>&lt;p&gt;&lt;b&gt;Daily briefing: Bejewelled dental tartar points to female scribes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Daily briefing: Bejewelled dental tartar points to female scribes, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00109-w&quot;&gt;doi:10.1038/d41586-019-00109-w&lt;/a&gt;&lt;/p&gt;Thousand-year-old teeth show women worked on medieval manuscripts, the magnetic north pole is fleeing Canada and why your PhD is not a liability.</content><direction>ltr</direction></content><commonTopics><item><label>conservation</label><id>nlp/f/topic/532</id><probability>0.904</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00109-w</originId><description>&lt;p&gt;&lt;b&gt;Daily briefing: Bejewelled dental tartar points to female scribes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Daily briefing: Bejewelled dental tartar points to female scribes, Published online: 10 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00109-w&quot;&gt;doi:10.1038/d41586-019-00109-w&lt;/a&gt;&lt;/p&gt;Thousand-year-old teeth show women worked on medieval manuscripts, the magnetic north pole is fleeing Canada and why your PhD is not a liability.</description><published>1547107200000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00109-w</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16838bec1bf:1423498:c2ce2e2e</id><title>Daily briefing: Bejewelled dental tartar points to female scribes</title><fingerprint>bb2ec9cf</fingerprint></item><item><engagement>0</engagement><crawled>1546997082984</crawled><fingerprint>e5f8defe</fingerprint><author><name>Reed, E.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/419838v2?rss=1</link><content><content>The need to reduce per sample cost of RNA-seq profiling for scalable data generation has led to the emergence of highly multiplexed RNA-seq. These technologies utilize barcoding of cDNA sequences in order to combine samples into single sequencing lane to be separated during data processing. In this study, we report the performance of one such technique denoted as sparse full length sequencing (SFL), a ribosomal RNA depletion-based RNA sequencing approach that allows for the simultaneous sequencing of 96 samples and higher. We offer comparisons to well established single-sample techniques, including: full coverage Poly-A capture RNA-seq and microarray, as well as another low-cost highly multiplexed technique known as 3&apos; digital gene expression (3&apos;DGE). Data was generated for a set of exposure experiments on immortalized human lung epithelial (AALE) cells in a two-by-two study design, in which samples received both genetic and chemical perturbations of known oncogenes/tumor suppressors and lung carcinogens. SFL demonstrated improved performance over 3&apos;DGE in terms of coverage, power to detect differential gene expression, and biological recapitulation of patterns of differential gene expression from in vivo lung cancer mutation signatures.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/419838v2?rss=1</originId><description>The need to reduce per sample cost of RNA-seq profiling for scalable data generation has led to the emergence of highly multiplexed RNA-seq. These technologies utilize barcoding of cDNA sequences in order to combine samples into single sequencing lane to be separated during data processing. In this study, we report the performance of one such technique denoted as sparse full length sequencing (SFL), a ribosomal RNA depletion-based RNA sequencing approach that allows for the simultaneous sequencing of 96 samples and higher. We offer comparisons to well established single-sample techniques, including: full coverage Poly-A capture RNA-seq and microarray, as well as another low-cost highly multiplexed technique known as 3&apos; digital gene expression (3&apos;DGE). Data was generated for a set of exposure experiments on immortalized human lung epithelial (AALE) cells in a two-by-two study design, in which samples received both genetic and chemical perturbations of known oncogenes/tumor suppressors and lung carcinogens. SFL demonstrated improved performance over 3&apos;DGE in terms of coverage, power to detect differential gene expression, and biological recapitulation of patterns of differential gene expression from in vivo lung cancer mutation signatures.</description><published>1546934400000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/419838v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16830362b68:7e1a5a:8675cc2c</id><title>Assessment of a highly multiplexed RNA sequencing platform and comparison to existing high-throughput gene expression profiling techniques [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/08/419838</canonicalUrl></item><item><engagement>0</engagement><crawled>1546608709447</crawled><fingerprint>d50cd060</fingerprint><author><name>Marti-Juan, G.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/339614v3?rss=1</link><content><content>Alzheimer&apos;s disease (AD) affects millions of people and is a major rising problem in health care worldwide. Recent research suggests that AD could have different subtypes, presenting differences in how the disease develops. Characterizing those subtypes could be key to deepen the understanding of this complex disease. In this paper, we used a multivariate, non-supervised clustering method over blood-based markers to find subgroups of patients defined by distinctive blood profiles. Our analysis on ADNI database identified 4 possible subgroups, each with a different blood profile. More importantly, we show that subgroups with different profiles have a different relationship between brain phenotypes detected in magnetic resonance imaging and disease condition.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/339614v3?rss=1</originId><description>Alzheimer&apos;s disease (AD) affects millions of people and is a major rising problem in health care worldwide. Recent research suggests that AD could have different subtypes, presenting differences in how the disease develops. Characterizing those subtypes could be key to deepen the understanding of this complex disease. In this paper, we used a multivariate, non-supervised clustering method over blood-based markers to find subgroups of patients defined by distinctive blood profiles. Our analysis on ADNI database identified 4 possible subgroups, each with a different blood profile. More importantly, we show that subgroups with different profiles have a different relationship between brain phenotypes detected in magnetic resonance imaging and disease condition.</description><published>1546588800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/339614v3?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16819100f47:3d548a:ad2b6584</id><title>Revealing heterogeneity of brain imaging phenotypes in Alzheimer&apos;s disease based on unsupervised clustering of blood marker profiles [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/04/339614</canonicalUrl></item><item><entities><item><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id><mentions><item><text>CSS</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id><mentions><item><text>Explorer</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id><mentions><item><text>JavaScript</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id><mentions><item><text>WEBSITEnature_com</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546530511732</crawled><visual><url>none</url></visual><author><name>Marko Hakovirta</name></author><origin><htmlUrl>http://feeds.nature.com/nbt/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nbt/current_issue/rss/</streamId><title>Nature Biotechnology</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/0qZSsMpEyvTD_JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I_oicon-166b30c5bda</icon></webfeeds><link>https://www.nature.com/articles/nbt.4331</link><content><content>&lt;p&gt;&lt;b&gt;Informal STEM education will accelerate the bioeconomy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Informal STEM education will accelerate the bioeconomy, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt.4331&quot;&gt;doi:10.1038/nbt.4331&lt;/a&gt;&lt;/p&gt;The bioeconomy demands special approaches for attracting youth to science, technology, engineering and mathematics disciplines and cultivating the multidisciplinary skills needed for a future workforce.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/nbt.4331</originId><description>&lt;p&gt;&lt;b&gt;Informal STEM education will accelerate the bioeconomy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Informal STEM education will accelerate the bioeconomy, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/nbt.4331&quot;&gt;doi:10.1038/nbt.4331&lt;/a&gt;&lt;/p&gt;The bioeconomy demands special approaches for attracting youth to science, technology, engineering and mathematics disciplines and cultivating the multidisciplinary skills needed for a future workforce.</description><published>1546502400000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/nbt.4331</href></item></alternate><id>0qZSsMpEyvTD/JmJ6fQGs2jjQHT0cDASmHnvbQXUs9I=_1681466db74:68a3831:3a104d3b</id><title>Informal STEM education will accelerate the bioeconomy</title><fingerprint>1eccd636</fingerprint></item><item><crawled>1547493334404</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1547424000000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Ipomoeassin_F_Binds_Sec61_to_Inhibit_Protein_Translocation/7581764</link><originId>https://chemrxiv.org/articles/Ipomoeassin_F_Binds_Sec61_to_Inhibit_Protein_Translocation/7581764</originId><description>The ipomoeassin
family of natural resin glycosides is underexplored chemical space with potent antitumor
activity revealed in the NCI-60 cell lines screen; however, its mode of action
has so far remained unexplored. In this
manuscript, we report our chemical proteomics and subsequent biology studies that
transform our collective knowledge of the ipomoeassin glycolipids from Organic Synthesis and Medicinal
Chemistry to biological
mechanism and provide a step change in our understanding of its action at a
cellular level. Hence, we created an
ipomoeassin F-based biotin affinity probe and used it in live cells to isolate
the ER membrane protein Sec61α as its presumptive molecular target. A direct interaction between Sec61α and ipomoeassin
F was confirmed by cell imaging, pulldown from purified ER membranes and
competition studies using a photo-crosslinking analogue of the cyclodepsipeptide cotransin,
a known Sec61α inhibitor. Crucially, we then
showed that ipomoeassin F binding has a profound effect on Sec61 function,
using both in vitro and in vivo assays for protein translocation and protein secretion
respectively. Although structurally quite distinct, the potency of ipomoeassin
F is comparable to that of mycolactone, a recently identified and intensely
studied inhibitor of Sec61. The ~1,000 fold increase
in the ipomoeassin F resistance of two cell lines expressing mutant forms of Sec61α
strongly supports our conclusion that the effect of the compound on Sec61α is
the primary basis for its potent cytotoxicity. However, we also provide evidence that ipomoeassin
F is mechanistically distinct from known Sec61α inhibitors, suggesting that it is
a novel structural class that may offer new opportunities to explore the Sec61
protein translocation complex as a therapeutic target for drug discovery.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Ipomoeassin_F_Binds_Sec61_to_Inhibit_Protein_Translocation/7581764</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1684dca5d84:2e4a289:c2ce2e2e</id><title>Ipomoeassin F Binds Sec61α to Inhibit Protein Translocation</title><fingerprint>2618c994</fingerprint><summary><content>The ipomoeassin
family of natural resin glycosides is underexplored chemical space with potent antitumor
activity revealed in the NCI-60 cell lines screen; however, its mode of action
has so far remained unexplored. In this
manuscript, we report our chemical proteomics and subsequent biology studies that
transform our collective knowledge of the ipomoeassin glycolipids from Organic Synthesis and Medicinal
Chemistry to biological
mechanism and provide a step change in our understanding of its action at a
cellular level. Hence, we created an
ipomoeassin F-based biotin affinity probe and used it in live cells to isolate
the ER membrane protein Sec61α as its presumptive molecular target. A direct interaction between Sec61α and ipomoeassin
F was confirmed by cell imaging, pulldown from purified ER membranes and
competition studies using a photo-crosslinking analogue of the cyclodepsipeptide cotransin,
a known Sec61α inhibitor. Crucially, we then
showed that ipomoeassin F binding has a profound effect on Sec61 function,
using both in vitro and in vivo assays for protein translocation and protein secretion
respectively. Although structurally quite distinct, the potency of ipomoeassin
F is comparable to that of mycolactone, a recently identified and intensely
studied inhibitor of Sec61. The ~1,000 fold increase
in the ipomoeassin F resistance of two cell lines expressing mutant forms of Sec61α
strongly supports our conclusion that the effect of the compound on Sec61α is
the primary basis for its potent cytotoxicity. However, we also provide evidence that ipomoeassin
F is mechanistically distinct from known Sec61α inhibitors, suggesting that it is
a novel structural class that may offer new opportunities to explore the Sec61
protein translocation complex as a therapeutic target for drug discovery.</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08168-9</href></item></canonical><engagement>0</engagement><crawled>1547548096718</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Brendan D. Hare</name></author><visual><height>361</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08168-9/MediaObjects/41467_2018_8168_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08168-9</link><content><content>&lt;p&gt;&lt;b&gt;Optogenetic stimulation of medial prefrontal cortex &lt;i&gt;Drd1&lt;/i&gt; neurons produces rapid and long-lasting antidepressant effects&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Optogenetic stimulation of medial prefrontal cortex &amp;lt;i&gt;Drd1&amp;lt;/i&gt; neurons produces rapid and long-lasting antidepressant effects, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08168-9&quot;&gt;doi:10.1038/s41467-018-08168-9&lt;/a&gt;&lt;/p&gt;Ketamine exerts fast-acting anti-depressant responses. Here the authors show that dopamine D1 receptor expressing neurons in the medial prefrontal cortex contribute to these antidepressant-like effects in mice.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/jtZmr17FSO4&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08168-9</originId><description>&lt;p&gt;&lt;b&gt;Optogenetic stimulation of medial prefrontal cortex &lt;i&gt;Drd1&lt;/i&gt; neurons produces rapid and long-lasting antidepressant effects&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Optogenetic stimulation of medial prefrontal cortex &amp;lt;i&gt;Drd1&amp;lt;/i&gt; neurons produces rapid and long-lasting antidepressant effects, Published online: 15 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08168-9&quot;&gt;doi:10.1038/s41467-018-08168-9&lt;/a&gt;&lt;/p&gt;Ketamine exerts fast-acting anti-depressant responses. Here the authors show that dopamine D1 receptor expressing neurons in the medial prefrontal cortex contribute to these antidepressant-like effects in mice.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/jtZmr17FSO4&quot; height=&quot;1&quot;&gt;</description><published>1547539200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/jtZmr17FSO4/s41467-018-08168-9</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_168510df8ce:3410ae9:8675cc2c</id><title>Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects</title><fingerprint>6f77c0f3</fingerprint></item><item><engagement>4</engagement><crawled>1547140895892</crawled><visual><height>324</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>250</width><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14062778/thumb.png</url></visual><published>1547078400000</published><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Pd-Catalyzed_C_N_Coupling_Reactions_Facilitated_by_Organic_Bases_Mechanistic_Investigation_Leads_to_Enhanced_Reactivity_in_the_Arylation_of_Weakly_Binding_Amines/7568978</link><originId>https://chemrxiv.org/articles/Pd-Catalyzed_C_N_Coupling_Reactions_Facilitated_by_Organic_Bases_Mechanistic_Investigation_Leads_to_Enhanced_Reactivity_in_the_Arylation_of_Weakly_Binding_Amines/7568978</originId><description>The ability to use soluble organic amine bases in
Pd-catalyzed C–N cross-coupling reactions has provided a long-awaited solution
to the many issues associated with employing traditional, heterogeneous
reaction conditions. However, little is known about the precise function of
these bases in the catalytic cycle and about the effect of variations in base
structure on catalyst reactivity. We used 19F NMR to analyze the
kinetic behavior of C–N coupling reactions facilitated by different organic
bases. In the case of aniline coupling reactions employing DBU, the resting
state was a DBU-bound oxidative addition complex, LPd(DBU)(Ar)X, and the reaction
was found to be inhibited by base. In general, however, depending on the binding
properties of the chosen organic base, increased concentration of the base can
have a positive or negative influence on the reaction rate. We propose a model
in which the turnover-limiting step of the catalytic cycle depends on the
relative nucleophilicity of the base compared to that of the amine. This
hypothesis guided the discovery of new reaction conditions for the coupling of
weakly binding amines, including secondary aryl amines, which were unreactive
nucleophiles in our original protocol.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Pd-Catalyzed_C_N_Coupling_Reactions_Facilitated_by_Organic_Bases_Mechanistic_Investigation_Leads_to_Enhanced_Reactivity_in_the_Arylation_of_Weakly_Binding_Amines/7568978</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16838c89494:14d336a:8675cc2c</id><title>Pd-Catalyzed C–N Coupling Reactions Facilitated by Organic Bases: Mechanistic Investigation Leads to Enhanced Reactivity in the Arylation of Weakly Binding Amines</title><fingerprint>967e9434</fingerprint><summary><content>The ability to use soluble organic amine bases in
Pd-catalyzed C–N cross-coupling reactions has provided a long-awaited solution
to the many issues associated with employing traditional, heterogeneous
reaction conditions. However, little is known about the precise function of
these bases in the catalytic cycle and about the effect of variations in base
structure on catalyst reactivity. We used 19F NMR to analyze the
kinetic behavior of C–N coupling reactions facilitated by different organic
bases. In the case of aniline coupling reactions employing DBU, the resting
state was a DBU-bound oxidative addition complex, LPd(DBU)(Ar)X, and the reaction
was found to be inhibited by base. In general, however, depending on the binding
properties of the chosen organic base, increased concentration of the base can
have a positive or negative influence on the reaction rate. We propose a model
in which the turnover-limiting step of the catalytic cycle depends on the
relative nucleophilicity of the base compared to that of the amine. This
hypothesis guided the discovery of new reaction conditions for the coupling of
weakly binding amines, including secondary aryl amines, which were unreactive
nucleophiles in our original protocol.</content><direction>ltr</direction></summary></item><item><entities><item><label>Madagascar</label><id>nlp/f/entity/en/w/Madagascar</id><mentions><item><text>Malagasy</text></item><item><text>Madagascar</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Ebony</label><id>nlp/f/entity/en/w/Ebony (magazine)</id><mentions><item><text>ebony</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Flora</label><id>nlp/f/entity/en/-/flora</id><mentions><item><text>Flora</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Dalbergia</label><id>nlp/f/entity/en/w/Dalbergia</id><mentions><item><text>Dalbergia spp</text></item><item><text>Dalbergia</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Diospyros</label><id>nlp/f/entity/en/w/Diospyros</id><mentions><item><text>Diospyros spp</text></item><item><text>Diospyros</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548854231688</crawled><visual><url>none</url></visual><author><name>Lucienne Wilmé</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00323-6</link><content><content>&lt;p&gt;&lt;b&gt;Brand Madagascar’s rosewood and ebony as endangered&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Brand Madagascar’s rosewood and ebony as endangered, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00323-6&quot;&gt;doi:10.1038/d41586-019-00323-6&lt;/a&gt;&lt;/p&gt;Brand Madagascar’s rosewood and ebony as endangered</content><direction>ltr</direction></content><commonTopics><item><label>wildlife</label><id>nlp/f/topic/2486</id><probability>0.996</probability></item><item><label>conservation</label><id>nlp/f/topic/532</id><probability>0.984</probability></item><item><label>ecology</label><id>nlp/f/topic/725</id><probability>0.758</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00323-6</originId><description>&lt;p&gt;&lt;b&gt;Brand Madagascar’s rosewood and ebony as endangered&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Brand Madagascar’s rosewood and ebony as endangered, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00323-6&quot;&gt;doi:10.1038/d41586-019-00323-6&lt;/a&gt;&lt;/p&gt;Brand Madagascar’s rosewood and ebony as endangered</description><engagementRate>0.5</engagementRate><published>1548835200000</published><engagement>1</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00323-6</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ee80288:ac1e7b:ad2b6584</id><title>Brand Madagascar’s rosewood and ebony as endangered</title><fingerprint>30ed8cc6</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08125-6</href></item></canonical><engagement>1</engagement><crawled>1548066469662</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Min Zhao</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>481</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08125-6/MediaObjects/41467_2018_8125_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08125-6</link><content><content>&lt;p&gt;&lt;b&gt;Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08125-6&quot;&gt;doi:10.1038/s41467-018-08125-6&lt;/a&gt;&lt;/p&gt;Current treatments for age-related neovascular macular degeneration (nAMD) suffer from limited efficacy. Here, Zhao et al. show that pharmacological inhibition or genetic deletion of the mineralocorticoid receptor (MR) limits choroidal neovascularisation in rodents, and show in a pilot clinical study that targeting the MR pathway may provide clinical benefits in nAMD patiens.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/NsjVU8MUGck&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08125-6</originId><description>&lt;p&gt;&lt;b&gt;Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration, Published online: 21 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08125-6&quot;&gt;doi:10.1038/s41467-018-08125-6&lt;/a&gt;&lt;/p&gt;Current treatments for age-related neovascular macular degeneration (nAMD) suffer from limited efficacy. Here, Zhao et al. show that pharmacological inhibition or genetic deletion of the mineralocorticoid receptor (MR) limits choroidal neovascularisation in rodents, and show in a pilot clinical study that targeting the MR pathway may provide clinical benefits in nAMD patiens.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/NsjVU8MUGck&quot; height=&quot;1&quot;&gt;</description><published>1548057600000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/NsjVU8MUGck/s41467-018-08125-6</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1686ff3b71e:1d335ed:ad2b6584</id><title>Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration</title><fingerprint>cf7bfa86</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36888-x</href></item></canonical><engagement>0</engagement><crawled>1548238772764</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Yegor Doush</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>512</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36888-x/MediaObjects/41598_2018_36888_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36888-x</link><content><content>&lt;p&gt;&lt;b&gt;SP1 and RARα regulate &lt;i&gt;AGAP2&lt;/i&gt; expression in cancer&lt;/b&gt;&lt;/p&gt;&lt;p&gt;SP1 and RARα regulate &amp;lt;i&gt;AGAP2&amp;lt;/i&gt; expression in cancer, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36888-x&quot;&gt;doi:10.1038/s41598-018-36888-x&lt;/a&gt;&lt;/p&gt;SP1 and RARα regulate &lt;i&gt;AGAP2&lt;/i&gt; expression in cancer&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/n5D9xfJLStE&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36888-x</originId><description>&lt;p&gt;&lt;b&gt;SP1 and RARα regulate &lt;i&gt;AGAP2&lt;/i&gt; expression in cancer&lt;/b&gt;&lt;/p&gt;&lt;p&gt;SP1 and RARα regulate &amp;lt;i&gt;AGAP2&amp;lt;/i&gt; expression in cancer, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36888-x&quot;&gt;doi:10.1038/s41598-018-36888-x&lt;/a&gt;&lt;/p&gt;SP1 and RARα regulate &lt;i&gt;AGAP2&lt;/i&gt; expression in cancer&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/n5D9xfJLStE&quot; height=&quot;1&quot;&gt;</description><published>1548230400000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/n5D9xfJLStE/s41598-018-36888-x</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1687a38da1c:2c4c181:3a104d3b</id><title>SP1 and RARα regulate AGAP2 expression in cancer</title><fingerprint>5a2fdac</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37244-9</href></item></canonical><engagement>0</engagement><crawled>1548843710327</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Jahae Kim</name></author><visual><height>390</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37244-9/MediaObjects/41598_2018_37244_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37244-9</link><content><content>&lt;p&gt;&lt;b&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37244-9&quot;&gt;doi:10.1038/s41598-018-37244-9&lt;/a&gt;&lt;/p&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Mv2aN0OYYxc&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37244-9</originId><description>&lt;p&gt;&lt;b&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37244-9&quot;&gt;doi:10.1038/s41598-018-37244-9&lt;/a&gt;&lt;/p&gt;Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Mv2aN0OYYxc&quot; height=&quot;1&quot;&gt;</description><published>1548835200000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/Mv2aN0OYYxc/s41598-018-37244-9</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1689e477777:9c5974:ad2b6584</id><title>Association of muscle and visceral adipose tissues with the probability of Alzheimer’s disease in healthy subjects</title><fingerprint>ce2ede7d</fingerprint></item><item><entities><item><label>MTOR</label><id>nlp/f/entity/en/w/MTOR</id><mentions><item><text>mTOR</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>M.</label><id>nlp/f/entity/en/-/m.</id><mentions><item><text>M.</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>A.</label><id>nlp/f/entity/en/-/a.</id><mentions><item><text>A.</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>S6</label><id>nlp/f/entity/en/-/s6</id><mentions><item><text>S6</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Republican Party</label><id>nlp/f/entity/en/w/Republican Party (United States)</id><mentions><item><text>R.</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548872162027</crawled><visual><height>288</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0895-y/MediaObjects/41586_2019_895_Fig1_HTML.png</url></visual><author><name>Mark J. Ranek</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-019-0895-y</link><content><content>&lt;p&gt;&lt;b&gt;PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress&lt;/b&gt;&lt;/p&gt;&lt;p&gt;PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0895-y&quot;&gt;doi:10.1038/s41586-019-0895-y&lt;/a&gt;&lt;/p&gt;Phosphorylation of one of two adjacent serine residues in TSC2 is both required and sufficient for PKG1-mediated cardiac protection against pressure overload in mice; these serine residues provide a genetic tool for the bidirectional regulation of stress-stimulated mTORC1 activity.</content><direction>ltr</direction></content><commonTopics><item><label>cell</label><id>nlp/f/topic/403</id><probability>1.0</probability></item><item><label>brain</label><id>nlp/f/topic/314</id><probability>0.999</probability></item><item><label>stem cells</label><id>nlp/f/topic/2185</id><probability>0.965</probability></item><item><label>immunology</label><id>nlp/f/topic/1145</id><probability>0.956</probability></item><item><label>biology</label><id>nlp/f/topic/263</id><probability>0.942</probability></item><item><label>cardiology</label><id>nlp/f/topic/387</id><probability>0.793</probability></item><item><label>neuroscience</label><id>nlp/f/topic/1565</id><probability>0.75</probability></item><item><label>neurology</label><id>nlp/f/topic/1563</id><probability>0.736</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-019-0895-y</originId><description>&lt;p&gt;&lt;b&gt;PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress&lt;/b&gt;&lt;/p&gt;&lt;p&gt;PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress, Published online: 30 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0895-y&quot;&gt;doi:10.1038/s41586-019-0895-y&lt;/a&gt;&lt;/p&gt;Phosphorylation of one of two adjacent serine residues in TSC2 is both required and sufficient for PKG1-mediated cardiac protection against pressure overload in mice; these serine residues provide a genetic tool for the bidirectional regulation of stress-stimulated mTORC1 activity.</description><published>1548835200000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0895-y</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1689ff99aeb:c7ac54:3a104d3b</id><title>PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress</title><fingerprint>b0baf3d1</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37115-3</href></item></canonical><engagement>0</engagement><crawled>1547029352254</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Yoshimitsu Tanaka</name></author><visual><height>349</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37115-3/MediaObjects/41598_2018_37115_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37115-3</link><content><content>&lt;p&gt;&lt;b&gt;Adiponectin promotes muscle regeneration through binding to T-cadherin&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Adiponectin promotes muscle regeneration through binding to T-cadherin, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37115-3&quot;&gt;doi:10.1038/s41598-018-37115-3&lt;/a&gt;&lt;/p&gt;Adiponectin promotes muscle regeneration through binding to T-cadherin&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/T_rMgOK1IUQ&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37115-3</originId><description>&lt;p&gt;&lt;b&gt;Adiponectin promotes muscle regeneration through binding to T-cadherin&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Adiponectin promotes muscle regeneration through binding to T-cadherin, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37115-3&quot;&gt;doi:10.1038/s41598-018-37115-3&lt;/a&gt;&lt;/p&gt;Adiponectin promotes muscle regeneration through binding to T-cadherin&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/T_rMgOK1IUQ&quot; height=&quot;1&quot;&gt;</description><published>1547020800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/T_rMgOK1IUQ/s41598-018-37115-3</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16832228f3e:a8de41:8675cc2c</id><title>Adiponectin promotes muscle regeneration through binding to T-cadherin</title><fingerprint>1adb1f00</fingerprint></item><item><updateCount>1</updateCount><canonical><item><type>text/html</type><href>https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006747</href></item></canonical><engagement>0</engagement><crawled>1548269383255</crawled><origin><htmlUrl>https://journals.plos.org/ploscompbiol/</htmlUrl><streamId>feed/http://www.ploscompbiol.org/article/feed</streamId><title>PLOS Computational Biology: New Articles</title></origin><published>1548280800000</published><link>10.1371/journal.pcbi.1006747</link><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><description>&lt;p&gt;by The PLOS Computational Biology Staff &lt;/p&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/-zyRxNmL1rg&quot; height=&quot;1&quot;&gt;</description><updated>1548280800000</updated><content><content>&lt;p&gt;by The PLOS Computational Biology Staff &lt;/p&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ploscompbiol/NewArticles/~4/-zyRxNmL1rg&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>10.1371/journal.pcbi.1006747</originId><author><name>The PLOS Computational Biology Staff</name></author><recrawled>1548278828375</recrawled><alternate><item><type>text/html</type><href>http://feeds.plos.org/~r/ploscompbiol/NewArticles/~3/-zyRxNmL1rg/article</href></item></alternate><id>dr8pjQGwW0OGu3B6mPW+uLGvtmW9y66ELGS9t7Ivrm4=_1687c0bee57:40443:875042c9</id><title>Notice of Republication: Simulating Cortical Development as a Self Constructing Process: A Novel Multi-Scale Approach Combining Molecular and Physical Aspects</title><fingerprint>46724d17</fingerprint></item><item><unread>True</unread><engagement>5</engagement><crawled>1546542450273</crawled><visual><url>none</url></visual><author><name>Ash, C.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><fingerprint>6f59ea9f</fingerprint><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6422/40-a?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6422/40-a?rss=1</originId><published>1546540591000</published><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6422/40-a?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168151d0661:699b3ac:ad2b6584</id><title>Sing on high, dance on the floor</title><canonicalUrl>http://science.sciencemag.org/content/363/6422/40.1.full</canonicalUrl></item><item><entities><item><label>CRISPR</label><id>nlp/f/entity/en/w/CRISPR</id><mentions><item><text>CRISPR</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>first International Summit on Human Gene</label><id>nlp/f/entity/en/-/first international summit on human gene</id><mentions><item><text>first International Summit on Human Gene</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Asilomar Conference on Recombinant DNA</label><id>nlp/f/entity/en/w/Asilomar Conference on Recombinant DNA</id><mentions><item><text>Asilomar Conference on Recombinant DNA</text></item><item><text>Asilomar</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Ted Kennedy</label><id>nlp/f/entity/en/w/Ted Kennedy</id><mentions><item><text>Edward Kennedy</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine</label><id>nlp/f/entity/en/w/Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine</id><mentions><item><text>Oviedo Convention</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546450619071</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07881-1/d41586-018-07881-1_16369436.jpg</url></visual><author><name>J. Benjamin Hurlbut</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07881-1</link><content><content>&lt;p&gt;&lt;b&gt;Human genome editing: ask whether, not how&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Human genome editing: ask whether, not how, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07881-1&quot;&gt;doi:10.1038/d41586-018-07881-1&lt;/a&gt;&lt;/p&gt;The scientific community’s response to the CRISPR twins should not pre-empt broader discussion across society, warns J. Benjamin Hurlbut.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/d41586-018-07881-1</originId><description>&lt;p&gt;&lt;b&gt;Human genome editing: ask whether, not how&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Human genome editing: ask whether, not how, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07881-1&quot;&gt;doi:10.1038/d41586-018-07881-1&lt;/a&gt;&lt;/p&gt;The scientific community’s response to the CRISPR twins should not pre-empt broader discussion across society, warns J. Benjamin Hurlbut.</description><published>1546416000000</published><engagement>5</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07881-1</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680fa3cabf:6141419:c2ce2e2e</id><title>Human genome editing: ask whether, not how</title><fingerprint>835a36fb</fingerprint></item><item><crawled>1547140895892</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1547078400000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Integrated_CO2_Capture_and_Conversion_into_Valuable_Hydrocarbons/7570664</link><originId>https://chemrxiv.org/articles/Integrated_CO2_Capture_and_Conversion_into_Valuable_Hydrocarbons/7570664</originId><description>The alarming atmospheric concentration and continuous emissions of carbon dioxide (CO2) require immediate action. As a result of advances in CO2 capture and sequestration technologies (generally involving point sources such as energy generation plants), large amounts of pure CO2 will soon be available. In addition to geological storage and other applications of the captured CO2, the development of technologies able to convert this carbon feedstock into commodity chemicals may pave the way towards a more sustainable economy. Here, we present a novel multifunctional catalyst consisting of Fe2O3 encapsulated in K2CO3 that can capture and simultaneously transform CO2 into olefins. In contrast to traditional systems in Fischer-Tropsch reactions, we demonstrate that when dealing with CO2 activation (in contrast to CO), very high K loadings are key to capturing the CO2 via the well-known ‘potassium carbonate mechanism’. The proposed catalytic process is demonstrated to be as productive as existing commercial processes based on synthesis gas while relying on economically and environmentally advantageous CO2 feedstock.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Integrated_CO2_Capture_and_Conversion_into_Valuable_Hydrocarbons/7570664</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16838c89494:14d336b:8675cc2c</id><title>Integrated CO2 Capture and Conversion into Valuable Hydrocarbons</title><fingerprint>bf398bca</fingerprint><summary><content>The alarming atmospheric concentration and continuous emissions of carbon dioxide (CO2) require immediate action. As a result of advances in CO2 capture and sequestration technologies (generally involving point sources such as energy generation plants), large amounts of pure CO2 will soon be available. In addition to geological storage and other applications of the captured CO2, the development of technologies able to convert this carbon feedstock into commodity chemicals may pave the way towards a more sustainable economy. Here, we present a novel multifunctional catalyst consisting of Fe2O3 encapsulated in K2CO3 that can capture and simultaneously transform CO2 into olefins. In contrast to traditional systems in Fischer-Tropsch reactions, we demonstrate that when dealing with CO2 activation (in contrast to CO), very high K loadings are key to capturing the CO2 via the well-known ‘potassium carbonate mechanism’. The proposed catalytic process is demonstrated to be as productive as existing commercial processes based on synthesis gas while relying on economically and environmentally advantageous CO2 feedstock.</content><direction>ltr</direction></summary></item><item><entities><item><label>Weyl semimetal</label><id>nlp/f/entity/en/w/Weyl semimetal</id><mentions><item><text>Weyl semimetal</text></item><item><text>Weyl semimetals</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Nat</label><id>nlp/f/entity/en/-/nat</id><mentions><item><text>Nat</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Hasan</label><id>nlp/f/entity/en/-/hasan</id><mentions><item><text>Hasan</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Fermi surface of semimetallic WTe 2</label><id>nlp/f/entity/en/-/fermi surface of semimetallic wte 2</id><mentions><item><text>Fermi</text></item><item><text>Fermi surface of semimetallic WTe 2</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Mod</label><id>nlp/f/entity/en/-/mod</id><mentions><item><text>Mod</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546452338856</crawled><visual><height>441</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0809-4/MediaObjects/41586_2018_809_Fig1_HTML.png</url></visual><author><name>Edbert J. Sie</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-018-0809-4</link><content><content>&lt;p&gt;&lt;b&gt;An ultrafast symmetry switch in a Weyl semimetal&lt;/b&gt;&lt;/p&gt;&lt;p&gt;An ultrafast symmetry switch in a Weyl semimetal, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0809-4&quot;&gt;doi:10.1038/s41586-018-0809-4&lt;/a&gt;&lt;/p&gt;Terahertz light pulses induce transitions between a topological and a trivial phase in the Weyl semimetal WTe2 through an interlayer shear strain.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41586-018-0809-4</originId><description>&lt;p&gt;&lt;b&gt;An ultrafast symmetry switch in a Weyl semimetal&lt;/b&gt;&lt;/p&gt;&lt;p&gt;An ultrafast symmetry switch in a Weyl semimetal, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0809-4&quot;&gt;doi:10.1038/s41586-018-0809-4&lt;/a&gt;&lt;/p&gt;Terahertz light pulses induce transitions between a topological and a trivial phase in the Weyl semimetal WTe2 through an interlayer shear strain.</description><published>1546416000000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0809-4</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680fbe08a8:6162cc4:c2ce2e2e</id><title>An ultrafast symmetry switch in a Weyl semimetal</title><fingerprint>3d965c37</fingerprint></item><item><entities><item><label>Yokoyama et al</label><id>nlp/f/entity/en/-/yokoyama et al</id><mentions><item><text>Yokoyama</text></item><item><text>Yokoyama et al</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Martincorena et al</label><id>nlp/f/entity/en/-/martincorena et al</id><mentions><item><text>Martincorena et al</text></item><item><text>Martincorena</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>P53</label><id>nlp/f/entity/en/w/P53</id><mentions><item><text>TP53</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Science</label><id>nlp/f/entity/en/w/Science</id><mentions><item><text>Science</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>OSCC</label><id>nlp/f/entity/en/-/oscc</id><mentions><item><text>OSCC</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546452338856</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07737-8/d41586-018-07737-8_16353130.jpg</url></visual><author><name>Francesca D. Ciccarelli</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07737-8</link><content><content>&lt;p&gt;&lt;b&gt;Mutations differ in normal and cancer cells of the oesophagus&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mutations differ in normal and cancer cells of the oesophagus, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07737-8&quot;&gt;doi:10.1038/d41586-018-07737-8&lt;/a&gt;&lt;/p&gt;What determines whether genetic mutations lead to cancer? Analyses of healthy cells in the human oesophagus reveal that a high level of genetic alterations arises as people age, yet this doesn’t usually result in cancer.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/d41586-018-07737-8</originId><description>&lt;p&gt;&lt;b&gt;Mutations differ in normal and cancer cells of the oesophagus&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Mutations differ in normal and cancer cells of the oesophagus, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07737-8&quot;&gt;doi:10.1038/d41586-018-07737-8&lt;/a&gt;&lt;/p&gt;What determines whether genetic mutations lead to cancer? Analyses of healthy cells in the human oesophagus reveal that a high level of genetic alterations arises as people age, yet this doesn’t usually result in cancer.</description><published>1546416000000</published><engagement>9</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07737-8</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680fbe08a8:6162cc3:c2ce2e2e</id><title>Mutations differ in normal and cancer cells of the oesophagus</title><fingerprint>90c33ff5</fingerprint></item><item><engagement>0</engagement><crawled>1547147463250</crawled><visual><url>none</url></visual><author><name>Szuromi, P.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6423/137-d?rss=1</link><entities><item><label>American Association for the Advancement of Science</label><id>nlp/f/entity/en/w/American Association for the Advancement of Science</id><mentions><item><text>AAAS</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Science</label><id>nlp/f/entity/en/w/Science</id><mentions><item><text>Science</text></item></mentions><salienceLevel>about</salienceLevel></item></entities><originId>http://science.sciencemag.org/cgi/content/short/363/6423/137-d?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6423/137.4.full</canonicalUrl><published>1547145461000</published><keywords><item>Chemistry</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6423/137-d?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_168392cca52:15708b6:8675cc2c</id><title>Broken on impact</title><fingerprint>3a6d682c</fingerprint></item><item><entities><item><label>Asia</label><id>nlp/f/entity/en/w/Asia</id><mentions><item><text>Asia</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Mount Everest</label><id>nlp/f/entity/en/w/Mount Everest</id><mentions><item><text>Everest</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Monsoon</label><id>nlp/f/entity/en/w/Monsoon</id><mentions><item><text>monsoon</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Fei Li</label><id>nlp/f/entity/en/-/fei li</id><mentions><item><text>Fei Li</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Hindu Kush</label><id>nlp/f/entity/en/w/Hindu Kush</id><mentions><item><text>Hindu Kush</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546420601561</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-018-07838-4/d41586-018-07838-4_16346854.jpg</url></visual><author><name>Jing Gao</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-018-07838-4</link><content><content>&lt;p&gt;&lt;b&gt;Collapsing glaciers threaten Asia’s water supplies&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Collapsing glaciers threaten Asia’s water supplies, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07838-4&quot;&gt;doi:10.1038/d41586-018-07838-4&lt;/a&gt;&lt;/p&gt;Tracking moisture, snow and meltwater across the ‘third pole’ will help communities to plan for climate change, argue Jing Gao and colleagues.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/d41586-018-07838-4</originId><description>&lt;p&gt;&lt;b&gt;Collapsing glaciers threaten Asia’s water supplies&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Collapsing glaciers threaten Asia’s water supplies, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-018-07838-4&quot;&gt;doi:10.1038/d41586-018-07838-4&lt;/a&gt;&lt;/p&gt;Tracking moisture, snow and meltwater across the ‘third pole’ will help communities to plan for climate change, argue Jing Gao and colleagues.</description><published>1546416000000</published><engagement>13</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-018-07838-4</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1680dd9c2d9:5fa0290:ad2b6584</id><title>Collapsing glaciers threaten Asia’s water supplies</title><fingerprint>2c5fabc5</fingerprint></item><item><engagement>75</engagement><crawled>1548266506557</crawled><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>402</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-0880-5/MediaObjects/41586_2019_880_Fig1_HTML.png</url></visual><author><name>H. Wang</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-019-0880-5</link><content><content>&lt;p&gt;&lt;b&gt;Rubisco condensate formation by CcmM in β-carboxysome biogenesis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Rubisco condensate formation by CcmM in β-carboxysome biogenesis, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0880-5&quot;&gt;doi:10.1038/s41586-019-0880-5&lt;/a&gt;&lt;/p&gt;The structure of a Rubisco–CcmM complex sheds light on the formation of carboxysomes in cyanobacteria.</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41586-019-0880-5</originId><description>&lt;p&gt;&lt;b&gt;Rubisco condensate formation by CcmM in β-carboxysome biogenesis&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Rubisco condensate formation by CcmM in β-carboxysome biogenesis, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-019-0880-5&quot;&gt;doi:10.1038/s41586-019-0880-5&lt;/a&gt;&lt;/p&gt;The structure of a Rubisco–CcmM complex sheds light on the formation of carboxysomes in cyanobacteria.</description><published>1548230400000</published><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-019-0880-5</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_1687be0093d:2e2c1c1:c2ce2e2e</id><title>Rubisco condensate formation by CcmM in β-carboxysome biogenesis</title><fingerprint>2a925a49</fingerprint></item><item><entities><item><label>Han Chinese</label><id>nlp/f/entity/en/w/Han Chinese</id><mentions><item><text>Han</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Han et al</label><id>nlp/f/entity/en/-/han et al</id><mentions><item><text>Han et al</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Zm KWL1 amino</label><id>nlp/f/entity/en/-/zm kwl1 amino</id><mentions><item><text>Zm KWL1 amino</text></item><item><text>Zm KWL1</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>maydis Cmu1</label><id>nlp/f/entity/en/-/maydis cmu1</id><mentions><item><text>Cmu1</text></item><item><text>maydis Cmu1</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>kiwellins</label><id>nlp/f/entity/en/-/kiwellins</id><mentions><item><text>Kiwellins</text></item><item><text>kiwellins</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547662375584</crawled><visual><height>450</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>800</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00092-2/d41586-019-00092-2_16395374.jpg</url></visual><author><name>Mary C. Wildermuth</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00092-2</link><content><content>&lt;p&gt;&lt;b&gt;Plants fight fungi using kiwellin proteins&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Plants fight fungi using kiwellin proteins, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00092-2&quot;&gt;doi:10.1038/d41586-019-00092-2&lt;/a&gt;&lt;/p&gt;Fungal infection can affect crop yield. A plant protein found to counter fungal-induced interference with host metabolism illuminates antifungal defences and mechanisms that inhibit metabolic enzymes.</content><direction>ltr</direction></content><commonTopics><item><label>plants</label><id>nlp/f/topic/1770</id><probability>0.999</probability></item><item><label>biochemistry</label><id>nlp/f/topic/257</id><probability>0.995</probability></item><item><label>microbiology</label><id>nlp/f/topic/1455</id><probability>0.922</probability></item><item><label>proteomics</label><id>nlp/f/topic/1840</id><probability>0.91</probability></item><item><label>agriculture</label><id>nlp/f/topic/54</id><probability>0.89</probability></item><item><label>ecology</label><id>nlp/f/topic/725</id><probability>0.84</probability></item><item><label>cell</label><id>nlp/f/topic/403</id><probability>0.835</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00092-2</originId><description>&lt;p&gt;&lt;b&gt;Plants fight fungi using kiwellin proteins&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Plants fight fungi using kiwellin proteins, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00092-2&quot;&gt;doi:10.1038/d41586-019-00092-2&lt;/a&gt;&lt;/p&gt;Fungal infection can affect crop yield. A plant protein found to counter fungal-induced interference with host metabolism illuminates antifungal defences and mechanisms that inhibit metabolic enzymes.</description><published>1547625600000</published><engagement>2</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00092-2</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16857ddbaa0:3dd05e5:3a104d3b</id><title>Plants fight fungi using kiwellin proteins</title><fingerprint>1d7c552d</fingerprint></item><item><crawled>1547752389672</crawled><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><author><name>Wang, L., Zhou, H., Hu, J., Huang, B., Sun, M., Dong, B., Zheng, G., Huang, Y., Chen, Y., Li, L., Xu, Z., Li, N., Liu, Z., Chen, Q., Sun, L.-D., Yan, C.-H.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6424/265?rss=1</link><content><content>&lt;p&gt;The components with soft nature in the metal halide perovskite absorber usually generate lead (Pb)&lt;sup&gt;0&lt;/sup&gt; and iodine (I)&lt;sup&gt;0&lt;/sup&gt; defects during device fabrication and operation. These defects serve as not only recombination centers to deteriorate device efficiency but also degradation initiators to hamper device lifetimes. We show that the europium ion pair Eu&lt;sup&gt;3+&lt;/sup&gt;-Eu&lt;sup&gt;2+&lt;/sup&gt; acts as the &amp;quot;redox shuttle&amp;quot; that selectively oxidized Pb&lt;sup&gt;0&lt;/sup&gt; and reduced I&lt;sup&gt;0&lt;/sup&gt; defects simultaneously in a cyclical transition. The resultant device achieves a power conversion efficiency (PCE) of 21.52% (certified 20.52%) with substantially improved long-term durability. The devices retained 92% and 89% of the peak PCE under 1-sun continuous illumination or heating at 85°C for 1500 hours and 91% of the original stable PCE after maximum power point tracking for 500 hours, respectively.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://science.sciencemag.org/cgi/content/short/363/6424/265?rss=1</originId><description>&lt;p&gt;The components with soft nature in the metal halide perovskite absorber usually generate lead (Pb)&lt;sup&gt;0&lt;/sup&gt; and iodine (I)&lt;sup&gt;0&lt;/sup&gt; defects during device fabrication and operation. These defects serve as not only recombination centers to deteriorate device efficiency but also degradation initiators to hamper device lifetimes. We show that the europium ion pair Eu&lt;sup&gt;3+&lt;/sup&gt;-Eu&lt;sup&gt;2+&lt;/sup&gt; acts as the &amp;quot;redox shuttle&amp;quot; that selectively oxidized Pb&lt;sup&gt;0&lt;/sup&gt; and reduced I&lt;sup&gt;0&lt;/sup&gt; defects simultaneously in a cyclical transition. The resultant device achieves a power conversion efficiency (PCE) of 21.52% (certified 20.52%) with substantially improved long-term durability. The devices retained 92% and 89% of the peak PCE under 1-sun continuous illumination or heating at 85°C for 1500 hours and 91% of the original stable PCE after maximum power point tracking for 500 hours, respectively.&lt;/p&gt;</description><canonicalUrl>http://science.sciencemag.org/content/363/6424/265.full</canonicalUrl><published>1547750305000</published><keywords><item>Physics, Applied</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/265?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce077:ad2b6584</id><title>A Eu3+-Eu2+ ion redox shuttle imparts operational durability to Pb-I perovskite solar cells</title><fingerprint>6713bd09</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-35983-3</href></item></canonical><engagement>0</engagement><crawled>1547201635151</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Shaoshuai Liang</name></author><visual><height>477</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-35983-3/MediaObjects/41598_2018_35983_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-35983-3</link><content><content>&lt;p&gt;&lt;b&gt;&lt;i&gt;SOX2&lt;/i&gt; participates in spermatogenesis of Zhikong scallop &lt;i&gt;Chlamys farreri&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;SOX2&amp;lt;/i&gt; participates in spermatogenesis of Zhikong scallop &amp;lt;i&gt;Chlamys farreri&amp;lt;/i&gt;, Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-35983-3&quot;&gt;doi:10.1038/s41598-018-35983-3&lt;/a&gt;&lt;/p&gt;&lt;i&gt;SOX2&lt;/i&gt; participates in spermatogenesis of Zhikong scallop &lt;i&gt;Chlamys farreri&lt;/i&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/6Z4jxV1rnDc&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-35983-3</originId><description>&lt;p&gt;&lt;b&gt;&lt;i&gt;SOX2&lt;/i&gt; participates in spermatogenesis of Zhikong scallop &lt;i&gt;Chlamys farreri&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&amp;lt;i&gt;SOX2&amp;lt;/i&gt; participates in spermatogenesis of Zhikong scallop &amp;lt;i&gt;Chlamys farreri&amp;lt;/i&gt;, Published online: 11 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-35983-3&quot;&gt;doi:10.1038/s41598-018-35983-3&lt;/a&gt;&lt;/p&gt;&lt;i&gt;SOX2&lt;/i&gt; participates in spermatogenesis of Zhikong scallop &lt;i&gt;Chlamys farreri&lt;/i&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/6Z4jxV1rnDc&quot; height=&quot;1&quot;&gt;</description><published>1547193600000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/6Z4jxV1rnDc/s41598-018-35983-3</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_1683c67634f:19fe6b3:8675cc2c</id><title>SOX2 participates in spermatogenesis of Zhikong scallop Chlamys farreri</title><fingerprint>f0651dd8</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07877-5</href></item></canonical><engagement>21</engagement><crawled>1546943421546</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Dogyun Byeon</name></author><visual><height>201</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07877-5/MediaObjects/41467_2018_7877_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-07877-5</link><content><content>&lt;p&gt;&lt;b&gt;Discovery of colossal Seebeck effect in metallic Cu&lt;sub&gt;2&lt;/sub&gt;Se&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Discovery of colossal Seebeck effect in metallic Cu&amp;lt;sub&gt;2&amp;lt;/sub&gt;Se, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07877-5&quot;&gt;doi:10.1038/s41467-018-07877-5&lt;/a&gt;&lt;/p&gt;Recent research efforts have aimed at discovering thermoelectric materials with high efficiency in the middle-low temperature range, where a majority of waste heat is lost to the ambient. Here, the authors discover colossal Seebeck coefficient values in metallic copper selenide from 340 K to 400 K.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/2NBlDTCJFNI&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-07877-5</originId><description>&lt;p&gt;&lt;b&gt;Discovery of colossal Seebeck effect in metallic Cu&lt;sub&gt;2&lt;/sub&gt;Se&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Discovery of colossal Seebeck effect in metallic Cu&amp;lt;sub&gt;2&amp;lt;/sub&gt;Se, Published online: 08 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07877-5&quot;&gt;doi:10.1038/s41467-018-07877-5&lt;/a&gt;&lt;/p&gt;Recent research efforts have aimed at discovering thermoelectric materials with high efficiency in the middle-low temperature range, where a majority of waste heat is lost to the ambient. Here, the authors discover colossal Seebeck coefficient values in metallic copper selenide from 340 K to 400 K.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/2NBlDTCJFNI&quot; height=&quot;1&quot;&gt;</description><published>1546934400000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/2NBlDTCJFNI/s41467-018-07877-5</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1682d035c6a:2a73e3:c2ce2e2e</id><title>Discovery of colossal Seebeck effect in metallic Cu2Se</title><fingerprint>2e56b44e</fingerprint></item><item><engagement>0</engagement><crawled>1547752389672</crawled><visual><url>none</url></visual><author><name>Stern, P.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6424/241-n?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6424/241-n?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6424/241.14.full</canonicalUrl><published>1547750305000</published><keywords><item>Neuroscience</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/241-n?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce08a:ad2b6584</id><title>The cerebellum and reward-driven behavior</title><fingerprint>598cc772</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07894-4</href></item></canonical><engagement>4</engagement><crawled>1546465890545</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>S. W. D. Turner</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>610</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07894-4/MediaObjects/41467_2018_7894_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-07894-4</link><content><content>&lt;p&gt;&lt;b&gt;Compound climate events transform electrical power shortfall risk in the Pacific Northwest&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Compound climate events transform electrical power shortfall risk in the Pacific Northwest, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07894-4&quot;&gt;doi:10.1038/s41467-018-07894-4&lt;/a&gt;&lt;/p&gt;Climate change will affect both the demand for electrical power and the generating capabilities of hydropower plants. Here the authors investigated the combined impact of these effects in the US Pacific Northwest by considering the dynamics of the regional power grid, where they reveal a profound impact of climate change on power shortfall risk by the year 2035.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/xKdgFpxxTy0&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-07894-4</originId><description>&lt;p&gt;&lt;b&gt;Compound climate events transform electrical power shortfall risk in the Pacific Northwest&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Compound climate events transform electrical power shortfall risk in the Pacific Northwest, Published online: 02 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07894-4&quot;&gt;doi:10.1038/s41467-018-07894-4&lt;/a&gt;&lt;/p&gt;Climate change will affect both the demand for electrical power and the generating capabilities of hydropower plants. Here the authors investigated the combined impact of these effects in the US Pacific Northwest by considering the dynamics of the regional power grid, where they reveal a profound impact of climate change on power shortfall risk by the year 2035.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/xKdgFpxxTy0&quot; height=&quot;1&quot;&gt;</description><published>1546416000000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/xKdgFpxxTy0/s41467-018-07894-4</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_168108cd0f1:6372ace:ad2b6584</id><title>Compound climate events transform electrical power shortfall risk in the Pacific Northwest</title><fingerprint>108dbc89</fingerprint></item><item><entities><item><label>Earth</label><id>nlp/f/entity/en/w/Earth</id><mentions><item><text>Earth</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>World Magnetic Model</label><id>nlp/f/entity/en/w/World Magnetic Model</id><mentions><item><text>World Magnetic Model</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Arnaud Chulliat</label><id>nlp/f/entity/en/-/arnaud chulliat</id><mentions><item><text>Arnaud Chulliat</text></item><item><text>Chulliat</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Google Maps</label><id>nlp/f/entity/en/w/Google Maps</id><mentions><item><text>Google Maps</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>National Oceanic and Atmospheric Administration</label><id>nlp/f/entity/en/w/National Oceanic and Atmospheric Administration</id><mentions><item><text>NOAA</text></item><item><text>National Oceanic and Atmospheric Administration</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547057114190</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00007-1/d41586-019-00007-1_16383828.jpg</url></visual><author><name>Alexandra Witze</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00007-1</link><content><content>&lt;p&gt;&lt;b&gt;Earth’s magnetic field is acting up and geologists don’t know why&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Earth’s magnetic field is acting up and geologists don’t know why, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00007-1&quot;&gt;doi:10.1038/d41586-019-00007-1&lt;/a&gt;&lt;/p&gt;Erratic motion of north magnetic pole forces experts to update model that aids global navigation.</content><direction>ltr</direction></content><commonTopics><item><label>astrophysics</label><id>nlp/f/topic/173</id><probability>0.952</probability></item><item><label>geology</label><id>nlp/f/topic/959</id><probability>0.745</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00007-1</originId><description>&lt;p&gt;&lt;b&gt;Earth’s magnetic field is acting up and geologists don’t know why&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Earth’s magnetic field is acting up and geologists don’t know why, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00007-1&quot;&gt;doi:10.1038/d41586-019-00007-1&lt;/a&gt;&lt;/p&gt;Erratic motion of north magnetic pole forces experts to update model that aids global navigation.</description><published>1547020800000</published><engagement>50</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00007-1</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b071:8675cc2c</id><title>Earth’s magnetic field is acting up and geologists don’t know why</title><fingerprint>9da10ea6</fingerprint></item><item><engagement>1</engagement><crawled>1547752389672</crawled><visual><url>none</url></visual><author><name>Yeston, J.</name></author><origin><htmlUrl>http://science.sciencemag.org</htmlUrl><streamId>feed/http://www.sciencemag.org/rss/current.xml</streamId><title>Science current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://science.sciencemag.org/cgi/content/short/363/6424/241-j?rss=1</link><originId>http://science.sciencemag.org/cgi/content/short/363/6424/241-j?rss=1</originId><canonicalUrl>http://science.sciencemag.org/content/363/6424/241.10.full</canonicalUrl><published>1547750305000</published><keywords><item>Chemistry</item></keywords><alternate><item><type>text/html</type><href>http://science.sciencemag.org/cgi/content/short/363/6424/241-j?rss=1</href></item></alternate><id>uYuHkca+SUqlKx8hrJBJkCoW+psRQpxBOVPrNKf627U=_1685d3b3c28:5ce08e:ad2b6584</id><title>Synthetic innovation in drug development</title><fingerprint>c6d8b7fc</fingerprint></item><item><canonical><item><type>text/html</type><href>http://dx.doi.org/10.1021/acs.jmedchem.8b01391</href></item></canonical><engagement>0</engagement><crawled>1547817471562</crawled><origin><htmlUrl>https://pubs.acs.org</htmlUrl><streamId>feed/http://feeds.feedburner.com/acs/jmcmar</streamId><title>Journal of Medicinal Chemistry: Latest Articles (ACS Publications)</title></origin><author><name>Romeo Romagnoli, Filippo Prencipe, Paola Oliva, Stefania Baraldi, Pier Giovanni Baraldi, Santiago Schiaffino Ortega, Mariem Chayah, Maria Kimatrai Salvador, Luisa Carlota Lopez-Cara, Andrea Brancale, Salvatore Ferla, Ernest Hamel, Roberto Ronca, Roberta Bortolozzi, Elena Mariotto, Elena Mattiuzzo, Giampietro Viola</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://dx.doi.org/10.1021/acs.jmedchem.8b01391</link><originId>http://dx.doi.org/10.1021/acs.jmedchem.8b01391</originId><description>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01391/20190118/images/medium/jm-2018-01391c_0015.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01391&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=C1ELmJWhh10:5g80XA7l3EU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/C1ELmJWhh10&quot; height=&quot;1&quot;&gt;</description><published>1547787600000</published><alternate><item><type>text/html</type><href>http://feedproxy.google.com/~r/acs/jmcmar/~3/C1ELmJWhh10/acs.jmedchem.8b01391</href></item></alternate><id>J+gBTJ3fLKJJhXvbycsPO6dp/EMBx8vQLIPzHkHHEfU=_168611c4e4a:13b2a9:1451c985</id><title>[ASAP] Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors</title><fingerprint>14f05028</fingerprint><summary><content>&lt;p&gt;&lt;img alt=&quot;TOC Graphic&quot; src=&quot;https://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jmcmar/0/jmcmar.ahead-of-print/acs.jmedchem.8b01391/20190118/images/medium/jm-2018-01391c_0015.gif&quot;&gt;&lt;/p&gt;&lt;div&gt;&lt;cite&gt;Journal of Medicinal Chemistry&lt;/cite&gt;&lt;/div&gt;&lt;div&gt;DOI: 10.1021/acs.jmedchem.8b01391&lt;/div&gt;&lt;div&gt;
&lt;a href=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?a=C1ELmJWhh10:5g80XA7l3EU:yIl2AUoC8zA&quot;&gt;&lt;img border=&quot;0&quot; src=&quot;http://feeds.feedburner.com/~ff/acs/jmcmar?d=yIl2AUoC8zA&quot;&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/acs/jmcmar/~4/C1ELmJWhh10&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1548789675639</crawled><visual><url>none</url></visual><author><name>Foley, J. F.</name></author><origin><htmlUrl>http://stke.sciencemag.org</htmlUrl><streamId>feed/http://stke.sciencemag.org/rss/current.xml</streamId><title>Science Signaling current issue</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://stke.sciencemag.org/cgi/content/short/12/566/eaaw7886?rss=1</link><content><content>&lt;p&gt;Loss of mitochondrial complex III in regulatory T cells reduces their suppressive activity without affecting their survival.&lt;/p&gt;</content><direction>ltr</direction></content><originId>http://stke.sciencemag.org/cgi/content/short/12/566/eaaw7886?rss=1</originId><description>&lt;p&gt;Loss of mitochondrial complex III in regulatory T cells reduces their suppressive activity without affecting their survival.&lt;/p&gt;</description><canonicalUrl>http://stke.sciencemag.org/content/12/566/eaaw7886.full</canonicalUrl><published>1548787889000</published><alternate><item><type>text/html</type><href>http://stke.sciencemag.org/cgi/content/short/12/566/eaaw7886?rss=1</href></item></alternate><id>RuJRIXzN26JgDGk9YhlIBfh4YrPi0r+1c4exm9G1IBw=_1689b0ef677:533ffb:3a104d3b</id><title>Immune suppression with complex III</title><fingerprint>11bd7283</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-37299-8</href></item></canonical><engagement>0</engagement><crawled>1548670772648</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Baptiste Rode</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>623</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37299-8/MediaObjects/41598_2018_37299_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-37299-8</link><content><content>&lt;p&gt;&lt;b&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice&lt;/b&gt;&lt;/p&gt;&lt;p&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37299-8&quot;&gt;doi:10.1038/s41598-018-37299-8&lt;/a&gt;&lt;/p&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Y_j3hq6nnZ8&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-37299-8</originId><description>&lt;p&gt;&lt;b&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice&lt;/b&gt;&lt;/p&gt;&lt;p&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice, Published online: 28 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-37299-8&quot;&gt;doi:10.1038/s41598-018-37299-8&lt;/a&gt;&lt;/p&gt;TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Y_j3hq6nnZ8&quot; height=&quot;1&quot;&gt;</description><published>1548662400000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/Y_j3hq6nnZ8/s41598-018-37299-8</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16893f8a5a8:4dee28d:ad2b6584</id><title>TRPC5 ion channel permeation promotes weight gain in hypercholesterolaemic mice</title><fingerprint>a794a9a6</fingerprint></item><item><engagement>0</engagement><crawled>1548695842093</crawled><visual><height>324</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>250</width><url>https://s3-eu-west-1.amazonaws.com/ppreviews-chemrxiv-7984736271254/14183069/thumb.png</url></visual><published>1548633600000</published><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Synthesis_of_Simplified_Azasordarin_Analogs_as_Potential_Antifungal_Agents/7634849</link><originId>https://chemrxiv.org/articles/Synthesis_of_Simplified_Azasordarin_Analogs_as_Potential_Antifungal_Agents/7634849</originId><description>A new series of simplified azasordarin analogs was synthesized using as key steps a Diels-Alder reaction to generate a highly substituted bicyclo[2.2.1]heptane core, followed by a subsequent nitrile alkylation. Several additional strategies were investigated for the generation of the key tertiary nitrile or aldehyde thought to be required for activity at the fungal protein eukaryotic elongation factor 2. This new series also features a morpholino glycone previously reported in semisynthetic sordarin derivatives with broad spectrum antifungal activity. Despite a lack of activity against C. albicans for these early de novo analogs, the synthetic route reported here permits more comprehensive modifications of the bicyclic core, and SAR studies that were not heretofore possible.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Synthesis_of_Simplified_Azasordarin_Analogs_as_Potential_Antifungal_Agents/7634849</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16895772d2d:50494a9:ad2b6584</id><title>Synthesis of Simplified Azasordarin Analogs as Potential Antifungal Agents</title><fingerprint>bd3099ec</fingerprint><summary><content>A new series of simplified azasordarin analogs was synthesized using as key steps a Diels-Alder reaction to generate a highly substituted bicyclo[2.2.1]heptane core, followed by a subsequent nitrile alkylation. Several additional strategies were investigated for the generation of the key tertiary nitrile or aldehyde thought to be required for activity at the fungal protein eukaryotic elongation factor 2. This new series also features a morpholino glycone previously reported in semisynthetic sordarin derivatives with broad spectrum antifungal activity. Despite a lack of activity against C. albicans for these early de novo analogs, the synthetic route reported here permits more comprehensive modifications of the bicyclic core, and SAR studies that were not heretofore possible.</content><direction>ltr</direction></summary></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41591-018-0310-5</href></item></canonical><entities><item><label>Cascading Style Sheets</label><id>nlp/f/entity/en/w/Cascading Style Sheets</id><mentions><item><text>CSS</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>WEBSITEnature_com</label><id>nlp/f/entity/en/-/websitenature_com</id><mentions><item><text>WEBSITEnature_com</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Explorer</label><id>nlp/f/entity/en/-/explorer</id><mentions><item><text>Explorer</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>JavaScript</label><id>nlp/f/entity/en/w/JavaScript</id><mentions><item><text>JavaScript</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546877155117</crawled><origin><htmlUrl>http://feeds.nature.com/nm/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nm/rss/current</streamId><title>Nature Medicine - Issue - nature.com science feeds</title></origin><author><name>Omer Gottesman</name></author><visual><height>404</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-018-0310-5/MediaObjects/41591_2018_310_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41591-018-0310-5</link><content><content>&lt;p&gt;&lt;b&gt;Guidelines for reinforcement learning in healthcare&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Guidelines for reinforcement learning in healthcare, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0310-5&quot;&gt;doi:10.1038/s41591-018-0310-5&lt;/a&gt;&lt;/p&gt;In this Comment, we provide guidelines for reinforcement learning for decisions about patient treatment that we hope will accelerate the rate at which observational cohorts can inform healthcare practice in a safe, risk-conscious manner.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/P0LfL_0Skqg&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>digital health</label><id>nlp/f/topic/657</id><probability>0.947</probability></item></commonTopics><originId>https://www.nature.com/articles/s41591-018-0310-5</originId><description>&lt;p&gt;&lt;b&gt;Guidelines for reinforcement learning in healthcare&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Guidelines for reinforcement learning in healthcare, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41591-018-0310-5&quot;&gt;doi:10.1038/s41591-018-0310-5&lt;/a&gt;&lt;/p&gt;In this Comment, we provide guidelines for reinforcement learning for decisions about patient treatment that we hope will accelerate the rate at which observational cohorts can inform healthcare practice in a safe, risk-conscious manner.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nm/rss/current/~4/P0LfL_0Skqg&quot; height=&quot;1&quot;&gt;</description><published>1546848000000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nm/rss/current/~3/P0LfL_0Skqg/s41591-018-0310-5</href></item></alternate><id>PYzmD3sAat15lWWcVxLHD9ulNM95ZfBPY1sahR81ofI=_1682910372d:1629683:3a104d3b</id><title>Guidelines for reinforcement learning in healthcare</title><fingerprint>b8f3711d</fingerprint></item><item><entities><item><label>M.</label><id>nlp/f/entity/en/-/m.</id><mentions><item><text>M.</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>E.</label><id>nlp/f/entity/en/-/e.</id><mentions><item><text>E.</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Astrophys</label><id>nlp/f/entity/en/-/astrophys</id><mentions><item><text>Astrophys</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>R. Astron</label><id>nlp/f/entity/en/-/r. astron</id><mentions><item><text>Astron</text></item><item><text>R. Astron</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Ser</label><id>nlp/f/entity/en/-/ser</id><mentions><item><text>Ser</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547057114190</crawled><visual><height>497</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-018-0791-x/MediaObjects/41586_2018_791_Fig1_HTML.png</url></visual><author><name>Pier-Emmanuel Tremblay</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/s41586-018-0791-x</link><content><content>&lt;p&gt;&lt;b&gt;Core crystallization and pile-up in the cooling sequence of evolving white dwarfs&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Core crystallization and pile-up in the cooling sequence of evolving white dwarfs, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0791-x&quot;&gt;doi:10.1038/s41586-018-0791-x&lt;/a&gt;&lt;/p&gt;Photometry and parallax data from the Gaia satellite provide direct observational evidence of a theoretically predicted pile-up in the cooling sequence of white dwarfs, which is associated with core crystallization.</content><direction>ltr</direction></content><commonTopics><item><label>classics</label><id>nlp/f/topic/477</id><probability>0.984</probability></item><item><label>alt right</label><id>nlp/f/topic/80</id><probability>0.958</probability></item><item><label>hbd</label><id>nlp/f/topic/1042</id><probability>0.934</probability></item><item><label>rationality</label><id>nlp/f/topic/1895</id><probability>0.805</probability></item><item><label>mp3</label><id>nlp/f/topic/1508</id><probability>0.792</probability></item><item><label>data science</label><id>nlp/f/topic/618</id><probability>0.786</probability></item><item><label>emergency medicine</label><id>nlp/f/topic/764</id><probability>0.779</probability></item><item><label>fat</label><id>nlp/f/topic/842</id><probability>0.742</probability></item></commonTopics><originId>https://www.nature.com/articles/s41586-018-0791-x</originId><description>&lt;p&gt;&lt;b&gt;Core crystallization and pile-up in the cooling sequence of evolving white dwarfs&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Core crystallization and pile-up in the cooling sequence of evolving white dwarfs, Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41586-018-0791-x&quot;&gt;doi:10.1038/s41586-018-0791-x&lt;/a&gt;&lt;/p&gt;Photometry and parallax data from the Gaia satellite provide direct observational evidence of a theoretically predicted pile-up in the cooling sequence of white dwarfs, which is associated with core crystallization.</description><published>1547020800000</published><engagement>9</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/s41586-018-0791-x</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16833ca2c4e:d2b07b:8675cc2c</id><title>Core crystallization and pile-up in the cooling sequence of evolving white dwarfs</title><fingerprint>11e74ed7</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-07974-5</href></item></canonical><engagement>0</engagement><crawled>1546511106786</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Marie-Christine Carpentier</name></author><visual><height>685</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>526</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-07974-5/MediaObjects/41467_2018_7974_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-07974-5</link><content><content>&lt;p&gt;&lt;b&gt;Retrotranspositional landscape of Asian rice revealed by 3000 genomes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Retrotranspositional landscape of Asian rice revealed by 3000 genomes, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07974-5&quot;&gt;doi:10.1038/s41467-018-07974-5&lt;/a&gt;&lt;/p&gt;Transposable elements (TE) are the dominant constituent of plant genomes. Here the authors develop a tool to analyze TE insertion sites in 3000 rice genomes and provide evidence for recent TE activity during cultivation and that external, rather than genetic, stimuli trigger most activations.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/vvsCpGqQOFY&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-07974-5</originId><description>&lt;p&gt;&lt;b&gt;Retrotranspositional landscape of Asian rice revealed by 3000 genomes&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Retrotranspositional landscape of Asian rice revealed by 3000 genomes, Published online: 03 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-07974-5&quot;&gt;doi:10.1038/s41467-018-07974-5&lt;/a&gt;&lt;/p&gt;Transposable elements (TE) are the dominant constituent of plant genomes. Here the authors develop a tool to analyze TE insertion sites in 3000 rice genomes and provide evidence for recent TE activity during cultivation and that external, rather than genetic, stimuli trigger most activations.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/vvsCpGqQOFY&quot; height=&quot;1&quot;&gt;</description><published>1546502400000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/vvsCpGqQOFY/s41467-018-07974-5</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_168133ec2e2:66e24dc:ad2b6584</id><title>Retrotranspositional landscape of Asian rice revealed by 3000 genomes</title><fingerprint>eebbba01</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/d41573-018-00016-1</href></item></canonical><entities><item><label>Infant respiratory distress syndrome</label><id>nlp/f/entity/en/w/Infant respiratory distress syndrome</id><mentions><item><text>IRDs</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Voretigene neparvovec</label><id>nlp/f/entity/en/w/Voretigene neparvovec</id><mentions><item><text>Luxturna</text></item><item><text>voretigene neparvovec</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Fiscal year</label><id>nlp/f/entity/en/w/Fiscal year</id><mentions><item><text>FY</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Food and Drug Administration</label><id>nlp/f/entity/en/w/Food and Drug Administration</id><mentions><item><text>FDA</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Advanced Micro Devices</label><id>nlp/f/entity/en/w/Advanced Micro Devices</id><mentions><item><text>AMD</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1548241094449</crawled><origin><htmlUrl>http://feeds.nature.com/nrd/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/nrd/rss/current</streamId><title>Nature Reviews Drug Discovery - Issue - nature.com science feeds</title></origin><author><name>Kathleen Gordon</name></author><visual><url>none</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/d41573-018-00016-1</link><content><content>&lt;p&gt;&lt;b&gt;Gene therapies in ophthalmic disease&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Gene therapies in ophthalmic disease, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-018-00016-1&quot;&gt;doi:10.1038/d41573-018-00016-1&lt;/a&gt;&lt;/p&gt;Gene therapies in ophthalmic disease&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/WlEUx7w8eMw&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><commonTopics><item><label>bioinformatics</label><id>nlp/f/topic/262</id><probability>0.834</probability></item><item><label>drug discovery</label><id>nlp/f/topic/697</id><probability>0.834</probability></item><item><label>genetics</label><id>nlp/f/topic/955</id><probability>0.823</probability></item><item><label>regulators</label><id>nlp/f/topic/1923</id><probability>0.809</probability></item><item><label>hematology</label><id>nlp/f/topic/1058</id><probability>0.792</probability></item><item><label>synthetic biology</label><id>nlp/f/topic/2228</id><probability>0.749</probability></item><item><label>stem cells</label><id>nlp/f/topic/2185</id><probability>0.733</probability></item></commonTopics><originId>https://www.nature.com/articles/d41573-018-00016-1</originId><description>&lt;p&gt;&lt;b&gt;Gene therapies in ophthalmic disease&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Gene therapies in ophthalmic disease, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41573-018-00016-1&quot;&gt;doi:10.1038/d41573-018-00016-1&lt;/a&gt;&lt;/p&gt;Gene therapies in ophthalmic disease&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/nrd/rss/current/~4/WlEUx7w8eMw&quot; height=&quot;1&quot;&gt;</description><published>1548230400000</published><engagement>0</engagement><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/nrd/rss/current/~3/WlEUx7w8eMw/d41573-018-00016-1</href></item></alternate><id>YLwIhSxZAzQIEnJq1FGGcXUQMCbQUlr9cyNMExMVeyY=_1687a5c4731:2c841be:3a104d3b</id><title>Gene therapies in ophthalmic disease</title><fingerprint>5d780a19</fingerprint></item><item><engagement>0</engagement><crawled>1547338812653</crawled><fingerprint>57f58aa9</fingerprint><author><name>Luo, Y.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/519413v1?rss=1</link><content><content>A plethora of biological functions are performed through various types of protein-peptide binding. Prime examples include the protein kinase phosphorylation on peptide substrates and the binding of major histocompatibility complex to neoantigens in the immune system. Understanding the specificity of protein-peptide interactions is critical for unraveling the architectures of functional pathways and the mechanisms of cellular processes in human cells. Despite mass-spectrometric techniques were developed for the identification of protein-peptide interactions, our understanding of the preferences of proteins on their binding peptides is still rudimentary. As a complementary direction, a line of computational prediction methods has been recently proposed to predict protein-peptide bindings which efficiently provide rich functional annotations on a large scale. To achieve a high prediction accuracy, these computational methods require a sufficient amount of data to build the prediction model. However, the number of experimentally verified protein-peptide bindings is often limited in real cases. For example, a majority of protein kinases have very few experimentally verified phosphorylation sites (e.g., less than 30 sites) in existing databases. These methods are thus limited to building accurate prediction models for only well-characterized proteins with a large volume of known binding peptides and cannot be extended to predict new binding peptides for less-studied proteins. In this paper, we introduce a generic framework to address this issue of data scarcity in protein binding prediction. We demonstrate the applicability of our framework in predicting kinase-specific phosphorylation sites. Our method uses an effective training strategy to build a prediction model with robust transferability. The model is able to predict the phosphorylation sites of a less-studied kinase, even if there is only a small number of phosphorylation sites known for this kinase. To achieve this, we train the model via a meta-learning phase followed by a few-shot learning phase. We demonstrate our framework has better transferability than state-of-the-art methods and is effective in utilizing limited data to accurately predict phosphorylation sites for less-characterized kinases. The implementation of our framework is available at https://github.com/luoyunan/MetaKinase.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/519413v1?rss=1</originId><description>A plethora of biological functions are performed through various types of protein-peptide binding. Prime examples include the protein kinase phosphorylation on peptide substrates and the binding of major histocompatibility complex to neoantigens in the immune system. Understanding the specificity of protein-peptide interactions is critical for unraveling the architectures of functional pathways and the mechanisms of cellular processes in human cells. Despite mass-spectrometric techniques were developed for the identification of protein-peptide interactions, our understanding of the preferences of proteins on their binding peptides is still rudimentary. As a complementary direction, a line of computational prediction methods has been recently proposed to predict protein-peptide bindings which efficiently provide rich functional annotations on a large scale. To achieve a high prediction accuracy, these computational methods require a sufficient amount of data to build the prediction model. However, the number of experimentally verified protein-peptide bindings is often limited in real cases. For example, a majority of protein kinases have very few experimentally verified phosphorylation sites (e.g., less than 30 sites) in existing databases. These methods are thus limited to building accurate prediction models for only well-characterized proteins with a large volume of known binding peptides and cannot be extended to predict new binding peptides for less-studied proteins. In this paper, we introduce a generic framework to address this issue of data scarcity in protein binding prediction. We demonstrate the applicability of our framework in predicting kinase-specific phosphorylation sites. Our method uses an effective training strategy to build a prediction model with robust transferability. The model is able to predict the phosphorylation sites of a less-studied kinase, even if there is only a small number of phosphorylation sites known for this kinase. To achieve this, we train the model via a meta-learning phase followed by a few-shot learning phase. We demonstrate our framework has better transferability than state-of-the-art methods and is effective in utilizing limited data to accurately predict phosphorylation sites for less-characterized kinases. The implementation of our framework is available at https://github.com/luoyunan/MetaKinase.</description><published>1547280000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/519413v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_16844948ced:235d232:c2ce2e2e</id><title>Mitigating Data Scarcity in Protein Binding Prediction Using Meta-Learning [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/12/519413</canonicalUrl></item><item><crawled>1548867468510</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1548806400000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Grafting_of_a_Molecular_Rhenium_CO2_Reduction_Catalyst_onto_Colloid-Imprinted_Carbon/7647203</link><originId>https://chemrxiv.org/articles/Grafting_of_a_Molecular_Rhenium_CO2_Reduction_Catalyst_onto_Colloid-Imprinted_Carbon/7647203</originId><description>An
aminophenethyl-substituted [Re(2,2’-bipyridine)(CO)3Cl] catalyst ([Re(NH2-bpy)]) was tethered
to nanoporous colloid-imprinted carbon (CIC) electrode surfaces via an electrochemical oxidative
grafting method. Hybrid CIC|[Re(NH2-bpy)]
electrodes showed an improved stability and an increased loading per
geometrical area in comparison to modified smooth glassy carbon electrodes. The
catalyst also remained active upon immobilization and CO2 was
selectively reduced to CO by the CIC|[Re(NH2-bpy)]
electrodes in acetonitrile with a Faradaic efficiency of 92 ± 6% and a Re-based
TON of approximately 900.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Grafting_of_a_Molecular_Rhenium_CO2_Reduction_Catalyst_onto_Colloid-Imprinted_Carbon/7647203</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_1689fb1fcde:bfaa06:3a104d3b</id><title>Grafting of a Molecular Rhenium CO2 Reduction Catalyst onto Colloid-Imprinted Carbon</title><fingerprint>afea2653</fingerprint><summary><content>An
aminophenethyl-substituted [Re(2,2’-bipyridine)(CO)3Cl] catalyst ([Re(NH2-bpy)]) was tethered
to nanoporous colloid-imprinted carbon (CIC) electrode surfaces via an electrochemical oxidative
grafting method. Hybrid CIC|[Re(NH2-bpy)]
electrodes showed an improved stability and an increased loading per
geometrical area in comparison to modified smooth glassy carbon electrodes. The
catalyst also remained active upon immobilization and CO2 was
selectively reduced to CO by the CIC|[Re(NH2-bpy)]
electrodes in acetonitrile with a Faradaic efficiency of 92 ± 6% and a Re-based
TON of approximately 900.</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1546441285245</crawled><fingerprint>3721475</fingerprint><author><name>Bermudez-Barrientos, J. R.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/508937v1?rss=1</link><content><content>Many organisms exchange small RNAs during their interactions, and these RNAs can target or bolster defense strategies in host-pathogen systems. Current sRNA-Seq technology can determine the small RNAs present in any symbiotic system, but there are very few bioinformatic tools available to interpret the results. We show that one of the biggest challenges comes from sequences that map equally well to the genomes of both interacting organisms. This arises due to the small size of the sRNA compared to large genomes, and because many of the produced sRNAs come from genomic regions that encode highly conserved miRNAs, rRNAs or tRNAs. Here we present strategies to disentangle sRNA-Seq data from samples of communicating organisms, developed using diverse plant and animal species that are known to exchange RNA with their parasites. We show that sequence assembly, both de novo and genome-guided, can be used for sRNA-Seq data, greatly reducing the ambiguity of mapping reads. Even confidently mapped sequences can be misleading, so we further demonstrate the use of differential expression strategies to determine the true parasitic sRNAs within host cells. Finally, we validate our methods on new experiments designed to probe the nature of the extracellular vesicle sRNAs from the parasitic nematode H. bakeri that get into mouse epithelial cells.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/508937v1?rss=1</originId><description>Many organisms exchange small RNAs during their interactions, and these RNAs can target or bolster defense strategies in host-pathogen systems. Current sRNA-Seq technology can determine the small RNAs present in any symbiotic system, but there are very few bioinformatic tools available to interpret the results. We show that one of the biggest challenges comes from sequences that map equally well to the genomes of both interacting organisms. This arises due to the small size of the sRNA compared to large genomes, and because many of the produced sRNAs come from genomic regions that encode highly conserved miRNAs, rRNAs or tRNAs. Here we present strategies to disentangle sRNA-Seq data from samples of communicating organisms, developed using diverse plant and animal species that are known to exchange RNA with their parasites. We show that sequence assembly, both de novo and genome-guided, can be used for sRNA-Seq data, greatly reducing the ambiguity of mapping reads. Even confidently mapped sequences can be misleading, so we further demonstrate the use of differential expression strategies to determine the true parasitic sRNAs within host cells. Finally, we validate our methods on new experiments designed to probe the nature of the extracellular vesicle sRNAs from the parasitic nematode H. bakeri that get into mouse epithelial cells.</description><published>1546416000000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/508937v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1680f155e7d:615cb34:3a104d3b</id><title>Disentangling sRNA-Seq data to study RNA communication between species [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/02/508937</canonicalUrl></item><item><entities><item><label>Face2Gene</label><id>nlp/f/entity/en/-/face2gene</id><mentions><item><text>Face2Gene</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>FDNA</label><id>nlp/f/entity/en/-/fdna</id><mentions><item><text>FDNA</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Cornelia Catharina de Lange</label><id>nlp/f/entity/en/w/Cornelia Catharina de Lange</id><mentions><item><text>Cornelia de Lange</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>ZUMA</label><id>nlp/f/entity/en/-/zuma</id><mentions><item><text>ZUMA</text></item></mentions><salienceLevel>about</salienceLevel></item><item><label>Michael Ares</label><id>nlp/f/entity/en/-/michael ares</id><mentions><item><text>Michael Ares</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1546878293764</crawled><visual><height>576</height><processor>feedly-nikon-v3.1</processor><contentType>image/jpeg</contentType><width>1024</width><url>https://media.nature.com/lw1024/magazine-assets/d41586-019-00027-x/d41586-019-00027-x_16375318.jpg</url></visual><author><name>Elie Dolgin</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00027-x</link><content><content>&lt;p&gt;&lt;b&gt;AI face-scanning app spots signs of rare genetic disorders&lt;/b&gt;&lt;/p&gt;&lt;p&gt;AI face-scanning app spots signs of rare genetic disorders, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00027-x&quot;&gt;doi:10.1038/d41586-019-00027-x&lt;/a&gt;&lt;/p&gt;Deep-learning algorithm helps to diagnose conditions that aren’t readily apparent to doctors or researchers.</content><direction>ltr</direction></content><commonTopics><item><label>ai</label><id>nlp/f/topic/56</id><probability>0.95</probability></item><item><label>neurology</label><id>nlp/f/topic/1563</id><probability>0.866</probability></item><item><label>pediatrics</label><id>nlp/f/topic/1714</id><probability>0.847</probability></item><item><label>genetics</label><id>nlp/f/topic/955</id><probability>0.752</probability></item><item><label>singularity</label><id>nlp/f/topic/2074</id><probability>0.749</probability></item><item><label>machine learning</label><id>nlp/f/topic/1381</id><probability>0.736</probability></item><item><label>hbd</label><id>nlp/f/topic/1042</id><probability>0.733</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00027-x</originId><description>&lt;p&gt;&lt;b&gt;AI face-scanning app spots signs of rare genetic disorders&lt;/b&gt;&lt;/p&gt;&lt;p&gt;AI face-scanning app spots signs of rare genetic disorders, Published online: 07 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00027-x&quot;&gt;doi:10.1038/d41586-019-00027-x&lt;/a&gt;&lt;/p&gt;Deep-learning algorithm helps to diagnose conditions that aren’t readily apparent to doctors or researchers.</description><published>1546848000000</published><engagement>8</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00027-x</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16829219704:16459d2:3a104d3b</id><title>AI face-scanning app spots signs of rare genetic disorders</title><fingerprint>b0df5ed0</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41598-018-36799-x</href></item></canonical><engagement>0</engagement><crawled>1547029352254</crawled><origin><htmlUrl>http://feeds.nature.com/srep/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/srep/rss/current</streamId><title>Scientific Reports - nature.com science feeds</title></origin><author><name>Catarina Silva-Costa</name></author><visual><height>429</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36799-x/MediaObjects/41598_2018_36799_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41598-018-36799-x</link><content><content>&lt;p&gt;&lt;b&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015), Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36799-x&quot;&gt;doi:10.1038/s41598-018-36799-x&lt;/a&gt;&lt;/p&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Dz0PLDKaUjc&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41598-018-36799-x</originId><description>&lt;p&gt;&lt;b&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015), Published online: 09 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41598-018-36799-x&quot;&gt;doi:10.1038/s41598-018-36799-x&lt;/a&gt;&lt;/p&gt;Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/srep/rss/current/~4/Dz0PLDKaUjc&quot; height=&quot;1&quot;&gt;</description><published>1547020800000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/srep/rss/current/~3/Dz0PLDKaUjc/s41598-018-36799-x</href></item></alternate><id>IymvE54Z9frpyk64iS4s0A80Qs78uuAlkaJGfGCL8/g=_16832228f3e:a8de3e:8675cc2c</id><title>Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)</title><fingerprint>1d1cf447</fingerprint></item><item><canonical><item><type>text/html</type><href>https://www.nature.com/articles/s41467-018-08057-1</href></item></canonical><engagement>0</engagement><crawled>1548271583607</crawled><origin><htmlUrl>http://feeds.nature.com/ncomms/rss/current</htmlUrl><streamId>feed/http://feeds.nature.com/ncomms/rss/current</streamId><title>Nature Communications - current - nature.com science feeds</title></origin><author><name>Jingyi Tian</name></author><visual><height>354</height><processor>feedly-nikon-v3.1</processor><contentType>image/png</contentType><width>685</width><url>https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-08057-1/MediaObjects/41467_2018_8057_Fig1_HTML.png</url></visual><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://www.nature.com/articles/s41467-018-08057-1</link><content><content>&lt;p&gt;&lt;b&gt;Active control of anapole states by structuring the phase-change alloy Ge&lt;sub&gt;2&lt;/sub&gt;Sb&lt;sub&gt;2&lt;/sub&gt;Te&lt;sub&gt;5&lt;/sub&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Active control of anapole states by structuring the phase-change alloy Ge&amp;lt;sub&gt;2&amp;lt;/sub&gt;Sb&amp;lt;sub&gt;2&amp;lt;/sub&gt;Te&amp;lt;sub&gt;5&amp;lt;/sub&gt;, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08057-1&quot;&gt;doi:10.1038/s41467-018-08057-1&lt;/a&gt;&lt;/p&gt;High-index dielectric nanoparticles support a great wealth of multipolar responses but active tunability is still elusive. Here, the authors report how structured Ge2Sb2Te5 can support multipolar Mie resonances and demonstrate the spectral shifting between electric dipole and anapole modes.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/8pSUseI6TCk&quot; height=&quot;1&quot;&gt;</content><direction>ltr</direction></content><originId>https://www.nature.com/articles/s41467-018-08057-1</originId><description>&lt;p&gt;&lt;b&gt;Active control of anapole states by structuring the phase-change alloy Ge&lt;sub&gt;2&lt;/sub&gt;Sb&lt;sub&gt;2&lt;/sub&gt;Te&lt;sub&gt;5&lt;/sub&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Active control of anapole states by structuring the phase-change alloy Ge&amp;lt;sub&gt;2&amp;lt;/sub&gt;Sb&amp;lt;sub&gt;2&amp;lt;/sub&gt;Te&amp;lt;sub&gt;5&amp;lt;/sub&gt;, Published online: 23 January 2019; &lt;a href=&quot;https://www.nature.com/articles/s41467-018-08057-1&quot;&gt;doi:10.1038/s41467-018-08057-1&lt;/a&gt;&lt;/p&gt;High-index dielectric nanoparticles support a great wealth of multipolar responses but active tunability is still elusive. Here, the authors report how structured Ge2Sb2Te5 can support multipolar Mie resonances and demonstrate the spectral shifting between electric dipole and anapole modes.&lt;img width=&quot;1&quot; alt=&quot;&quot; src=&quot;http://feeds.feedburner.com/~r/ncomms/rss/current/~4/8pSUseI6TCk&quot; height=&quot;1&quot;&gt;</description><published>1548230400000</published><alternate><item><type>text/html</type><href>http://feeds.nature.com/~r/ncomms/rss/current/~3/8pSUseI6TCk/s41467-018-08057-1</href></item></alternate><id>jwXlck1dDuZkRMiQieilKprXSaqkYbbYUBRtrvL+pQ0=_1687c2d8177:2f7efe1:ad2b6584</id><title>Active control of anapole states by structuring the phase-change alloy Ge2Sb2Te5</title><fingerprint>14dd2cc1</fingerprint></item><item><crawled>1548433431313</crawled><origin><htmlUrl>https://chemrxiv.org/</htmlUrl><streamId>feed/https://chemrxiv.org/rss/portal/chemrxiv</streamId><title>ChemRxiv RSS Feed</title></origin><published>1548374400000</published><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>https://chemrxiv.org/articles/Synthesis_of_-Heterosubstituted_Ketones_Through_Sulfur_Mediated_Difunctionalization_of_Internal_Alkynes/7624025</link><originId>https://chemrxiv.org/articles/Synthesis_of_-Heterosubstituted_Ketones_Through_Sulfur_Mediated_Difunctionalization_of_Internal_Alkynes/7624025</originId><description>Synthesis of α-heterosubstituted ketones was achieved through sulfur mediated difunctionalization of internal alkynes in one-pot. The reaction design involves: phenyl substituted internal alkyne attacking the triflic anhydride activated diphenyl sulfoxide to give a sulfonium vinyl triflate intermediate, hydrolysis to give the α-sulfonium ketone, and then substitution with various nucleophiles. This method provides a unified route to access α-amino ketones, α-acyloxy ketones, α-thio ketones, α-halo ketones, α-hydroxy ketones, and related heterocyclic structures, in a rapid fashion.</description><author><name>NA</name></author><alternate><item><type>text/html</type><href>https://chemrxiv.org/articles/Synthesis_of_-Heterosubstituted_Ketones_Through_Sulfur_Mediated_Difunctionalization_of_Internal_Alkynes/7624025</href></item></alternate><id>R0sSyrOt3qz11n623gGB7cGypp5KEPrcBBGYnBmf/zQ=_16885d31b11:3da3143:3a104d3b</id><title>Synthesis of α-Heterosubstituted Ketones Through Sulfur Mediated Difunctionalization of Internal Alkynes</title><fingerprint>3572881d</fingerprint><summary><content>Synthesis of α-heterosubstituted ketones was achieved through sulfur mediated difunctionalization of internal alkynes in one-pot. The reaction design involves: phenyl substituted internal alkyne attacking the triflic anhydride activated diphenyl sulfoxide to give a sulfonium vinyl triflate intermediate, hydrolysis to give the α-sulfonium ketone, and then substitution with various nucleophiles. This method provides a unified route to access α-amino ketones, α-acyloxy ketones, α-thio ketones, α-halo ketones, α-hydroxy ketones, and related heterocyclic structures, in a rapid fashion.</content><direction>ltr</direction></summary></item><item><engagement>0</engagement><crawled>1546810782707</crawled><fingerprint>ff412d9e</fingerprint><author><name>Huffman, G.</name></author><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/512152v1?rss=1</link><content><content>The performance of ultrasensitive LC-MS/MS methods, such as Single-Cell Proteomics by Mass Spectrometry (SCoPE-MS), depends on multiple interdependent parameters. This interdependence makes it challenging to specifically pinpoint bottlenecks in the LC-MS/MS methods and approaches for resolving them. For example, low signal at MS2 level can be due to poor LC separation, ionization, apex targeting, ion transfer, or ion detection. We sought to specifically diagnose such bottlenecks by interactively visualizing data from all levels of bottom-up LC-MS/MS analysis. Many search engines, such as MaxQuant, already provide such data, and we developed an open source platform for their interactive visualization and analysis: Data-driven Optimization of MS (DO-MS). We found that in many cases DO-MS not only specifically diagnosed bottlenecks but also enabled us to rationally optimize them. For example, we used DO-MS to diagnose poor sampling of the elution peak apex and to optimize it, which increased the efficiency of delivering ions for MS2 analysis by 370 %. DO-MS is easy to install and use, and its GUI allows for interactive data subsetting and high-quality figure generation. The modular design of DO-MS facilitates customization and expansion. DO-MS is available for download from GitHub: https://github.com/SlavovLab/DO-MS</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/512152v1?rss=1</originId><description>The performance of ultrasensitive LC-MS/MS methods, such as Single-Cell Proteomics by Mass Spectrometry (SCoPE-MS), depends on multiple interdependent parameters. This interdependence makes it challenging to specifically pinpoint bottlenecks in the LC-MS/MS methods and approaches for resolving them. For example, low signal at MS2 level can be due to poor LC separation, ionization, apex targeting, ion transfer, or ion detection. We sought to specifically diagnose such bottlenecks by interactively visualizing data from all levels of bottom-up LC-MS/MS analysis. Many search engines, such as MaxQuant, already provide such data, and we developed an open source platform for their interactive visualization and analysis: Data-driven Optimization of MS (DO-MS). We found that in many cases DO-MS not only specifically diagnosed bottlenecks but also enabled us to rationally optimize them. For example, we used DO-MS to diagnose poor sampling of the elution peak apex and to optimize it, which increased the efficiency of delivering ions for MS2 analysis by 370 %. DO-MS is easy to install and use, and its GUI allows for interactive data subsetting and high-quality figure generation. The modular design of DO-MS facilitates customization and expansion. DO-MS is available for download from GitHub: https://github.com/SlavovLab/DO-MS</description><published>1546761600000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/512152v1?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_168251b73f3:115099c:ad2b6584</id><title>DO-MS: Data-Driven Optimization of Mass Spectrometry Methods [NEW RESULTS]</title><canonicalUrl>https://www.biorxiv.org/content/early/2019/01/06/512152</canonicalUrl></item><item><entities><item><label>Swedish university</label><id>nlp/f/entity/en/-/swedish university</id><mentions><item><text>Swedish university</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Proc</label><id>nlp/f/entity/en/-/proc</id><mentions><item><text>Proc</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Natl Acad</label><id>nlp/f/entity/en/-/natl acad</id><mentions><item><text>Natl Acad</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>Lewis triangle</label><id>nlp/f/entity/en/-/lewis triangle</id><mentions><item><text>Lewis triangle</text></item></mentions><salienceLevel>mention</salienceLevel></item><item><label>WEBSITEgo_nature_com</label><id>nlp/f/entity/en/-/websitego_nature_com</id><mentions><item><text>WEBSITEgo_nature_com</text></item></mentions><salienceLevel>mention</salienceLevel></item></entities><crawled>1547644798374</crawled><visual><url>none</url></visual><author><name>Kate Campbell</name></author><origin><htmlUrl>http://feeds.nature.com/nature/rss/current</htmlUrl><streamId>feed/http://www.nature.com/nature/current_issue/rss</streamId><title>Nature</title></origin><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><webfeeds><icon>https://storage.googleapis.com/test-site-assets/BJi9nUvd4jCSd9rf0lPNeaPIDvhjO_Py-q6EVKn1X88_oicon-1658664fbd2</icon></webfeeds><link>https://www.nature.com/articles/d41586-019-00119-8</link><content><content>&lt;p&gt;&lt;b&gt;Define working culture, don’t leave it to chance&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Define working culture, don’t leave it to chance, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00119-8&quot;&gt;doi:10.1038/d41586-019-00119-8&lt;/a&gt;&lt;/p&gt;Define working culture, don’t leave it to chance</content><direction>ltr</direction></content><commonTopics><item><label>culture</label><id>nlp/f/topic/597</id><probability>0.806</probability></item></commonTopics><originId>https://www.nature.com/articles/d41586-019-00119-8</originId><description>&lt;p&gt;&lt;b&gt;Define working culture, don’t leave it to chance&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Define working culture, don’t leave it to chance, Published online: 16 January 2019; &lt;a href=&quot;https://www.nature.com/articles/d41586-019-00119-8&quot;&gt;doi:10.1038/d41586-019-00119-8&lt;/a&gt;&lt;/p&gt;Define working culture, don’t leave it to chance</description><published>1547625600000</published><engagement>4</engagement><alternate><item><type>text/html</type><href>https://www.nature.com/articles/d41586-019-00119-8</href></item></alternate><id>BJi9nUvd4jCSd9rf0lPNeaPIDvhjO/Py+q6EVKn1X88=_16856d185a6:3bfe65e:3a104d3b</id><title>Define working culture, don’t leave it to chance</title><fingerprint>ecfffeff</fingerprint></item><item><crawled>1548824796712</crawled><origin><htmlUrl>http://biorxiv.org</htmlUrl><streamId>feed/http://hwmaint.biorxiv.highwire.org/cgi/collection/rss?coll_alias=bioinformatics</streamId><title>bioRxiv Subject Collection: Bioinformatics</title></origin><author><name>Guidi, G.</name></author><engagement>0</engagement><unread>True</unread><categories><item><label>journalblitz</label><id>user/54bfafe6-b2f6-43fa-96fe-3d8989ac4cd9/category/journalblitz</id></item></categories><link>http://biorxiv.org/cgi/content/short/464420v2?rss=1</link><content><content>De novo assembly is the process of accurately reconstructing a genome sequence using only overlapping, error-containing DNA sequence fragments (reads) that redundantly sample a genome. While longer reads simplify genome assembly and improve the contiguity of the reconstruction, current long-read technologies come with high error rates. A crucial step of de novo genome assembly for long reads consists of finding overlapping reads. We present Berkeley Long-Read to Long-Read Aligner and Overlapper (BELLA), a novel algorithm for computing overlaps and alignments that balances the goals of recall (completeness) and precision (avoiding incorrect overlaps), consistently performing well on both, and doing so with reasonable compute time and memory usage. We present a probabilistic model which demonstrates the soundness of using short, fixed length k-mers to detect overlaps, avoiding expensive pairwise alignment of each read against all others. We then introduce a notion of reliable k-mers based on our probabilistic model. The use of reliable k-mers eliminates both the k-mer set explosion, that would otherwise occur with highly erroneous reads, and the spurious overlaps from k-mers originating in repetitive regions. Finally, we present a new method for separating true (genomic) overlaps from false positives using a combination of alignment techniques and probabilistic modeling. Using this methodology the probability of false positives drops exponentially as the length of overlap between sequences increases. On both real and simulated data, BELLA on average outperforms previous tools in the F1 score, meaning that both precision and recall are the best or close to the best. On simulated data, BELLA achieves an average of 2.7% higher recall, 17.9% higher precision, and 10.9% higher F1 score than state-of-the-art tools, while remaining runtime performance competitive.</content><direction>ltr</direction></content><originId>http://biorxiv.org/cgi/content/short/464420v2?rss=1</originId><description>De novo assembly is the process of accurately reconstructing a genome sequence using only overlapping, error-containing DNA sequence fragments (reads) that redundantly sample a genome. While longer reads simplify genome assembly and improve the contiguity of the reconstruction, current long-read technologies come with high error rates. A crucial step of de novo genome assembly for long reads consists of finding overlapping reads. We present Berkeley Long-Read to Long-Read Aligner and Overlapper (BELLA), a novel algorithm for computing overlaps and alignments that balances the goals of recall (completeness) and precision (avoiding incorrect overlaps), consistently performing well on both, and doing so with reasonable compute time and memory usage. We present a probabilistic model which demonstrates the soundness of using short, fixed length k-mers to detect overlaps, avoiding expensive pairwise alignment of each read against all others. We then introduce a notion of reliable k-mers based on our probabilistic model. The use of reliable k-mers eliminates both the k-mer set explosion, that would otherwise occur with highly erroneous reads, and the spurious overlaps from k-mers originating in repetitive regions. Finally, we present a new method for separating true (genomic) overlaps from false positives using a combination of alignment techniques and probabilistic modeling. Using this methodology the probability of false positives drops exponentially as the length of overlap between sequences increases. On both real and simulated data, BELLA on average outperforms previous tools in the F1 score, meaning that both precision and recall are the best or close to the best. On simulated data, BELLA achieves an average of 2.7% higher recall, 17.9% higher precision, and 10.9% higher F1 score than state-of-the-art tools, while remaining runtime performance competitive.</description><published>1548748800000</published><alternate><item><type>text/html</type><href>http://biorxiv.org/cgi/content/short/464420v2?rss=1</href></item></alternate><id>etqytnxFjd3GAn8xMJJp7LqVqHOESySVtRTYAVCTxTI=_1689d26de28:824fc6:ad2b6584</id><title>BELLA: Berkeley Efficient Long-Read to Long-Read Aligner and Overlapper [NEW RESULTS]</title><fingerprint>10419f7f</fingerprint></item></channel></rss>